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Abstract 
The enantioselective synthesis of functionalized, acyclic, quaternary stereocenter- 
containing building blocks was achieved from diastereomerically pure 
alkylidenemorpholinones by employing Suzuki-Miyaura cross-coupling and Prins 
reactions as the key steps. In a separate approach, the enantioselective conjugate addition 
of a variety of 3-alkyl-and/or 3-aryl tetronic acids or 3-alkyl-and/or 3-aryl tetramic acids 
to α,β-unsaturated systems catalyzed by chiral aminothioureas, aminosquaramides and 
cinchona alkaloids was examined. These studies provided the quaternary stereocenter-
containing furan-2,4-diones and pyrrolidine-2,4-diones with moderate enantiomeric 
excess.  
A variety of 3-aryl tetronic acids were synthesized by employing an undirected, 
intermolecular C−H functionalization reaction of arenes with 3-diazofuran-2,4-dione as 
the key step. This method was applied in the synthesis of a series of biologically active, 
naturally occurring 3-aryl-5-arylidene tetronic acid derivatives such as pulvinic acids and 
pulvinones.  
A concise synthesis of ()-(R,R)-L-factor was achieved in four steps by using an 
organocatalytic asymmetric direct vinylogous aldol reaction of -crotonolactone and 
hexanal as the key step. 
 
 
 
 
iv 
 
Acknowledgements 
 First and foremost, I would like to express my sincere gratitude to my advisor 
Prof. Sunil V. Pansare for his continuous support of my Ph. D. studies and research, for 
his patience, motivation, enthusiasm, and immense knowledge. His guidance helped me 
throughout my programme and during the writing of this thesis. I have been extremely 
lucky to have a supervisor who cared so much about my work, and who responded to my 
questions and queries so promptly. I could not have imagined having a better supervisor 
for my Ph. D. studies. 
 I express my gratitude to other members of my supervisory committee, Dr. Ray 
Poirier and Dr. Karen Hattenhauer for providing me their valuable comments and 
suggestions over the years. I would like to thank Dr. Graham Bodwell for organizing the 
SOCCER conferences, which provided me with the opportunity to interact with 
distinguished Professors from other universities. I am also thankful to have had the 
opportunity to have helpful discussions and encouragement from Dr. Paris Georghiou, Dr. 
Yuming Zhao and Dr. Huck K. Grover during my Ph. D programme and my graduate 
courses. 
 I would like to thank all the researchers in the Pansare lab for their extensive 
support throughout. Dr. Rajendar Dyapa and Dr. Eldho Paul were the senior students in 
the lab and they were waiting for their defence dates to be finalized when I stared my 
programme. Their help, suggestions and co-operation made it easy for me to adjust to the 
work culture of the lab. I would like to take this opportunity to specially thank Dr. Dyapa 
v 
 
who helped me a lot when I was new to St. John’s. Dr. Rakesh G. Thorat and Dr. 
Kaivalya G. Kulkarni were the greatest of companions and they helped me during my 
first year in the lab by teaching me the lab techniques and the operation of various 
instruments. Their involvement not only made an incredible contribution to my lab work 
but also to the social life I had in St. John’s. I would also like to thank all the other 
members of the group, Mr. Guru Moorthy, Mr. Gopinathan Muthusamy, Mr. Ritesh 
Annadate and Ms. Seerat Virk for their support and encouragement. I would like to thank 
Mr. Christopher Cooze and Ms. Lise Desquien for their help and support. Support from 
my colleagues from other research groups at Memorial University is greatly appreciated. I 
also thank Sourav Biswas for proof reading my thesis and correcting grammatical errors. 
 I would like to thank Nick Ryan for training me on the IR instrument, Dr. Celine 
Schneider for help with NMR spectroscopy and special thanks to Linda Winsor for 
assistance with mass spectroscopic analysis.  
 I would like to thank Mr. Dave Murphy for his help with computer-related 
matters. I thank Ms. Mary Flinn, Ms. Rosalind Collins, Ms. Ebony Penney, Ms. Melissa 
Norris and Ms. Debbie Dunn in the Chemistry department for their assistance with 
administrative matters. I thank Mr. Steve Ballard, Ms. Bonita Smith and Mr. Randy Earl 
for providing store-room support. I would like to acknowledge the undergraduate 
teaching lab demonstrators Mr. Cliff McCarthy, Ms. Anne Sheppard, and Mr. Dave 
Stirling for their wonderful support.  
vi 
 
 I also would like to thank the Department of Chemistry, Memorial University of 
Newfoundland, the Natural Sciences and Engineering Research Council of Canada, and 
the Canada Foundation for Innovation for financial support. 
 The time spent in St John’s was wonderful because of the friends I met inside as 
well as outside the university. I would like to thank all of them for making my time 
during the Ph. D. program enjoyable. 
 Finally, I sincerely thank my parents and my brother for their continuous 
encouragement and support, without which this thesis would not have been possible. 
 
 
 
 
 
 
 
 
 
 
 
 
 
vii 
 
Table of Contents 
               Page 
Abstract .............................................................................................................................. iii 
Acknowledgements ............................................................................................................. iv 
Table of Contents .............................................................................................................. vii 
List of Tables ................................................................................................................... xiii 
List of Figures ................................................................................................................... xvi  
List of Abbreviations ..................................................................................................... xviii 
 
               Page 
 
Chapter 1: Enantioselective Synthesis of Functionalized Quaternary Stereocenters 
from Chiral Alkylidenemorpholinones .............................................................................. 01 
1.1 Introduction .............................................................................................................. 02 
1.2 Recent reports on the enantioselective, auxiliary mediated, synthesis of  
       quaternary stereocenters .......................................................................................... 02 
1.2.1 The Gleason synthesis of acyclic quaternary stereocenter .................................. 02 
1.2.2 The Myers synthesis of functionalized quaternary stereocenters ........................ 05 
1.2.3 The Marek synthesis of quaternary stereocenters ............................................... 07 
1.2.4 The Roush synthesis of functionalized acyclic quaternary stereocenters ........... 08 
1.3 Objective .................................................................................................................. 10 
viii 
 
1.4 Previous work on ephedrine-derived morpholinones in the Pansare reseach               
      group ........................................................................................................................ 11 
1.5 Results and Discussion ............................................................................................. 15 
1.6 Conclusion ................................................................................................................ 32 
1.7 Experimental section ................................................................................................ 33 
1.8 References ................................................................................................................ 82 
1.9 Selected 1H and 13C NMR spectral data ................................................................... 85 
Chapter 2: Organocatalytic Asymmetric Michael Addition Reactions of                     
3-Alkyl/Aryl Tetronic Acids for the Construction of Functionalized Quaternary 
Stereocenters .................................................................................................................... 132 
2.1 Introduction ............................................................................................................ 133 
2.2 Asymmetric Michael additions of tetronic acids ................................................... 134 
2.3 Objective ................................................................................................................ 135 
2.3.1 Previous reports on the asymmetric synthesis of the White intermediate ......... 137 
2.4 Results and Discussion ........................................................................................... 140 
2.4.1 Summary of results ............................................................................................ 152 
2.4.2 Stereochemical model for the Michael addition reactions of tetronic and   
         tetramic acids ..................................................................................................... 153 
2.5 Conclusion .............................................................................................................. 154 
ix 
 
2.6 Experimental Section ............................................................................................. 156 
2.7 References .............................................................................................................. 178 
2.8 Selected 1H and 13C NMR spectral data ................................................................. 180 
2.9 Selected HPLC traces ............................................................................................. 202 
Chapter 3: Catalytic Undirected Intermolecular C-H Functionalization of Arenes 
with 3-Diazofuran-2,4-dione. Synthesis of 3-Aryl Tetronic Acids, Vulpinic Acid, 
Pinastric Acid, and Methyl Isoxerocomate ...................................................................... 225 
3.1 Introduction ............................................................................................................ 226 
3.2 Known synthetic routes to 3-aryl tetronic acids, vulpinic acids and pulvinic  
       acids ....................................................................................................................... 227 
3.2.1 The Smith synthesis of tetronic acids ................................................................ 227 
3.2.2 The Ramage synthesis of pulvinic acids ........................................................... 228 
3.2.3 The Pattenden syntheses of pulvinic acids ........................................................ 229 
3.2.4 The Langer synthesis of vulpinic acid ............................................................... 231 
3.2.5 The Le Gall and Mioskowski synthesis of pulvinic acids ................................. 231 
3.2.6 The Le Gall synthesis of vulpinic acids ............................................................ 233 
3.2.7 The Le Gall synthesis of tetronic acids ............................................................. 234 
3.2.8 The Xiao and Zhu synthesis of 3-aryltetronic acids from aryl acetic acid ........ 235 
3.3 Objective ................................................................................................................ 236 
x 
 
3.3.1 Previous studies on C-H insertion reactions of arenes and cyclic diazo          
         compounds ........................................................................................................ 237 
3.4 Results and Discussion ........................................................................................... 239 
3.4.1 Synthesis of naturally occurring tetronic acid derivatives ................................ 244 
3.4.2 Determination of stereochemistry of aldol condensation products ................... 247 
3.4.3 The unique reactivity of diazotetronic acid ....................................................... 250 
3.5 Conclusion .............................................................................................................. 252 
3.6 Experimental Section ............................................................................................. 253 
3.7 References .............................................................................................................. 279 
3.8 Selected 1H and 13C NMR spectral data ................................................................. 283 
Chapter 4: Stereoselective Synthesis of Naturally Occurring Pulvinones by Aldol 
Condensation and Undirected Rh(II)-Catalyzed C-H Insertion Reactions of 
Diazotetronic Acid ........................................................................................................... 310 
4.1 Introduction ............................................................................................................ 311 
4.2 Known synthetic routes to pulvinones ................................................................... 312 
4.2.1 The Pattenden synthesis of pulvinones ............................................................. 312 
4.2.2 The Ramage synthesis of 3',4',4-trihydroxypulvinone ...................................... 313 
4.2.3 The Campbell syntheses of pulvinones ............................................................. 314 
4.2.4 The Gill synthesis of pulvinones ....................................................................... 316 
xi 
 
4.2.5 The Antane syntheses of pulvinones ................................................................. 317 
4.2.6 The Brückner syntheses of pulvinones .............................................................. 318 
4.2.7 The Le Gall synthesis of pulvinones ................................................................. 320 
4.2.8 The Yamada synthesis of aspulvinone E ........................................................... 321 
4.3 Objective ................................................................................................................ 322 
4.4 Results and Discussion ........................................................................................... 323 
4.4.1 Synthesis of naturally occurring pulvinones ..................................................... 326 
4.4.2 Determination of stereochemical configuration of aldol condensation products ....  
          ........................................................................................................................... 327 
4.4.3 Other synthetic approaches aspulvinones B and D ........................................... 333 
4.4.4 Synthesis of unnatural pulvinones ..................................................................... 334 
4.5 Conclusion .............................................................................................................. 335 
4.6 Experimental Section ............................................................................................. 336 
4.7 References .............................................................................................................. 374 
4.8 Selected 1H and 13C NMR spectral data ................................................................. 376 
Chapter 5: Synthesis of ()-(R,R)-L-factor Involving an Organocatalytic Direct 
Vinylogous Aldol Reaction .............................................................................................. 413 
5.1 Introduction ............................................................................................................ 414 
5.2 Previous synthetic approaches to the L-factors ...................................................... 415 
xii 
 
5.2.1 The Kotsuki synthesis of (4S,5S)-L-factor ........................................................ 415 
5.2.2 The Gallos synthesis of (+)-(4S,5R)-L-factor ................................................... 416 
5.2.3 The Bhaumik synthesis of ()-(4R,5R)-L-factor ............................................... 416 
5.2.4 The Raji Reddy synthesis of (4R,5R)-L-factor .................................................. 418 
5.2.5 The Fernandes synthesis of (4R,5R)-L-factor ................................................... 418 
5.2.6 The Sabitha synthesis of (4S,5S)-L-factor ......................................................... 419 
5.3 Objective ................................................................................................................ 420 
5.4 Previous work on the direct vinylogous aldol reaction of -crotonolactone in   
      the Pansare group ................................................................................................... 422 
5.5 Results and Discussion ........................................................................................... 423 
5.5.1 Stereochemical model for the vinylogous aldol reaction of -crotonolactone  
         with aliphatic aldehydes .................................................................................... 426 
5.6 Conclusion .............................................................................................................. 428 
5.7 Experimental Section ............................................................................................. 430 
5.8 References .............................................................................................................. 435 
5.9 Selected 1H and 13C NMR spectral data ................................................................. 438 
5.10 Selected HPLC traces ........................................................................................... 444 
Chapter 6: Conclusions .................................................................................................. 449 
6.1 Summary of the thesis ............................................................................................ 449 
xiii 
 
6.2 Future Work ........................................................................................................... 454 
6.3 References .............................................................................................................. 456 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xiv 
 
List of Tables 
Table 1.1 Optimization of the synthesis of diphenylmorpholinedione 71 ......................... 13 
Table 1.2 Optimization of Suzuki-Miyaura cross-coupling reaction ................................. 22 
Table 1.3 Screening of Prins reaction conditions .............................................................. 25 
Table 2.1 Catalysts survey for the Michael addition of methyltetronic acid (25) to  
                 MVK ............................................................................................................... 142 
Table 2.2 Catalyst survey for the Michael addition of phenyltetronic acid (57) to MVK ..... 
                  ......................................................................................................................... 144 
Table 2.3 Catalyst survey for the Michael addition of benzyltetronic acid (61) 
                 to MVK ........................................................................................................... 145 
Table 2.4 Solvent survey for the Michael addition of phenyltetronic acid (57) to MVK ...... 
                 .......................................................................................................................... 146 
Table 2.5 Catalyst survey for the Michael addition of tetramic acids to MVK ............... 147 
Table 2.6 Catalyst survey for the Michael addition of methyltetronic acid (25) 
                 to -nitrostyrene .............................................................................................. 149 
Table 2.7 Solvent survey for the Michael addition of methyltetronic acid (25) 
                to -nitrostyrene ............................................................................................... 150 
xv 
 
Table 2.8 Summary of the best results obtained for the Michael addition reactions of  
                tetronic and tetramic acids ............................................................................... 153 
Table 3.1 Optimization of the intermolecular aryl C−H insertion reaction of 59 ............ 240 
Table 3.2 Optimization of the aldol condensation reaction of 59 .................................... 246 
Table 4.1 Optimization of the aldol condensation of 72 with p-tolualdehyde ................. 324 
Table 4.2 Optimization of C-H insertion reaction of chroman 93 ................................... 330 
Table 5.1 Solvent survey for organocatalytic direct vinylogous aldol reaction of  
                -crotonolactone and tridecanal ....................................................................... 424 
Table 5.2 Organocatalytic direct vinylogous aldol reaction of -crotonolactone 
                and tridecanal ................................................................................................... 425 
 
 
 
 
 
 
 
 
 
 
 
 
xvi 
 
List of Figures 
Figure 1.1 Transition states for 12 ..................................................................................... 05 
Figure 1.2 Transition states for 17 ..................................................................................... 06 
Figure 1.3 Transition states for 25 and 26 ......................................................................... 08 
Figure 1.4. Strategy for the synthesis of functionalized quaternary stereocenters ............ 11 
Figure 1.5 Morpholinediones 52 and 71 ............................................................................ 15 
Figure 1.7 Chemical shifts of diagnostic protons in bromoalkylidene morpholinones 
and in prenyl derivatives .................................................................................................... 20 
Figure 1.8 Suzuki-Miyaura cross-coupling of bromoalkylidene morpholinones .............. 23 
Figure 1.9 Prins reactions of alkylidenemorpholinones..................................................... 26 
Figure 1.10 Plausible mechanism for Prins reaction ......................................................... 27 
Figure 2.1 Selected quaternary stereocenter-containing natural products ....................... 133 
Figure 2.2 Generic structures of 3-substituted tetronic and tetramic acids ...................... 134 
Figure 2.3 Chiral organocatalysts examined for the Michael addition of tetronic acids . 140 
Figure 2.5 Proposed transition states for the Michael addition of 3-alkyl/aryltetronic    
                  acids to MVK ................................................................................................. 154 
Figure 3.1 Generic structures of naturally occurring tetronic acids ................................. 226 
Figure 3.2 Naturally occurring 3-aryl tetronic acid derivatives ....................................... 227 
Figure 3.3 Intermolecular aryl C-H insertion of 59 ......................................................... 242 
xvii 
 
Figure 3.4 Plausible mechanism for the C-H insertion reactions .................................... 244 
Figure 3.5 Strategy for the synthesis of naturally occurring pulvinates from 59 ............ 245 
Figure 4.1 Naturally occurring pulvinones ...................................................................... 312 
Figure 4.2 Retrosynthetic strategy for synthesis of pulvinones and their derivatives ...........  
                   ........................................................................................................................ 323 
Figure 4.3 Aldol condensation reactions of 72 ................................................................ 325 
Figure 4.4 1H and 13C chemical shifts of Z- and E- pulvinones ....................................... 327 
Figure 4.5 1H chemical shifts of Z-87 and E-87 .............................................................. 328 
Figure 4.6 Retrosynthetic route for synthesis of aspulvinones B (7) and D (8) .............. 333 
Figure 5.1 Selected -butenolide- and -butanolide-based natural products ................... 414 
Figure 5.2 Organocatalytic direct vinylogous aldol route to 5-hydroxyalkyl butenolide   
                  and butanolide natural products ..................................................................... 418 
Figure 5.3 Aminosquaramide and aminothiourea catalysts selected for this study ......... 421 
Figure 5.4 Proposed transition state for the ODVA reaction leading to the anti aldol   
                  product ........................................................................................................... 427 
 
 
 
 
 
 
xviii 
 
List of Abbreviations and Symbols 
Ac   acetyl  
AD   asymmetric dihydroxylation 
AIBN    azobisisobutyronitrile  
APCI    atmospheric pressure chemical ionization  
APPI   atmospheric pressure photoionization 
aq.   aqueous  
BAIB   bis(acetoxy)iodobenzene 
BINOL  1,1′-dinaphthalene-2,2′-diol 
bmim   1-butyl-3-methylimidazolium 
BnBr    benzyl bromide  
Boc    tert-butoxycarbonyl  
br   broad  
BzCl    benzoyl chloride  
CAN    ceric ammonium nitrate  
cat.    catalytic  
CDI   1,1'-carbonyldiimidazole 
CI    chemical ionization  
DABCO   1,4-diazabicyclo[2.2.2]octane  
DABN   (S)-()-2,2′-diamino-1,1′-binaphthalene  
DBU    1,8-diazabicyclo[5.4.0]undec-7-ene  
DCC   N,N′-dicyclohexylcarbodiimide 
xix 
 
DCE   1,2-dichloroethylene 
DIBAL-H  diisobutylaluminum hydride  
DIPEA  N,N-diisopropylethylamine  
DMAP   4-(dimethylamino)pyridine  
DMF   N,N-dimethylformamide 
DMP   Dess-Martin periodinane 
DMPU   1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone 
DMSO   dimethyl sulfoxide  
dr   diastereomeric ratio  
EDG    electron donating group  
ee   enantiomeric excess  
EI    electrospray ionization  
eq.    equivalent (s)  
ESI   electrospray ionization 
esp   α,α,α',α'-tetramethyl-1,3-benzenediproponoate 
EtOAc   ethyl acetate  
EVK   ethyl vinyl ketone 
EWG    electron withdrawing group  
g    gram (s)  
h    hour (s)  
HPLC   high performance liquid chromatography 
HRMS   high resolution mass spectrum  
HWE    Horner-Wadsworth-Emmons  
xx 
 
Hz    Hertz (s)  
i-Bu    isobutyl  
IBX    2-iodoxybenzoic acid 
Ipc    diisopinocampheyl 
IR    infrared  
J   coupling constant  
L   ligand  
LAH    lithium aluminium hydride  
LCPA   lithium N-cyclohexyl-N-isopropylamide  
LDA    lithium diisopropyl amide  
LHMDS  lithium hexamethyldisilazide  
LICA   lithium isopropyl cyclohexylamide  
LiDBB  lithium di-tert-butylbiphenylide 
LiHMDS   lithium bis(trimethylsilyl)amide  
M   molar  
M+    molecular ion  
Me    methyl  
mg   milligram(s)  
MIDA   N-methylimidodiacetic 
min    minute (s)  
mL    milliliter (s)  
mmol    millimole (s)  
mp    melting point  
xxi 
 
MS    mass spectrum  
MsCl    methanesulfonyl chloride  
MTBD   7-methyl-1,5,7-triazabicyclo[4.4.0]dec-5-ene  
MVK   methyl vinyl ketone  
NBS    N-bromosuccinimide  
NMR    nuclear magnetic resonance  
PCC    pyridinium chlorochromate  
Ph    phenyl  
ppm    parts per million  
PTSA/p-TsOH  para-toluenesulphonic acid  
Rf    retention factor 
rt   room temperature  
TBAF    tetra-n-butylammonium fluoride 
TBDMS/TBS   tert-butyldimethylsilyl  
TCA    trichloroacetic acid 
TEMPO   2,2,6,6-tetramethylpiperidine-1-oxyl  
TFA    trifluoroacetic acid  
TfOH   trifluoromethanesulfonic acid 
THF    tetrahydrofuran  
TLC    thin layer chromatography  
TMS    tetramethylsilane  
TMSOTf   trimethylsilyl trifluoromethanesulfonate  
UV    ultraviolet  
xxii 
 
α   alpha  
β    beta  
γ   gamma 
δ    chemical shift (in NMR spectroscopy)  
 1 
 
Chapter 1 
 
 
 
 
 
Enantioselective Synthesis of Functionalized Quaternary Stereocenters 
from Chiral Alkylidenemorpholinones  
 
 
 
 
 
The work described in this chapter has been published in the European Journal of Organic 
Chemistry: 
Manchoju, A.; Thorat, G. R.; Pansare, S. V. Eur. J. Org. Chem. 2015, 5939. 
Most of the synthetic work described in this chapter was carried out by A. Manchoju 
Preliminary studies on the synthesis of one of the bromoalkylidene morpholinones 
described in this chapter and its cross-coupling reactions were conducted by R. G. Thorat. 
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1.1 Introduction  
Quaternary stereocenters are interesting structural motifs which present a unique 
synthetic challenge. They are encountered as structural units in several natural products and 
hence enantioselective approaches to quaternary stereocenters have been intensely 
investigated in recent years.1 Several non-catalytic2 as well as catalytic3 enantioselective 
methods have been developed for assembling quaternary stereocenters. While some of 
these efforts are in the realm of natural product synthesis,1a,c other studies showcase 
methodology for the construction of quaternary stereocenters by employing suitably 
functionalized starting materials.1d,2,3  
In this context, opportunities exist for the construction of quaternary centers in 
acyclic fragments that have functionality for further elaboration.4 To explore this prospect, 
we chose to examine the synthesis of hydroxy aldehydes and carboxylic acids with a 
quaternary -stereocenter. The following section provides a summary of the auxiliary-
based syntheses of functionalized quaternary stereocenters reported2 during the past 
decade. While several of the recent methods rely on an auxiliary-controlled stereoselective 
C-C bond forming reaction as the key step, catalytic procedures are also known.3  
1.2 Recent reports on the enantioselective, auxiliary mediated synthesis of quaternary 
stereocenters 
1.2.1 The Gleason synthesis of acyclic quaternary stereocenters 
In 2006, Gleason and coworkers2e developed a methodology for the synthesis of 
acyclic quaternary stereocenters from the chiral bicyclic thioglycolate lactam 1, derived 
from (S)-valinol (Scheme 1.01). The strategy relies on sequential stereoselective 
alkylations of an amide enolates derived from 1. The first two alkylations of 1 with alkyl 
 3 
 
halides in the presence of lithium diisopropylamide (LDA) and LiCl furnished 3 in good 
yields with excellent diastereoselectivities. The high stereoselectivity of alkylations of 1 is 
due to approach of the electrophile (alkyl halide) from the sterically less hindered exo face 
(convex face) of the lactam enolate 2 (Scheme 1.01). Notably, the authors state that the 
isopropyl group in 2 occupies a pseudo-equatorial position and hence it has no significant 
role in facial discrimination of the enolate. Reduction of the dialkylated bicyclic lactams 4 
under Birch reduction conditions generates the ,-disubstituted enolates 5 which were 
alkylated with alkyl halides to provide 6 in good yields and with high diastereoselectivities. 
Subsequently, the chiral auxiliary was removed using one of two methods. The first method 
involves acid hydrolysis of amides in 6 to give the carboxylic acids 7. In the second method, 
6 were subjected to reduction using lithium amidoborohydride to furnish the alcohols 8 
(Scheme 1.01). 
 
Scheme 1.01 
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In 2009, the same group2f synthesized the quaternary stereocenter containing            
-amino acids 12 from 9 using benzenesulfonyl imines 10 instead of alkyl halides as the 
electrophiles (Scheme 1.02). The ,-disubstituted lithium enolates derived from the 
lactams 9 were treated with imines 10 followed by partial acid-hydrolysis (acetal cleavage) 
to afford 11. The valinol portions of 11 (the auxiliary) were removed by a three step 
hydrolysis which involves, in sequence, N to O acyl transfer under acidic conditions, N-
acetylation of the resulting amino esters and finally basic hydrolysis of the esters to provide 
the -amino acids 12.  
 
Scheme 1.02 
The authors propose that the high stereoselectivity of the Mannich reactions can be 
explained by a Zimmerman-Traxler transition states (Figure 1.1) assembly. Transition state 
14 is destabilized by a syn-pentane interaction between one of the enolate substituents and 
R. The transition state 13 is free from this interaction and is therefore favoured, giving rise 
to the high diastereoselectivity.  
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Figure 1.1 
1.2.2 The Myers synthesis of functionalized quaternary stereocenters 
In 2012, Myers and coworkers2g developed the alkylation of chiral amides 15 
derived from pseudoephenamine to afford functionalized quaternary stereocenter 
containing amides 17 with high diastereoselectivities (Scheme 1.03). Amides 15 were 
synthesized from (1R,2S)-1,2-diphenyl-2-aminoethanol in five steps. Stereoselective 
enolization of amides 15 in the presence of LDA gave enolates 16 which were alkylated 
with various alkyl halides to afford the quaternary stereocenter-containing products 17 in 
good yields and with high diastereoselectivity (Scheme 1.03). 
 
Scheme 1.03  
The high diastereoselectivity of the alkylation reactions can be explained by the 
transition state (TS) assemblies TS-18 and TS-19 shown in Figure 1.2. As shown in TS-19, 
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the top faces of the amides are sterically hindered by a solvated lithium alkoxide side chain 
and hence the base approaches from the bottom face of the amides (as drawn) to form 
selectively Z-enolates by deprotonation, as shown in TS-18. This results in stereoselective 
enolization of the amides. Similarly, alkylating agents approach the enolates from the less 
hindered bottom face to provide the alkylation products with high distereoselectivity. 
 
Figure 1.2 
The conjugate addition-alkylation reactions of -alkyl-,-unsaturated 
pseudoephenamine amides 21 were also examined (Scheme 1.04). The hydroxy groups in 
amides 21 were first deprotonated with methyllithium (MeLi) followed by a conjugate 
addition of alkyllithium (R2Li) to generate the corresponding enolates 22. Reactions of 22 
with alkyl halides under steric control (as shown in Figure 1.2) provided the products 23 in 
good yield and with high diastereomeric excess. 
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Scheme 1.04 
1.2.3 The Marek synthesis of quaternary stereocenters 
In 2013, Marek and coworkers2d reported the synthesis of diastereomerically and 
enantiomerically enriched acyclic systems, with a functionalized quaternary stereocenter, 
from ynamides 24 via aldol and Mannich reactions (Scheme 1.05). This methodology 
employs the regioselective carbocupration reaction of ynamides 24 with oraganocuparates 
(Me2CuLi·LiBr·Me2S) followed by oxidation using tert-butyl hydroperoxide (t-BuOOH) 
to give stereodefined, trisubstituted copper enolates 29. Reaction of the enolates 28 with 
aldehydes and sulfonyl imines furnished the aldol products 25 and the Mannich products 
26 respectively, both with high diastereoselectivity. 
 
Scheme 1.05 
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The high stereoselectivity of the reactions of 29 can be explained by Zimmerman-
Traxler transition states (chair-like conformation, TS-30, TS-31, Figure 1.3) in which the 
benzyl group of the oxazolidinone auxiliary shields one stereoface of the enolate, thereby 
promoting addition of the electrophile from the other face. Depending on the nature of the 
electrophile, the oxazolidinone carbonyl group is either coordinated to the copper (as in 31) 
or it is not (as in 30). This conformational change results in a switch of the facial selectivity 
of the copper enolate. 
 
Figure 1.3 
1.2.4 The Roush synthesis of functionalized acyclic quaternary stereocenters 
In 2013, Roush and coworkers2h developed a methodology for the enantioselective 
synthesis of functionalized acyclic quaternary stereocenters. The key step in this approach 
is a stereoselective 1,4 hydroboration of ,-unsaturated morpholine carboxamides 32 with 
(diisopinocampheyl)borane ((lIpc)2BH, Scheme 1.06) which selectively provides the Z-
enolborinates 34. Reaction of 34 with alkyl or aryl aldehydes provides -hydroxy amides 
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36 with high diastereo- and enantioselectivity. The authors state that the stereoselectivity 
of this reaction is due to the formation of a highly organized chair-like transition state 
assembly 35 (Scheme 1.06).  
 
Scheme 1.06 
In related studies, -ethyl acrylamide 37 was treated with (lIpc)2BH to give the E-
enolborinate 39 which furnished the aldol products 41 with high diastereo- and 
enantioselectivity (Scheme 1.07).  
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Scheme 1.07 
1.3 Objective 
The objective of our studies was to develop new methodology for the construction 
of enantiomerically enriched acyclic motifs that contained functionalized quaternary 
stereocenters. Such motifs can be used as precursors or intermediates for the synthesis of 
small organic molecules with quaternary stereocenters or they can be incorporated into 
more complex structures. 
Our approach to the enantioselective synthesis of functionalized quaternary 
stereocenters is shown in Figure 1.4. The strategy is based on the use of enantiomerically 
enriched, amino alcohol-derived, bromoalkylidene morpholinones 42 and 43 as the starting 
materials. The stereoselective cross-coupling reactions of morpholinones 42/43 with aryl 
or alkyl boronic acids, or their derivatives, should provide the disubstituted alkylidene 
morpholinones 44. A stereoselective Prins reaction of the cross-coupling products 44 would 
generate the spiromorpholinones 45 which contain the target quaternary stereocenter. 
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Removal of the amino alcohol portion in 45 should provide the enantiomerically enriched, 
-hydroxyamides 46 with a quaternary stereocenter (Figure 1.4). 
 
Figure 1.4. Strategy for the synthesis of functionalized quaternary stereocenters. 
1.4 Previous work on ephedrine-derived morpholinones in the Pansare reseach group5 
 Since the work described in this chapter is conceptually based on previuos work 
conducted in the Pansare group, a brief discussion of the relevant prior studies is provided 
below. 
In 1998, enantiomerically enriched -hydroxy carboxylic acids5a 51 were 
synthesized from ephedrine-derived morpholinone hemiacetals by stereoselective 
allylation reactions (Scheme 1.08). (1R,2S)-Ephedrine hydrochloride (47) was subjected to 
acylations with aliphatic -keto acid chlorides to give the corresponding hemiacetals 48. 
Stereoselective allylation of 48 with allyltrimethylsilane/TiCl4 provided 49 as single 
diastereomers. Removal of the ephedrine portion in 49 by dissolving metal reduction 
afforded the -hydroxy amides 50, which were then converted to known -hydroxy 
carboxylic acids 51 by reduction of the double bond and hydrolysis of the amide. 
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Scheme 1.08 
 In 2003, the Pansare group reported an efficient enantioselective method for the 
synthesis of analogues of pantolactone 575b (Scheme 1.09) from ephedrine-derived chiral 
alkylidene morpholinones by employing the Prins reaction as a key step. Dione 52 was 
treated with Grignard reagents to provide the corresponding hemiacetals, which were 
dehydrated to afford alkylidene morpholinone 53. The Prins reaction of 53 gave 
spiromorpholinones 54 as single diastereomers. The opening of dioxane rings in 54 in the 
presence of TiCl4/triethylsilane afforded 55, which was subjected to dissolving metal 
reduction to provide the corresponding -hydroxy amides 56. The amides 56 were 
converted to analogues of pantolactone 57 by a one pot demethylation and acid-catalyzed 
lactonization protocol. 
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Scheme 1.09 
 In 2006, the enantiomerically enriched key precursor 625c of ()-quinic acid (63) 
was synthesized from an ephedrine-derived morpholinedione 58 by stereoselective 
allylation and ring-closing metathesis as the key reactions (Scheme 1.10). Dione 58 was 
treated with the Grignard reagent derived from 4-bromobutene to give hemiacetal 59 which 
was subjected to an allylation reaction to provide 60 as a single diastereomer. Compound 
60 was converted into the key precursor 62 in three steps, namely, ring-closing metathesis, 
dissolving metal reduction and bromolactonization. 
 14 
 
 
Scheme 1.10 
  In the same year, the Pansare group also developed enantioselective routes to 
functionalized, seven-, eight-, and nine-membered oxacycles5d from ephedrine-derived 
methylidene morpholinone 64 (Scheme 1.11). Stereoselective epoxidation and Prins 
reaction of 64 provided 65 and 66 as single diastereomers respectively. The 
diastereoselective and regioselective transformations of 65 and 66 provided functionalized, 
seven-, eight-, and nine-membered oxacycles 67-70. 
 
Scheme 1.11 
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1.5 Results and Discussion  
Two morpholinediones 52 and 71 were chosen as the synthetic precursors for the 
bromoalkylidene morpholinones 42 and 43 that were required for our studies. 
Commercially available (1R,2S)-ephedrine hydrochloride (47) was used to prepare 42. The 
amino alcohol S-2-(methylamino)-1,1-diphenylpropanol (74), required for preparing 71, 
was chosen as a potential alternative to ephedrine, which is a controlled drug precursor. In 
recent years, this has limited its availability for research in synthetic chemistry.  
 
Figure 1.5 Morpholinediones 52 and 71. 
Amino alcohol 74 was synthesized from (S)-alanine methyl ester hydrochloride (72, 
Scheme 1.12) following the literature procedures.6 Thus, the reaction of 72 with four 
equivalents of the phenylmagnesium bromide provided the tertiary alcohol 73.                        
N-Formylation of 73 using acetic formic anhydride followed by reduction of the formyl 
group, using LiAlH4, furnished the required amino alcohol 74. 
 
Scheme 1.12 Synthesis of amino alcohol 74 
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With the amino alcohols 47 and 74 in hand, they were converted to the 
morpholinediones 52 and 71 by treatment with ethyl oxalyl chloride and oxalyl chloride 
respectively by employing the procedure previously developed in the Pansare group5d,7 
(Scheme 1.13). While this method (Et3N as the base and CH2Cl2 as the solvent) works well 
for the reaction of 1R, 2S-ephedrine with ethyl oxalyl chloride for the synthesis of 52, a 
similar reaction with 74 provided only the open chain amido-ester 75 (Scheme 1.13), which 
could not be cyclized to the required dione (NaH, THF, reflux). Although, the reaction of 
74 with oxalyl chloride (Et3N as the base and CH2Cl2 as the solvent) provided 71, the yield 
was low (46%, Table 1.2, entry 1). Hence, an optimization study was conducted for the 
reaction of 74 and oxalyl chloride. 
 
Scheme 1.13 Synthesis of morpholinediones 52 and 71. 
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Table 1.1 Optimization of the synthesis of diphenylmorpholinedione 71 
 
Entry Conditions Yielda 
1 Et3N, DMAP, CH2Cl2, 0 °C to rt, 8 h 46% 
2 Et3N, DMAP, THF, 0 °C to rt, 10 h 57% 
3 CH3COOH, Et3N, CH2Cl2, 0 °C to rt, 9 h 56% 
4 CF3COOH, CH2Cl2, 0 °C to rt, 20 h >99% 
5 CH2Cl2, 0 °C to rt, 12 h 75% 
aisolated yields 
Changing the reaction solvent to THF improved the yield of 71 to 57% (Table 1.1, 
entry 2). Since the formation of 71 was always accompanied by the formation of significant 
amounts of an intractable insoluble material, it was reasoned that polymerization of the 
initially formed N-acyl derivative 77 or 78 (Figure 1.6), as opposed to cyclization, was a 
potential issue. A reasonable solution to this problem would be the preferential formation 
of the O-acyl derivative 80 which should cyclize to provide the dione. With this objective 
in mind, amino alcohol 74 was first treated with one equivalent of acetic acid to make the 
ammonium acetate 79 (Figure 1.6) in situ. Subsequent addition of oxalyl chloride and then 
triethylamine provided 71 in slightly higher yield (56%, Table 1.2, entry 3). Surprisingly, 
formation of the dione 71 was observed in this reaction even before addition of the 
triethylamine. This suggested that the amine base was not necessary for the cyclization. 
Indeed, treatment of 74 with one equivalent of trifluoroacetic acid followed by the dropwise 
addition of oxalyl chloride furnished 71 in near-quantitative yield (>99%, Table 1.2, entry 
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4). The reasons for the high yield of 71 under these conditions is not clear at present. 
Interestingly, the reaction of 74 with oxalyl chloride in the absence of added base or acid 
also provided 71, although in 75% yield (Table 1.2, entry 5). 
 
Figure 1.6 
The above results are intriguing since they contradict conventional wisdom for       
N-acylation reactions, involving an acid chloride and an amine, which suggests that the 
addition of a base is necessary for neutralization of the acid generated during the reaction 
which would otherwise stop the acylation process by protonating the amine. The fact that 
the addition of trifluoroacetic acid actually increases the yield of 71 is, therefore, surprising.  
Morpholinediones 52 and 71 were converted into bromoalkylidene morpholinones 
in a few steps. Treatment of 52 with ethylmagnesium bromide or propylmagnesium 
chloride provided the corresponding hemiacetals 81 and 82 which were dehydrated to 
furnish the alkylidene morpholinones 647a (96%) and 837b (98%, Scheme 1.14). These were 
converted to the key Z-bromoalkylidene morpholinones 86 and 87 respectively by 
conversion to the bromohemiacetals 84 and 85 (Br2/H2O) and subsequent dehydration. 
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Notably, under optimized conditions (Scheme 1.14), the corresponding E-isomers were 
generally not obtained.  
 
Scheme 1.14 Synthesis of bromoalkylidene morpholinones 86 and 87. 
The Z-alkene geometry in 86 and 87 was assigned on the basis of anisotropic 
deshielding (1H NMR) of the -hydrogens8 in the embedded butenamide motif (CH3 
appears at δ 2.88 in 86 and the CH2 appears at δ 3.33-3.12 in 87, Figure 1.7) as compared 
to the corresponding E-isomers (CH3 appears at δ 2.49 in (E)-86 and the CH2 appears at δ 
2.90-2.67 in (E)-87 respectively, Figure 1.7) which were occasionally obtained in trace 
amounts (<5%, (E)-86 and (E)-87). A similar trend in the chemical shift of the characteristic 
C3-protons in isomerically pure prenyl derivatives 88 (Figure 1.7) is reported by Solladié.8 
In Z-88, the proton at C3 appears at δ 5.49, whereas in E-88 it appears at δ 5.02. The 
deshielding of the proton at C3 in Z-88 is attributed to anisotropic deshielding by the 
aldehyde carbonyl group. 
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Figure 1.7 Chemical shifts of diagnostic protons in bromoalkylidene morpholinones and 
in prenyl derivatives. 
The synthetic strategy in Scheme 1.14 was also utilized for the synthesis of 
(bromoalkylidene)morpholinones 95 and 96 (Scheme 1.15) from 71. Treatment of 71 with 
ethylmagnesium bromide or propylmagnesium chloride provided the corresponding 
hemiacetals 89 and 90 which were dehydrated to furnish the alkylidenemorpholinones 91 
(74%) and 92 (54%, Scheme 1.15). These were converted to the key (Z-
bromoalkylidene)morpholinones 95 and 96 respectively by conversion to the 
bromohemiacetals 93 and 94 (Br2/H2O) and subsequent dehydration. Here, as well, the 
corresponding E-isomers were generally not obtained. As before, the Z-alkene geometry in 
96 was assigned on the basis of anisotropic deshielding (1H NMR) of the methylene group 
(appeared at δ 3.15)8 in Z-96 as compared to the corresponding E-96 (methylene group 
appered at δ 2.97), which was obtained by dehydration of the bromohemiacetal 94 at 50 oC 
in ~5% yield.9 The morpholinone (E)-95 could not be obtained for comparison with 95. 
However, since dehydration of the bromohemiacetal 94 obtained from 92 at ambient 
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temperature had provided 96 as the only isolable product, 95 was assigned the Z-geometry 
by analogy. 
 
Scheme 1.15 Synthesis of bromoalkylidene morpholinones 95 and 96. 
At this stage, the morpholinones 86, 87, 95 and 96 possess one (methyl or ethyl) of 
three substituents that would eventually adorn the quaternary -carbon in the target 
carboxylic acids or aldehydes. The next objective was the introduction of an additional 
substituent by cross-coupling of the vinyl bromide moiety in 86, 87, 95 and 96. Clearly, the 
stereoselectivity of this C-C bond forming step was critical for the formation of a 
stereodefined (at the alkene) alkylidenemorpholinone. Initial attempts to introduce an alkyl 
substituent in 86 by the Negishi or Kumada cross-coupling10 of alkylmetal reagents 
(alkylzinc bromides and alkylmagnesium halides) with the vinyl bromide were uniformly 
unsuccessful under a variety of conditions. These reactions either proceeded in very low 
yield or resulted in reduction of the vinyl bromide to the corresponding alkene. Attempted 
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Suzuki-Miyaura cross-couplings of 86 with alkylboronic acids11a 100 (Table 1.2, entries 1-
6) or B-alkyl MIDA boronates11b 101 (Table 1.2, entries 7-9) were similarly unsuccessful. 
Fortunately, the use of potassium alkyl trifluorobrates12 102  as the cross-coupling partners 
provided the coupled product 97 (Table 1.2, entry 10) in 80% yield. The optimized 
conditions (Table 1.2, entry 10) were used in subsequent cross coupling reactions of 86 
with various potassium alkyl trifluoroborates. 
Table 1.2 Optimization of Suzuki-Miyaura cross-coupling reaction. 
 
Entry Organoborane Catalyst Conditions Result 
1a 
 
 
98+Pd(OAc)2 KF, THF, rt, 24 h, reflux, 30 h NR 
2 Pd(PPh3)4 K2CO3, DME, reflux, 4 h 
E-64 
(30%)b 
3 PdCl2(dppf)2 K2CO3, DME, reflux, 6 h 97+E-64 
4a Pd(OAc)2 K2CO3, DME, reflux, 8 h NR 
5a 99 
Na2CO3, acetone/water (1:1), 
rt, 22 h, 50 °C, 13 h 
NR 
6a 99 
Cs2CO3, CH3CN, rt, 20 h, 
reflux, 6 h 
NR 
7 
 
PdCl2(dppf)2 
K2CO3, THF/H2O (5:1), reflux, 
43 h 
E-64 
8a 99 
Na2CO3, acetone/water (1:1), 
rt, 29 h, 70 °C, 8 h 
NR 
9 Pd(PPh3)4 Cs2CO3, CH3CN, reflux, 52 h 97+E-64 
10 
 
PdCl2(dppf)2 Cs2CO3, toluene, H2O, 80 ºC 97 (80%)
b 
a86 was recovered, bisolated yields, NR = no reaction 
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Suzuki-Miyaura cross-couplings of the morpholinones 86, 87, 95 and 96 with a 
variety of primary alkyl trifluoroborates were then examined. All alkyl trifluoroborates 
were successfully coupled with morpholinones 86, 87, 95 and 96 to give the corresponding 
cross-coupled products in good yields (Figure 1.8). With the exception of 
cyclopropyltrifluoroborate, secondary alkylboronic acids or secondary alkyl 
trifluoroborates did not furnish the expected cross-coupling products. However, cross-
coupling reactions of 86, 87 and 95 with arylboronic acids10 proceeded smoothly and 
provided the corresponding alkyl/aryl substituted morpholinones (97 and 103-114, Figure 
1.8). 
 
Figure 1.8 Suzuki-Miyaura cross-coupling of bromoalkylidene morpholinones. 
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 The stereoselectivity of the cross-coupling reaction was ascertained by the 
conversion of diastereomerically pure bromoalkenes to diastereomeric cross-coupling 
products. Thus, cross-coupling of bromoalkene 87 with potassium benzyltrifluoroborate 
provided the alkylidenemorpholinone (Z)-111 whereas (E)-87 gave the diastereomeric (E)-
111 (Scheme 1.16). Similarly, the cross-coupling of 96 with potassium 
methyltrifluoroborate provided (E)-114, but (Z)-114 was obtained from a similar reaction 
of (E)-96 (Scheme 1.16). Notably, the cross coupling of 95 with potassium 
ethyltrifluoroborate also provided (Z)-114. Since none of the diastereomeric cross-coupling 
product was detected (1H NMR) in the reactions of 87/(E)-87 and 96/(E)-96, all of the 
cross-coupling reactions of 86, 87, 95 and 96 were assumed to proceed with retention of 
configuration to provide the morpholinones 97 and 103-114. As with the bromoalkenes, the 
stereochemical assignments for the cross-coupling products are based on the anisotropic 
deshielding of the -hydrogens in the alkene substituent that is syn to the morpholinone 
carbonyl group.8 
 
Scheme 1.16 Diastereoselective cross-coupling reactions of bromoalkylidene 
morpholinones. 
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With the disubstituted alkylidenemorpholinones in hand, the stage was set for the 
final step in the construction of the quaternary stereocenter. To this effect, the 
alkylidenemorpholinone 113 was subjected to a Prins-type reaction13 with 
paraformaldehyde or trioxane under various conditions (Table 1.3). Classical Prins reaction 
conditions (paraformaldehyde, acetic acid and conc. H2SO4) provided 115 in 48% yield 
from 113 (Table 1.3, entry 1). Conducting the reaction in TFA instead of acetic acid and 
avoiding the use of H2SO4 was beneficial, and 115 was obtained in 87% yield (Table 1.3, 
entry 7). 
Table 1.3 Screening of Prins reaction conditions 
 
S. No Conditions Product 115a 
1 (CH2O)n, AcOH, Cat. H2SO4, 85 °C, 21 h 48% 
2 (CH2O)n, AcOH, Cat. H2SO4, 55 °C, 54 h 46% 
3b (CH2O)n, AcOH, Cat. H2SO4, 85 °C, 2.5 h, MW - 
4b (CH2O)n, ZnCl2, THF, rt, 24 h, reflux, 24 h NR 
5c 1,3,5-trioxane, ZnCl2, THF, rt, 48 h NR 
6c 1,3,5-trioxane, TiCl4, THF, 0 °C to rt, 24 h NR 
7 (CH2O)n, TFA, rt , 5 days 87% 
aisolated yields, bNMR of crude prod. is complex, c113 was recovered, NR = no reaction 
 Depending on the substrate, these two methods were applied to a variety of 
alkylidenemorpholinones (Figure 1.9), one employing the more classical acetic acid/cat. 
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H2SO4 protocol with heating if necessary, and the other employing TFA as the solvent (at 
ambient temperature or at 0 oC). Pleasingly, these reactions generated the 
spiromorpholinones 115-127 in good yield (Figure 1.9). The yield of 122, from 
morpholinone 106, is relatively low (32%) due to competing substitution on the aromatic 
ring. Notably, the Prins products were obtained as single diastereomers, the only exception 
being 127 which was obtained as a 5:1 mixture of diasteromers. In this case, purification 
provided diastereomerically pure 127 (71%). The reason for the moderate 
diastereoselectivity for 127 is not clear at present. 
 
Figure 1.9 Prins reactions of alkylidenemorpholinones. 
 The stereochemistry at the newly-formed quaternary carbon and at the spiroacetal 
stereocenter in 115-127 are assigned by analogy to other reactions of the morpholinone 
template6 which proceed from the less-substituted face of the morpholinone ring (Figure 
1.10). We propose a mechanism for the Prins reaction in which formaldehyde adds from 
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the Re-face of 128 to generate the boat-like oxocarbenium ion 129. Excess of formaldehyde 
reacts with primary alcohol in 129 to furnish hemiacetal 130. Axial addition of the primary 
alcohol to the oxocarbenium ion provides the spiromorpholinones 131 as single 
diastereomers. 
 
Figure 1.10 Plausible mechanism for Prins reaction. 
 Having constructed the quaternary stereocenter, we next examined the removal of 
the amino alcohol portion in the spiromorpholinones in order to liberate the functionalized 
quaternary-carbon bearing building blocks that were the objective of this study. Previous 
studies6 on ephedrine-derived morpholinones had shown that dissolving metal reduction 
accomplishes cleavage of the benzylic CO bond as well as the CN bond - to the phenyl 
group in the morpholinone. Hence, it was anticipated that a dissolving metal reduction of 
the spiromorpholinones prepared in this study would generate -hydroxy amides based on 
the 1,3-dioxanyl scaffold (Scheme1.17). 
 
Scheme 1.17 Dissolving metal reduction of ephedrine-derived morpholinones. 
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 In initial studies, two representative spiromorpholinones, one with two alkyl groups 
at the quaternary carbon (116) and the other with an alkyl and an aryl substituent (120), 
were subjected to dissolving metal reduction (Na/NH3). Unexpectedly, but pleasingly, the 
reduction of 120 provided the ,-dihydroxy amide 138 (56%) after quenching the reaction 
with MeOH/water followed by stirring at room temperature for 30 min (Scheme 1.18). 
Presumably, initial C-O and C-N bond cleavage in the morpholinone generates an 
intermediate which undergoes fragmentation of the dioxane ring to provide an -keto 
amide which is reduced further to the dihydroxy amide 137. Thus, four transformations are 
accomplished in one step. Notably, products arising from reduction of the phenyl ring on 
the dioxane portion in 120 were not observed. Futhermore, stirring the quenched 
(MeOH/H2O) reaction mixture, obtained from 116, at ambient temperature for 8 h directly 
provided the hydroxy acid 139 in good yield (86%, Scheme 1.18). 
 
Scheme 1.18 Dissolving metal reduction of spiromorpholinones 116 and 120. 
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 Although the in-situ reduction of the -keto amides is not diastereoselective (1:1 
dr), it was expected that the -stereocenter can be manipulated by oxidation of a suitably 
protected derivative to the ketone followed by diastereoselective reduction.14 If required, 
the diastereomers of 138 and 139 can be easily separated by chromatography. ,-
Dihydroxy acids and amides such as 139 and 138 are precursors of ,-disubstituted--
butyrolactones that are analogs of pantolactone. Such lactones provide synthetic 
pantothenamides (N-modified,-dihydroxy amides) by aminolysis.15 Recent studies16 
have shown that the biological activity of pantothenamides depends on the substitution at, 
and the configuration of, the quaternary carbon. Notably, these key structural features can 
be controlled with the modular assembly of quaternary stereocenters described for 138 and 
139. 
 Determination of the absolute configuration of the quaternary carbon in the hydroxy 
acids required their conversion to known aldehydes or carboxylic acids for correlation. This 
conversion would also achieve the objective of preparing quaternary stereocenter-
containing acyclic motifs that are amenable to functionalization. Hence, in order to 
demonstrate the generality of the amino alcohol removal and conversion of the -hydroxy 
acid products into the targets, selected spiromorpholinones derived either from 1R,2S- 
ephedrine or from S-2-(methylamino)-1,1-diphenylpropanol, both bearing alkyl, aryl or 
arylalkyl substituents were converted into functionalized, quaternary stereocenter-
containing building blocks (Schemes 1.19 and 1.120). 
 The crude carboxylic acid 139 obtained from the dissolving metal reduction of the 
spiromorpholinone 116 was subjected to a two-step protocol involving reduction with 
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borane followed by oxidative cleavage of the resulting vicinal diol 140 to aldehyde 141. 
Aldehyde 141 was directly employed in a Horner-Wadsworth-Emmons (HWE) reaction to 
provide 142 (Scheme 1.19).  
 
Scheme 1.19 Conversion of spiromorpholinone 116 to ,-unsaturated ester 142. 
 Similarly, selected spiromorpholinones were converted to corresponding hydroxy 
carboxylic acids 146-149 (Scheme 1.20). Spiromorpholinones 115, 116, 120 and 125 were 
subjected to dissolving metal reduction to provide respective dihydroxy carboxylic acids 
143, which were transformed into corresponding aldehydes 145 by borane reduction 
followed by oxidative cleavage of vicinal diols 144. Pinnick oxidation of aldehydes 145 
furnished corresponding -hydroxy carboxylic acids 146-149 respectively (Scheme 1.20). 
Comparison of the optical rotations of the acids 14717 and 14818 with reported values 
confirmed the ‘R’ configurations. The formation of the ‘R’ enantiomers also confirms the 
stereochemical outcomes of the Prins reaction. The configurations of 142, 146 and 149 are 
assigned by analogy.  
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Scheme 1.20 Conversion of spiromorpholinones to -hydroxy carboxylic acids. 
 Notably, the methyl ester of the hydroxy acid 148 prepared in this study serves as a 
key starting material in the synthesis of (+)--cuparenone (150),18 a quaternary stereocenter 
containing sesquiterpene. We anticipate that the other spiromorpholinones prepared in this 
study will also provide quaternary stereocenter-containing hydroxy aldehydes or carboxylic 
acids by employing a protocol similar to the ones described in Schemes1.19 and 1.20. 
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1.6 Conclusion: 
 In conclusion, a modular synthesis of functionalized quaternary carbon containing 
building blocks has been developed. The procedure involves sequential, stereoselective     
C-C bond-forming reactions on chiral amino alcohol-derived alkylidene morpholinones. 
The methodology has the potential to rapidly assemble a variety of quaternary carbons that 
are adorned with a selection of alkyl and aryl substituents. This study has also identified   
S-2-(methylamino)-1,1-diphenylpropanol as a potential replacement for 1R,2S-ephedrine 
in the morpholinone template-based methodology.  
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1.7 Experimental section 
General: 
 All commercially available reagents were used without purification. All reactions 
requiring anhydrous conditions were performed under an atmosphere of dry nitrogen using 
oven dried glassware. CH2Cl2 and THF were distilled from CaH2 and 
sodium/benzophenone respectively. Commercial precoated silica gel plates were used for 
TLC. All melting points are uncorrected. Silica gel for flash column chromatography was 
230-400 mesh. IR spectra were recorded on a Bruker TENSOR 27 FT-IR instrument. 1H 
NMR and 13C NMR spectra were recorded on a Bruker AVANCE III 300 or an AVANCE 
500 instrument. Mass spectra were obtained on an Agilent 1100 series LC/MSD (Trap) or 
an Agilent 6200 LC/MSD (TOF) chromatographic system. High-resolution mass spectra 
(EI or ESI) were obtained on a Waters GCT Premier Micromass mass spectrometer. Optical 
rotations were measured at the sodium D line on a JASCO-DIP 370 digital polarimeter at 
ambient temperature. 
(5S,6R)-4,5-dimethyl-6-phenylmorpholine-2,3-dione(52):7b 
 
 Prepared from 1R,2S ephedrine hydrochloride (47) and ethyloxalyl chloride 
according to the literature procedure. Spectroscopic data for 52 was identical to the reported 
data.7b 
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(S)-4,5-Dimethyl-6,6-diphenylmorpholin-2,3-dione (71): 
 
 To a solution of (S)-2-(methylamino)-1,1-diphenylpropan-1-ol (74)6 (100 mg, 
0.410 mmol) in THF (12 mL) were added DMAP (5.0 mg, 0.041 mmol) and triethylamine 
(0.230 mL, 1.65 mmol) followed by dropwise addition of oxalyl chloride (53 µL, 0.62 
mmol) at 0 ºC. The mixture was stirred at 0 ºC for 1 h and then at ambient temperature for 
10 h. Cold water was added and the mixture was extracted with dichloromethane (3 x 10 
mL). The combined organic layers were washed with HCl (0.1 M, 2 x 5 mL), brine, dried 
over Na2SO4 and concentrated under reduced pressure to give a black solid. Purification of 
the crude product by flash chromatography on silica gel (hexane/EOAc, 55:45) provide 75 
mg (61%) of 71 as light brown solid. Rf = 0.24 (hexanes/EtOAc, 1:1); mp: 135.3-137.6 °C; 
[α]D20 = – 325.7 (c 1, CH2Cl2); IR (neat): 2297, 1763, 1681, 1495, 769 cm-1; 1H NMR (500 
MHz, CDCl3): δ 7.44-7.27 (m, 10H, ArH), 4.47 (q, 1H, J = 7.5 Hz, CHCH3), 3.15 (s, 3H, 
NCH3), 1.22 (d, 3H, J = 7.5 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 156.4 (OCO), 
153.3 (NCO), 141.4 (ArCipso), 139.5 (ArCipso), 129.3 (ArC), 128.9 (ArC), 128.7 (ArC), 
128.1 (ArC), 125.4 (ArC), 124.6 (ArC), 87.0 (CCH), 59.0 (CHCH3), 33.9 (NCH3), 15.0 
(CH3); MS (APCI): 296.1 (M+H)
+; HRMS (CI): m/z 296.1280 (296.1287 calc. for 
C18H18NO3, (M+H)
+). 
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General procedure for the synthesis of alkylidene morpholinones 64, 83, 91 and 92:7a 
To suspension of the morpholinedione 527b or 71 in THF was added the appropriate 
alkylmagnesium halide at 0 °C and the mixture was stirred at ambient temperature. A 
aqueous saturated NH4Cl solution was added, the mixture was extracted with ethyl acetate 
to provide the product hemiacetal, which was then used in the next step without 
purification. To a solution of the crude hemiacetal in CH2Cl2 was added BF3.OEt2 at                
-78 °C and the solution was stirred at ambient temperature for 14 h. It was then cooled to  
0 °C and water was added. The resulting mixture was extracted with CH2Cl2. The combined 
organic layers were washed with brine, dried over anhydrous Na2SO4 and concentrated. 
The residue was purified by flash chromatography on silica gel to provide the alkylidene 
morpholinone. 
(S,E)-2-Ethylidene-4,5-dimethyl-6-phenylmorpholin-3-one (64):7a,5a 
 
Prepared according to the general procedure. Reaction (S)-4,5-dimethyl-6-
phenylmorpholin-2,3-dione 52 (4.50 g, 20.5 mmol) and ethylmagnesium bromide (8.21 
mL, 24.6 mmol, 3.00 M in diethylether) provided 5.03 g (99%) of the hemiacetal 5S-2-
ethyl-2-hydroxy-4,5-dimethyl-6-phenylmorpholin-3-one (51) as a white foam (dr = 6.6:1). 
Dehydration of the hemiacetal in CH2Cl2 (30 mL) with BF3.OEt2 (7.73 mL, 61.6 mmol) 
provided 4.54 g (96% over two steps) of 64 as a pale-yellow gum. This was used in the 
next step without purification. Spectroscopic data for 64 was identical to the reported data.7b  
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(S,E)-2-Propylidene-4,5-dimethyl-6-phenylmorpholin-3-one (83):5a  
 
Prepared according to the general procedure. Reaction (S)-4,5-dimethyl-6-
phenylmorpholin-2,3-dione 52 (1.00 g, 4.56 mmol) and propylmagnesium chloride (3.42 
mL, 6.84 mmol, 2.00 M in diethylether) provided 1.90 g (99%) of the hemiacetal 5S-2-
propyl-2-hydroxy-4,5-dimethyl-6-phenylmorpholin-3-one (82) as a pale yellow solid (dr = 
10:1) Dehydration of the hemiacetal in CH2Cl2 (15 mL) with BF3.OEt2 (1.71 mL, 13.7 
mmol) to provided the pure alkylidene morpholinone without purification 1.08 g (98% over 
two steps) of 83 as a yellow gum. Spectroscopic data for 83 was identical to the reported 
data.5a  Rf = 0.29 (EtOAc/hexanes, 2:3); 
1H NMR (300 MHz, CDCl3): δ 7.44-7.29 (m, 5H, 
ArH), 6.06 (t, 1H, J = 7.5 Hz, C=CH), 5.21 (d, 3 1H, J = 2.7 Hz, PhCH), 3.54 (dq, 1H, J = 
6.6, 2.7 Hz, CHCH3), 3.08 (s, 3H, NCH3), 2.27 (quint., 1H, J = 7.5 Hz, CH3CH2), 1.05 (t, 
3H, J = 7.5 Hz, C=CCH2CH3), 1.08 (d, 3H, J = 6.6 Hz, CH3CH); 
13C NMR (75 MHz, 
CDCl3): δ 159.8 (NC=O), 143.5 (ArCipso or C-C=O), 137.2 (ArCipso or C-C=O), 128.5 (2 × 
ArC), 127.9 (ArC), 125.5 (2 × ArC), 118.5 (C=CH), 77.0 (PhCH), 58.6 (CHCH3), 33.6 
(NCH3), 18.3 (C=CCH2CH3), 13.5 (C=CCH2CH3), 11.7 (CHCH3). 
(S,E)-2-Ethylidene-4,5-dimethyl-6,6-diphenylmorpholin-3-one (91): 
N
O
Ph
Ph
O
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 This was prepared according to the general procedure. Reaction of the dione 71 
(1.00 g, 3.38 mmol) in anhydrous THF (10 mL) with ethylmagnesium bromide (4.06 mL, 
4.06 mmol, 1.00 M in THF) provided 1.01 g (99%) of the hemiacetal (S)-2-ethyl-2-
hydroxy-4,5-dimethyl-6,6-diphenylmorpholin-3-one (89) as a white solid (dr = 4.5:1). 
Dehydration of the hemiacetal 89 in CH2Cl2 (10 mL) with BF3.OEt2 (1.270 mL, 10.14 
mmol) provided the crude alkylidene morpholinone. This was purified by flash 
chromatography on silica gel (hexanes/EtOAc, 7:3) to provide 767 mg (74% over two 
steps) of 91 as a white solid. Rf = 0.30 (EtOAc/hexanes, 1:1); mp: 138.7-140.1 °C; [α]D20 = 
– 270.5 (c 1, CH2Cl2); IR (neat): 3066, 2982, 2932, 1619, 1480, 1450, 1401, 1325, 1152, 
1071, 1040, 1020 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.46-7.39 (m, 2H, ArH),7.36-7.05 
(m, 8H, ArH), 6.06 (q, 1H, J = 7.2 Hz, C=CH), 4.32 (q, 1H, J = 6.4 Hz, CHCH3), 3.07 (s, 
3H, NCH3), 1.91 (d, 3H, J = 7.2 Hz, C=CHCH3), 1.08 (d, 3H, J = 6.4 Hz, CH3CH); 
13C 
NMR (75 MHz, CDCl3): δ 159.5 (NC=O), 142.9 (ArCipso or C-C=O), 142.3 (ArCipso or C-
C=O), 142.1 (ArCipso or C-C=O), 128.7 (2 × ArC), 128.4 (2 × ArC), 127.6 (ArC), 127.1 
(ArC), 126.0 (2 × ArC), 124.9 (2 × ArC), 112.7 (C=CH), 81.9 (Ph2C), 58.4 (CHCH3), 33.7 
(N-CH3), 14.5 (=CCH3), 10.6 (CHCH3); MS (EI, pos.): m/z 308.2 (M+H)
+; HRMS (EI, 
pos.): m/z 307.1571 (307.1572 calc. for C20H21NO2 (M
+)). 
(S,Z)-4,5-Dimethyl-6,6-diphenyl-2-propylidenemorpholin-3-one (92): 
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 This was prepared according to the general procedure. Reaction of the dione 71 
(1.00 g, 3.38 mmol) in anhydrous THF (10 mL) with propylmagnesium bromide (2.53 mL 
of a 2.00 M soln. in ether, 5.06 mmol) provided 1.02 g (89%) of the hemiacetal (S)-2-proyl-
2-hydroxy-4,5-dimethyl-6,6-diphenylmorpholin-3-one (90) as a white solid (dr = 5.6:1). 
Dehydration of the hemiacetal 90 in CH2Cl2 (12 mL) with BF3.OEt2 (1.27 mL, 10.1 mmol) 
provided the crude alkylidene morpholinone. This was purified by flash chromatography 
on silica gel (hexanes/EtOAc, 7:3) to provide 583 mg (54% over two steps) of 92 as a white 
solid. Rf = 0.36 (CH2Cl2/EtOAc, 1:1); mp: 122.2-124.0 °C; [α]D20 = – 209.9 (c 0.76, 
CH2Cl2); IR (neat): 2968, 2931, 1624, 1489, 1450, 1400, 1337, 1318, 1174, 1158, 1072, 
1034 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.44-7.38 (m, 2H, ArH), 7.36-7.26 (m, 6H, 
ArH), 7.24-7.14 (m, 2H, ArH), 6.01 (t, 1H, J = 7.5 Hz, C=CH), 4.32 (q, 1H, J = 6.4 Hz, 
CHCH3), 3.07 (s, 3H, NCH3), 2.43 (quint., 2H, J = 7.5 Hz, C=CCH2CH3), 1.10 (t, 3H, J = 
7.5 Hz, C=CCH2CH3), 1.08 (d, 3H, J = 6.4 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3): δ 
159.7 (NC=O), 142.3 (ArCipso), 142.1 (ArCipso), 141.6 (C-C=O), 128.7 (2 × ArC), 128.4 (2 
× ArC), 127.6 (ArC), 127.1 (ArC), 126.1 (2 × ArC), 124.9 (2 × ArC), 119.6 (C=CH), 81.9 
(CPh2), 58.3 (CHCH3), 33.8 (NCH3), 18.6 (C=CCH2CH3), 14.5 (C=CCH2CH3), 13.4 
(CHCH3); MS (APCI, pos.): m/z 322.2 (M+H)
+; HRMS (EI, pos.): m/z 321.1742 (321.1729 
calc. for C21H23NO2 (M
+)).  
General procedure for the synthesis of bromoalkylidene morpholinones 86, 87, 95 and 
96: 
 To a solution of the alkene in CH2Cl2 at room temperature was added a solution of 
bromine in water. The mixture was stirred for 3 h at room temperature and then extracted 
with CH2Cl2. The combined organic layers were washed with aqueous 5% Na2S2O3, brine, 
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dried over Na2SO4 and concentrated under reduced pressure to provide the crude 
bromohemiacetal this was dissolved in acetic anhydride and conc. H2SO4 (specified 
amount) was added to the solution. The mixture was stirred at room temperature and the 
acetic anhydride was removed under reduced pressure. The residue was cooled to 0 °C and 
basified with aqueous NaOH (10%). The resulting mixture was extracted with CH2Cl2. The 
combined organic layers were washed with brine, dried over Na2SO4 and concentrated 
under reduced pressure. The residue was purified by flash chromatography on silica gel. 
(5S,6R,Z)-2-(1-Bromoethylidene)-4,5-dimethyl-6-phenylmorpholin-3-one (86): 
 
 This was prepared according to the general procedure. Reaction of the alkene 64 
(2.50 g, 10.8 mmol) in CH2Cl2 (20 mL) at room temperature with bromine (6.50 mL of a 
2.00 M soln. in H2O, 13.0 mmol) provided 3.43 g of the crude bromohemiacetal. This was 
dehydrated in acetic anhydride (10 mL) and conc. H2SO4 (0.25 mL) for 48 h to provide, 
after flash chromatography on silica gel (hexane/EtOAc, 7:3), 2.30 g (69% over two steps) 
of 86 as a pale-yellow gum. Rf = 0.29 (hexanes/EtOAc, 6:4); [α]D20 = – 194.8 (c 0.86, 
CH2Cl2); IR (neat): 1660, 1610, 1441, 1389, 1284, 1212, 1151, 1065, 1023 cm
-1; 1H NMR 
(300 MHz, CDCl3): δ 7.45-7.39 (m, 4H, ArH), 7.36-7.32 (m, 1H, ArH), 5.28 (d, 1H, J = 
2.8 Hz, PhCH), 3.60 (dq, 1H, J = 6.5, 2.8 Hz, CHCH3), 3.08 (s, 3H, NCH3), 2.88 (s, 3H, 
C=CH3), 0.99 (d, 3H, J = 6.5 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 158.5 (C=O), 
140.2 (C-C=O), 136.4 (ArC), 128.5 (2 x ArC), 128.0 (ArC), 125.5 (2 x ArC), 
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117.2(C=CBr), 77.02 (Ph-C), 58.8 (NCH), 33.6 (NCH3), 24.9 (C=CH3), 11.9 (CHCH3); 
MS (EI, pos.): m/z 310.1 (M+1(79Br))+ and 312.1 (M+1(81Br))+; HRMS (CI): m/z 310.0436 
(310.0443 calc. for C14H17
79BrNO2 (M+H)
+) and 312.0423 (312.0422 calc. for 
C14H17
81BrNO2 (M+H)
+). 
(5S,6R,E)-2-(1-Bromoethylidene)-4,5-dimethyl-6-phenylmorpholin-3-one (E-86): 
 
 In some experiments, dehydration of the bromohemiacetal obtained from 64 
provided a mixture of 86 and E-86 which was separated by flash chromatography on silica 
gel (hexanes/EtOAc, 7:3) to provide E-86 (2-4%) as a gum. Rf = 0.27 (hexanes/EtOAc, 
6:4); [α]D20 = – 140.3 (c 0.9, CH2Cl2); IR (neat): 2979, 2917, 1657, 1610, 1440, 1396, 1377, 
1283, 1265, 1212, 1188, 1142, 1101, 1063, 1025 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.45-
7.32 (m, 5H, ArH), 5.24 (d, 1H, J = 2.8 Hz, PhCH), 3.60 (dq, 1H, J = 2.8, 6.5 Hz, NCH), 
3.09 (s, 3H, NCH3), 2.49 (s, 3H, C=CH3), 0.99 (d, 3H, J = 6.5 Hz, CHCH3); 
13C NMR (75 
MHz, CDCl3): δ 158.1 (C=O), 140.5 (C-C=O), 136.6 (ArCipso), 128.6 (2 x ArC), 128.1 
(ArC), 125.3 (2 x ArC), 110.8 (C=CBr), 77.5 (Ph-C), 59.0 (CHCH3), 33.8 (NCH3), 24.7 
(H3CC=C), 11.9 (CHCH3); MS (APCI, pos.): m/z 310.1(M+1(
79Br))+ and 312.0 
(M+1(81Br))+; HRMS (CI): m/z 309.0377 (309.0364 calc. for C14H16
79BrNO2 (M
+)) and 
312.0430 (312.0422 calc. for C14H17
81BrNO2 (M+H)
+). 
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(5S,6R,Z)-2-(1-Bromopropylidene)-4,5-dimethyl-6-phenylmorpholin-3-one (87): 
 
 This was prepared according to the general procedure. Reaction of the alkene 83 
(1.10 g, 4.48 mmol) in CH2Cl2 (10 mL) at room temperature with bromine in water (5.38 
mL of a 1.00 M soln. in H2O, 5.38 mmol) provided 1.40 g (4.10 mmol) of the crude 
bromohemiacetal as a white foam. This was dehydrated in acetic anhydride (10 mL) and 
conc. H2SO4 (0.5 mL) for 23 h to provide, after flash chromatography on silica gel 
(hexanes/EtOAc, 3:1), 713 mg (53% over two steps) of 87 as a brown gum. Rf = 0.47 
(EtOAc/hexanes, 1:1); [α]D20 = – 161.3 (c 1.7, CH2Cl2); IR (neat): 2975, 2933, 2875, 1656, 
1606, 1449, 1398, 1380, 1287, 1266, 1214, 1191, 1152, 1062, 995 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.46-7.28 (m, 5H, ArH), 5.25 (d, 1H, J = 2.6 Hz, CHPh), 3.58 (dq, 1H, J 
= 6.6, 2.7 Hz, CHCH3), 3.33 (ABX3, 1H, JAB = 14.4 Hz, JAX = JBX = 7.2 Hz, CH2CH3), 
3.12 (ABX3, 1H, JAB = 14.4 Hz, JAX = JBX = 7.2 Hz, CH2CH3), 3.08 (s, 3H, NCH3), 1.21 (t, 
3H, J = 7.2 Hz, CH2CH3), 0.97 (d, 3H, J = 6.6 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3): 
δ 158.1 (NC=O), 139.7 (ArCipso or C-C=O), 136.4 (ArCipso or C-C=O), 128.5 (2 × ArC), 
128.0 (ArC), 125.4 (2 × ArC), 125.0 (C=CCH2), 77.6 (PhC), 58.7 (CHCH3), 33.6 (N-CH3), 
30.4 (CH2CH3), 13.8 (CHCH3), 11.8 (CH2CH3); MS (APCI, pos.): m/z  324.1 (M+1(
79Br))+ 
and 326.1 (M+1(81Br))+; HRMS (APPI, pos.): m/z 323.0513 (323.0521 calc. for 
C15H18
79BrNO2 (M
+)) and 326.0567 (326.0579 calc. for C15H18
81BrNO2 (M+H)
 +). 
 
 
 42 
 
(5S,6R,E)-2-(1-Bromopropylidene)-4,5-dimethyl-6-phenylmorpholin-3-one (E-87): 
 
 In some experiments, dehydration of the bromohemiacetal obtained from 83 
provided a mixture of 87 and E-87 which was separated by flash chromatography on silica 
gel (hexanes/EtOAc, 3:1) to provide E-87 in (3-5%) yield as a pale-yellow solid. Rf = 0.39 
(EtOAc/hexanes, 1:1); mp: 90.9-92.1 °C; [α]D20 = –151.6 (c 0.8, CH2Cl2); IR (neat): 2970, 
2930, 2871, 1650, 1605, 1455, 1444, 1394, 1378, 1287, 1256, 1187, 1140, 1107, 1063, 
1003 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.46-7.30 (m, 5H, ArH), 5.23 (d, 1H, J = 2.7 
Hz, CHPh), 3.58 (dq, 1H, J = 6.6, 2.7 Hz, CHCH3), 3.09 (s, 3H, NCH3), 2.90-2.67 (m, 2H, 
CH2CH3), 1.16 (t, 3H, J = 7.4 Hz, CH2CH3), 0.99 (d, 3H, J = 6.6 Hz, CH3CH); 
13C NMR 
(75 MHz, CDCl3): δ 158.3 (NC=O), 139.9 (ArCipso or C-C=O), 136.6 (ArCipso or C-C=O), 
128.6 (2 × ArC), 128.1 (ArC), 125.3 (2 × ArC), 118.4 (C=CCH2), 77.6 (PhC), 59.0 
(CHCH3), 33.9 (N-CH3), 30.5 (CH2CH3), 12.6 (CHCH3), 11.9 (CH2CH3); MS (APCI, 
pos.): m/z  324.1 (M+1(79Br))+ and 326.1 (M+1(81Br))+; HRMS (APPI, pos.): m/z 323.0507 
(323.0521 calc. for C15H18
79BrNO2 (M
+)) and 326.0560 (325.0579 calc. for C15H18
81BrNO2 
(M+H)+). 
(S,Z)-2-(1-Bromoethylidene)-4,5-dimethyl-6,6-diphenylmorpholin-3-one (95): 
N
O
Ph
Ph
O
Br  
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 This was prepared according to the general procedure. Reaction of the alkene 91 
(1.10 g, 3.58 mmol) in CH2Cl2 (15 mL) with bromine in water (4.29 mL of a 1.00 M soln., 
4.29 mmol) provided 1.58 g of the crude bromohemiacetal as a white foam. This was 
dehydrated in acetic anhydride (10 mL) and conc. H2SO4 (0.10 mL) to provide, after 
purification by flash chromatography on silica gel (hexane/EtOAc, 3:1), 1.17 g (85% over 
two steps) of 95 as a white solid. Rf = 0.32 (hexanes/EtOAc, 7:3); mp: 130.0-131.3 °C; 
[α]D20 = – 149.6° (c 1, CH2Cl2); IR (neat): 1652, 1604, 1448, 1308, 1266, 1203, 1147, 972 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.51-7.48 (m, 2H, ArH), 7.42-7.37 (m, 2H, ArH), 
7.34-7.27 (m, 4H, ArH), 7.23-7.17 (m, 2H, ArH), 4.38 (q, 1H, J = 6.5 Hz, CHCH3), 3.05 
(s, 3H, NCH3), 2.81 (s, 3H, CCH3), 1.10 (d, 3H, J = 6.5 Hz, CH3CH); 
13C NMR (75 MHz, 
CDCl3): δ 158.4 (NC=O), 141.8 (ArCipso), 141.7 (ArCipso), 138.6 (C-C=O), 128.9 (2 × 
ArC), 128.5 (2 × ArC), 127.9 (ArC), 127.2 (ArC), 125.7 (2 × ArC), 124.9 (2 × ArC), 119.1 
(C=CBr), 83.4 (CPh2), 58.8 (CHCH3), 33.9 (N-CH3), 25.0 (H3CC=C), 14.6 (CHCH3); MS 
(APCI, pos.): m/z 386.1 (M+1(79Br))+ and 388.1 (M+1(81Br))+; HRMS (EI, pos.): m/z 
385.0687 (385.0677 calc. for C20H20
79BrNO2 (M
+)) and 387.0671 (387.0657 calc. for 
C20H20
81BrNO2 (M
+)). 
(S,Z)-2-(1-Bromopropylidene)-4,5-dimethyl-6,6-diphenylmorpholin-3-one (96): 
 
 This was prepared according to the general procedure. Reaction of the alkene 92 
(457 mg, 1.42 mmol) with bromine in water (1.70 mL of a 1.00 M soln., 1.70 mmol) 
provided 584 mg (1.40 mmol) of the crude bromohemiacetal as white foam. This was 
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dehydrated in acetic anhydride (5 mL) and conc. H2SO4 (5 drops) for 6 h to provide, after 
purification by flash chromatography on silica gel (hexanes/EtOAc, 17:3), 426 mg (75% 
over two steps) of 96 as a reddish brown solid. Rf = 0.46 (EtOAc/hexanes, 3:7); mp = 113.1-
115.1 °C; [α]D25 = – 138.0 (c 1, CH2Cl2); IR (neat): 2961, 2931, 1663, 1648, 1615, 1599, 
1474, 1447, 1397, 1316, 1269, 1206, 1153, 994, 980 cm-1. 1H NMR (300 MHz, CDCl3): δ 
7.53-7.47 (m, 2H, ArH), 7.42-7.36 (m, 2H, ArH), 7.35-7.26 (m, 4H, ArH), 7.23-7.16 (m, 
2H, ArH), 4.37 (q, 1H, J = 6.5 Hz, CHCH3), 3.15 (ABX3, 2H, JAB = 15.1 Hz, JAX = JBX = 
7.2 Hz, C=CCH2CH3), 3.04 (s, 3H, NCH3), 1.11 (t, 3H, J = 7.2 Hz, C=CCH2CH3), 1.11 (d, 
3H, J = 6.5 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3): δ 158.3 (NC=O), 142.0 (ArCipso), 
141.8 (ArCipso), 138.3 (C-C=O), 129.0 (2 × ArC), 128.7 (2 × ArC), 128.0 (ArC), 127.5 
(C=CBr), 127.4 (ArC), 125.9 (2 × ArC), 125.1 (2 × ArC), 83.7 (CPh2), 59.0 (CHCH3), 34.1 
(NCH3), 30.6 (C=CCH2CH3), 14.8 (C=CCH2CH3), 14.0 (CHCH3); MS (APCI, pos.): m/z 
400.1 (M+1(79Br))+ and 402.1 (M+1(81Br))+; HRMS (APPI, pos.): m/z 399.0837 (399.0834 
calc. for C21H22
79BrNO2 (M
+)) and 402.0891 (402.0891 calc. for C21H23
81BrNO2 (M+H)
+). 
(S,E)-2-(1-Bromopropylidene)-4,5-dimethyl-6,6-diphenylmorpholin-3-one (E-96): 
 
      Dehydration of the bromohemiacetal obtained from 92 (60 mg, 0.14 mmol) at 
50 oC provided a mixture of 96 and E-96 which was separated by flash chromatography on 
silica gel (CH2Cl2/EtOAc, 98:2) to provide and 41 mg (72%) of 96 and 4 mg (7%) of E-96 
as a yellow solid. Rf =0.24 (CH2Cl2/EtOAc, 97:3); mp = 119.8-121.8 °C; [α]D25 = – 48.0 (c 
0.3, CH2Cl2); IR (neat): 2964, 2922, 2852, 1649, 1600, 1449, 1400, 1310, 1257, 1199, 1181, 
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1148, 1102, 1000, 981 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.38-7.27 (m, 8H, ArH), 7.25-
7.18 (m, 2H, ArH), 4.34 (q, 1H, J = 6.5 Hz, CHCH3), 3.08 (s, 3H, NCH3), 2.97 (ABX3, 2H, 
JAB = 13.9 Hz, JAX = JBX = 7.3 Hz, C=CCH2CH3), 1.27 (t, 3H, J = 7.4 Hz, C=CCH2CH3), 
1.09 (d, 3H, J = 6.5 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3): δ 158.1 (NC=O), 142.0 
(ArCipso), 141.6 (ArCipso), 138.0 (C-C=O), 128.9 (2 × ArC), 128.5 (2 × ArC), 128.0 (ArC), 
127.3 (ArC), 126.1 (2 × ArC), 124.8 (2 × ArC), 118.5 (C=CBr), 82.7 (CPh2), 58.8 
(CHCH3), 34.3 (NCH3), 30.4 (C=CCH2CH3), 14.7 (C=CCH2CH3), 12.7 (CHCH3); MS 
(APCI, pos.): m/z 400.1 (M+1(79Br))+ and 402.1 (M+1(81Br))+; HRMS (APPI, pos.): m/z 
399.0832 (399.0834 calc. for C21H22
79BrNO2 (M
+)) and 402.0887 (402.0891 calc. for 
C21H23
81BrNO2 (M+H)
+). 
 
General Procedure 1 for Suzuki coupling with arylboronic acids:  
 To the bromoalkene at room temperature were added the arylboronic acid, Cs2CO3 
and CH3CN (purged with N2 for 15 min) followed by PdCl2(dppf)•CH2Cl2. The mixture 
was heated to reflux until complete consumption of the bromoalkene (TLC), then cooled 
to room temperature and aqueous saturated NH4Cl (5 mL) was added. The mixture was 
extracted with CH2Cl2 (3 x 10 mL) and the combined extracts were washed with aq. NaOH 
(10%), brine, dried over Na2SO4 and concentrated under reduced pressure. The residue was 
purified by flash column chromatography on silica gel. 
 
General Procedure 2 for Suzuki coupling with alkyltrifluoroborates:  
 To the bromoalkene at room temperature were added the alkyl trifluoroborate salt, 
Cs2CO3, a mixture of toluene and water (3:1, purged with N2 for 15 min) followed by 
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PdCl2(dppf)•CH2Cl2. The mixture was heated at 80 °C until complete consumption of the 
bromoalkene (TLC), then cooled to room temperature and aqueous saturated NH4Cl (5 mL) 
was added. The mixture was extracted with CH2Cl2 (3 x 10 mL) and the combined extracts 
were washed with brine, dried over Na2SO4 and concentrated under reduced pressure. The 
residue was purified by flash column chromatography on silica gel. 
(5S,6R,Z)-2-(4-Methylpentan-2-ylidene)-4,5-dimethyl--6-phenylmorpholin-3-one 
(97): 
 
 The reaction of bromoalkene 86 (58 mg, 0.18 mmol), potassium                                       
2-methylpropyltrifluoroborate (0.24 mmol), Cs2CO3 (0.56 mmol) and PdCl2(dppf)·CH2Cl2 
(0.018 mmol) in toluene/water (3:1, 2 mL) for 24 h according to General Procedure 2 
provided, after purification by flash chromatography on silica gel (hexane/EtOAc, 9:1), 43 
mg (80%) of 97 as a colorless liquid. Rf = 0.27 (hexane/EtOAc, 7:3); [α]D20 = –107.2 (c 1, 
CH2Cl2); IR (neat): 2957, 1661, 1451, 1399, 1379, 1294, 1266, 1161, 1143, 1068, 1026 cm
-
1; 1H NMR (300 MHz, CDCl3): δ 7.43-7.28 (m, 5H, ArH), 5.10 (d, 1H, J = 2.6 Hz, CHPh), 
3.53 (dq, 1H, J = 6.5, 2.6 Hz, CHCH3), 3.06 (s, 3H, NCH3), 2.23 (s, 3H, C=CCH3), 2.21 
(ABX, 2H, JAB = 12.2 Hz, JAX = 7.5 Hz, JBX = 6.8 Hz, C=CCH2), 1.96-1.80 (septet, 1H, J 
= 6.8 Hz, CH3CHCH3), 0.96 (d, 3H, J = 2.4 Hz, CH3CHCH3), 0.93 (d, 3H, J = 2.4 Hz, 
CH3CHCH3), 0.89 (d, 3H, J = 6.5 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3): δ 161.1 
(NC=O), 138.8 (ArCipso or C-C=O), 137.7 (ArCipso or C-C=O), 130.5 (C=CCH3), 128.4 (2 
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× ArC), 127.7 (ArC), 125.4 (2 × ArC), 76.8 (PhC), 58.9 (CHCH3), 42.9 (C=CCH2), 33.5 
(NCH3), 27.1 (CH3CHCH3), 22.7 (CH3CHCH3), 18.9 (H3CC=C), 12.0 (CHCH3); MS 
(APCI, pos.): m/z 288.2 (M+H)+; HRMS (EI, pos.): m/z 287.1887 (287.1885 calc. for 
C18H25NO2 (M
+)). 
(5S,6R,Z)-2-(Hexan-2-ylidene)-4,5-dimethyl-6-phenylmorpholin-3-one (103): 
 
 The reaction of bromoalkene 86 (300 mg, 0.970 mmol), potassium                                    
n-butyltrifluoroborate (3.88 mmol), Cs2CO3 (2.91 mmol) and PdCl2(dppf)·CH2Cl2 (0.097 
mmol) in toluene/water (3:1, 5 mL) for 3 h according to General Procedure 2 provided, 
after purification by flash chromatography on silica gel (CH2Cl2/EtOAc, 97:3), 257 mg 
(92%) of 103 as a pale-yellow liquid. Rf = 0.26 (CH2Cl2/EtOAc, 96:4); [α]D20 = – 118.4 (c 
0.74, CH2Cl2); IR (neat): 1659, 1617, 1443, 1386, 1286, 1211, 1165 cm
-1; 1H NMR (300 
MHz, CDCl3): δ 7.40-7.28 (m, 5H, ArH), 5.12 (d, 1H, J = 2.7 Hz, PhCH), 3.54 (dq, 1H, J 
= 6.6, 2.7 Hz, NCH), 3.06 (s, 3H, NCH3), 2.39-2.24 (m, 2H, C=CCH2), 2.24 (s, 3H, 
C=CCH3), 1.52-1.40 (m, 2H, CH2CH2), 1.38-1.28 (m, 2H, CH2CH2), 0.95 (d, 3H, J = 6.6 
Hz, CHCH3), 0.90 (t, 3H,J = 7.2 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3): δ 161.0 (C=O), 
138.4 (C-C=O), 137.7 (ArCipso), 131.2 (C=CCH2CH3), 128.4 (2 x ArC), 127.7(ArC), 125.4 
(2 x ArC), 76.8 (PhCH), 58.9 (NCH), 33.44 (NCH3), 33.42 (C=CCH2), 29.6 (CH2), 22.6 
(CH2), 18.4 (C=CCH3), 14.0 (CH2CH3), 11.9 (CHCH3); MS (APCI, pos.): m/z 288.3 
(M+H)+; HRMS (EI, pos.): m/z 287.1887 (287.1885 calc. for C18H25NO2 (M
+)). 
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(5S,6R,Z)-4,5-Dimethyl-6-phenyl-2-(1-phenylpropan-2-ylidene)morpholin-3-one 
(104): 
 
 The reaction of bromoalkene 86 (51 mg, 0.16 mmol), benzylboronic acid pinacol 
ester (0.33 mmol), Cs2CO3 (0.33 mmol) and PdCl2(dppf)·CH2Cl2 (0.016 mmol) in CH3CN 
(2 mL) for 1 h according to General Procedure 1 provided, after purification by flash 
chromatography on silica gel (CH2Cl2), 38 mg (72%) of 104 as a colorless liquid. Rf = 0.43 
(CH2Cl2/EtOAc, 96:4); [α]D20 = – 54.7 (c 0.75, CH2Cl2); IR (neat): 2980, 2925, 1655, 1624, 
1451, 1398, 1378, 1290, 1159, 1087, 1067, 1030 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.40-
7.14 (m, 10H, ArH), 5.20 (d, 1H, J = 2.7 Hz, CHPh), 3.78 (d, 1H, J = 13.7 Hz, CH2Ph), 
3.57 (dq, 1H, J = 6.5, 2.7 Hz, CHCH3), 3.54 (d, 1H, J = 13.5 Hz, CH2Ph), 3.08 (s, 3H, 
NCH3), 2.20 (s, 3H, C=CCH3), 1.00 (d, 3H, J = 6.5 Hz, CH3CH); 
13C NMR (75 MHz, 
CDCl3): δ 160.9 (NC=O), 139.8 (ArCipso or C-C=O), 138.8 (ArCipso or C-C=O), 137.4 
(ArCipso or C-C=O), 129.1 (C=CCH3), 128.9 (2 × ArC), 128.5 (2 × ArC), 128.4 (2 × ArC), 
127.8 (ArC), 126.0 (ArC), 125.5 (2 × ArC), 77.2 (PhC), 59.0 (CHCH3), 39.3 (CH2Ph), 33.6 
(NCH3), 18.2 (H3CC=C), 12.1 (CHCH3); MS (APCI, pos.): m/z 322.2 (M+H)
+; HRMS (EI, 
pos.): m/z 321.1740 (321.1729 calc. for C21H23NO2 (M
+)). 
(5S,6R,Z)-2-(1-Cyclopropylethylidene)-4,5-dimethyl-6-phenylmorpholin-3-one (105): 
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 The reaction of bromoalkene 86 (140 mg, 0.450 mmol), potassium 
cyclopropyltrifluoroborate (1.80 mmol), Cs2CO3 (1.80 mmol) and PdCl2(dppf)•CH2Cl2 
(0.045 mmol) in toluene/water (3:1, 2 mL) for 66 h according to General Procedure 2 
provided, after purification by flash chromatography on silica gel (CH2Cl2/EtOAc, 98:2), 
88 mg (72%, 75% based on recovery of 86) of 105 as a white solid. Rf = 0.33 
(CH2Cl2/EtOAc, 96:4); mp = 118.0-120.1 °C; [α]D20 = – 169.6 (c 1.1, CH2Cl2); IR (neat): 
2970, 2928, 2863, 1644, 1605, 1439, 1395, 1376, 1298, 1252, 1212, 1164, 1066, 1027, 918, 
895 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.43-7.35 (m, 4H, ArH), 7.35-7.28 (m, 1H, ArH), 
5.17 (d, 1H, J = 2.7 Hz, CHPh), 3.55 (dq, 1H, J = 6.5, 2.7 Hz, CHCH3), 3.06 (s, 3H, NCH3), 
2.40-2.32 (m, 1H, C=CCH), 1.85 (s, 3H, C=CCH3), 0.98 (d, 3H, J = 6.5 Hz, CH3CH), 0.82-
0.75 (m, 1H, CH2CH2), 0.70-0.63 (m, 3H, CH2CH2); 
13C NMR (75 MHz, CDCl3) δ 160.7 
(NC=O), 139.2 (ArCipso or C-C=O), 137.7 (ArCipso or C-C=O), 131.2 (C=CCH3), 128.4 (2 
× ArC), 127.7 (ArC), 125.5 (2 × ArC), 77.1 (PhC), 58.8 (CHCH3), 33.5 (N-CH3), 12.3 
(CHCH3), 12.0 (HCC=C), 11.1 (H3CC=C), 5.0 (CH2CH2), 4.9 (CH2CH2); MS (APCI, 
pos.): m/z 272.1 (M+H)+. HRMS (EI, pos.): m/z 271.1581 (271.1572 calc. for C17H21NO2 
(M+)). 
(5S,6R,Z)-4,5-Dimethyl-6-phenyl-2-(1-phenylethylidene)morpholin-3-one (106): 
 
 The reaction of bromoalkene 86 (300 mg, 0.970 mmol), phenylboronic acid (1.94 
mmol), Cs2CO3 (1.94 mmol) and PdCl2(dppf)·CH2Cl2 (0.097 mmol) in CH3CN (5 mL) for 
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2 h according to General Procedure 1 provided, after purification by flash chromatography 
on silica gel (CH2Cl2/EtOAc, 98:2), 274 mg (92%) of 107 as a light brown gum. Rf = 0.31 
(CH2Cl2/EtOAc, 96:4); [α]D20 = –170.8 (c 1.1, CH2Cl2); IR (neat): 1649, 1606, 1490, 1440, 
1295, 1256, 1176, 912 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.42-7.19 (m, 8H, ArH), 7.14-
7.09 (m, 2H, ArH), 5.18 (d, 1H, J = 2.7 Hz, PhCH), 3.60 (dq, 1H, J = 6.5, 2.7 Hz, NCH), 
3.12 (s, 3H, NCH3), 2.57 (s, 3H, C=CCH3), 0.96 (d, 3H, J = 6.5 Hz, CHCH3); 
13C NMR 
(75 MHz, CDCl3): δ 161.2 (C=O), 141.7 (C-C=O), 138.7 (ArCipso), 137.0 (C=CCH3), 128.4 
(2 x ArC), 128.3 (2 x ArC), 128.1 (ArC), 127.7 (2 x ArC), 127.6 (ArC), 126.9 (ArC), 125.3 
(2 x ArC), 77.03 (PhCH), 58.8 (NCH), 33.7 (NCH3), 20.1 (C=CCH3), 12.0 (CHCH3); MS 
(APCI, pos.): m/z 308.4 (M+H)+; HRMS (EI): m/z 307.1574 (307.1572 calc. for C20H21NO2 
(M+)). 
(5S,6R,Z)-4,5-Dimethyl-2-(1-(naphthalen-2-yl)ethylidene)-6-phenylmorpholin-3-one 
(107): 
 
 The reaction of bromoalkene 86 (68 mg, 0.22 mmol), 2-naphthylboronic acid (0.44 
mmol), Cs2CO3 (0.44 mmol) and PdCl2(dppf)·CH2Cl2 (0.022 mmol) in CH3CN (2 mL) for 
3 h according to General Procedure 1 provided, after purification by flash chromatography 
on silica gel (CH2Cl2/EtOAc, 99:1), 75 mg (96%) of 107 as a light yellow solid. Rf = 0.31 
(CH2Cl2/EtOAc, 97:3); mp = 112.9-114.3 °C; [α]D20 = – 159.6 (c 1, CH2Cl2); IR (neat): 
2977, 2930, 2908, 2856, 1650, 1615, 1439, 1378, 1287, 1259, 1210, 1173, 1149, 1025, 821 
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cm-1; 1H NMR (300 MHz, CDCl3): δ 7.86 (br s, 1H, ArH), 7.84-7.72 (m, 3H, ArH), 7.54 
(dd, 1H, J = 8.5, 1.1 Hz, ArH), 7.47-7.40 (m, 2H, ArH), 7.26-7.08 (m, 5H, ArH), 5.20 (d, 
1H, J = 2.6 Hz, CHPh), 3.60 (dq, 1H, J = 6.6, 2.6 Hz, CHCH3), 3.13 (s, 3H, NCH3), 2.68 
(s, 3H, C=CCH3), 0.97 (d, 3H, J = 6.6 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3): δ 161.2 
(NC=O), 139.3 (ArCipso or C-C=O), 139.2 (ArCipso or C-C=O), 137.0 (ArCipso), 133.2 
(ArC), 132.5 (ArC), 128.4 (2 × ArC), 128.1 (ArC), 127.9 (C=CCH3), 127.6 (2 × ArC), 
127.3 (ArC), 127.2 (ArC), 126.9 (ArC), 125.94 (ArC), 125.88 (ArC), 125.3 (ArC), 77.2 
(PhC), 58.8 (CHCH3), 33.8 (NCH3), 20.3 (H3CC=C), 12.0 (CHCH3); MS (APCI, pos.): m/z 
358.2 (M+H)+; HRMS (APPI, pos.): m/z 357.1734 (357.1729 calc. for C24H23NO2 (M
+)). 
(5S,6R,Z)-2-(1-(4-Methoxyphenyl)ethylidene)-4,5-dimethyl-6-phenylmorpholin-3-
one (108): 
 
 The reaction of bromoalkene 86 (360 mg, 1.16 mmol), 4-methoxyphenylboronic 
acid (2.32 mmol), Cs2CO3 (2.32 mmol) and PdCl2(dppf)·CH2Cl2 (0.116 mmol) in CH3CN 
(5 mL) for 3 h according to General Procedure 1 provided, after purification by flash 
chromatography on silica gel (CH2Cl2/EtOAc, 97:3), 371 mg (94%) of 108 as a brown 
solid. Rf = 0.30 (CH2Cl2/EtOAc, 96:4); mp = 125.3-126.7 °C; [α]D20 = – 220.8 (c 1, 
CH2Cl2); IR (neat): 1654, 1606, 1508, 1438, 1386, 1289, 1246, 1175, 1107, 1026, 830, 758, 
696 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.36-34 (m, 2H, ArH), 7.33-7.23 (m, 3H, ArH), 
7.21-7.15 (m, 2H, ArH), 6.90-6.83 (m, 2H, ArH), 5.18 (d, 1H, J = 2.7 Hz, PhCH), 3.81 (s, 
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3H, OCH3), 3.60 (dq, 1H, J = 6.5, 2.7 Hz, NCH), 3.11 (s, 3H, NCH3), 2.56 (s, 3H, 
C=CCH3), 0.96 (d, 3H, J = 6.5 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 161.3 (C=O), 
158.4 (ArCipso), 138.5 (ArCipso), 137.0 (ArCipso), 133.8 (C-C=O), 129.8 (2 x ArC), 128.3 (2 
x ArC), 127.7 (C=CCH3), 127.5 (ArC), 125.3 (2 x ArC), 113.0 (2 x ArC), 77.1 (PhCH), 
58.8 (NCH), 55.2 (OCH3), 33.7 (NCH3), 20.1 (CCH3), 11.9 (CHCH3); MS (APCI, pos.): 
m/z 338.3 (M+H)+; HRMS (EI pos.): m/z 337.1677 (337.1678 calc. for C21H23NO3 (M
+)). 
Benzyl-4-((Z)-1-((5S,6R)-4,5-dimethyl-3-oxo-6-phenylmorpholin-2-
ylidene)ethyl)phenylcarbamate (109): 
 
 The reaction of bromoalkene 86 (180 mg, 0.580 mmol), 4-Cbz-aminophenyl 
boronic acid (1.16 mmol), Cs2CO3 (1.16 mmol) and PdCl2(dppf)•CH2Cl2 (0.058 mmol) in 
CH3CN (4 mL) for 2.5 h according to General Procedure 1 provided, after purification by 
flash chromatography on silica gel (CH2Cl2/EtOAc, 94:6), 234 mg (88%) of 109 as a light 
brown solid. Rf = 0.32 (CH2Cl2/EtOAc, 9:1); mp = 160.6-162.1 °C; [α]D20 = – 170 (c 0.5, 
CH2Cl2); IR (neat): 3285, 2977, 2934, 2898, 1718, 1602, 1518, 1442, 1394, 1376, 1318, 
1255, 1210, 1174, 1135, 1048, 1026, 1006, 978 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.45-
7.20 (m, 12 H, ArH), 7.19-7.13 (m, 2H, ArH) 6.71 (br s, 1H, NHCO), 5.21 (s, 2H, PhCH2), 
5.17 (d, 1H, J = 2.7 Hz, PhCH), 3.58 (dq, 1H, J = 6.5, 2.7 Hz, CHCH3), 3.11 (s, 3H, NCH3), 
2.55 (s, 3H, C=CCH3), 0.96 (d, 3H, J = 6.5 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 
161.3 (NC=O), 153.4 (ArNHCO), 138.9 (ArCipso or C-C=O), 137.1 (ArCipso or C-C=O), 
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136.8 (ArCipso or C-C=O), 136.6 (ArCipso or C-C=O), 136.2 (ArCipso or C-C=O), 129.5 (2 
× ArC), 128.7 (2 × ArC), 128.51 (2 × ArC), 128.47 (2 × ArC), 128.4 (2 × ArC), 127.7 
(ArC), 127.4 (C=CCH3), 125.4 (2 × ArC), 117.9 (ArC), 77.3 (PhCH), 67.1 (PhCH2O), 58.9 
(CHCH3), 33.9 (NCH3), 20.1 (C=CCH3), 12.1 (CHCH3); MS (APCI, pos.): m/z 457.2 
(M+H)+; HRMS (APPI, pos.): m/z 456.2063 (456.2049 calc. for C28H28N2O4 (M
+)). 
Methyl-4-((Z)-1-((5S,6R)-4,5-dimethyl-3-oxo-6-phenylmorpholin-2-
ylidene)ethyl)benzoate (110): 
 
 The reaction of bromoalkene 86 (230 mg, 0.740 mmol),                                                            
4-methoxycarbonylphenylboronic acid (1.48 mmol), Cs2CO3 (1.48 mmol) and 
PdCl2(dppf)·CH2Cl2 (0.074 mmol) in CH3CN (4 mL) for 3 h according to General 
Procedure 1 provided, after purification by flash chromatography on silica gel 
(CH2Cl2/EtOAc, 92:8), 241 mg (89%) of 110 as a light brown solid. Rf = 0.25 
(CH2Cl2/EtOAc, 9:1); mp = 136.1-137.9 °C; [α]D20 = – 220.4 (c 1, CH2Cl2); IR (neat): 1706, 
1610, 1472, 1440, 1392, 1273, 1179, 1104, 1021, 971 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 8.00 (d, 2H, J = 8.5 Hz, ArH), 7.45 (d, 2H, J = 8.5 Hz, ArH), 7.33-7.23 (m, 3H, ArH), 
7.13-7.08 (m, 2H, ArH), 5.20 (d, 1H, J = 2.7 Hz, CHPh), 3.92 (s, 3H, OCH3), 3.60 (dq, 1H, 
J = 6.5, 2.7 Hz, CHCH3), 3.13 (s, 3H, NCH3), 2.56 (s, 3H, C=CCH3), 0.97 (d, 3H, J = 6.5 
Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 167.1 (CO2CH3), 160.8 (NC=O), 146.7 
(ArCipso), 139.3 (ArCipso or C-C=O), 136.8 (ArCipso or C-C=O), 129.1 (2 × ArC), 128.6 (2 
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× ArC), 128.55 (2 × ArC), 128.49 (ArCipso or C-C=O), 127.8 (ArC), 126.8 (C=CCH3), 
125.7 (2 × ArC), 77.3 (PhC), 58.9 (CHCH3), 52.2 (OCH3), 33.8 (NCH3), 19.9 (H3CC=C), 
12.0 (CHCH3); MS (APCI, pos.): m/z 366.2 (M+H)
+; HRMS (APPI, pos.): m/z 365.1635 
(365.1627 calc. for C22H23NO4 (M
+)). 
(5S,6R,Z)-4,5-Dimethyl-6-phenyl-2-(1-phenylbutan-2-ylidene)morpholin-3-one (111): 
 
 The reaction of bromoalkene 87 (85 mg, 0.26 mmol), potassium 
benzyltrifluoroborate (0.79 mmol), Cs2CO3 (0.79 mmol) and PdCl2(dppf)·CH2Cl2 (0.026 
mmol) in toluene/water (3:1, 2 mL) for 2 h according to General Procedure 2 provided, 
after purification by flash chromatography on silica gel (CH2Cl2/EtOAc, 98:2), 75 mg 
(85%) of 111 as a colorless liquid. Rf = 0.32 (CH2Cl2/EtOAc, 97:3); [α]D20 = –20.6 (c 1.6, 
CH2Cl2); IR (neat): 2975, 2930, 2871, 1654, 1620, 1450, 1395, 1285, 1209, 1159, 1049, 
1012 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.39-7.13 (m, 10H, ArH), 5.18 (d, 1H, J = 2.7 
Hz, CHPh), 3.83 (d, 1H, J = 13.8 Hz, CH2Ph), 3.55 (dq, 1H, J = 6.5, 2.7 Hz, CHCH3), 3.51 
(d, 1H, J = 13.8 Hz, CH2Ph), 3.08 (s, 3H, NCH3), 2.80 (ABX3, 1H, JAB = 12.5 Hz, JAX = 
JBX = 7.4 Hz, CH2CH3), 2.48 (ABX3, 1H, JAB = 12.5 Hz, JAX = JBX = 7.4 Hz, CH2CH3), 
1.08 (t, 3H, J = 7.4 Hz, CH2CH3), 0.99 (d, 3H, J = 6.5 Hz, CH3CH); 
13C NMR (75 MHz, 
CDCl3): δ 160.3 (NC=O), 140.1 (ArCipso or C-C=O), 138.8 (ArCipso or C-C=O), 137.3 
(ArCipso or C-C=O), 134.8 (C=CCH2), 128.8 (2 × ArC), 128.4 (2 × ArC), 128.3 (2 × ArC), 
127.8 (ArC), 125.9 (ArC), 125.5 (2 × ArC), 77.1 (PhCH), 58.8 (CHCH3), 36.7 (CH2Ph), 
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33.5 (NCH3), 24.3 (H2CC=C), 13.4 (CHCH3), 12.0 (CH2CH3); MS (APCI, pos.): m/z 336.2 
(M+H)+; HRMS (EI, pos.): m/z 335.1883 (335.1885 calc. for C22H25NO2 (M
+)). 
(S,Z)-2-(Butan-2-ylidene)-4,5-dimethyl-6,6-diphenylmorpholin-3-one (112): 
 
 The reaction of bromoalkene 95 (60 mg, 0.15 mmol), potassium 
ethyltrifluoroborate (0.62 mmol), Cs2CO3 (0.46 mmol) and PdCl2(dppf)•CH2Cl2 (0.015 
mmol) in toluene/water (3:1, 2 mL) for 19 h according to General Procedure 2 provided, 
after purification by flash chromatography on silica gel (CH2Cl2/EtOAc, 99:1), 42 mg 
(80%, 87% based on recovery of 95) of 112 as a white solid. Rf = 0.30 (CH2Cl2/EtOAc, 
98:2); mp = 160.4-162.5 °C; [α]D20 = –225.8 (c 0.82, CH2Cl2); IR (neat): 2962, 2932, 1648, 
1613, 1475, 1450, 1399, 1375, 1313, 1259, 1159, 1139 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.44-7.36 (m, 2H, ArH), 7.34-7.15 (m, 8H, ArH), 4.30 (q, 1H, J = 6.4 Hz, CHCH3), 3.05 
(s, 3H, NCH3), 2.60 (ABX3, 1H, JAB = 12.7 Hz, JAX = JBX = 7.4 Hz, CH2CH3), 2.38 (ABX3, 
1H, JAB = 12.7 Hz, JAX = JBX = 7.4 Hz, CH2CH3), 2.14 (s, 3H, C=CCH3), 1.18 (t, 3H, J = 
7.5 Hz, CH2CH3), 1.06 (d, 3H, J = 6.4 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3): δ 160.8 
(NC=O), 142.9 (ArCipso), 142.5 (ArCipso), 135.8 (C-C=O), 132. 5 (H3CC=C), 128.6 (2 × 
ArC), 128.4 (2 × ArC), 127.5 (ArC), 127.0 (ArC), 126.2 (2 × ArC), 125.0 (2 × ArC), 81.5 
(CPh2), 58.7 (CHCH3), 33.9 (NCH3), 27.0 (CH3H2CC=C), 17.8 (CH3C=C), 14.7 (CHCH3), 
11.9 (CH3H2CC=C); MS (APCI, pos.): m/z 336.2 (M+H)
+; HRMS (EI, pos.): m/z 335.1887 
(335.1885 calc. for C22H25NO2 (M
+)). 
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A similar reaction of bromoalkene E-96 and potassium methyltrifluoroborate provided 112 
(50%) as a white solid. 
(S,Z)-4,5-Dimethyl-6,6-diphenyl-2-(1-p-tolylethylidene)morpholin-3-one (113): 
 
 The reaction of bromoalkene 95 (150 mg, 0.380 mmol), 4-methylphenylboronic 
acid (0.77 mmol), Cs2CO3 (0.77 mmol) and PdCl2(dppf)·CH2Cl2 (0.038 mmol) in CH3CN 
(4 mL) for 2.5 h according to General Procedure 1 provided, after purification by flash 
chromatography on silica gel (CH2Cl2/EtOAc, 99:1), 144 mg (93%) of 113 as a white solid. 
Rf = 0.30 (CH2Cl2/EtOAc, 98:2); mp = 163.1-164.5 °C; [α]D20 = –170.4 (c 1, CH2Cl2); IR 
(neat): 3024, 2981, 1639, 1607, 1475, 1450, 1398, 1320, 1265, 1173, 1152, 1126, 976, 818 
cm-1; 1H NMR (300 MHz, CDCl3): δ 7.41-7.34 (m, 2H, ArH), 7.29-7.06 (m, 12H, ArH), 
4.33 (q, 1H, J = 6.4 Hz, CHCH3), 3.09 (s, 3H, NCH3), 2.43 (s, 3H, C=CCH3), 2.42 (s, 3H, 
ArCH3), 1.12 (d, 3H, J = 6.4 Hz, CH3CH); 
13C NMR (75 MHz, CDCl3): δ 161.0 (NC=O), 
142.5 (ArCipso), 142.0 (ArCipso), 139.3 (C-C=O), 136.5 (2 × ArCipso), 129.7 (H3CC=C), 
128.5 (4 × ArC), 128.2 (4 × ArC), 127.5 (ArC), 126.8 (ArC), 126.2 (2 × ArC), 125.0 (2 × 
ArC), 82.5 (Ph2C), 58.6 (CHCH3), 34.0 (NCH3), 21.3 (C=CCH3), 20.4 (ArCH3) 14.7 
(CHCH3); MS (APCI, pos.): m/z 398.3 (M+H)
+; HRMS (APPI, pos.): m/z 397.2047 
(397.2042 calc. for C27H27NO2 (M
+)), 398.2120 (398.2118 calc. for C27H28NO2 (M+H)
+). 
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(S,E)-2-(Butan-2-ylidene)-4,5-dimethyl-6,6-diphenylmorpholin-3-one (114): 
 
 The reaction of bromoalkene 96 (50 mg, 0.12 mmol), potassium 
methyltrifluoroborate (0.37 mmol), Cs2CO3 (0.37 mmol) and PdCl2(dppf)·CH2Cl2 (0.012 
mmol) in toluene and water (3:1, 2 mL) for 37 h according to General Procedure 2 provided, 
after purification by flash chromatography on silica gel (CH2Cl2), 23 mg (55%, 64% based 
on recovery of 96) of 114 as a white solid. Rf = 0.30 (CH2Cl2/EtOAc, 98:2); mp = 119.5-
121.3 °C; [α]D20 = –220.6 (c 1, CH2Cl2); IR (neat): 2964, 2936, 1644, 1611, 1450, 1399, 
1313, 1277, 1159, 1137, 981 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.45-7.38 (m, 2H, ArH), 
7.35-7.14 (m, 8H, ArH), 4.30 (q, 1H, J = 6.4 Hz, CHCH3), 3.04 (s, 3H, NCH3), 2.72 (ABX3, 
1H, JAB = 12.7 Hz, JAX = JBX = 7.4 Hz, CH2CH3), 2.56 (ABX3, 1H, JAB = 12.7 Hz, JAX = 
JBX = 7.4 Hz, CH2CH3), 2.02 (s, 3H, C=CCH3), 1.08 (d, 3H, J = 6.4 Hz, CH3CH), 0.95 (t, 
3H, J = 7.4 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3): δ 160.2 (NC=O), 142.9 (ArCipso), 
142.4 (ArCipso), 136.1 (C-C=O), 133.6 (H3CC=C), 128.6 (2 × ArC), 128.3 (2 × ArC), 127.5 
(ArC), 127.0 (ArC), 126.0 (2 × ArC), 125.0 (2 × ArC), 81.6 (CPh2), 58.7 (CHCH3), 33.8 
(NCH3), 26.5 (CH3H2CC=C), 18.0 (CH3C=C), 14.7 (CHCH3), 13.1 (CH3H2CC=C); MS 
(APCI, pos.): m/z 336.2 (M+H)+; HRMS (APPI, pos.): m/z 335.1892 (335.1885 calc. for 
C22H25NO2 (M
+)).  
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(5S,6R,E)-4,5-Dimethyl-6-phenyl-2-(1-phenylbutan-2-ylidene)morpholin-3-one (E-
111): 
 
 The reaction of bromoalkene E-87 (40 mg, 0.12 mmol), 
potassiumbenzyltrifluoroborate (0.37 mmol), Cs2CO3 (0.37 mmol) and 
PdCl2(dppf)·CH2Cl2 (0.012 mmol) in toluene and water (3:1, 1 mL) for 2 h according to 
General Procedure 2 provided, after purification by flash chromatography on silica gel 
(CH2Cl2/EtOAc, 99:1), 28 mg (67%) of E-111 as a brown solid. Rf = 0.39 (CH2Cl2/EtOAc, 
98:2); mp = 98.8-100.5 °C; [α]D20 = –84.4 (c 1.1, CH2Cl2); IR (neat): 2971, 2933, 2909, 
2849, 1646, 1582, 1462, 1449, 1434, 1394, 1373, 1282, 1234, 1152, 1010 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.44-7.12 (m, 10H, ArH), 5.20 (d, 1H, J = 2.7 Hz, CHPh), 4.69 (d, 
1H, J = 13.9 Hz, CH2Ph), 3.99 (d, 1H, J = 13.9 Hz, CH2Ph), 3.58 (dq, 1H, J = 6.5, 2.7 Hz, 
CHCH3), 3.10 (s, 3H, NCH3), 2.23 (ABX3, 2H, JAB = 12.6 Hz, JAX = JBX = 7.5 Hz, 
CH2CH3), 1.00 (t, 3H, J = 7.5 Hz, CH2CH3), 1.00 (d, 3H, J = 6.5 Hz, CH3CH); 
13C NMR 
(75 MHz, CDCl3): δ 160.6 (NC=O), 140.5 (ArCipso or C-C=O), 139.4 (ArCipso or C-C=O), 
137.5 (ArCipso or C-C=O), 134.2 (C=CCH2), 129.0 (2 × ArC), 128.5 (2 × ArC), 128.1 (2 × 
ArC), 127.8 (ArC), 125.7 (ArC), 125.4 (2 × ArC), 77.0 (PhCH), 58.9 (CHCH3), 36.2 
(CH2Ph), 33.6 (NCH3), 24.3 (H2CC=C), 12.2 (CHCH3), 11.9 (CH2CH3); MS (APCI, pos.): 
m/z 336.2 (M+H)+; HRMS (APPI, pos.): m/z 335.1884 (335.1885 calc. for C22H25NO2 
(M+)). 
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General procedure 3 for the Prins reaction of alkylidene morpholinones:  
To a solution of the alkene in TFA was added paraformaldehyde. Depending on the 
nature of the alkene substituent, the reaction mixture was stirred at ambient temperature 
(aromatic alkene substituent) or at 0 oC (aliphatic alkene substituent). After completion of 
the reaction (TLC), the TFA was removed under reduced pressure. The residue was 
dissolved in ethyl acetate (5 mL) and the solution was washed with saturated aqueous 
NaHCO3, brine, dried over Na2SO4 and concentrated under reduced pressure. The residue 
was purified by flash column chromatography on silica gel. 
General procedure 4 for the Prins reaction of alkylidene morpholinones: 
To a mixture of paraformaldehyde in glacial acetic acid was added 2-3 drops of conc. 
H2SO4 and the mixture heated until the paraformaldehyde dissolved (~5 min) in a preheated 
oil bath set at 85 °C. The mixture was cooled to room temperature, the alkene was added 
and the reaction mixture was heated at 85 °C. After completion of the reaction (TLC), the 
mixture was cooled to room temperature and the acetic acid was removed under reduced 
pressure. The residue was dissolved in ethyl acetate (5 mL) and the solution was washed 
with saturated aqueous NaHCO3, brine, dried over Na2SO4 and concentrated under reduced 
pressure. The residue was purified by flash column chromatography on silica gel. 
(5R,6R,9S)-5,9,10-Trimethyl-8,8-diphenyl-5-p-tolyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (115): 
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 The reaction of alkene 113 (100 mg, 0.250 mmol), paraformaldehyde (1.25 mmol) 
in TFA (2 mL) for 5.5 days at room temparature according to General Procedure 3 
provided, after purification by flash chromatography on silica gel (hexane/EtOAc, 3:1), 97 
mg (87%) of 115 as a white solid. Rf = 0.30 (hexane/EtOAc, 11:9); mp = 159.2-161.7 °C; 
[α]D20 = –204.4 (c 1, CH2Cl2); IR (neat): 2922, 2880, 1647, 1456, 1323, 1186, 1075, 1028, 
994, 952 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.45-7.02 (m, 14H, ArH), 5.15 (d, 1H, J = 
10.5 Hz, OCH2), 5.14 (d, 1H, J = 5.7 Hz, OCH2O), 4.39 (d, 1H, J = 5.7 Hz, OCH2O), 3.92 
(q, 1H, J = 6.6 Hz, CHCH3), 3.81 (d, 1H, J = 10.5 Hz, OCH2), 3.10 (s, 3H, NCH3), 2.25 (s, 
3H, ArCH3), 1.84 (s, 3H, Ar-C-CH3), -0.30 (d, 3H, J = 6.6 Hz, CH3CH); 
13C NMR (75 
MHz, CDCl3): δ 164.3 (NC=O), 144.2 (ArCipso), 142.8 (ArCipso), 139.3 (ArCipso), 136.7 
(ArCipso), 129.0 (3 × ArC), 128.22 (2 × ArC), 128.17 (2 × ArC), 128.1 (ArC), 128.0 (3 × 
ArC), 127.2 (3 × ArC), 99.2 (O-C-O), 86.9 (OCH2O), 80.2 (Ph2C), 71.6 (OCH2), 59.8 
(CHCH3), 45.5 (Ar-C-CH3), 34.1 (N-CH3), 22.6 (ArCH3), 21.0 (Ar-C-CH3), 13.3 
(CHCH3); MS (APCI, pos.): m/z 458.3 (M+H)
+ and 398.3 (M-C2H4O2+H)
+; HRMS (APPI, 
pos.): m/z 457.2262 (457.2253 calc. for C29H31NO4 (M
+)) and 397.2047 (397.2042 calc. for 
C27H27NO2 (M-C2H4O2)
+). 
(5R,6R,8R,9S)-5-Butyl-5,9,10-trimethyl-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (116): 
 
 61 
 
 The reaction of alkene 103 (250 mg, 0.870 mmol), paraformaldehyde (4.35 mmol) 
in TFA (3 mL) for 23 h at 0 °C according to General Procedure 3 provided, after purification 
by flash chromatography on silica gel (hexane/EtOAc, 7:3), 264 mg (87%) of 116 as a 
white solid. Rf = 0.27 (hexane/EtOAc, 6:4); mp = 92.3-94.1 °C; [α]D20 = – 46.8 (c 1, 
CH2Cl2); IR (neat): 1656, 1457, 1380, 1288, 1139, 1090, 1024, 976 cm
-1; 1H NMR (300 
MHz, CDCl3): δ 7.45-7.29 (m, 5H, ArH), 5.42 (d, 1H, J = 3.0 Hz, PhCH), 5.00 (d, 1H, J = 
5.6 Hz, OCH2O), 4.96 (d, 1H, J = 5.6 Hz, OCH2O), 4.03 (d, 1H, J = 10.8 Hz, OCH2), 3.71 
(d, 1H, J = 10.8 Hz, OCH2), 3.50 (dq, 1H, J = 3.0, 6.5 Hz, NCH), 3.01 (s, 3H, NCH3), 1.51-
1.48 (m, 2H, CH2), 1.44 (s, 3H, C-CH3), 1.36-1.14 (m, 4H, CH2), 0.97 (d, 3H, J = 6.5 Hz, 
CHCH3), 0.90 (t, 3H,  J = 7.1 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3) δ 164.9 (C=O), 
137.3 (ArCipso), 128.7 (2 x ArC), 127.9 (ArC), 125.5 (2 x ArC), 99.9 (O-C-O), 87.6 (OCH2-
O), 73.1 (OCH2), 70.6 (PhCH), 59.1 (NCH), 41.1 (CCH3), 34.0 (NCH3), 33.7 (C-CH2), 
25.4 (CH2), 23.8 (CH2), 19.5 (C-CH3), 14.2 (CHCH3), 12.6 (CH2CH3). MS (APCI, pos.): 
m/z 348.3 (M+H)+; HRMS (EI, pos.): m/z 347.2105 (347.2097 calc. for C20H29NO4, (M
+)); 
348.2172 (348.2175 calc. for C20H30NO4 (M+H)
+). 
(5R,6R,8R,9S)-5-Isobutyl-5,9,10-trimethyl-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (117): 
 
 The reaction of alkene 97 (20 mg, 0.070 mmol), paraformaldehyde (0.35 mmol) in 
TFA (1 mL) for 18 h at 0 °C according to General Procedure 3 provided, after purification 
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by flash chromatography on silica gel (hexanes/EtOAc, 17:3), 19 mg (79%) of 117 as a 
white solid. Rf = 0.40 (hexanes/EtOAc, 1:1); mp = 92.6-94.2 °C; [α]D20 = –67.1 (c 0.8, 
CH2Cl2); IR (neat): 2951, 2917, 2875, 1650, 1472, 1453, 1378, 1294, 1176, 1146, 1092, 
1068, 972, 944 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.46-7.29 (m, 5H, ArH), 5.41 (d, 1H, 
J = 3.1 Hz, CHPh), 5.01 (d, 1H, J = 5.5 Hz, OCH2O), ), 4.95 (d, 1H, J = 5.5 Hz, OCH2O), 
4.08 (d, 1H, J = 10.7 Hz, CH2OCH2), 3.87 (d, 1H, J = 10.7 Hz, CH2OCH2), 3.49 (dq, 1H, 
J = 6.5, 3.1 Hz, CHCH3), 3.01 (s, 3H, NCH3), 1.82-1.67 (m, 1H, CH3CHCH3), 1.58 (dd, 
1H, J = 14.1, 7.1 Hz, CH2CH), 1.50 (s, 3H, C-CH3), 1.31 (dd, 1H, J = 14.1, 4.4 Hz, 
CH2CH), 0.98 (d, 3H, J = 6.5 Hz, CH3CH), 0.95 (d, 3H, J = 2.9 Hz, (CH3CHCH3), 0.93 (d, 
3H, J = 2.9 Hz, CH3CHCH3); 
13C NMR (75 MHz, CDCl3): δ 164.7 (NC=O), 137.2 
(ArCipso), 128.6 (2 × ArC), 127.8 (ArC), 125.4 (2 × ArC), 100.1 (O-C-O), 87.4 (OCH2O), 
72.8 (OCH2), 70.5 (PhCH), 59.0 (CHCH3), 42.7 (CH2CH(CH3)2), 41.6 (
iBu-C-CH3), 33.9 
(NCH3), 25.8 ((CH3)2CH), 25.1 (CH3CHCH3), 23.5 (CH3CHCH3), 19.5 (
iBu-C-CH3), 12.7 
(CHCH3); MS (APCI, pos.): m/z 348.2 (M+H)
+ and 288.2 ((M-C2H4O2)+H)
+; HRMS 
(APPI, pos.): m/z 347.2103 (347.2097 calc. for C20H29NO4 (M
+)) and 287.1887 (287.1885 
calc. for C18H25NO2 (M-C2H4O2)
+). 
(5R,6R,8R,9S)-5-Benzyl-5,9,10-trimethyl-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (118): 
 
 The reaction of alkene 104 (22 mg, 0.060 mmol), paraformaldehyde (0.34 mmol) 
in TFA (1 mL) for 7 h at RT according to General Procedure 3 provided, after purification 
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by flash chromatography on silica gel (hexanes/EtOAc, 4:1), 19 mg (73%) of 118 as a white 
solid. Rf = 0.46 (hexanes/EtOAc, 1:1); mp = 152.7-153.9 °C; [α]D20 = – 61.8 (c 1, CH2Cl2); 
IR (neat): 2983, 2969, 2891, 1644, 1482, 1455, 1397, 1364, 1291, 1209, 1176, 1132, 1084, 
1026, 1003, 978, 948 cm-1; 1H NMR (500 MHz, CDCl3): δ 7.44-7.37 (m, 4H, ArH), 7.36-
7.21 (m, 6H, ArH), 5.53 (d, 1H, J = 3.1 Hz, CHPh), 5.29 (d, 1H, J = 5.5 Hz, OCH2O), 5.08 
(d, 1H, J = 5.5 Hz, OCH2O), 3.96 (d, 1H, J = 11.0 Hz, CH2OCH2), 3.83 (d, 1H, J = 11.0 
Hz, CH2OCH2), 3.55 (dq, 1H, J = 6.4, 3.1 Hz, CHCH3), 3.35 (d, 1H, J = 13.1 Hz, PhCH2), 
3.05 (s, 3H, NCH3), 2.76 (d, 1H, J = 13.1 Hz, PhCH2), 1.14 (s, 3H, C-CH3), 1.03 (d, 3H, J 
= 6.4 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 165.1 (NC=O), 137.2 (ArCipso), 137.1 
(ArCipso), 131.1 (2 × ArC), 128.6 (2 × ArC), 128.0 (2 × ArC), 127.8 (ArC), 126.3 (ArC), 
125.4 (2 × ArC), 99.4 (O-C-C=O), 89.1 (OCH2O), 70.7 (PhCH), 70.2 (OCH2), 58.9 
(CHCH3), 41.4 (Bn-C-CH3), 38.6 (CH2Ph), 33.8 (NCH3), 18.0 (Bn-C-CH3), 12.7 (CHCH3); 
MS (APCI, pos.): m/z 382.2 (M+H)+; HRMS (EI, pos.): m/z 381.1952 (381.1940 calc. for 
C23H27NO4 (M
+)). 
(5R,6R,8R,9S)-5-Cyclopropyl-5,9,10-trimethyl-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (119): 
 
 The reaction of alkene 105 (40 mg, 0.15 mmol), paraformaldehyde (0.74 mmol), 
conc. H2SO4 (2 drops) in acetic acid (1 mL) for 2 min. at 85 °C according to General 
Procedure 4 provided, after purification by flash chromatography on silica gel 
 64 
 
(hexane/EtOAc, 7:3), 37 mg (77%) of 119 as a colorless liquid. Rf = 0.33 (hexane/EtOAc, 
1:1); [α]D20 = –36.1 (c 0.8, CH2Cl2); IR (neat): 2980, 2927, 2882, 1660, 1452, 1384, 1292, 
1206, 1164, 1127, 1095, 1065, 1031, 980, 961, 942, 839 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.46-7.29 (m, 5H, ArH), 5.42 (d, 1H, J = 3.1 Hz, PhCH), 5.08 (d, 1H, J = 5.6 Hz, OCH2O), 
4.90 (d, 1H, J = 5.6 Hz, OCH2O), 4.21 (d, 1H, J = 10.5 Hz, OCH2), 3.61 (d, 1H, J = 10.5 
Hz, OCH2), 3.51 (dq, 1H, J = 6.5, 3.1 Hz, CHCH3), 3.01 (s, 3H, NCH3), 1.13 (s, 3H, C-
CH3), 1.11-1.04 (m, 1H, C-CH), 1.01 (d, 3H, J = 6.5 Hz, CHCH3), 0.40-0.23 (m, 4H, 
CH2CH2); 
13C NMR (75 MHz, CDCl3) δ 164.8 (C=O), 137.4 (ArCipso), 128.7 (2 x ArC), 
128.0 (ArC), 125.5 (2 x ArC), 100.3 (O-C-O), 87.2 (OCH2O), 74.4 (OCH2), 71.0 (PhCH), 
59.3 (CHCH3), 40.6 (CCH3), 34.1 (NCH3), 15.1 (CHCH3), 13.2 (CCH3), 12.5 (CCH), -0.3 
(CH2CH2), -0.4 (CH2CH2); MS (APCI, pos.): m/z 332.2 (M+H)
+ and 272.2 (M-
C2H4O2+H)
+; HRMS (APPI, pos.): m/z 331.1777 (331.1784 calc. for C19H25NO4 (M
+)) and 
271.1567 (271.1572 calc. for C17H21NO2 (M-C2H4O2)
+). 
(5R,6R,8R,9S)-5,9,10-Trimethyl-5,8-diphenyl-1,3,7-trioxa-10-azaspiro[5.5]undecan-
11-one (120): 
 
 The reaction of alkene 106 (270 mg, 0.880 mmol), paraformaldehyde (4.34 mmol) 
in TFA (4 mL) for 18 h at RT according to General Procedure 3 provided, after purification 
by flash chromatography on silica gel (hexane/EtOAc, 7:3), 295 mg (92%) of 120 as a 
white foam. Rf = 0.28 (hexane/EtOAc, 6:4); mp = 58.9-60.7 °C; [α]D20 = +11.0 (c 1, 
CH2Cl2); IR (neat): 1656, 1493, 1448, 1383, 1238, 1161, 1091, 1029, 986 cm
-1; 1H NMR 
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(300 MHz, CDCl3): δ 7.40-7.27 (m, 7H, ArH), 7.24-7.16 (m, 3H, ArH), 5.22 (d, 1H, J = 
2.9 Hz, PhCH), 5.13 (d, 1H, J = 5.7 Hz, OCH2O), 5.04 (d, 1H, J = 10.3 Hz, OCH2), 4.91 
(d, 1H, J = 5.7 Hz, OCH2O), 3.82 (d, 1H, J = 10.3 Hz, OCH2), 3.22 (dq, 1H, J = 6.6, 2.9 
Hz, NCH), 2.93 (s, 3H, NCH3), 2.04 (s, 3H, C-CH3), -0.07 (d, 3H, J = 6.6 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 164.2 (C=O), 142.1 (ArCipso), 136.9 (ArCipso), 128.5 (2 x 
ArC), 128.2 (2 x ArC), 127.8 (ArC), 126.9 (2 x ArC), 126.8 (ArC), 125.4 (2 x ArC), 99.8 
(O-C-O), 86.8 (OCH2O), 71.7 (OCH2), 71.3 (PhCH), 59.1 (NCH), 44.8 (Ph-C-CH3), 33.8 
(NCH3), 22.2 (C-CH3), 10.6 (CHCH3); MS (APCI, pos.): m/z 368.4 (M+H)
+; HRMS (CI, 
pos.): m/z 368.1862 (368.1862 calc. for C22H26NO4 (M+H)
+). 
(5R,6R,8R,9S)-5,9,10-Trimethyl-5-(naphthalen-2-yl)-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (121): 
 
 The reaction of alkene 107 (41 mg, 0.11 mmol), paraformaldehyde (0.57 mmol), 
conc. H2SO4 (2 drops) in acetic acid (1 mL) for 20 min. at 85 °C according to General 
Procedure 4 provided, after purification by flash chromatography on silica gel 
(hexane/EtOAc, 7:3), 29 mg (60%) of 121 as a white solid. Rf = 0.34 (hexane/EtOAc, 1:1); 
mp = 142.3-144.1 °C; [α]D20 = +56.6 (c 1, CH2Cl2); IR (neat): 2981, 2921, 2871, 1657, 
1479, 1452, 1380, 1293, 1194, 1164, 1147, 1086, 1030, 993, 947 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.87-7.72 (m, 4H, ArH), 7.57-7.39 (m, 3H, ArH), 7.37-7.12 (m, 5H, ArH), 5.24 
(d, 1H, J = 2.7 Hz, CHPh), 5.18 (d, 1H, J = 5.5 Hz, OCH2O), 5.16 (d, 1H, J = 10.3 Hz, 
CH2OCH2), 4.96 (d, 1H, J = 5.5 Hz, OCH2O), 3.95 (d, 1H, J = 10.3 Hz, CH2OCH2), 3.18 
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(dq, 1H, J = 6.4, 2.7 Hz, CHCH3), 2.93 (s, 3H, N-CH3), 2.13 (s, 3H, C-CH3), -0.28 (d, 3H, 
J = 6.4 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 164.5 (NC=O), 139.8 (ArCipso), 137.0 
(ArCipso), 133.4 (ArC), 132.2 (ArC), 128.6 (2 × ArC), 128.1 (ArC), 127.9 (ArC), 127.7 
(ArC), 127.5 (ArC), 126.2 (ArC), 126.0 (2 × ArC), 125.5 (2 × ArC), 125.1 (ArC), 100.1 
(O-C-O), 87.1 (OCH2O), 72.1 (OCH2), 71.4 (PhCH), 59.3 (CHCH3), 45.1 (2-naphthyl-C-
CH3), 34.1 (N-CH3), 22.6 (2-naphthyl-C-CH3), 10.8 (CHCH3); MS (APCI, pos.): m/z 418.2 
(M+H)+ and 358.2 (M-C2H4O2+H)
+; HRMS (APPI, pos.): m/z 417.1957 (417.1940 calc. for 
C26H27NO4 (M
+)) and 357.1743 (357.1729 calc. for C24H23NO2 (M-C2H4O2)
+). 
(5R,6R,8R,9S)-5-(4-Methoxyphenyl)-5,9,10-trimethyl-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (122): 
 
 To a solution of the alkene 108 (150 mg, 0.440 mmol) in glacial acetic acid (2 mL) 
at room temperature was added paraformaldehyde (66 mg, 2.2 mmol) followed by 6 drops 
of conc. H2SO4 and the reaction mixture was stirred for 20 h at room temparature. The 
acetic acid was removed under reduced pressure. The residue was dissolved in ethyl acetate 
(5 mL) and the solution was washed with saturated aqueous NaHCO3 (1 x 3 mL), brine, 
dried over Na2SO4 and concentrated under reduced pressure. The residue was purified by 
flash column chromatography on silica gel (hexane/EtOAc, 7:3) to provide 56 mg (32%) 
of 122 as a gum. Rf = 0.28 (hexane/EtOAc, 3:2); [α]D20 = +38.7 (c 1, CH2Cl2); IR (neat): 
2957, 2927, 1663, 1516, 1457, 1381, 1295, 1255, 1192, 1166, 1094, 1033, 988 cm-1; 1H 
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NMR (300 MHz, CDCl3): δ 7.40-7.27 (m, 5H, ArH), 7.25-7.19 (m, 2H, ArH), 6.86 (d, 2H, 
J = 8.9 Hz, ArH), 5.23 (d, 1H, J = 2.9 Hz, CHPh), 5.13 (d, 1H, J = 5.6 Hz, OCH2O), 4.98 
(d, 1H, J = 10.3 Hz, CH2O), 4.91 (d, 1H, J = 5.6 Hz, OCH2O), 3.78 (d, 1H, J = 10.3 Hz, 
CH2O), 3.77 (s, 3H, OCH3), 3.24 (dq, 1H, J = 6.5, 2.9 Hz, CHCH3), 2.92 (s, 3H, NCH3), 
2.01 (s, 3H, Ar-C-CH3), 0.01 (d, 3H, J = 6.5 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 
164.2 (C=O), 158.3 (ArCipso), 137.0 (ArCipso), 134.2 (ArCipso), 128.5 (2 x ArC), 128.0 (2 x 
ArC), 127.8 (ArC), 125.4 (2 x ArC), 113.5 (2 x ArC), 99.9 (O-C-O), 86.8 (OCH2O), 71.9 
(CH2O), 71.3 (PhCH), 59.1 (CHCH3), 55.3 (OCH3), 44.21 (CH3-C-Ar), 33.9 (NCH3), 22.3 
(CHCH3), 10.8 (CH3-C-Ar); MS (APCI, pos.): m/z 398.2 (M+H)
+ and 338.2 (M-
C2H4O2+H)
+; HRMS (APPI, pos.): m/z 397.1907 (397.1889 calc. for C23H27NO5 (M
+)) and 
337.1694 (337.1678 calc. for C21H23NO3 (M-C2H4O2)
+). 
Benzyl-4-((5R,6R,8R,9S)-5,9,10-trimethyl-11-oxo-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-5-yl)phenylcarbamate (123): 
 
 The reaction of alkene 109 (53 mg, 0.11 mmol), paraformaldehyde (0.58 mmol), 
conc. H2SO4 (2 drops) in acetic acid (1 mL) for 50 min.at 85 °C according to General 
Procedure 4 provided, after purification by flash chromatography on silica gel 
(CH2Cl2/EtOAc, 9:1), 34 mg (58%) of 123 as a colorless liquid. Rf = 0.29 (CH2Cl2/EtOAc, 
85:15); [α]D20 = +32.2 (c 0.6, CH2Cl2); IR (neat): 3291, 1730, 1650, 1598, 1529, 1453, 
1406, 1323, 1295, 1216, 1194, 1165, 1090, 1066, 1031, 1012 cm-1; 1H NMR (300 MHz, 
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CDCl3): δ 7.41-7.27 (m, 12 H, ArH), 7.23-7.18 (m, 2H, ArH), 6.61 (br s, 1H, NH), 5.22 (d, 
1H, J = 2.8 Hz, PhCH), 5.18 (s, 2H, OCH2Ph), 5.12 (d, 2H, J = 5.6 Hz, OCH2O), 4.98 (d, 
1H, J = 10.3 Hz, CH2O), 4.90 (d, 1H, J = 5.6 Hz, OCH2O), 3.78 (d, 2H, J = 10.3 Hz, CH2O), 
3.24 (dq, 1H, J = 6.4, 2.8 Hz, CHCH3), 2.91 (s, 3H, NCH3), 2.00 (s, 3H, Ar-C-CH3), 0.05 
(d, 3H, J = 6.4 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 164.2 (NC=O), 153.2 (NCO2), 
137.2 (ArCipso), 136.9 (ArCipso), 136.4 (ArCipso), 135.9 (ArCipso), 128.6 (2 x ArC), 128.5 (2 
x ArC), 128.4 (ArC), 128.3 (2 x ArC), 127.8 (ArC), 127.6 (2 x ArC), 125.4 (2 x ArC), 
118.1 (2 x ArC), 99.8 (O-C-O), 86.8 (OCH2O), 71.8 (OCH2), 71.3 (PhCH), 67.0 (PhCH2), 
59.1 (CHCH3), 44.4 (Ar-C-CH3), 33.9 (NCH3), 22.2 (Ar-C-CH3), 10.9 (CHCH3); MS 
(APCI, pos.): m/z 517.2 (M+H)+, 457.2 (M-C2H4O2+H)
+ and (M-PhCH2)
+; HRMS (APPI, 
pos.): m/z 516.2259 (516.2260 calc. for C30H32N2O6 (M
+)) and 456.2048 (456.2049 calc. 
for C28H28N2O4 (M-C2H4O2)
+). 
Methyl 4-((5R,6R,8R,9S)-5,9,10-trimethyl-11-oxo-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-5-yl)benzoate (124): 
 
 The reaction of alkene 110 (390 mg, 1.07 mmol), paraformaldehyde (5.34 mmol) 
in TFA (5 mL) for 4.5 days at room tempearature according to General Procedure 3 
provided, after purification by flash chromatography on silica gel (hexane/EtOAc, 7:3), 389 
mg (86%) of 124 as a white solid. Rf = 0.30 (hexane/EtOAc, 3:2); mp = 117.4-119.2 °C; 
[α]D20 = +64.9 (c 1.1, CH2Cl2); IR (neat): 2989, 2941, 2892, 1705, 1652, 1447, 1394, 1283, 
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1188, 1154, 1087, 1020, 975 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.07-8.03 (m, 2H, ArH), 
7.51-7.47 (m, 2H, ArH), 7.43-7.32 (m, 3H, ArH), 7.24-7.21 (m, 2H, ArH), 5.29 (d, 1H, J = 
3.0 Hz, CHPh), 5.18 (d, 1H, J = 5.7 Hz, OCH2O), 5.08 (d, 1H, J = 10.3 Hz, CH2O), 4.98 
(d, 1H, J = 5.7 Hz, OCH2O), 3.95 (s, 3H, OCH3), 3.90 (d, 1H, J = 10.3 Hz, CH2O), 3.3 (dq, 
1H, J = 6.6, 3.0 Hz, CHCH3), 2.98 (s, 3H, NCH3), 2.10 (s, 3H, Ar-C-CH3), -0.01 (d, 3H, J 
= 6.6 Hz, CHCH3); 
13C NMR (75 MHz, CDCl3): δ 166.8 (CO2CH3), 164.0 (N-C=O), 147.6 
(ArCipso), 136.7 (ArCipso), 129.4 (2 x ArC), 128.5 (2 x ArC), 128.5 (ArCipso), 127.9 (2 x 
ArC), 127.0 (2 x ArC), 125.3 (2 x ArC), 99.5 (O-C-O), 86.9 (OCH2O), 71.6 (CH2O), 71.3 
(PhCH), 59.1 ( CHCH3), 52.1 (OCH3), 45.1 (Ar-C-CH3), 33.9 (NCH3), 22.1 (Ar-C-CH3), 
10.9 (CHCH3); MS (APCI, pos.): m/z 426.2 (M+H)
+ and 366.2 (M-C2H4O2+H)
+; HRMS 
(APPI, pos.): m/z 425.1838 (425.1838 calc. for C24H27NO6 (M
+)). 
(5R,6R,8R,9S)-5-Benzyl-5-ethyl-9,10-dimethyl-8-phenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (125): 
 
 The reaction of alkene 111 (100 mg, 0.290 mmol), paraformaldehyde (1.49 mmol) 
in TFA (1.5 mL) for 30 h at 0 °C according to General Procedure 3 provided, after 
purification by flash chromatography on silica gel (hexanes/EtOAc, 4:1), 83 mg (70%) of 
125 as a white solid. Rf = 0.39 (EtOAc/hexane, 2:3); mp = 133.1-135.6 °C; [α]D20 = –56.0 
(c 1, CH2Cl2); IR (neat): 2989, 2912, 2884, 1642, 1482, 1454, 1204, 1177, 1130, 1092, 
1015, 973, 917 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.44-7.18 (m, 10H, ArH), 5.69 (d, 1H, 
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J = 3.6 Hz, CHPh), 5.31 (d, 1H, J = 5.6 Hz, OCH2O), 5.08 (d, 1H, J = 5.6 Hz, OCH2O), 
4.23 (d, 1H, J = 12.0 Hz, CH2OCH2), 3.63 (d, 1H, J = 12.0 Hz, CH2OCH2), 3.57 (dq, 1H, 
J = 6.6, 3.6 Hz, CHCH3), 3.30 (d, 1H, J = 13.1 Hz, PhCH2), 3.03 (s, 3H, NCH3), 3.01 (d, 
1H, J = 13.1 Hz, PhCH2), 1.66-1.45 (m, 2H, CH2CH3), 1.01 (d, 3H, J = 6.6 Hz, CHCH3), 
0.93 (t, 3H, J = 7.6 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3): δ 165.1 (NC=O), 137.9 
(ArCipso), 137.3 (ArCipso), 131.1 (2 × ArC), 128.5 (2 × ArC), 128.0 (2 × ArC), 127.7 (ArC), 
126.2 (ArC), 125.5 (2 × ArC), 99.0 (O-C-O), 89.4 (OCH2O), 70.0 (CHPh), 68.7 (OCH2), 
58.6 (CHCH3), 44.2 (Bn-C-Et), 35.2 (br, CH2Ph), 33.7 (NCH3), 23.4 (Bn-C-CH2CH3), 13.0 
(CHCH3), 9.4 (CH2CH3); MS (APCI, pos.): m/z 396.2 (M+H)
+ and 336.2 ((M-
C2H4O2)+H)
+; HRMS (APPI, pos.): m/z 395.2106 (395.2097 calc. for C24H29NO4 (M
+)) 
and 335.1892 (335.1885 calc. for C22H25NO2 (M-C2H4O2)
+). 
(5R,6R,9S)-5-Ethyl-5,9,10-trimethyl-8,8-diphenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (126): 
 
     The reaction of alkene 112 (37 mg, 0.11 mmol), paraformaldehyde (0.55 mmol) in TFA 
(1 mL) for 27 h at 0 °C according to General Procedure 3 provided, after purification by 
flash chromatography on silica gel (CH2Cl2/EtOAc, 95:5), 32 mg (73%) of 126 as a white 
solid. Rf = 0.36 (CH2Cl2/EtOAc, 96:4); mp = 200.7-202.3 °C; [α]D20 = –317.8 (c 1, CH2Cl2); 
IR (neat): 2980, 2951, 1651, 1448, 1320, 1172, 1136, 1077, 1029, 997, 982, 953 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 7.38-7.08 (m, 10H, ArH), 4.87 (d, 1H, J = 5.8 Hz, OCH2O), 
 71 
 
4.43 (d, 1H, J = 5.8 Hz, OCH2O), 4.23 (q, 1H, J = 6.5 Hz, CHCH3), 4.09 (d, 1H, J = 10.7 
Hz, OCH2), 3.69 (d, 1H, J = 10.7 Hz, OCH2), 3.18 (s, 3H, NCH3), 1.71 (ABX3, 1H, JAB = 
13.7 Hz, JAX = JBX = 7.5 Hz, CH2CH3), 1.52 (ABX3, 1H, JAB = 13.7 Hz, JAX = JBX = 7.5 
Hz, CH2CH3), 1.28 (s, 3H, C-CH3), 0.98 (d, 3H, J = 6.5 Hz, CH3CH), 0.86 (t, 3H, J = 7.5 
Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3): δ 164.7 (NC=O), 144.5 (ArCipso), 142.9 
(ArCipso), 128.4 (2 × ArC), 128.3 (2 × ArC), 128.0 (ArC), 127.9 (2 × ArC), 127.3 (ArC), 
125.8 (2 × ArC), 99.3 (O-C-O), 87.4 (OCH2O), 79.9 (CPh2), 72.2 (OCH2), 59.7 (CHCH3), 
41.9 (Et-C-CH3), 34.2 (NCH3), 26.9 (CH2CH3), 19.0 (Et-C-CH3), 16.0 (CHCH3), 8.0 
(CH2CH3); MS (APCI, pos.): m/z 396.2 (M+H)
+ and 336.2 (M-C2H4O2+H)
+; HRMS (APPI, 
pos.): m/z 395.2106 (395.2097 calc. for C24H29NO4 (M
+)) and 335.1891 (335.1885 calc. for 
C22H25NO2 (M-C2H4O2)
+). 
(5S,6R,9S)-5-Ethyl-5,9,10-trimethyl-8,8-diphenyl-1,3,7-trioxa-10-
azaspiro[5.5]undecan-11-one (127): 
 
 The reaction of alkene 114 (50 mg, 0.15 mmol), paraformaldehyde (0.75 mmol) in 
TFA (1 mL) for 42 h at 0 °C according to General Procedure 3 provided crude 105 (dr = 
5:1). Purification by flash chromatography on silica gel (CH2Cl2/EtOAc, 98:2) provided 42 
mg (71%) of 127 as a single diaseteromer (white solid). Rf = 0.29 (CH2Cl2/EtOAc, 96:4); 
mp. = 152.3-153.9 °C; [α]D20 = –349.1 (c 1.2, CH2Cl2); IR (neat): 2971, 2924, 2883, 1660, 
1635, 1449, 1155, 1117, 1080, 1017, 986, 960, 945 cm-1; 1H NMR (500 MHz, CDCl3): δ 
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7.36-7.11 (m, 10H, ArH), 4.85 (d, 1H, J = 5.7 Hz, OCH2O), 4.55 (d, 1H, J = 5.7 Hz, 
OCH2O), 4.25 (q, 1H, J = 6.5 Hz, CHCH3), 3.93 (AB system, 2H, ∆νAB = 12.9 Hz JAB= 
11.2 Hz, OCH2), 3.17 (s, 3H, NCH3), 2.05 (ABX3, 1H, JAB = 14.1 Hz, JAX = JBX = 7.4 Hz 
CH2CH3), 1.53 (ABX3, 1H, JAB = 14.1 Hz, JAX = JBX = 7.4 Hz, CH2CH3), 1.08 (s, 3H, C-
CH3), 0.99 (d, 3H, J = 6.5 Hz, CH3CH), 0.84 (t, 3H, J = 7.4 Hz, CH2CH3); 
13C NMR (75 
MHz, CDCl3): δ 164.8 (NC=O), 144.4 (ArCipso), 142.8 (ArCipso), 128.3 (2 × ArC), 128.1 
(2 × ArC), 127.79 (ArC), 127.76 (2 × ArC), 127.1 (ArC), 125.7 (2 × ArC), 99.3 (O-C-O), 
87.6 (OCH2O), 79.9 (CPh2), 69.5 (OCH2), 59.4 (CHCH3), 41.7 (Et-C-CH3), 34.0 (NCH3), 
25.6 (CH2CH3), 18.1 (Et-C-CH3), 15.9 (CHCH3), 7.9 (CH3CH2); MS (APCI, pos.): m/z 
396.2 (M+H)+ and 336.2 (M-C2H4O2+H)
+; HRMS (APPI, pos.): m/z 395.2108 (395.2097 
calc. for C24H29NO4 (M
+)) and 335.1893 (335.1885 calc. for C22H25NO2 (M-C2H4O2)
+). 
 
Procedure for the synthesis of 138 and 139: 
 To anhydrous liquid ammonia (distilled over sodium) was added sodium metal at 
78 °C and the mixture was stirred for 15 min. To the resulting blue solution was added a 
solution of the Prins product in anhydrous THF and the mixture was stirred at -78 °C. A 
mixture of MeOH/H2O (3:1, 2 mL) was added and the reaction mixture was brought to 
ambient temperature and stirred for 8 h (for 139) or for 30 min (for 138). For 138, the 
resulting solution was diluted with water and extracted with ethylacetate. For 139, the 
aqueous solution was extracted with ethyl acetate and then acidified with aqueous 1.0 N 
HCl. Extraction of the acidic solution with ethyl acetate provided the crude product. 
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(3R)-2,4-Dihydroxy-N,3-dimethyl-3-phenylbutanamide (138): 
 
 Reduction of 120 (250 mg, 0.680 mmol) in anhydrous THF (2 mL) with sodium (94 
mg, 4.1 mmol) in liquid ammonia (6 mL) for 10 min followed by addition of MeOH/H2O 
and stirring at ambient temperature for 30 min., the residue was purified by flash 
chromatography on silica gel (hexane/EtOAc, 2:8) to provide 59 mg of major diastereomer 
and 28 mg of minor diastereomer (56% combined yield of the two isomers) of the -
hydroxyamide 138 (dr = 2:1) as a colorless gum. Major diastereomer: Rf = 0.24 
(hexanes/EtOAc, 1:9); [α]D20 = –31.5 (c 1, CH2Cl2); IR (neat): 3353 (br), 2932, 1645, 1539, 
1453, 1408, 1290, 1246, 1159, 1085, 1023 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.47-7.38 
(m, 4H, ArH), 7.35-7.29 (m, 1H, ArH), 5.05 (br s, 1H, NH), 4.52 (br s, 1H, CHOH), 4.12 
(d, 1H, J = 11.3, OCH2), 3.82 (s, 1H, OH), 3.65 (d, 1H, J = 11.3, OCH2), 3.10 (s, 1H, OH), 
2.63 (d, 3H, J = 4.9, NCH3), 1.40 (s, 3H, C-CH3); 
13C NMR (75 MHz, CDCl3): δ 172.6 
(C=O), 141.9 (ArCipso), 129.1 (2 x ArC), 127.6 (ArC), 126.9 (2 x ArC), 76.9 (PhCH), 70.7 
(OCH2), 47.2 (Ph-C), 26.2 (NCH3), 16.7 (C-CH3); MS (CI, pos.): m/z 206.1 (M-OH); 224.1 
(M+H)+; HRMS (CI, pos.): m/z 224.1292 (224.1287 calc. for C12H18NO3 (M+H)
+); Minor 
diastereomer: Rf = 0.25 (hexanes/EtOAc, 1:9); [α]D20 = – 52.2 (c 1, CH2Cl2); IR (neat): 
3351 (br), 2935, 1643, 1541, 1455, 1409, 1371, 1247, 1155, 1081, 1028, 910 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.54-7.51 (m, 2H, ArH), 7.41-7.36 (m, 2H, ArH), 7.32-7.29 (m, 1H, 
ArH), 6.80 (br s, 1H, NH), 4.59 (br s, 1H, CHOH), 4.32-4.29 (br t, 1H, J = 5.8, OH), 4.00 
(br dd, 1H, J = 3.3, 11.5, OCH2), 3.64 (br dd, 1H, J = 5.5, 11.5, OCH2), 2.87 (d, 3H, J = 
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5.0, NCH3), 1.60 (br s, 1H, OH), 1.30 (s, 3H, C-CH3); 
13C NMR (75 MHz, CDCl3): δ 173.1 
(C=O), 143.6 (ArCipso), 129.0 (2 x ArC), 127.3 (ArC), 126.6 (2 x ArC), 77.0 (C(O)CH), 
70.3 (OCH2), 47.8 (Ph-C), 25.8 (NCH3), 15.8 (CCH3); HRMS (APPI, pos.): m/z 223.1214 
(223.1208 calc. for C12H17NO3 (M)
+). 
 
(R)-2-Hydroxy-3-(hydroxymethyl)-3-methylheptanoic acid (139): 
 
 Reduction of 116 (250 mg, 0.720 mmol) in anhydrous THF (2.5 mL) with sodium 
(99 mg, 4.3 mmol) in liquid ammonia (6 mL) for 10 min followed by addition of 
MeOH/H2O and stirring at ambient temperature for 8 h provided 118 mg (86%) of the -
hydroxy carboxylic acid 139 (dr = 1:1) as a colorless liquid. Rf = 0.39 (hexane/EtOAc, 3:2); 
IR (neat): 3431, 2958, 2932, 2872, 2862, 1763, 1459, 1185, 1111, 1092, 999 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 4.20 (d, 1H, J = 9.1 Hz, CH2OH), 4.18 (s, 1H, CHOH), 4.14 (s, 1H, 
CHOH), 3.99 (AB system, 2H, ∆νAB = 14.7 Hz, J = 9.0 Hz, CH2OH), 3.87 (d, 1H, J = 9.1 
Hz, CH2OH), 3.59 (br s, 1H, CO2H), 1.67-1.22 (m, 12H, CH2), 1.20 (s, 3H, C-CH3), 1.08 
(s, 3H, C-CH3), 0.92 (t, 3H, J = 7.0 Hz, CH2CH3), 0.91 (t, 3H, J = 7.0 Hz, CH2CH3); 
13C 
NMR (75 MHz, CDCl3): δ 178.11 (C=O), 178.06 (C=O), 76.0 (CHOH), 75.9 (CH2OH), 
75.4 (CHOH), 74.2 (CH2OH), 43.9 (nBu-C-CH3), 43.4 (nBu-C-CH3), 37.4 (CH2), 31.2 
(CH2), 26.4 (CH2), 26.1 (CH2), 23.3 (CH2), 23.2 (CH2), 21.5 (CH3), 16.5 (CH3), 14.0 (CH3), 
13.9 (CH3); MS (APCI, neg.): m/z 189.0 (M-H); HRMS (APPI, neg.): m/z 190.1198 
(190.1205 calc. for C9H18O4 (M)
-). 
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General procedure for conversion of the Prins products into β-hydroxy carboxylic 
acids: 
 To anhydrous liquid ammonia (distilled over sodium) was added sodium metal at 
78 °C and the mixture was stirred for 15 min. To the resulting blue solution was added a 
solution of the Prins product in anhydrous THF and the mixture was stirred at -78 °C. A 
mixture of MeOH/H2O (3:1, 2 mL) was added and the reaction mixture was brought to 
ambient temperature and stirred for 8-9 h. Water (2 mL) was added and the mixture was 
extracted with ethylacetate (1 x 10 mL). The aqueous layer was acidified to pH ~4 with 1M 
HCl and the mixuture was extracted with ethyl acaetate. The combined extracts were dried 
over Na2SO4 and concentrated under reduced pressure to provide the hydroxy carboxylic 
acid. This was used in the next step without purification. 
 To a stirred solution of the hydroxy carboxylic acid in THF at 0 ºC was added a 
solution of BH3•THF (1M solution in THF) and the mixture was stirred at room temperature 
until complete consumption of the acid (TLC). The mixture was cooled to 0 °C, acidified 
with aqueous HCl (1M, 2 mL), stirred at room temperature for 15 min and then extracted 
with ethyl acetate (3 x 10 mL). The combined extracts were washed with aq. NaOH (10%) 
followed by brine and then dried over Na2SO4 and concentrated under reduced pressure to 
provide the product triol. This was used in the next step without purification. 
 To a stirred solution of the triol in MeOH/H2O (100/1) at 0 ºC was added NaIO4. 
The mixture was stirred at room temperature until complete consumption of the triol (TLC) 
and cold, aqueous saturated sodium bicarbonate was added. The mixture was extracted with 
ethyl acetate (3 x 15 mL) and the combined extracts were washed with brine, dried over 
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Na2SO4 and concentrated under reduced pressure to provide the product aldehyde. This was 
used in the next step without purification.  
 To a solution of the aldehyde in t-butyl alcohol were added a solution of 2-methyl-
2-butene (2M solution in THF) followed by a solution of NaClO2 and NaH2PO4 in H2O       
(1 mL). The resulting solution was stirred at room temperature and the mixture was then 
concentrated under reduced pressure. The residue was treated with aq. NaOH (10%, 2 mL), 
the mixture was stirred at room temperature for 30 min and then extracted with ethyl acetate 
(1 x 10 mL). The aqueous layer was acidified to pH ~4 with aqueous HCl (1.0 M, 2 mL) 
and extracted with ethyl acetate. The combined extracts were dried over Na2SO4 and 
concentrated under reduced pressure provide the pure hydroxy carboxylic acid. 
 
(S,E)-Ethyl 4-(hydroxymethyl)-4-methyloct-2-enoate (142): 
 
 This was prepared from 116 by adaptation of the general procedure upto the 
aldehyde stage. Reduction of the Prins product 116 (250 mg, 0.720 mmol) in anhydrous 
THF (2.5 mL) with sodium (99 mg, 4.3 mmol) in liquid ammonia (6 mL) for 10 min 
followed by addition of MeOH/H2O and stirring at ambient temperature for 8 h provided 
118 mg (86%) of the -hydroxy carboxylic acid as a colorless liquid. Reduction of this acid 
(89 mg, 0.47 mmol) in THF (2 mL) with BH3·THF (4.7 mL, 1.0 M solution in THF, 4.7 
mmol) for 37 h provided 76 mg (93%) of the product triol as a colorless liquid. Oxidative 
 77 
 
cleavage of the triol (76 mg, 0.43 mmol) with NaIO4 (369 mg, 1.73 mmol) in MeOH/H2O 
(100/1, 3 mL) for 3 h, provided 53 mg (85%) of the aldehyde as a colorless liquid. The 
aldehyde was subjected to a Horner-Wadsworth-Emmons reaction. Reaction of the 
aldehyde (62 mg, 0.43 mmol) in acetonitrile (1 mL) with triethylphosphonoacetate (0.13 
mL, 0.64 mmol) and DBU (96 µL, 0.64 mmol) at ambient temperature for 3 h gave after 
purification by flash chromatography on silica gel (hexane/EtOAc, 4:1), 49 mg (53%) of 
142 as a colorless liquid. Rf = 0.31 (hexane/EtOAc, 7:3); [α]D20 = +9.1 (c 1.2, CH2Cl2); IR 
(neat): 3444, 2958, 2931, 2872, 2862, 1715, 1700, 1648, 1465, 1367, 1309, 1269, 1180, 
1034, 991 cm-1; 1H NMR (300 MHz, CDCl3): δ 6.90 (d, 1H, J = 16.0 Hz, HC=CHCO2Et), 
5.81 (d, 1H, J =16.0 Hz, HC=CHCO2Et), 4.19 (q, 2H, J = 7.1 Hz, OCH2CH3), 3.46 (AB 
system, 2H, ∆νAB = 20.0 Hz J = 10.7 Hz, CH2OH), 1.49-1.09 (m, 6H, CH2), 1.30 (t, 3H, J 
= 7.1 Hz, OCH2CH3), 1.06 (s, 3H, CCH3), 0.89 (t, 3H, J = 7.0 Hz, CH2CH3); 
13C NMR (75 
MHz, CDCl3): δ 116.8 (C-C=O), 154.5 (HC=CHCO2Et), 120.7 (HC=CHCO2Et), 69.8 
(CH2OH), 60.4 (OCH2CH3), 42.4 (CH3-C-nBu), 36.7 (C-CH2), 26.0 (CH2), 23.4 (CH2), 
19.8 (C-CH3), 14.3 (CH3), 14.0 (CH3); MS (APCI, pos.): m/z 215.1 (M+H)
+, 197.1 (M-
OH)+ and 169.1 (M-OC2H5)
+; HRMS (APPI, pos.): m/z 214.1566 (214.1569 calc. for 
C12H22O3 (M
+)). 
(R)-2-(Hydroxymethyl)-2-methylhexanoic acid (146): 
 
 This was prepared from 116 by adaptation of the general procedure upto the 
aldehyde stage. Oxidation of the aldehyde (52 mg, 0.36 mmol) with NaClO2 (130 mg, 1.44 
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mmol) and NaH2PO4 (172 mg, 1.44 mmol) in 1 mL H2O, t-butyl alcohol (3 mL), 2-methyl-
2-butene (1.8 mL, 2.0 M solution in THF, 3.6 mmol) and for 15 h provided 35 mg (61%) 
of the carboxylic acid 146 as a colorless liquid. Rf = 0.29 (hexane/EtOAc, 7:3); [α]D20 = –
14.5 (c 0.8, CHCl3); IR (neat): 3439 (br), 2929, 1699, 1461, 1407, 1381, 1282, 1220, 1160, 
1032 cm-1. 1H NMR (300 MHz, CDCl3): δ 7.0-5.5 (br, CO2H), 3.75 (d, 1H, J = 9.5 Hz, 
OCH2), 3.52 (d, 1H, J = 9.5 Hz, OCH2), 1.69-1.53 (m, 2H, CH2), 1.30-1.26 (m, 4H, CH2) 
1.22 (s, 3H, C-CH3), 0.90 (t, 3H, J = 6.5 Hz, CH2CH3); 
13C NMR (75 MHz, CDCl3): δ 
182.9 (C=O), 68.0 (OCH2), 47.7 (C-C=O), 35.5 (C-CH3), 26.3 (CH2), 23.2 (CH2), 19.4 
(CH2), 13.9 (CH2CH3); MS (APCI, neg.): m/z159.1 (M-H)
-; HRMS (CI neg.): m/z159.1028 
(159.1021 calc. for C8H15O3 (M-H)
-. 
(R)-3-Hydroxy-2-methyl-2-phenylpropanoic acid (147): 
 
 Prepared according to the general procedure. Reduction of the Prins product 120 
(185 mg, 0.500 mmol) in anhydrous THF (1.5 mL) with sodium (103 mg, 4.50 mmol) in 
liquid ammonia (5 mL) for 10 min followed by addition of MeOH/H2O and stirring at 
ambient temperature for 8 h provided 75 mg (71%) of the -hydroxy carboxylic acid (dr 
=3.5:1) as a colorless liquid. Reduction of this acid (60 mg, 0.28 mmol) in THF (1 mL) 
with BH3·THF (2.85 mL, 1.00 M solution in THF, 2.85 mmol) for 27 h provided 42 mg 
(75%) of the product triol as a colorless liquid. Oxidative cleavage of the triol (39 mg, 0.19 
mmol) with NaIO4 (170 mg, 0.790 mmol) in MeOH/H2O (100/1, 2 mL) for 3 h, provided 
28 mg (87%) of the aldehyde as a colorless liquid. Oxidation of the aldehyde (27 mg, 0.16 
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mmol) with NaClO2 (59 mg, 0.65 mmol) and NaH2PO4 (78 mg, 0.65 mmol) in 1 mL H2O, 
t-butyl alcohol (2 mL), 2-methyl-2-butene (0.80 mL, 2.0 M solution in THF, 1.6 mmol) 
and for 12 h provided 22 mg (74%) of the carboxylic acid 147 as a colorless liquid. Rf = 
0.24 (hexane/EtOAc, 65:35); [α]D20 = +23.6 (c 1.9, EtOH), lit.17 [α]D20 = +26.6 (c 2, EtOH), 
IR (neat): 3061 (br), 1701, 1498, 1454, 1379, 1254, 1157, 1122, 1027 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.39-7.29 (m, 5H, ArH), 4.12 (d, 1H, J= 11.5 Hz, OCH2), 3.70 (d, 1H, J 
= 11.5 Hz, OCH2), 1.70 (s, 3H, CH3); 
13C NMR (75 MHz, CDCl3): δ 180.9 (C=O), 139.6 
(ArCipso), 128.7 (2 x ArC), 127.7 (ArC), 126.3 (2 x ArC), 69.1 (OCH2), 52.4 (Ph-C), 20.1 
(C-CH3); MS (APCI, neg.): m/z 179.1 (M–H)-; HRMS (CI pos.): m/z 181.0872 (181.0865 
calc. for C10H13O3 (M+H)
+). 
(R)-3-Hydroxy-2-methyl-2-p-tolylpropanoic acid (148): 
 
  Prepared according to the general procedure. Reduction of the Prins product 115 
(150 mg, 0.33 mmol) in anhydrous THF (2 mL) with sodium (45 mg, 2.0 mmol) in liquid 
ammonia (5 mL) for 3 min. followed by addition of MeOH/H2O and stirring at ambient 
temperature for 9 h provided 59 mg (81%) of the -hydroxy carboxylic acid (single 
diastereomer) as a white foam. Reduction of this acid (35 mg, 0.15 mmol) in THF (1 mL) 
with BH3·THF (1.56 mL, 1.00 M solution in THF, 1.56 mmol) for 47 h provided 30 mg 
(91%) of the product triol as a colorless liquid. Oxidative cleavage of the triol (30 mg, 0.14 
mmol) with NaIO4 (122 mg, 0.570 mmol) in MeOH/H2O (100/1, 2 mL) for 3 h, provided 
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24 mg (96%) of the aldehyde as a colorless liquid. Oxidation of the aldehyde (24 mg, 0.13 
mmol) with NaClO2 (49 mg, 0.54 mmol) and NaH2PO4 (65 mg, 0.54 mmol) in 1 mL H2O, 
t-butyl alcohol (2 mL), 2-methyl-2-butene (0.670 mL, 2.00 M solution in THF, 1.34 mmol) 
and for 15 h provided 19 mg (73%) of the carboxylic acid 148 as a white solid. Rf = 0.40 
(hexane/EtOAc, 1:1); mp = 103.8-104.9 °C; [α]D20 = +31.2 (c 0.7, CHCl3), lit.18 [α]D20 =     
–39 (c 1, CHCl3) for the S enantiomer); IR (neat): 3423, 2981, 2923, 2636, 1700, 1514, 
1455, 1393, 1264, 1250, 1208, 1195, 1031, 1018 cm-1; 1H NMR (300 MHz, acetone-d6): δ 
7.15 (d, 2H, J = 8.1 Hz, ArH), 7.00 (d, 2H, J = 8.1 Hz, ArH), 3.98 (d, 1H, J = 10.6 Hz, 
CH2OH), 3.57 (d, 1H, J = 10.6 Hz, CH2OH), 3.40-2.40 (br, CO2H), 2.16 (s, 3H, ArCH3), 
1.45 (s, 3H, C-CH3); 
13C NMR (75 MHz, acetone-d6): δ 176.7 (C=O), 139.8 (ArCipso), 
137.0 (ArCipso), 129.7 (2 × ArC), 127.1 (2 × ArC), 69.2 (CH2OH), 52.7 (CH3-C-Ar), 21.1 
(ArCH3 or CH3-C-Ar), 20.9 (ArCH3 or CH3-C-Ar); MS (APCI, neg.): m/z 193.0 (M-1); 
HRMS (APPI, neg.): m/z 194.0955 (194.0943 calc. for C11H14O3 (M)). 
(R)-2-Benzyl-2-(hydroxymethyl)butanoic acid (149): 
 
 Prepared according to the general procedure. Reduction of the Prins product 125 
(120 mg, 0.300 mmol) in anhydrous THF (4 mL) with sodium (104 mg, 4.54 mmol) in 
liquid ammonia (7 mL) for 35 min followed by addition of MeOH/H2O and stirring at 
ambient temperature for 8 h provided 55 mg (90%) of the -hydroxy carboxylic acid (dr = 
1.4:1) as a colorless liquid. Reduction of this acid (50 mg, 0.21 mmol) in THF (2 mL) with 
BH3·THF (2.1 mL, 1.0 M solution in THF, 2.1 mmol) for 50 h provided 45 mg (95%) of 
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the product triol as a colorless liquid. Oxidative cleavage of the triol (44 mg, 0.19 mmol) 
with NaIO4 (168 mg, 0.780 mmol) in MeOH/H2O (100/1, 2 mL) for 6 h, provided 35 mg 
(94%) of the aldehyde as a colorless liquid. Oxidation of the aldehyde (34 mg, 0.17 mmol) 
with NaClO2 (64 mg, 0.70 mmol) and NaH2PO4 (84 mg, 0.70 mmol) in 1 mL H2O, t-butyl 
alcohol (2 mL), 2-methyl-2-butene (0.88 mL, 2.0 M solution in THF, 1.8 mmol) and for   
12 h provided 28 mg (76%) of the carboxylic acid 149 as a white solid. Rf = 0.44 
(hexane/EtOAc, 1:1); mp = 97.8-99.3 °C; [α]D20 = –15.1 (c 1, MeOH); IR (neat): 3436, 
3029, 2967, 2920, 2881, 1710, 1694, 1382, 1316, 1210, 1157, 1133, 1053, 965 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 7.33-7.19 (m, 5H, ArH), 7.00-5.90 (br, CO2H), 3.74 (d, 1H, J 
= 11.4 Hz, CH2OH), 3.53 (d, 1H, J = 11.4 Hz, CH2OH), 3.14 (d, 1H, J = 13.4 Hz, PhCH2), 
2.89 (d, 1H, J = 13.4 Hz, PhCH2), 1.73 (ABX3, 1H, JAB = 14.4 Hz, JAX = JBX = 7.3 Hz, 
CH3CH2), 1.54 (ABX3, 1H, JAB = 14.4 Hz, JAX = JBX = 7.3 Hz, CH3CH2), 0.93 (t, 3H, J = 
7.3 Hz, CH3CH2); 
13C NMR (75 MHz, CDCl3): δ 181.9 (C=O), 136.6 (ArCipso), 130.3 (2 × 
ArC), 128.2 (2 × ArC), 126.7 (ArC), 63.2 (CH2OH), 52.5 (Et-C-Bn), 38.4 (PhCH2), 26.1 
(CH3CH2), 8.7 (CH3CH2); MS (APCI, neg.): m/z 207.0 (M-1)
-; HRMS (APPI, neg.): m/z 
208.1093 (208.1099 calc. for C12H16O3 (M
-)). 
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1.9 Selected 1H NMR and 13C NMR Spectra 
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3-Alkyl/Aryl Tetronic Acids for the Construction of Functionalized 
Quaternary Stereocenters 
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2.1 Introduction 
Enantiomerically enriched and functionalized quaternary stereocenter-containing 
furan-2,4(3H,5H)-diones are important building blocks in organic synthesis and 
functionalized furan-2,4-diones are used as intermediates in the syntheses of several natural 
products and pharmaceuticals.1 Some examples of natural products with quaternary 
stereocenters are trisporic acid A (1),2 trisporic acid B (2),2 trisporic acid C (3), trisporic 
acid D (4), trisporic acid E (5), saudin (6),3 (+)-cassiol (7),4 ()-cassioside (8),4 
fraxinellonone (9),5 fraxinellone (10), and isofraxinellone (11, Figure 2.1).1-5 The complex 
natural product, saudin (6), which has hypoglycemic activity,2 was isolated from the leaves 
of the plant Clutia richardiana. (+)-Cassiol (7) and ()-cassioside (8) are obtained from the 
stem of Cinnamomum cassia Blume and show potent antiulcer activity.4 Fraxinellonone (9) 
was isolated from rutaceae and meliaceae plants and it shows antifeeding and growth- 
regulating activities against insects.5  
 
Figure 2.1 Selected quaternary stereocenter-containing natural products. 
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Dihydrofuran-2(3H)-ones with vinylogous carboxylic acids are named as tetronic 
acids 12. Whereas pyrrolidin-2-ones with vinylogous carboxylic acids are called tetramic 
acids 13 (Figure 2.2).  
 
Figure 2.2 Generic structures of 3-substituted tetronic and tetramic acids. 
2.2 Asymmetric Michael additions of tetronic acids 
To the best of our knowledge, there is only one report on the Michael addition of 
tetronic acids. Recently, Ramachary and coworkers reported1 the asymmetric cascade 
Michael-aldol reactions of 3-alkyl tetronic acids 17 with the alkyl vinyl ketones in the 
presence of L-proline or quinine/TCA (trichloroacetic acid) as catalysts (Scheme 2.1). The 
first part of this methodology describes the synthesis of a variety of 3-alkyl tetronic acids 
17 from tetronic acid (14) by the S-proline-catalyzed three-component reductive alkylation 
(TCRA) reaction. The proline-catalyzed reactions of tetronic acid (14) with aryl aldehydes 
or alkyl aldehydes using Hantzsch ester (15) as the reducing agent provided the 
corresponding 3-alkyl tetronic acids 17 in 50-95% yields. Next, asymmetric cascade 
Michael-aldol reactions of 3-alkyl tetronic acids 17 with alkyl vinyl ketones were 
investigated using a variety of chiral primary/secondary and cinchona alkaloids as catalysts. 
From the catalyst survey, S-proline and 9-amino-9-deoxyepiquinine/TCA provided 
moderate enantioselectivities for the corresponding bicyclic lactones 18 and 19 (30-50% ee 
with S-proline and 34-60% ee with quinine/TCA, Scheme 2.1). 
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Scheme 2.1 Michael-aldol reaction of 3-alkyl tetronic acids with alkyl vinyl ketones 
2.3 Objective  
As presented above, a single report1 has described the use of asymmetric Michael 
addition reactions of 3-alkyl tetronic acids to obtain functionalized quaternary stereocenter-
containing bicyclic-alcohols 18 and 19. However, this study only reported vinyl ketones as 
the Michael acceptors and the enantiomeric excess of 18 and 19 is low. Thus, a general 
method that provides quaternary stereocenter-containing furan-2,4-diones, precursors of 
bicyclic-alcohols 18 and 19, with good enantiomeric excess would be useful.  
With this objective in mind, the main focus of our studies was the enantioselective 
synthesis of functionalized quaternary stereocenter containing furan-2,4-diones 23 and 
pyrrolidine-2,4-diones 24 from 3-alkyl-and/or 3-aryl tetronic acids 20 and 3-alkyl-and/or 
3-aryl tetramic acids 21 respectively (Scheme 2.2). Our approach relies on the 
organocatalytic conjugate additions of a variety of 3-alkyl-and/or 3-aryl tetronic acids 20 
or 3-alkyl-and/or 3-aryl tetramic acids 21 to a variety of α,β-unsaturated systems 22 
(Michael acceptors) in the presence of chiral bifunctional catalysts such as aminothioureas 
and aminosquaramides (Scheme 2.2). 
136 
 
 
Scheme 2.2 Strategy for the Michael additions of tetronic or tetramic acids to α,β-
unsaturated systems. 
 If successful, the Michael adducts obtained from this methodology can be useful 
intermediates in natural product synthesis. For example, the conversion of Michael adduct 
26 to the bicyclic-ketone 27 (Scheme 2.3) is known1. White and coworkers6 first reported 
the synthesis of 27 (kwon as White’s intermediate), which was used as a key intermediate 
in the synthesis of natural products such as fraxinellonone (9), saudin (6), trisporic acids 
A-B (1-2) and (+)-cassiol (7, Scheme 2.3).1-6 Using our proposed methodology, the key 
chiral intermediate 27 can be synthesized enantioselectively from 25 (Scheme 2.3). 
 
Scheme 2.3 Our synthetic strategy for the synthesis of White intermediate 27. 
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2.3.1 Previous reports on the asymmetric synthesis of the White’s intermediate  
 In 1994, Rúveda and coworkers reported2 the synthesis of key intermediate 27 from 
28 via a chiral auxiliary-controlled asymmetric Michael addition reaction as the key step 
(Scheme 2.4). The reaction of 28 with ethyl vinyl ketone provided 30 as mixture of 
diastereomers (dr = 7:2:0.5:0.5). The diastereomeric adducts 30 were subjected to 
dehydration in the presence of CuSO4 adsorbed on the silica gel to give 31, which was then 
treated with aqueous 6 N HCl to furnish 32 in 73% yield. 32 was transformed into White’s 
intermediate 27 by NaBH4 reduction followed by Jones oxidation of the resulting lactol. 
(Scheme 2.4).  
 
Scheme 2.4 Synthesis of White’s intermediate 27 from 28 
Ramachary and coworkers1 applied their methodology (Scheme 2.1) in the 
synthesis of 27 (Scheme 2.5). The S-proline-catalyzed reaction of methyl tetronic acid (25) 
with ethyl vinyl ketone afforded 26 in 95% yield with very low enantioselectivity (<5% 
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ee). The Michael adduct 26 then subjected to a kinetic resolution using S-proline as the 
catalyst (Scheme 2.5) to provide a mixture of bicyclic-alcohol 33 with improved ee (72% 
ee) and unreacted 26. Dehydration of 33 furnished bicyclic-ketone 27 with 72% ee (Scheme 
2.5). 
 
Scheme 2.5 Synthesis of White’s intermediate 27 from 25 
In 2011, Boeckman and coworkers also reported3d an asymmetric synthesis of the 
White intermediate 27, which was then used as a key starting material in the total synthesis 
of ()-saudin (6, Scheme 2.6). Chiral primary amine 34 was condensed with methyl tetronic 
acid (25) to give enamine 35, which was treated with ethyl vinyl ketone (EVK) in the 
presence of TMSCl/ZnCl2 to give 26 with 60% ee and 73% yield. As in Ramachary’s 
synthesis (Scheme 2.5), a kinetic resolution of 26 was achieved by intramolecular aldol 
reaction of 26 with S-proline to provide a mixture of 33 (55%) with improved enantiomeric 
excess (89% ee) along with unreacted starting material 26 in 45% yield. Dehydration of 33 
gave the key intermediate 27 (Scheme 2.6).  
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Scheme 2.6 Synthesis of White’s intermediate using chiral amine 34 
As described above (Schemes 2.4-2.6), only three reports are available on the 
asymmetric synthesis of the White intermediate 27. The Ramachary and Boeckman 
approaches (Schemes 2.4 and 2.6) are limited by the low to moderate enantioselectivities 
for the Michael adducts. Although the enantiomeric excess of the Michael adducts was 
improved by kinetic resolution, only half of the material can be converted to the product. 
Furthermore, although Rúveda’s auxiliary-controlled synthesis2 gives 27 with good 
enantiomeric excess (94% ee, Scheme 2.4), this method requires the use of stoichiometric 
amounts of 8--naphthylmenthol as the chiral auxiliary. Notably, the Boeckman procedure 
also employs stoichiometric amounts of a chiral amine as the auxiliary. In order to 
overcome these limitations, it was decided to investigate a general, organocatalytic 
asymmetric synthesis of functionalized quaternary stereocenter containing furan-2,4-
diones. 
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2.4 Results and Discussion  
In initial studies, several classes of chiral bifunctional and primary/secondary amine 
catalysts have been examined for Michael addition reactions of a variety of 3-alkyl-and/or 
3-aryl tetronic acids or 3-alkyl-and/or 3-aryl tetramic acids with α,β-unsaturated systems. 
The chiral catalysts that were examined are: (i) cyclohexanediamine,7a stilbenediamine,7b 
cinchonidine,7c,d cinchonine7e,f and proline-derived thioureas (36, 37, 38, 39 and 40), (ii) 
cyclohexanediamine, stilbenediamine, cinchonidine, cinchonine and (S)-(−)-2,2′-diamino-
1,1′-binaphthalene (DABN)-derived squaramides (41, 42, 43, 44 and 45),7g-j (iii) 
MacMillan’s catalysts 46 and 47, (iv) proline-derived catalysts 48 and 49, (v) primary 
amine catalysts 50, 34 and 55 and (vi) cinchona alkaloids 52-54 (Figure 2.3). 
 
Figure 2.3 Chiral organocatalysts examined for the Michael addition of tetronic acids 
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 Initially, a catalyst survey for the Michael addition reactions of methyl tetronic acid 
(25) with methyl vinyl ketone (MVK) was conducted. Reactions with the aminothiourea 
catalysts (36-40) were feasible. When catalyst 36 was used, the expected product 56 was 
obtained with 39% ee (36% yield, Table 2.1, entry 1). Reactions of 25 with MVK in the 
presence of selected aminosquarmide catalysts (41-44) provided 56 in 22-88% yields, but 
with low to moderate enantioselectivities (16-49% ee, Table 2.1, entries 6-9). With catalyst 
41, 56 was obtained with 49% ee (22% yield, Table 2.1, entry 6). Similarly, reactions were 
conducted with 42 at room temperature as well as at 0 ºC to afford 56 with 33% ee and 47% 
ee, respectively (Table 2.1, entries 7 and 8). Although cooling the reaction to 0 ºC improved 
the ee of 56 to 47%, the enantioselectivity decreased to 38% when the reaction was 
conducted at 15 ºC (Table 2.1, entry 9). This may be due to the low solubility of the 
catalyst at 15 ºC. Low to moderate enantioselectivities were also obtained with all of the 
other catalysts, except for 46 and 47 which failed to provide any of the required product. 
These results are summarized in Table 2.1.  
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Table 2.1 Catalyst survey for the Michael addition of methyl tetronic acid (25) to MVK. 
 
Entry Catalyst Time Temp Yield (%)a ee (%)b 
1 36 20 h 0 ºC 36 39 
2 37 185 h 0 ºC 29 33 
3 38 186 h 0 ºC 62 27 
4 39 188 h 0 ºC 61 18 
5 40 206 h 0 ºC 27 18 
6 41 20 h 0 ºC 22 49 
7 42 36 h rt 88 33 
8 42 6 h 0 ºC 31 47 
9 42 53 h -15 ºC 24 38 
10 43 208 h 0 ºC 62 23 
11 44 209 h 0 ºC 71 16 
12 46 240 h 0 ºC - - 
13 47 240 h 0 ºC - - 
14 52 115 h 0 ºC 35 12 
15 53 115 h 0 ºC 43 10 
16 54 115 h 0 ºC 43 5 
17 Sc(OTf)3 +R-BINOL 120 h rt 76 5 
18 48+PTSA 57 h rt 26 8 
19 34 72 h rt 64 4 
aisolated yields, bchiral HPLC 
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In related studies, a catalyst survey for the Michael addition reactions of phenyl 
tetronic acid (57) with methyl vinyl ketone (MVK) was also conducted. All of the selected 
aminothiourea catalysts (36-40) were capable of providing the Michael adduct, but with 
low enantioselectivities (6-16% ee, Table 2.2, entries 1-5). With catalyst 36, the expected 
product 58 was obtained in 88% yield, but only 16% ee (Table 2.2, entry 1), which is the 
best result with aminothiourea catalysts examined in this study. Similarly, reactions were 
also feasible in the presence of the squaramide catalysts 41-44 (Table 2.2, entry 6-9) but 45 
failed to catalyze the reaction. Reactions with catalyst 42 were conducted at room 
temperature as well as at reflux in CH2Cl2 to furnish 58 with 39% ee and 36% ee 
respectively (Table 2.2, entries 7 and 8). When catalyst 34 was used, the Michael adduct 
58 was obtained as the minor product (27%, Table 2.2, entry 17), with 59, the product of 
an intramolecular aldol reaction of 58 being the major product (67% yield, 5% ee). 
Unfortunately, as with the tetronic acid 25, the reactions of the tetronic acid 57 also 
provided the Michael adduct 58 in good yield but the enantioselectivities were low to 
moderate only. These results are summarized in Table 2.2. 
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Table 2.2 Catalyst survey for the Michael addition of phenyl tetronic acid (57) to MVK 
 
Entry Catalyst Time Yield (%)a ee of 58 (%)b 
1 36 150 h 88 16 
2 37 151 h 95 14 
3 38 212 h 76 8 
4 39 120 h 87 6 
5 40 152 h 65 11 
6 41 120 h 13 4 
7 42 89 h 43 39 
8c 42 30 h 57 36 
9 43 167 h 67 27 
10 44 79 h 32 27 
11 45 168 h - - 
12d 46 140 h 90 3 
13d 47 408 h 45 rac 
14d Sc(OTf)3 + 42 197 h 11 rac 
15 49 72 h 80 rac 
16 50 90 h 55 4 
17e 34 20 h 27 rac 
aisolated yields; bchiral HPLC; creaction under reflux; dreaction in CHCl3; 
ecatalyst 34 
gave 58 and 59 
 The organocatalytic Michael additions of benzyl tetronic acid (60) to methyl vinyl 
ketone (MVK) were also examined with the aminothioureas (36-40), aminosquaramides 
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(41-44) and MacMillan’s catalysts (46 and 47). With catalyst 36, the expected product 61 
was obtained in 89% yield and 24% ee (Table 2.3, entry 1), which is the best result obtained 
for 61 in terms of enantioselectivity. Although all of the catalysts examined provided the 
Michael adduct 61 in excellent yield, the enantioselectivities for these reactions were low. 
These results are summarized in Table 2.3. 
Table 2.3 Catalyst survey for the Michael addition of benzyl tetronic acid (61) to MVK. 
 
S. No Catalyst Time Yield (%)c ee (%)d 
1 36 195 h 89 24 
2 37 192 h 89 13 
3 38 63 h 94 7 
4 39 149 h 96 5 
5 40 196 h 95 12 
6 41 96 h 89 13 
7 42 96 h 82 19 
8a 42 55 h 35 18 
9 43 48 h 91 16 
10 44 124 h 96 11 
11b 46 103 h 29 rac 
12b 47 144 h 26 7 
areaction at 0 ºC; breaction in CHCl3; 
cisolated yields; dchiral HPLC 
 From the catalyst survey studies (Tables 2.1 to 2.3), it was observed that catalyst 42 
afforded good enantioselectivities for 56 (47% ee) and 58 (39% ee) in the conjugate 
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addition reactions of methyl tetronic acid (25) and phenyl tetronic acid (57), respectively. 
Based on these results, a solvent survey was conducted for the Michael addition of phenyl 
tetronic acid (57) to MVK in the presence of catalyst 42 (Table 2.4). The conjugate addition 
reaction worked in all of the solvents except DMF. Chloroform, dichloromethane and 1,2-
dichloroethane emerged as promising solvents in terms of the enantioselectivity of the 
conjugate addition (Table 2.4, entries 3, 4 and 11). These results are summarized in Table 
2.4. 
Table 2.4 Solvent survey for the Michael addition of phenyl tetronic acid (57) to MVK. 
 
Entry Solvent Time Yield (%)a ee (%)b 
1 ethyl acetate 140 h 64 24 
2 toluene 148 h 31 16 
3 CHCl3 162 h 51 32 
4 CH2Cl2 89 h 43 39 
5 THF 167 h 83 5 
6 diethylether 174 h 8 19 
7 dioxane 168 h 73 22 
8 DMF 166 h 61 0 
9 CH3OH 168 h 74 2 
10 CH3CN 169 h 13 9 
11 CH2ClCH2Cl 265 h 43 32 
12 CCl4 284 h 9 8 
aisolated yields; bchiral HPLC 
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Since the reactions of tetronic acids proceeded with low to moderate 
enantioselectivities, it was decided to change the nucleophile to a tetramic acid and, 
accordingly, a catalyst survey was conducted for the reactions of phenyl tetramic acid (62) 
and methyl tetramic acid (63) with MVK (Table 2.5). The aminothiourea 36 and the 
aminosquaramides 41, 42 and 43 were screened in the Michael addition. Catalyst 42 
provided 27% ee and 26% ee for 62 and 63 respectively (Table 2.5, entries 3 and 9), which 
are the best results obtained in terms of enantioselectivity for tetramic acids. Chiral 
phosphoric acid 51 also provided 64 with very low ee (4% ee, Table 2.5, entry 5). 
Unfortunately, these reactions also provided the Michael adducts in good yields, but with 
low enantioselectivities. These results are summarized in Table 2.5 
Table 2.5 Catalyst survey for the Michael addition of tetramic acids to MVK. 
 
S. No R Catalyst Time Solvent Yield (%)a ee (%)b 
1 Ph 36 92 h CH2Cl2 71 rac 
2 Ph 41 101 h CH2Cl2 75 2 
3 Ph 42 41 h CH2Cl2 97 27 
4 Ph 43 92 h CH2Cl2 67 4 
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5 Ph 51 102 h CH2Cl2 36 4 
7 Ph 42 74 h toluene 69 7 
8 Ph 42 76 h DMF 41 rac 
9 CH3 42 27 h CH2Cl2 77 26 
aisolated yields; bchiral HPLC 
Since changing the nucleophile from a tetronic acid to a tetramic acid did not 
improve the enantioselectivity of the Michael addition with MVK, a change in the 
electrophile was examined next. A catalyst survey was conducted for the reaction of methyl 
tetronic acid (25) with -nitrostyrene. The aminothiourea 36, the aminosquaramides 41 and 
42, the alkaloids cinchonine (52) and quinidine (53), the proline-derived diamine (48) and 
ephedrine (55) were used as catalysts in this reaction. Unfortunately, all of these catalysts 
furnished the required product 66 with low diastereoselectivity. Within this selection of 
catalysts, the best results were obtained with catalysts 42 and 55 (dr = 1.8:1, Table 2.6, 
entries 3 and 8). These results are summarized in Table 2.6. Since the diastereoselectivity 
of the reaction was low, the enantiomeric excess of the individual diastereomers was not 
examined in this study. 
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Table 2.6 Catalyst survey for the Michael addition of methyl tetronic acid (25) to                    
-nitrostyrene. 
 
Entry Catalyst Time Solvent dra Product 66c 
1 36 100 h CH2Cl2 1.6:1 26 
2 41 46 h CH2Cl2 1.5:1 36 
3 42 100 h CH2Cl2 1.8:1 39 
4c 42 50 h CHCl3 1.5:1 41 
5 48+PTSA 240 h DMF 1.6:1 18 
6 52 46 h CH2Cl2 1.6:1 27 
7 53 46 h CH2Cl2 1.7:1 31 
8 55 42 h CH2Cl2 1.8:1 37 
a1H NMR, bisolated yields, c5 equivalents of methyl tetronic acid (25); 
Solvent survey has been conducted for the Michael addition of methyl tetronic acid 
(25) to -nitrostyrene in the presence of catalyst 42. Unfortunately, as seen from Table 2.7, 
the reaction is relatively insensitive to a change in the solvent and 66 was obtained in low 
diastereoselectivity in all of the solvents examined. 
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Table 2.7 Solvent survey for the Michael addition of methyl tetronic acid (25) to                     
-nitrostyrene. 
 
Entry Time Solvent Temp dra 
1 192 h DMF rt 1.5:1 
2 240 h DMF 0 ºC 2.0:1 
3 192 h THF rt 1.6:1 
4 192 h ethyl acetate rt 1.5:1 
5 192 h CHCl3 rt 1.8:1 
6 192 h CH3OH rt 1.7:1 
acrude 1H NMR 
 Further variation of electrophile (Michael acceptor) structure in the conjugate 
addition reactions of tetronic acids was also examined (Figure 2.4). In these studies, we 
chose methyl tetronic acid (25) and phenyl tetronic acid (57) as the nucleophiles, and a 
range of , -unsaturated compounds, 6478, that differed in the electron withdrawing 
functional group, as the Michael acceptors. The aminosquaramide 42 was employed as the 
catalyst in all of these reactions (Figure 2.4).  
Only the Michael acceptors 67-72, which do not have a substituent at the -position 
provided the corresponding Michael adducts in good yields. Electrophiles 67-72 afforded 
corresponding Michael adducts 56, 58 and 81-86 in good yields with low to moderate 
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enantioselectivities (Figure 2.4). Reactions with the allyl trichloroacetimidates 73 and 74 
provided the corresponding Oallylated or O-cinnamylated tetronate derivatives instead of 
the required Calkylation products. The reactions with electrophiles 75-79, which have a 
substituent at the -position, were not successful and only starting materials were 
recovered. Presumably, in these cases, steric hindrance by the -substituent in the Michael 
acceptor prevents CC bond formation with the nucleophile. Interestingly, the reaction of 
57 with 80 afforded only the Z-isomer of 86 in 28% yield, but as a racemate.  
 
Figure 2.4 Study of various electrophiles in the Michael addition reactions. 
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 A reaction of isoxazol-5(4H)-one 87 with MVK was also examined in the presence 
of catalyst 42. In this case, a mixture of the product of Calkylation 88 (43% yield, 8% ee) 
the product of Nalkylation 89 (55% yield, Scheme 2.7) was obtained.  
 
Scheme 2.7 
2.4.1 Summary of results 
The best results obtained for the Michael addition reactions, in terms of 
enantioselectivity, are summarized in Table 2.8. Methyl tetronic acid (25) afforded 56 with 
49% ee using catalyst 38 with MVK (Table 2.8, entry 1). Similarly, phenyl tetronic acid 
(57), phenyl tetramic acid (62) and methyl tetramic acid (63) with MVK in the presence of 
catalyst 42 provided the corresponding Michael adducts 58 (39% ee), 64 (27% ee) and 65 
(26% ee) respectively (Table 2.8, entry 2 and 4). Catalyst 36 afforded 61 with 24% ee for 
benzyl tetronic acid (60, Table 2.8, entry 3). Among all the electrophiles, MVK in 
dichloromethane provided better enantioselectivities for the Michael additions as compared 
with the other electrophiles examined. 
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Table 2.8 Summary of the best results obtained for the Michael addition reactions of 
tetronic and tetramic acids. 
Entrya Nucleophile Electrophile Catalyst Product ee(%) 
1 
 
 
  
49 
2 
    
39 
3 
  
  
24 
4 
 
 
 
 
27 (64) 
 
26 (65) 
aReactions were conducted in dichloromethane 
2.4.2 Stereochemical model for the Michael addition reactions of tetronic and 
tetramic acids  
Two plausible transition state assemblies can be considered for the Michael addition 
reactions of 3-alkyl/aryl tetronic acids to MVK (Figure 2.5) in which the carbonyl group of 
the electrophile is hydrogen-bonded8 with the squaramide7g-j functionality and the 
deprotonated nucleophile is associated with the ammonium group in the catalyst by ionic 
interaction. In the transition state assembly I, the electrophile (MVK) adds to the Si-face of 
the tetronic acid to give the ‘S’ enantiomer of 90, whereas in assembly II, MVK adds to the 
Re-face of the tetronic acid to provide the ‘R’ enantiomer of 90. Based on the results 
obtained, it is likely that there is not much steric interaction between the electrophile 
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(MVK) and the tetronic acid, and the C-3 substituent does not affect the orientation of the 
tetronic acid in the transition state assembly. Consequently, the difference in energies for I 
and II is low, which might explain the low enantioselectivities of the Michael additions 
examined in this study. 
 
Figure 2.5 Proposed transition states for the Michael addition of 3-alkyl/aryl tetronic 
acids to MVK. 
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2.5 Conclusion  
In summary, the organocatalytic asymmetric Michael additions of 3-alkyl/aryl 
tetronic acids or 3-alkyl/aryl tetramic acids to various Michael acceptors for the 
construction of functionalized quaternary stereocenters were studied. The reactions were 
feasible with the vast majority of chiral catalysts that were examined, and provided the 
expected Michael adducts in good yields but with low to moderate enantiomeric excess. 
Reactions with -nitrostyrene provided Michael adducts with low diastereomeric excess 
and reactions with other -substituted electrophiles were unsuccessful. Structural changes 
in the Michael acceptor influence the enantioselectivities of the Michael addition, but not 
significantly. Further optimization of these reactions is required, and these studies are 
continuing in the Pansare group.  
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2.6 Experimental Section 
4-Hydroxy-3-methylfuran-2(5H)-one (25):9 
 
To a suspension of K2CO3 (2.90 g, 21.1 mmol) in acetone (15 mL) was added ethyl 
acetoacetate (91) (2.44 mL, 19.2 mmol) followed by methyl iodide (1.40 mL, 23.0 mmol) 
at room temperature. The reaction mixture was then heated to reflux for 5 h. The mixture 
was cooled to room temperature and the white precipitate was removed by filtration using 
diethyl ether (30 mL). The filtrates were concentrated to give ethyl 2-methylacetoacetate 
(92), 2.54 g (92%) as colorless liquid. This was used in the next step without purification. 
To a mixture of ethyl 2-methylacetoacetate (92) (2.00 g, 13.9 mmol) and water         
(6 mL) was added bromine (0.710 mL, 13.9 mmol) over 5 min at 0 °C. The reaction mixture 
was then warmed to room temperature and stirred for 15 h. After completion of the reaction, 
the mixture was extracted with CH2Cl2 (3 × 10 mL). The combined organic layers were 
washed with brine, dried (Na2SO4) and concentrated under reduced pressure to provide the 
bromoketone, 2.80 g as pale-yellow liquid. This was used in the next step without 
purification. 
To the bromoketone (2.80 g, 12.6 mmol) were added 4 drops of HBr (48% w/v in 
H2O) at room temperature and the mixture was heated to reflux (100 °C) for 18 h. The 
mixture was then cooled to room temperature and the precipitate obtained was isolated by 
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filtration and washed with ethyl acetate. The light brown residue thus obtained is pure 
methyl tetronic acid (25), 1.58 g (51%, over two steps).  
Rf = 0.17 (CH2Cl2/CH3OH, 9:1); mp: 183-186 °C; IR (neat): 2959 (br), 2669 (br), 2522 
(br), 1722, 1589, 1517, 1443, 1409, 1390, 1345, 1243, 1090, 1029, 911, 846 cm-1; 1H NMR 
(300 MHz, DMSO-d6): δ 11.83 (brs, 1H, OH), 4.56 (q, 2H, J = 1.3 Hz, OCH2), 1.57 (t, 3H, 
J = 1.3 Hz, CH3); 
13C NMR (75 MHz, DMSO-d6): δ 175.3 (C=O or C=COH), 173.0 (C=O 
or C=COH), 94.5 (C=COH), 66.6 (OCH2), 6.0 (CH3). 
4-Hydroxy-3-phenylfuran-2(5H)-one (57):10 
 
 To a solution of phenylacetic acid (3.58 g, 26.3 mmol) in acetone (30 mL) was 
added anhydrous K2CO3 (4.95 g, 35.9 mmol) followed by ethyl bromoacetate (2.64 mL, 
24.0 mmol) at room temperature. The resulting mixture was stirred at room temperature for 
5 h. The mixture was filtered through celite and the residue was washed with EtOAc (20 
mL). The filtrates were concentrated under reduced pressure to provide 3.50 g of the diester 
93 as a colorless liquid. This was used in the next step without purification. 
To a suspension of t-BuOK (3.50 g, 39.5 mmol) in dry THF (30 mL) was added the 
solution of diester 93 (3.50 g 15.7 mmol) in THF (20 mL) over 15 min at room temperature. 
The reaction mixture was then heated to reflux for 8 h. The mixture was cooled to room 
temperature and cold water (20 mL) was added. The solvent THF was removed under 
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reduced pressure and the resulting aqueous suspension was extracted with EtOAc (2 × 10 
mL). The aqueous layer was acidified with aqueous 2.0 N HCl (pH~3) and the resulting 
yellow suspension was extracted with EtOAc (3 × 20 mL). The combined organic layers 
were dried (Na2SO4) and concentrated. The crude product was purified by recrystallization 
from acetone to provide 1.08 g (81% over two steps) of phenyl tetronic acid 57 as light-
yellow crystals. 
Rf = 0.34 (EtOAc/hexanes, 3:2); mp: 203-206 °C; IR (neat): 2933 (br), 2579 (br), 1692, 
1574, 1460, 1431, 1394, 1351, 1314, 1161, 1059, 1018, 958, 856 cm-1; 1H NMR (300 MHz, 
DMSO-d6): δ 7.95-7.88 (m, 2H, ArH), 7.42-7.33 (m, 2H, ArH), 7.26-7.20 (m, 1H, ArH), 
4.78 (s, 2H, OCH2); 
13C NMR (75 MHz, DMSO-d6):δ 175.0 (C=O or C=COH), 172.9 (C=O 
or C=COH), 130.5 (ArCipso), 128.1 (2 × ArC), 126.3 (3 × ArC), 97.4 (C=COH), 66.0 
(OCH2). 
3-Benzyl-4-hydroxyfuran-2(5H)-one (60):11 
 
To a suspension of t-BuOK (5.11 g, 45.6 mmol) in dry THF (40 mL) was added 
ethyl acetoacetate (91) (5.78 mL, 45.6 mmol) over 5 min at 0 °C, the mixture was stirred 
for 30 min. and benzyl bromide (4.20 mL, 35.1 mmol) was added dropwise over 10 min at 
0 °C. The mixture was warmed to room temperature and heated to reflux for 16 h. The 
mixture was cooled to room temperature, and then saturated NH4Cl (30 mL) was added. 
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The resulting mixture was extracted with diethyl ether (3 × 30 mL). The combined organic 
layers were washed with brine, dried (Na2SO4) and concentrated under reduced pressure to 
provide 7.52 g (97%) of ethyl 2-benzylacetoacetate (94) as a colorless liquid. This was used 
in the next step without purification.  
To a solution of ethyl 2-benzylacetoacetate (94) (4.00 g, 18.2 mmol) in CHCl3 (8 
mL) was added the solution of bromine (1.03 mL, 20.0 mmol) in CHCl3 (3 mL) over 15 
min at 0 °C. The reaction mixture was warmed to room temperature and stirred for 3 h. The 
mixture was concentrated, and the resulting residue was heated at 130 °C for 4 h. The 
mixture was then cooled to room temperature and the precipitate in the reaction mixture 
was washed with CH2Cl2 (3 × 2 mL). The residue was purified by recrystallization from 
CH3OH to provide 1.18 g (35% over two steps) of benzyl tetronic acid (60) as a white solid. 
Rf = 0.23 (CH2Cl2/CH3OH, 9:1); mp: 153-155 °C; IR (neat): 2970 (br), 2934 (br), 2679 
(br), 2644 (br), 2619 (br), 1716, 1585, 1443, 1392, 1360, 1324, 1172, 1097, 1024, 1010, 
853 cm-1; 1H NMR (300 MHz, DMSO-d6): δ 12.08 (brs, 1H, OH), 7.30-7.12 (m, 5H, ArH), 
4.65 (s, 2H, OCH2), 3.41 (s, 2H, PhCH2); 
13C NMR (75 MHz, DMSO-d6): δ 174.7 (C=O 
or C=COH), 174.0 (C=O or C=COH), 139.5 (ArCipso), 128.2 (2 × ArC), 128.0 (2 × ArC), 
125.9 (ArC), 98.4 (C=COH), 66.6 (OCH2), 26.6 (PhCH2).  
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tert-Butyl 4-hydroxy-2-oxo-3-phenyl-2,5-dihydro-1H-pyrrole-1-carboxylate (62):12 
 
To a suspension of methyl glycinate hydrochloride (96) (4.55 g, 36.3 mmol) in 
CH2Cl2 (40 mL) was added triethylamine (5.76 mL, 39.6 mmol) followed by the dropwise 
addition of phenylacetyl chloride (95) (5.10 g, 33.0 mmol) in CH2Cl2 (10 mL) over 30 min 
at 0°C. The reaction mixture was warmed to room temperature and stirred for 48 h. 1.0 N 
NaHCO3 (30 mL) was added and the resulting mixture was extracted with EtOAc (3 × 30 
mL). The combined organic layers were washed with brine, dried (Na2SO4) and 
concentrated under reduced pressure to provide 6.60 g (97%) of the amide 97 as a light 
yellow liquid. This was used in the next step without purification. 
To a solution of 97 (6.60 g, 31.9 mmol) in acetonitrile (60 mL) was added DMAP 
(194 mg, 1.59 mmol) followed by Boc2O (8.30 g, 38.2 mmol) at 0 °C. The reaction mixture 
was warmed to room temperature and stirred for 17 h. The mixture was concentrated and 
cold water (40 mL) was added. The resulting mixture was extracted with EtOAc                     
(3 × 50 mL). The combined organic layers were washed with brine, dried (Na2SO4) and 
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concentrated. The residue was purified by flash column chromatography on silica gel 
(hexane/EtOAc, 9:1) to give 5.10 g (52%) of 98 as light-yellow liquid. 
To a solution of 98 (4.10 g, 13.3 mmol) in DMF (40 mL) was added t-BuOK (1.80 
g, 16.0 mmol) at room temperature. The reaction mixture was stirred for 20 min. Saturated 
NH4Cl (40 mL) was added and the mixture was extracted with EtOAc (4 × 40 mL). The 
combined organic layers were washed with water (2 × 20 mL), dried (Na2SO4) and 
concentrated. The crude product was purified by trituration with diethyl ether/ hexane (4:1) 
to afford 2.60 g (71%) of the pure phenyl tetramic acid (62) as a light brown solid. 
Rf = 0.17 (CH2Cl2/CH3OH, 9:1); mp: 147-151 °C; IR (neat): 3143 (br), 2998 (br), 2971 
(br), 1744, 1717, 1703, 1662, 1638, 1425, 1408, 1349, 1312, 1152, 1102, 1073, 980, 897, 
850 cm-1; 1H NMR(300 MHz, DMSO-d6): δ 12.38 (br s, 1H, OH), 7.88-7.82 (m, 2H, ArH), 
7.39-7.30 (m, 2H, ArH), 7.24-7.17 (m, 1H, ArH), 4.27 (s, 2H, OCH2), 1.48 (s, 9H, 
OC(CH3)3); 
13C NMR(75 MHz, DMSO-d6): δ 169.4 (C=O or C=COH), 168.0 (C=O or 
C=COH), 149.0 (NCOO), 131.1 (ArCipso), 127.8 (2 × ArC), 127.1 (2 × ArC), 126.2 (ArC), 
103.6 (C=COH), 81.1 (O-C(CH3)3), 47.9 (NCH2), 27.8 (O-C(CH3)3). 
tert-Butyl 4-hydroxy-3-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxylate (63):13 
 
To a suspension of methyl glycinate hydrochloride (96) (4.50 g, 36.0 mmol) in Et2O 
(10 mL) was added a saturated, aqueous solution of K2CO3 (19 mL) followed by dropwise 
addition of propanoyl chloride (4.90 g, 54.0 mmol) over 15 min at 0 °C. The reaction 
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mixture was stirred for 5 h at 0 °C and cold water (10 mL) was added and the resulting 
mixture was extracted with dichloromethane (3 × 30 mL). The combined organic layers 
were washed with brine, dried (Na2SO4) and concentrated under reduced pressure to 
provide 3.90 g (75%) of the crude amide 99 as a light-yellow liquid. This was used in the 
next step without purification.  
To a solution of 99 (2.00 g, 13.8 mmol) in acetonitrile (15 mL) were added DMAP 
(170 mg, 0.140 mmol) and DIPEA (3.60 mL, 20.7 mmol) followed by Boc2O (3.60 g, 16.5 
mmol) at 0 °C. The reaction mixture was then warmed to room temperature and stirred for 
25 h and brine (10 mL) was added. The resulting mixture was extracted with EtOAc (3 × 
20 mL). The combined organic layers were washed with cold water (2 × 10 mL), dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
column chromatography on silica gel (hexane/EtOAc, 9:1) to give 1.36 g (41%) of 100 as 
light-yellow liquid.  
To a refluxing suspension of NaH (244 mg, 6.10 mmol, 60% dispersion in mineral 
oil) in dry THF (10 mL) was added dropwise a solution of 100 (1.36 g, 5.55 mmol) in THF 
(2 mL) over 5 min and the reflux was continued for 19 h. The mixture was cooled to room 
temperature and cold water (10 mL) was added at 0 °C. The solvent THF was removed 
under reduced pressure and the residue was washed with EtOAc (2 × 10 mL). The aqueous 
layer was acidified with 2.0 N HCl (pH~3) and the resulting light brown suspension was 
extracted with EtOAc (4 × 10 mL). The combined organic layers were dried (Na2SO4) and 
concentrated. The crude was purified by trituration in CH2Cl2/hexane (9/1) to provide      
201 mg (31%) of the pure methyl tetramic acid (63) as a light-yellow solid.  
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Rf = 0. 24 (CH2Cl2/CH3OH, 9:1); mp: 122-129 °C; IR (neat): 2978 (br), 2932 (br), 1747, 
1698, 1630, 1437, 1408, 1363, 1308, 1243, 1158, 1083, 1000 cm-1; 1H NMR (300 MHz, 
DMSO-d6): δ 11.45 (brs, 1H, OH), 4.06 (s, 2H, OCH2), 1.53 (s, 3H, CH3), 1.45 (s, 9H, 3 × 
CH3); 
13C NMR (75 MHz, DMSO-d6): δ 170.0 (C=O or C=COH), 167.4 (C=O or C=COH), 
148.9 (NCOO), 100.8 (C=COH), 80.7 (O-C(CH3)3), 48.1 (NCH2), 27.8 (O-C(CH3)3), 5.9 
(CH3). 
 
General procedure for the catalytic Michael addition of tetronic or tetramic acids 
To a suspension of the tetronic or tetramic acid and the Michael acceptor in 
dichloromethane was added catalyst (10 mol%) at room temperature or 0 ºC. The reaction 
mixture was stirred until complete consumption (TLC) of the tetronic or tetramic acid and 
then concentrated. The residue was purified by flash chromatography on silica gel. 
 
3-Methyl-3-(3-oxobutyl)furan-2,4(3H,5H)-dione (56):1 
 
Best ee experiment: The reaction of methyl tetronic acid (25) (163 mg, 1.43 
mmol), methyl vinyl ketone (58 µL, 0.71 mmol), catalyst 38 (32 mg, 7.1 x 10-2 mmol) in 
dichloromethane (2 mL) at 0 ºC for 20 h according to the general procedure provided, after 
purification by flash column chromatography on silica gel (hexanes/EtOAc, 3:1), 29 mg 
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(22%) of 56 as a colorless liquid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 80:20, flow 
rate 1 mL min−1, λ = 254 nm): tminor = 23.66 min; tmajor = 28.15 min; 49% ee.  
Best yield experiment: The reaction of methyl tetronic acid (25) (146 mg, 1.28 
mmol), methyl vinyl ketone (68 µL, 0.86 mmol), catalyst 42 (46 mg, 8.6 × 10-2 mmol) in 
dichloromethane (2 mL) at room temperature for 36 h according to the general procedure 
provided, after purification by flash column chromatography on silica gel (hexanes/EtOAc, 
3:1), 139 mg (88%) of 56 with ee = 33%.  
Rf = 0.27 (hexanes/EtOAc, 3:2); IR (neat): 2983, 2938, 1800, 1750, 1711, 1434, 1371, 
1342, 1300, 1171, 1125, 1097, 1077, 1041 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.74, 4.65 
(AB system, 2H, ∆νAB = 20.1 Hz, JAB = 16.9 Hz, OCH2), 2.57 (t, 2H, J = 7.2 Hz, 
COCH2CH2), 2.14 (s, 3H, COCH3), 2.10-1.91 (m, 2H, COCH2CH2), 1.32 (s, 3H, CCH3); 
13C NMR (75 MHz, CDCl3):δ 209.2 (CCOC), 207.4 (CCOC), 176.8 (COO), 72.3 
(OCH2CO), 46.5 (CH3-C-CH2), 37.4 (COCH2CH2), 29.9 (COCH3), 28.3 (COCH2CH2), 
20.2 (C-CH3). 
3-(3-Oxobutyl)-3-phenylfuran-2,4(3H,5H)-dione (58): 
 
Best ee experiment: The reaction of phenyl tetronic acid (57) (60 mg, 0.34 mmol), 
methyl vinyl ketone (55 µL, 0.68 mmol), catalyst 42 (19 mg, 3.4 x 10-2 mmol) in 
dichloromethane (2 mL) at room temperature for 89 h according to the general procedure 
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provided, after purification by flash column chromatography on silica gel (hexanes/EtOAc, 
3:1), 36 mg (43%) of 58 as a colorless liquid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 
80:20, flow rate 1 mL min−1, λ = 254 nm): tminor = 18.9 min; tmajor = 23.5 min; 39% ee. 
Best yield experiment: The reaction of phenyl tetronic acid (57) (60 mg, 0.34 
mmol), methyl vinyl ketone (55 µL, 0.68 mmol), catalyst 37 (17 mg, 3.4 x 10-2 mmol) in 
dichloromethane (2 mL) at room temperature for 151 h according to the general procedure 
provided, after purification by flash column chromatography on silica gel (hexanes/EtOAc, 
3:1), 80 mg (95%) of 58 with ee = 14%. 
Rf = 0.42 (hexanes/EtOAc, 7:3); IR (neat): 2939, 1801, 1750, 1710, 1494, 1434, 1368, 
1340, 1289, 1241, 1167, 1067, 1043 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.45-7.30 (m, 
5H, ArH), 4.71, 4.62 (AB system, 2H, ∆νAB = 23.3 Hz, JAB= 16.5 Hz, OCH2), 2.73-2.58 
(m, 1H, COCH2CH2 or COCH2CH2), 2.56-2.28 (m, 3H, COCH2CH2), 2.10 (s, 3H, COCH3); 
13C NMR (75 MHz, CDCl3): δ 207.5 (CCOC), 205.5 (CCOC), 174.3 (COO), 133.5 
(ArCipso), 129.5 (2 × ArC), 128.8 (ArC), 126.6 (2 × ArC), 72.3 (OCH2CO), 55.5 (Ph-C-
CH2), 37.9 (COCH2CH2), 30.0 (COCH3), 29.2 (COCH2CH2); HRMS (APPI, pos.): m/z 
246.0878 (246.0892 calc. for C14H14O4, (M)
+) and 247.0951 (247.0970 calc. for C14H15O4, 
(M+H)+). 
3a-Hydroxy-7a-phenyltetrahydroisobenzofuran-1,5(3H,6H)-dione (59): 
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The reaction of phenyl tetronic acid (57) (60 mg, 0.34 mmol), methyl vinyl ketone 
(55 µL, 0.68 mmol), catalyst 34 (11 µL, 6.8 x 10-2 mmol) in dichloromethane (2 mL) at 
room temperature for 20 h according to the general procedure provided, after purification 
by flash column chromatography on silica gel (hexanes/EtOAc, 3:1), 23 mg (27%) of 
racemic 58 and 58 mg (67%) of 59 as a colorless liquid. HPLC of 59: Chiralpak AS-H 
(hexanes/i-PrOH, 70:30, flow rate 1 mL min−1, λ = 254 nm): tminor = 20.77 min; tmajor = 
25.92 min; 5% ee.  
Rf = 0.37 (hexanes/EtOAc, 3:2); IR (neat): 3392 (br), 3324 (br), 2962, 2935, 2911, 2853, 
1774, 1702, 1499, 1403, 1331, 1265, 1205, 1172, 1099, 1026, 1005, 967 cm-1. 1H NMR 
(300 MHz, CDCl3): δ 7.51-7.32 (m, 5H, ArH), 4.06 (dd, 1H, J = 9.3, 1.7 Hz, OCH2), 3.92 
(d, 1H, J = 9.3 Hz, OCH2), 2.79 (s, 2H, COCH2), 2.71-2.43 (m, 4H, COCH2CH2); 2.28 (br 
s, 1H, OH); 13C NMR (75 MHz, CDCl3): δ 207.3 (CCOC), 177.4 (COO), 135.0 (ArCipso), 
129.5 (2 × ArC), 128.9 (ArC), 127.6 (2 × ArC), 78.7 (OH-C), 74.6 (OCH2CO), 54.9 (Ph-
C-CH2), 48.8 (COCH2), 37.1 (COCH2), 29.6 (CH2); HRMS (APPI, pos.): m/z 246.0905 
(246.0892 calc. for C14H14O4, (M)
+) and 247.0977 (247.0970 calc. for C14H15O4, (M+H)
+). 
3-Benzyl-3-(3-oxobutyl)furan-2,4(3H,5H)-dione (61):1 
 
Best ee experiment: The reaction of benzyl tetronic acid (60) (60 mg, 0.32 mmol), 
methyl vinyl ketone (51 µL, 0.63 mmol), catalyst 36 (13 mg, 3.2 x 10-2 mmol) in 
dichloromethane (2 mL) at room temperature for 195 h according to the general procedure 
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provided, after purification by flash column chromatography on silica gel (hexanes/EtOAc, 
4:1), 72 mg (89%) of 61 as a colorless liquid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 
80:20, flow rate 1 mL min−1, λ = 254 nm): tminor = 17.24 min; tmajor = 20.06 min; 24% ee.  
Best yield experiment: The reaction of benzyl tetronic acid (60) (60 mg, 0.34 
mmol), methyl vinyl ketone (51 µL, 0.63 mmol), catalyst 39 (19 mg, 3.2 x 10-2 mmol) in 
dichloromethane (2 mL) at room temperature for 151 h according to the general procedure 
provided, after purification by flash column chromatography on silica gel (hexanes/EtOAc, 
4:1), 79 mg (96%) of 61 with ee = 11%.  
Rf = 0.39 (hexanes/EtOAc, 3:2); IR (neat): 3033, 2928, 1800, 1750, 1706, 1451, 1428, 
1408, 1361, 1348, 1229, 1205, 1166, 1119, 1069, 1047 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.31-7.22 (m, 3H, ArH), 7.14-7.07 (m, 2H, ArH), 4.37 (d, 1H, J = 16.8 Hz, OCH2), 3.49 
(d, 1H, J = 16.8 Hz, OCH2), 3.10, 3.02 (AB system, 2H, ∆νAB = 24.3 Hz, JAB = 12.8 Hz, 
PhCH), 2.67-2.47 (m, 2H, COCH2CH2), 2.26-2.03 (m, 2H, COCH2CH2), 2.13 (s, 3H, 
COCH3); 
13C NMR (75 MHz, CDCl3):δ 209.9 (CCOC), 207.2 (CCOC), 176.2 (COO), 
133.7 (ArCipso), 129.6 (2 × ArC), 128.9 (2 × ArC), 127.9 (ArC), 73.3 (OCH2CO), 54.2 (Bn-
C-CH2), 43.1 (PhCH2), 37.8 (COCH2CH2), 29.9 (COCH3), 28.2 (COCH2CH2). 
tert-Butyl 2,4-dioxo-3-(3-oxobutyl)-3-phenylpyrrolidine-1-carboxylate (64): 
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Best ee and yield experiment: The reaction of phenyl tetramic acid (62) (60 mg, 
0.22 mmol), methyl vinyl ketone (35 µL, 0.46 mmol), catalyst 42 (12 mg, 2.2 x 10-2 mmol) 
in dichloromethane (2 mL) at room temperature for 41 h according to the general procedure 
provided, after purification by flash column chromatography on silica gel (hexanes/EtOAc, 
3:1), 73 mg (97%) of 64 as a white solid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 90:10, 
flow rate 1 mL min−1, λ = 254 nm): tmajor = 13.01 min; tminor = 15.90 min; 27% ee. 
Rf = 0.41 (hexanes/EtOAc, 3:2); mp: 109-111 °C; IR (neat): 2992, 2968, 2936, 2894, 1788, 
1751, 1714, 1445, 1351, 1276, 1249, 1217, 1145, 898, 852 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.43-7.29 (m, 5H, ArH), 4.20 (AB system, 2H, ∆νAB = 28.8 Hz, JAB= 18.2 Hz, 
NCH2), 2.66-2.46 (m, 2H, CH2), 2.45-2.26 (m, 2H, CH2), 2.07 (s, 3H, COCH3), 1.56 (s, 
9H, C-(CH3)3); 
13C NMR (75 MHz, CDCl3):δ 207.4 (CCOC), 204.0 (CCOC), 171.4 
(NCOC), 149.1 (NCOO), 134.3 (ArCipso), 129.3 (2 × ArC), 128.5 (ArC), 126.7 (2 × ArC), 
84.4 (O-C(CH3)3), 60.6 (Ph-C-CH2), 54.6 (NCH2), 38.2 (COCH2CH2), 30.0 (COCH3), 29.3 
(COCH2CH2), 28.0 (O-C(CH3)3). 
tert-Butyl 3-methyl-2,4-dioxo-3-(3-oxobutyl)pyrrolidine-1-carboxylate (65): 
 
The reaction of methyl tetramic acid (63) (50 mg, 0.23 mmol), methyl vinyl ketone 
(38 µL, 0.47 mmol), catalyst 42 (13 mg, 2.3 x 10-2 mmol) in dichloromethane (2 mL) at 
room temperature for 27 h according to the general procedure provided, after purification 
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by flash column chromatography on silica gel (hexanes/EtOAc, 3:1), 51 mg (77%) of 65 as 
a colorless liquid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 95:5, flow rate 1 mL min−1, λ 
= 254 nm): tminor = 18.14 min; tmajor = 20.80 min; 26% ee.  
Rf = 0.47 (hexanes/EtOAc, 1:1); IR (neat): 2980, 2935, 1794, 1757, 1734, 1712, 1453, 
1440, 1369, 1343, 1307, 1277, 1252, 1149, 1091, 984, 952, 851 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 4.22 (AB system, 2H, ∆νAB = 22.7 Hz, JAB = 18.6 Hz, NCH2), 2.53 (td, 2H, J = 
7.3, 2.1 Hz, COCH2CH2), 2.12 (s, 3H, COCH3), 2.00 (t, 2H, J= 7.3 Hz, COCH2CH2), 1.57 
(s, 9H, C-(CH3)3), 1.28 (s, 3H, C-CH3); 
13C NMR (75 MHz, CDCl3): δ 207.27 (CCOC), 
207.25 (CCOC), 173.8 (NCOC), 149.2 (NCOO), 84.3 (O-C(CH3)3), 54.4 (NCH2), 52.0 
(CH3-C-CH2), 37.6 (COCH2CH2), 29.9 (COCH3), 28.5 (COCH2CH2), 28.0 (O-C(CH3)3), 
19.9 (C-CH3). 
3-Methyl-3-(2-nitro-1-phenylethyl)furan-2,4(3H,5H)-dione (66): 
 
The reaction of methyl tetronic acid (25) (92 mg, 0.80 mmol), -nitrostyrene (100 
mg, 0.670 mmol), catalyst 42 (36 mg, 6.7 x 10-2 mmol) in DMF (2 mL) at 0 °C for 240 h 
according to the general procedure provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 8.5:1.5), 39 mg (22%) of 66 as a yellow 
solid and 55 mg (31%) as a mixture of diastereomers as a yellow solid.  
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Major diastereomer: Rf = 0.43 (hexanes/EtOAc, 3:1); mp: 85-93 °C; IR (neat): 2956, 
2924, 1746, 1558, 1426, 1338, 1245, 1225, 1162, 1124, 1078, 1040 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.36-7.28 (m, 3H, ArH), 7.22-7.14 (m, 2H, ArH), 5.09 (ABX, 2H, ∆νAB = 
34.6 Hz, JAB = 13.6 Hz, JAX = 10.2 Hz, JBX = 5.0 Hz, CH2NO2), , 4.38 (d, 1H, J = 17.2 Hz, 
OCH2), 3.94 (dd, 1H, J = 10.2, 5.0 Hz, PhCH), 3.49 (d, 1H, J = 17.2 Hz, OCH2), 1.47 (s, 
3H, C-CH3); 
13C NMR (75 MHz, CDCl3):δ 207.7 (CCOC), 175.6 (COO), 133.7 (ArCipso), 
129.5 (2 × ArC), 129.2 (ArC), 128.3 (2 × ArC), 74.5 (OCH2 or CH2NO2), 72.6 (OCH2 or 
CH2NO2), 51.02 (OC-C-COO), 48.0 (PhCH), 18.5 (CCH3); MS (APPI, neg.): m/z 263.0800 
(263.0794 calc. for C13H13NO5, (M)
-) and 290.0670 (290.0665 calc. for C14H12NO6, 
((M+HCOO)H2O). 
Minor diastereomer (mixture with major diastereomer): Rf = 0.42 (hexanes/EtOAc, 
3:1); IR (neat): 2952, 2922, 1797, 1747, 1555, 1426, 1378, 1244, 1081, 1042 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 7.37-7.29 (m, 3H, ArH), 7.25-7.16 (m, 2H, ArH), 5.03 (d, 2H, J = 
7.8 Hz, CH2NO2), 4.48 (d, 1H, J = 17.3 Hz, OCH2), 4.04 (t, 1H, J = 7.8 Hz, PhCH), 4.0 (d, 
1H, J = 17.3 Hz, OCH2), 1.41 (s, 3H, CCH3); 
13C NMR (75 MHz, CDCl3):δ 209.6 (CCOC), 
174.9 (COO), 133.7(ArCipso), 129.4 (2 × ArC), 129.3 (ArC), 128.4 (2 × ArC), 74.0 (OCH2 
or CH2NO2), 72.5 (OCH2 or CH2NO2), 51.0 (OC-C-COO), 47.5 (PhCH), 19.2 (C-CH3). 
3-Methyl-3-(3-oxo-3-phenylpropyl)furan-2,4(3H,5H)-dione (81): 
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The reaction of methyl tetronic acid (25) (60 mg, 0.53 mmol), phenyl vinyl ketone 
(139 mg, 1.05 mmol), catalyst 42 (28 mg, 5.3 x 10-2 mmol) in dichloromethane (2 mL) at 
room temperature for 20 h according to the general procedure provided, after purification 
by flash column chromatography on silica gel (hexanes/EtOAc, 8.5:1.5), 126 mg (98%) of 
81 as yellow solid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 80:20, flow rate 1 mL min−1, 
λ = 254 nm): tmajor = 20.16 min; tminor = 26.95 min; 13% ee.  
Rf = 0.28 (hexanes/EtOAc, 4:1); mp: 89-93 °C; IR (neat): 2948, 2922, 1788, 1748, 1673, 
1594, 1578, 1446, 1427, 1379, 1366, 1345, 1298, 1281, 1216, 1199, 1145, 1079, 1, 857 cm-
1; 1H NMR (300 MHz, CDCl3): δ 7.93-7.86 (m, 2H, ArH), 7.60-7.53 (m, 1H, ArH), 7.49-
7.41 (m, 2H, ArH), 4.73 (AB system, 2H, ∆νAB = 38.4 Hz, JAB = 16.8 Hz, OCH2), 3.21-
3.00 (m, 2H, CH2CH2CO), 2.30-2.11 (m, 2H, CH2CH2CO), 1.38 (s, 3H, CCH3); 
13C NMR 
(75 MHz, CDCl3):δ 209.1 (CO), 198.9 (CO), 176.9 (COO), 136.2 (ArCipso), 133.5 (ArC), 
128.7 (2 × ArC), 128.0 (2 × ArC), 72.3 (OCH2CO), 46.7 (OC-C-COO), 32.6 (COCH2CH2), 
28.8 (COCH2CH2), 20.5 (C-CH3); HRMS (APPI, pos.): m/z 246.0881 (246.0892 calc. for 
C14H14O4, (M)
+) and 247.0953 (247.0970 calc. for C14H15O4, (M+H)
+). 
3-Methyl-3-(3-oxo-3-(2-oxopyrrolidin-1-yl)propyl)furan-2,4(3H,5H)-dione (82): 
 
The reaction of methyl tetronic acid (25) (60 mg, 0.53 mmol), Michael acceptor 69 
(146 mg, 1.05 mmol), catalyst 42 (29 mg, 5.3 x 10-2 mmol) in dichloromethane (2 mL) at 
room temperature for 41 h according to the general procedure provided, after purification 
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by flash column chromatography on silica gel (hexanes/EtOAc, 3:2), 131 mg (98%) of 82 
as a pale-yellow liquid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 80:20, flow rate 1 mL 
min−1, λ = 254 nm): tmajor = 33.67 min; tminor = 38.85 min; 7% ee.  
Rf = 0.26 (hexanes/EtOAc, 3:2); IR (neat): 2982, 2939, 2901, 1802, 1735, 1682, 1455, 
1434, 1388, 1361, 1254, 1224, 1193, 1073, 1041 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.69 
(AB system, 2H, ∆νAB = 32.5 Hz, JAB= 16.7 Hz, OCH2), 3.78-3.70 (br ddd, 2H, J = 8.3, 
6.1, 1.0 Hz, NCH2), 3.09-2.89 (m, 2H, NCOCH2), 2.59 (A2X2 system, 2H, JAX = 7.6 Hz, 
COCH2CH2), 2.14 (A2B2 system, 2H, J = 7.6 Hz, COCH2CH2), 2.09-1.97 (m, 2H, 
NCOCH2CH2), 1.35 (s, 3H, CCH3); 
13C NMR (75 MHz, CDCl3):δ 209.4 (CCOC), 176.9 
(COO or CON), 175.5 (COO or CON), 173.0 (COO or CON), 72.4 (OCH2CO), 47.0 (OC-
C-CO), 45.4 (N-CH2), 33.5 (CH2), 31.4 (CH2), 29.1 (CH2), 21.0 (C-CH3), 17.2 (CH2). 
HRMS (APPI, pos.): m/z 253.0942 (253.0950 calc. for C12H15NO5, (M)
+) and 254.1017 
(254.1028 calc. for C12H16NO5, (M+H)
+). 
3-(3-(3,5-Dimethyl-1H-pyrazol-1-yl)-3-oxopropyl)-3-methylfuran-2,4(3H,5H)-dione 
(83): 
 
The reaction of methyl tetronic acid (25) (60 mg, 0.53 mmol), Michael acceptor 70 
(158 mg, 1.05 mmol), catalyst 42 (29 mg, 5.3 x 10-2 mmol) in dichloromethane (2 mL) at 
room temperature for 21 h according to the general procedure provided, after purification 
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by flash column chromatography on silica gel (hexanes/EtOAc, 4:1), 130 mg (93%) of 83 
as a colorless liquid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 98:2, flow rate 1 mL min−1, 
λ = 254 nm): tmajor = 31.45 min; tminor = 34.99 min; 21% ee.  
Rf = 0.49 (hexanes/EtOAc, 3:2); IR (neat): 3273 (br), 3148, 2971, 2931, 2876, 1712, 1577, 
1457, 1457, 1415, 1379, 1270, 1213, 1166, 1075, 1015 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 5.95 (br d, 1H, J = 1.0 Hz, C=C-H), 4.71 (AB system, 2H, ∆νAB = 27.1 Hz, JAB = 16.8 
Hz, OCH2CO), 3.31-3.08 (m, 2H, COCH2CH2), 2.48 (br d, 3H, J = 1.0 Hz, C=CCH3), 2.31-
2.13 (m, 2H, COCH2CH2), 2.21 (s, 3H, C=CCH3), 1.39 (s, 3H, CCH3); 
13C NMR (75 MHz, 
CDCl3): δ 209.2 (CCOC), 176.7 (COO or CON), 172.6 (COO or CON), 152.4 (N=C), 144.1 
(N─C(CH3)=C), 111.4 (C=CH), 72.4 (OCH2COO), 47.0 (OC-C-COO), 29.9 (CH2), 29.2 
(CH2), 20.9 (CH3), 14.4 (CH3), 13.8 (CH3). 
3-Methyl-3-(3-oxo-3-(2-oxooxazolidin-3-yl)propyl)furan-2,4(3H,5H)-dione (84): 
  
The reaction of methyl tetronic acid (25) (60 mg, 0.53 mmol), Michael acceptor 71 
(148 mg, 1.05 mmol), catalyst 42 (29 mg, 5.3 x 10-2 mmol) in dichloromethane (2 mL) at 
room temperature for 3 h according to the general procedure provided, after purification by 
flash column chromatography on silica gel (hexanes/EtOAc, 7:3), 109 mg (81%) of 84 as 
a white solid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 80:20, flow rate 1 mL min−1, λ = 
254 nm): tminor = 16.41 min; tmajor = 25.80 min; 2% ee.  
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Rf = 0.27 (hexanes/EtOAc, 1:1); mp: 96-102 °C; IR (neat): 2995, 2939, 1750, 1680, 1451, 
1434, 1395, 1367, 1344, 1299, 1223, 1163, 1138, 1120, 1094, 1080, 1036, 1010, 960 cm-1; 
1H NMR (300 MHz, CDCl3): δ 4.69 (AB system, 2H, ∆νAB = 26.1 Hz, JAB = 16.8 Hz, 
OCH2CO), 4.42 (t, 2H, J = 7.5 Hz, NCH2CH2), 4.03-3.88 (m, 2H, NCH2CH2), 3.12-2.93 
(m, 2H, COCH2CH2), 2.16 (t, 2H, J = 7.5 Hz, COCH2CH2), 1.36 (s, 3H, CCH3); 
13C NMR 
(75 MHz, CDCl3): δ 209.2 (CCOC), 176.7 (CO), 172.3 (CO), 153.4 (OCON), 72.4 
(OCH2CO), 62.2 (NCH2CH2O), 46.9 (OC-C-CO), 42.4 (N-CH2), 29.8 (CH2), 28.8 (CH2), 
21.1 (C-CH3); HRMS (APPI, pos.): m/z 255.0726 (255.0743 calc. for C11H13NO6, (M)
+), 
256.0799 (256.0821 calc. for C11H14NO6, (M+H)
+) and 273.1064 (273.1087 calc. for 
C11H17N2O6, (M+NH4)
+). 
Dimethyl 2-((2,4-dioxo-3-phenyltetrahydrofuran-3-yl)methyl)malonate (85): 
 
The reaction of phenyl tetronic acid (57) (60 mg, 0.34 mmol), dimethyl 2-
methylenemalonate (72) (98 mg, 0.68 mmol), catalyst 42 (19 mg, 3.4 x 10-2 mmol) in 
dichloromethane (2 mL) at room temperature for 120 h according to the general procedure 
provided, after purification by flash column chromatography on silica gel (hexanes/EtOAc, 
8.5:1.5), 16 mg (15%) of 85 as a colorless. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 
80:20, flow rate 1 mL min−1, λ = 254 nm): t1 = 11.98 min; t2 = 25.33 min; racemic.  
Rf = 0.37 (hexanes/EtOAc, 3:1); IR (neat): 3006, 2956, 1801, 1751, 1727, 1494, 1436, 
1339, 1259, 1237, 1199, 1154, 1124, 1038 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.45-7.30 
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(m, 5H, ArH), 4.63 (AB system, 2H, ∆νAB = 31.3 Hz, JAB = 16.2 Hz, OCH2), 3.76-3.71 (m, 
1H, CH2CH), 3.71 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 2.75 (ABX, 2H, JAB = 14.8 Hz, JAX 
= 8.3 Hz, JBX = 7.0 Hz, CH2CH);
 13C NMR (75 MHz, CDCl3): δ 204.7 (CCOC), 173.9 
(COO), 169.4 (COO), 169.1 (COO), 133.6 (ArCipso), 129.8 (2 × ArC), 129.2 (ArC), 126.8 
(2 × ArC), 72.5 (OCH2CO), 55.6 (Ph-C-CH2), 53.0 (OCH3), 52.9 (OCH3), 47.2 (CH2CH), 
33.7 (CH2CH); HRMS (APPI, pos.): m/z 320.0911 (320.0896 calc. for C16H16O7, (M)
+) and 
321.0986 (321.0974 calc. for C16H17O7, (M+H)
+). 
(Z)-3-(3-Oxobut-1-en-1-yl)-3-phenylfuran-2,4(3H,5H)-dione (86): 
 
The reaction of phenyl tetronic acid (57) (50 mg, 0.28 mmol), but-3-yn-2-one (80) 
(44 µL, 0.57 mmol), catalyst 42 (15 mg, 2.8 x 10-2 mmol) in dichloromethane (2 mL) at 
room temperature for 66 h according to the general procedure provided, after purification 
by flash column chromatography on silica gel (hexanes/EtOAc, 4:2), 19 mg (28%) of 86 as 
a colorless white solid. HPLC: Chiralpak AS-H (hexanes/i-PrOH, 80:20, flow rate 1 mL 
min−1, λ = 254 nm): t1 = 8.7; t2 = 14.5 min; racemic.  
Rf = 0.57 (hexanes/EtOAc, 7:3); mp: 116-121 °C; IR (neat): 3060, 2923, 2853, 1801, 1749, 
1685, 1603, 1492, 1435, 1405, 1340, 1271, 1210, 1193, 1084, 1072, 1052, 1001, 971 cm-1; 
1H NMR (300 MHz, CDCl3): δ 7.47-7.37 (m, 5H, ArH), 6.46, 6.29 (AX, 2H, ∆νAB = 109.3 
Hz, JAB = 10.7 Hz, HC=CH), 4.97, 4.65 (AX, 2H, ∆νAB = 94.0 Hz, JAB = 15.6 Hz, OCH2), 
2.30 (s, 3H, COCH3); 
13C NMR (75 MHz, CDCl3): δ 199.9 (CCOC), 198.5 (CCOC), 171.5 
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(COO), 142.8 (OC=CH), 135.1 (ArCipso), 129.8 (2 × ArC), 129.2 (C=CH or ArC), 128.9 
(C=CH or ArC), 127.1 (2 × ArC), 74.2 (OCH2), 60.9 (Ph-C-CH), 31.0 (COCH3); HRMS 
(APPI, pos.): m/z 244.0729 (244.0736 calc. for C14H12O4, (M)
+) and 245.0803 (245.0814 
calc. for C14H13O4, (M+H)
+). 
4-Methyl-4-(3-oxobutyl)-3-phenylisoxazol-5(4H)-one (88): 
 
The reaction of isoxazol-5(4H)-one 87 (60 mg, 0.34 mmol), methyl vinyl ketone 
(56 µL, 0.69 mmol), catalyst 42 (19 mg, 3.4 x 10-2 mmol) in dichloromethane (2 mL) at 
room temperature for 17 h according to the general procedure provided, after purification 
by flash column chromatography on silica gel (hexanes/EtOAc, 3:1), 36 mg (43%) of 88 as 
colorless liquid and 46 mg (55%) of 89 brown solid. HPLC of 88: Chiralcel OD-H 
(hexanes/i-PrOH, 93:7, flow rate 1 mL min−1, λ = 254 nm): tminor = 8.10 min; tmajor = 9.22 
min; 8% ee. 
Rf = 0.57 (hexanes/EtOAc, 7:3); IR (neat): 3063, 2978, 2936, 1788, 1714, 1553, 1454, 
1418, 1358, 1226, 1164, 1144, 1093, 882 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.81-7.73 
(m, 2H, ArH), 7.59-7.44 (m, 3H, ArH), 2.49-2.17 (m, 4H, COCH2CH2), 2.08 (s, 3H, 
COCH3), 1.64 (s, 3H, CCH3); 
13C NMR (75 MHz, CDCl3): δ 205.7 (CCOC), 180.9 (CO), 
168.2 (N=C), 132.0 (ArC), 129.4 (2 × ArC), 127.4 (ArCipso), 126.7 (2 × ArC), 49.5 (OC-
C-CO), 38.2 (COCH2CH2), 30.4 (COCH2CH2), 30.0 (CH3), 22.2 (CH3); HRMS (APPI, 
pos.): m/z 245.1042 (245.1052 calc. for C14H15NO3, (M)
+) and 426.1115 (246.1130 calc. 
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for C14H16NO3, (M+H)
+). 
4-Methyl-2-(3-oxobutyl)-3-phenylisoxazol-5(2H)-one (89): 
 
Rf = 0.22 (hexanes/EtOAc, 7:3); mp: 63-69 ºC; IR (neat): 2962, 2925, 2871, 2851, 1726, 
1704, 1635, 1447, 1366, 1330, 1254, 1186, 1166, 1066, 1011, 866 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.57-7.45 (m, 5H, ArH), 3.53 (t, 2H, J = 6.6 Hz, NCH2CH2), 2.84 (t, 2H, 
J = 6.6 Hz, NCH2CH2), 2.18 (s, 3H, COCH3), 1.93 (s, 3H, CCH3); 
13C NMR (75 MHz, 
CDCl3): δ 205.7 (CCOC), 172.1 (COO), 164.7 (PhC=C), 131.0 (ArC), 129.2 (2 × ArC), 
128.4 (2 × ArC), 127.8 (ArCipso), 102.2 (PhC=C), 49.0 (NCH2CH2), 39.4 (NCH2CH2), 30.5 
(COCH3), 7.7 (CH3C=C); HRMS (APPI, pos.): m/z 245.1022 (245.1052 calc. for 
C14H15NO3, (M)
+) and 246.1095 (246.1130 calc. for C14H16NO3, (M+H)
+). 
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2.8 Selected 1H NMR and 13C NMR Spectra 
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2.9 Selected HPLC traces 
 
203 
 
 
 
 
56 (racemic) 
204 
 
 
 
 
56 
205 
 
 
 
 
58 (racemic) 
206 
 
 
 
 
 
58  
207 
 
 
 
 
 
59 
208 
 
 
 
 
 
61 (racemic)  
209 
 
 
 
 
61  
210 
 
 
 
 
 
64 (racemic) 
211 
 
 
 
 
 
64 
212 
 
 
 
 
 
65 (racemic) 
213 
 
 
 
 
 
65 
214 
 
 
 
 
 
81 (racemic) 
215 
 
 
 
 
81  
216 
 
 
 
 
 
82 (racemic) 
217 
 
 
 
 
 
82  
218 
 
 
 
 
 
83 (racemic) 
219 
 
 
 
 
 
83  
220 
 
 
 
 
 
84 (racemic) 
221 
 
 
 
 
 
84  
222 
 
 
 
 
 
85 
223 
 
 
 
 
86 
224 
 
 
 
 
 
88 
225 
 
Chapter 3 
 
 
 
Catalytic Undirected Intermolecular C-H Functionalization of Arenes 
with 3-Diazofuran-2,4-dione 
Synthesis of 3-Aryl Tetronic Acids, Vulpinic Acid, Pinastric Acid, and 
Methyl Isoxerocomate 
 
 
 
 
 
 
 
A portion of the work described in this chapter has been published in Organic Letters:  
Manchoju, A.; Pansare, S. V. Org. Lett. 2016, 18, 5952. 
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3.1 Introduction 
Tetronic acid1 was first synthesized from ethyl 4-bromoacetoacetate by Wolffe and 
Schwabe in 1896. Naturally-occurring tetronic acids belong to a large family of compounds 
that are divided into three categories based on the non-aryl functional group on C6 (Figure 
3.1). In ‘pulvinic’ acids, this group is a -CO2H, whereas in ‘vulpinic’ acids the group is -
CO2Me. A related class of natural products which lack this non-aryl substituent on C6 are 
called ‘pulvinones’ (Figure 3.1).2 
 
Figure 3.1 Generic structures of naturally occurring tetronic acids. 
As a distinctive feature of many natural products, the tetronic acid functionality has 
attracted considerable attention in recent years.3 Many tetronic acid derivatives display a 
wealth of biological activity which include insecticidal and acaricidal,4 HIV-I protease 
inhibitory,5 antineoplastic,6 antiinflammatory,7 and cyclooxygenase inhibitory activity.8 In 
addition, these tetronic acids are also of interest for their role as pigments in mushrooms 
and lichens.3 Among a large group of structurally related tetronates that are substituted at 
C3 with an aryl group are pulvinic acid (1, Figure 3.2), vulpinic acid (2), 4-hydroxypulvinic 
acid (3), pinastric acid (4) and their oxygenated analogues 9  like xerocomic acid (5), 
methylisoxerocomate (6) and variegatic acid (7). More elaborate congeners include 
xerocomorubin (8),10a norbadione A (9)10b and badione A (10).10b 
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Figure 3.2 Naturally occurring 3-aryl tetronic acid derivatives. 
3.2 Known synthetic routes to 3-aryl tetronic acids, vulpinic acids and pulvinic acids 
3.2.1 The Smith synthesis of tetronic acids  
In 1979, Smith and coworkers11 reported the one-pot syntheses of tetronic acids and 
pulvinones from -hydroxyketones 11 (Scheme 3.01). In this methodology, dianions 12, 
prepared in situ from -hydroxyketones 11 using LDA, were condensed with                           
1, 1'-cabonyldiimidazole (CDI) to afford 3-aryl tetronic acids 13. 
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Scheme 3.01 
3.2.2 The Ramage synthesis of pulvinic acids 
In 1984, Ramage and coworkers12 reported the biomimetic synthesis of pulvinic 
acids from phosphorane 14 (Scheme 3.02). The reaction of methyl arylglyoxylates 15 with 
phosphorane 14 gave a mixture of alkenes 16 (E-major with trace amount of Z) which were 
separable by column chromatography. Lithium enolates 17, generated from corresponding 
t-butyl arylacetates 18 using LDA, were treated with E-16 to furnish selectivity E-5-
arylidenetetronic acids 20. Hydrolysis of the t-butyl ester groups in 20 provided the 
corresponding pulvinic acids 21. Distinctly, in this strategy the regioselectivity of 
cyclization can be controlled by increasing the bulkiness of the alkyl (t-butyl) group at the 
ester functionality. 
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Scheme 3.02 
3.2.3 The Pattenden syntheses of pulvinic acids 
Pattenden and coworkers13 reported two methods for the synthesis of pulvinic acids 
from the corresponding 2-aryl-3-methoxymaleic anhydrides 22 (Scheme 3.03). The first 
approach involves the conversion of 22 to the phosphonates 23 followed by a Wadsworth-
Emmons olefination whereas the second approach relies on Reformatsky-type reactions of 
22. 
The reaction between 2-aryl-3-methoxymaleic anhydrides 22 with sodium dimethyl 
phosphite gave the corresponding phosphonates 23, which were further treated with 
arylbenzoyl formates to provide a mixture of Z and E isomers of O-methylvulpinic acids 
24, with the E-isomers as major product. The mixture of Z and E alkenes can be separated 
by column chromatography or crystallization. In addition, when a solution of E/Z mixture 
was exposed to daylight for several days, the Z isomer underwent isomerization to the E-
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isomers. Treatment of E-24 with trimethylsilyl iodide (TMSI), cleaved the enol O-methyl 
ethers as well as phenolic O-methyl ethers to furnish pulvinic acids 26 (Scheme 3.03).  
In the second approach (Scheme 3.03), the Reformatsky-type reaction of 2-aryl-3-
methoxymaleic anhydrides 22 with zinc enolates derived from the corresponding aryl 
acetates, prepared by using LDA and ZnCl2, gave hydroxy esters 25, as single 
diastereomers in most of the cases. Hydroxy esters 25 were dehydrated by elimination of 
the corresponding mesylates to provide Z and E mixtures of the O-methylvulpinic acids 25. 
As desribed above, photoisomerization and demethylation of 25 provided pulvinic acids 
26. 
 
Scheme 3.03 
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3.2.4 The Langer synthesis of vulpinic acid (2)  
In 2004, Langer and coworkers14 reported the synthesis of vulpinic acid (2, Scheme 
3.04). Condensation of 27 with 28 gave ester 29, which was converted to 1,3-bis-silyl enol 
ether 31 in two steps via silyl enol ether 30. Compound 31 was treated with oxalyl chloride 
in the presence of TMSOTf to furnish 32 as a single diastereomer. The -
benzylidenebutenolide 32 was converted to the triflate 33, which was then subjected to a 
Suzuki cross-coupling reaction with phenylboronic acid to provide 34. Demethylation of 
the enol ether moiety in 34 provided vulpinic acid (2). 
 
Scheme 3.04 
3.2.5 The Le Gall and Mioskowski synthesis of pulvinic acids 
In 2005, the Le Gall and Mioskowski groups 15 a developed the synthesis of 
symmetrical pulvinic acids 38 from methyl arylacetates 35 (Scheme 3.05). Silyl ketene 
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acetals 36 were synthesized by treating methyl arylacetates 35 with LDA and trimethylsilyl 
chloride (TMSCl). Next, reactions were performed between 36 and oxalyl chloride in the 
presence of DBU, followed by acidification, to provide the corresponding methyl 
pulvinates 37 (vulpinic acids). These methyl esters 37 were subjected to saponification 
reactions with aqueous 0.5 N NaOH to furnish corresponding pulvinic acids 38. 
 
Scheme 3.05 
A mechanism has been proposed for the key cyclization reaction, which is the 
conversion of a diketone 39 to the corresponding vulpinic acid 42 (Scheme 3.06). The 
diketone 39 can exist in equilibrium with bis-enols 40 in methanol. The treatment of bis-
enols 40 with DBU induces a lactonization reaction involving an enolate oxygen and a 
suitable ester. Acidification provides the vulpinic acid 42 as a single diastereomer (Scheme 
3.06). 
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Scheme 3.06 
3.2.6 The Le Gall synthesis of vulpinic acids 
In 2007, Le Gall and coworkers16 developed a method to synthesize vulpinic acids 
48 (Scheme 3.07). Reaction of the anion of 43 and methyl benzoylformate provided the 
alcohol 44 as a mixture of diastereomers. Subsequent dehydration of 44 in the presence of 
trifluoroacetic anhydride furnished the E-alkene 45 with a small amount of the Z-alkene  
(5-10%). Iodination of 45 with iodine and ceric ammonium nitrate (CAN) provided 46. 
Finally, Suzuki-Miyaura cross-coupling reactions of 46 with various aryl boronates 
provided mixtures of the corresponding alkenes 47, with the E-isomers as the major 
products. The debenzylation of 47 afforded pure E-48 after removal of the minor Z-isomers 
by column chromatography. 
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Scheme 3.07 
3.2.7 The Le Gall synthesis of tetronic acids  
In 2009, Le Gall and coworkers17 reported the synthesis of 3-aryl tetronic acids 
from methyl arylacetates 50 via transesterification followed by the Dieckmann 
condensation (Scheme 3.08). The reactions were conducted between methyl arylacetates 
50 and methyl hydroxyacetates 49 in the presence of potassium tert-butoxide (t-BuOK) to 
provide the corresponding 3-aryl tetronic acids 51 (39-98%). Depending on the substrates, 
either DMF or THF had to be used as solvents for this reaction. 
 
Scheme 3.08 
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The 3-aryl tetronic acids synthesized in this study were used as starting materials in 
the synthesis of vulpinic acids (Scheme 3.09). Thus, tetronic acid 52 was treated with 
lithium diisopropylamide (LDA) to generate the corresponding dianion which was reacted 
with α-keto esters 53 to give alcohols 54 as a mixture of diastereomers. Dehydration of 54 
using trifluoroacetic anhydride and pyridine provided a mixture of E-and Z- isomers of 55 
(E/Z = 47:5358:42). These mixtures were subjected to UV irradiation or left exposed to 
daylight to provide pure E-55. 
 
Scheme 3.09 
3.2.8 The Xiao and Zhu synthesis of 3-aryl tetronic acids from aryl acetic acid  
In 2011, the Xiao and Zhu groups18 reported a synthesis of 3-aryl tetronic acids 
from the corresponding arylacetic acids 56 as the starting materials (Scheme 3.10). This 
methodology follows the esterification of arylacetic acids 56 with ethyl bromoacetate to 
give diesters 57, which were converted to 3-aryl tetronic acids by the Dieckmann 
condensation in the presence of NaH, followed by acidification. 
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Scheme 3.10 
3.3 Objective  
As described above, the majority of the reported syntheses of 3-aryl tetronates 
require a starting material which contains the aryl group that is needed in the target. The 
majority of these methods use aryl acetic acids (Scheme 3.10),18 esters (Scheme 3.08)17 or 
-hydroxy alkyl aryl ketones (Scheme 3.01)11 as the starting materials. An alternative, but 
synthetically intensive, approach (Scheme 3.04 and 3.07)14,16 involves the cross-coupling 
of arylboronic acid derivatives with C3-functionalized tetronic acid derivatives. All of these 
procedures are primarily limited by the availability of suitably functionalized starting 
materials and, consequently, methodology that overcomes this limitation, would be useful. 
With this objective in mind, a review of the literature indicated a scarcity of reports 
on the synthetic applications of 3-diazofuran-2,4-dione (59, Scheme 3.11),19 and a sole 
report describing an undesired, low yield, C-H insertion reaction of this diazo compound.19c 
We were therefore intrigued by the prospect of developing intermolecular aryl C-H 
insertion reactions of 59, easily prepared from commercially available tetronic acid by a 
single step procedure,19a,c as a direct route to 3-aryl tetronates (Scheme 3.11). The results 
of our studies on this strategy and application of the methodology in the synthesis of 
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vulpinic acid (2), pinastric acid (4) and methyl isoxerocomate (6, Figure 3.2) are presented 
below. 
 
Scheme 3.11 A strategy for the synthesis of 3-aryl tetronic acids 
3.3.1 Previous studies on C-H insertion reactions of arenes and diazo 1,3-dicarbonyl 
compounds 
Intramolecular and substrate-directed C-H functionalization of arenes with diazo 
compounds are well-known.20  Undirected, intermolecular, arene C-H functionalization 
reactions21a have also been investigated. The majority of these studies have examined          
a-aryl diazo esters21b-i or diazooxindoles21j-l and only a few studies are reported for diazo 
1,3-dicarbonyl compounds.21m-p The C-H insertion reactions of diazo 1,3-dicarbonyl 
compounds are summarized below (Schemes 3.12-3.15).  
 Recently, Best and coworkers reported21m a one-pot synthesis of arylacetic acid 
esters, thioesters and amides 64 using C-H insertion of Meldrum’s acid-derived diazo 
compound 62 with electron rich-arenes 61 (Scheme 3.12). This methodology employs C-
H insertion reactions of 62 with arenes 61 to give 63, which were further condensed with 
alcohols or thiols or amines, followed by decarboxylation in the presence of 
trimethylamine, to afford 64.  
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Scheme 3.12 
Pirrung and coworkers21n studied rhodium (II)-catalyzed reactions of a cyclic diazo 
compound, namely 2-diazo-1,3-cyclohexanedione (65), with heteroaromatics (Scheme 
3.13). These reactions provide a mixture of C-H insertion products as regioisomers 67, 68 
and 1,3 dipolar cycloaddition products 69 and 70.  
 
Scheme 3.13 
In related studies, Shechter and coworkers22o examined the reactions of arenes, and 
olefins with 2-diazo-l,3-indanedione (71) in the presence of Rh2(OAc)4 as the catalyst 
(Scheme 3.14). The reactions of 71 with arenes provide the corresponding C-H insertion 
products 72. On the other hand, reactions of 71 with olefins afford spirocyclopropanes 73. 
 
Scheme 3.14 
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Maryanoff reported22p that copper (II) catalyzed reactions of dimethyl 
diazomalonate (75) and ethyl 2-diazoacetoacetate (76) with N-methylpyrrole (74) provide 
the corresponding C-H insertion products as regioisomers 77 and 78 (Scheme 3.15). 
 
Scheme 3.15 
3.4 Results and Discussion 
As described above (Scheme 3.12-3.15), only four studies addressed the C-H 
insertion reactions of diazo 1,3-dicarbonyl compounds and arenes. Given the relative 
shortage of information available on the key step of our proposed synthetic plan, a survey 
of catalysts and reaction conditions was necessary. Accordingly, we first attempted the 
reaction of 59 with anisole in the presence of Cu(OTf)2,
21l Co(OAc)2
22  and 
(Ph3P)AuCl/AgSbF6
21d as catalysts. With Cu(OTf)2, 79 was obtained in low yield (11%, 
Table 3.1, entry 1). Although the Co- and Au-derived catalysts are known to promote diazo 
decomposition, only unreacted 59 was observed in these reactions. 
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Table 3.1 Optimization of the intermolecular aryl C−H insertion reaction of 59 
 
Entrya Catalyst Solvent t (h) Product Yield (%)b 
1 Cu(OTf)2 - 26 79 11 (36)
c 
2 Co(OAc)2 - 10 - - 
3 (PPh3)AuCl/AgSbF6 - 76 - - 
4 Rh2(OAc)4 - 6 79 96 
5 Rh2(OAc)4 (CH2)2Cl2
d 12 80 36 
6  CH2Cl2
d 79  21 (34)c 
7  PhCF3
e 168  47 (55)c 
8  [bmim]PF6
d 65  13 
9  [bmim]BF4
d 96  16 (22)c 
10 Rh2(CF3CO2)4 (CH2)2Cl2 24  27 
11  CH2Cl2 96  - 
12  PhCF3
e 5  51 (67)f 
13  PhCF3
e 21  35(46)f,g 
14  [bmim]PF6 92  19 (22)
c 
15  [bmim]BF4 72  42 
16 Rh2(NHCOC3F7)4 (CH2)2Cl2 5  19 
17  CH2Cl2 7  - 
18  PhCF3
h 2.5  23 
19  [bmim]PF6 22  21 
20  [bmim]BF4 55  23 
aanisole (entries 1-4) and biphenyl (entries 5-20) as arenes. bisolated yields. cbased on 
recovered 59. dat reflux or at 100 oC for ionic liquids. eat 70 oC. eat 100 oC. fincluding 
regioisomer. greaction with 2 equivalents of biphenyl. hreaction at 80 oC. 
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We therefore turned to the more conventional rhodium-based catalysts. 
Interestingly, heating a solution of 59 in anisole in the presence of Rh2(OAc)4 provided 79 
in excellent yield (96%) as a single regioisomer (Table 3.1, entry 4). This procedure 
(Method A) was suitable for simple arenes which could be used as the solvent and then 
easily separated from the tetronic acid product and recovered. 
In order to expand the scope of the methodology to other arenes, an optimization of 
the insertion reaction was conducted by varying the solvent, the catalyst and the 
stoichiometry of the arene. These studies, with biphenyl as the representative arene, are 
summarized in Table 3.1. 
Conventional chlorinated solvents, ionic liquids and -
trifluoromethylbenzene were selected as the reaction media and a set of rhodium (II) 
catalysts differing in the ligand were screened. The choice of rhodium catalysts that are 
more electrophilic than Rh2(OAc)4 was based on previous studies on competitive 
intramolecular reactions of diazo carbonyl compounds 23  in which electron-deficient 
rhodium catalysts favoured aromatic substitution (net C-H insertion) reactions over 
competing cyclopropanation. As seen from Table 3.1, almost all of the reactions provided 
80, but  -trifluoromethyl benzene was clearly a superior solvent (Table 3.1, entries 
7 and 12), and Rh2(CF3CO2)4 is the catalyst of choice (compare entries 7, 12 and 18 in 
Table 3.1). The best results were obtained with an excess of biphenyl (4 equiv, Table 3.1, 
entry 12) and reducing this amount was not beneficial (46% yield with 2 equiv. of biphenyl; 
Table 3.1, entry 13). This procedure (PhCF3 as the solvent, Rh2(CF3CO2)4 as the catalyst 
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and 4 equiv of the arene; Method B) or Method A, described above, were applicable to the 
C-H insertion reactions of 59 with a variety of arenes to provide 79-98 (Figure 3.3). 
 
Figure 3.3 Intermolecular aryl C-H insertion of 59 
The C-H insertion reactions of 59 with alkyl benzenes and with electronically 
activated arenes proceeded readily and in moderate to good yields (Method A, 12 examples, 
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72% average yield; Method B, 7 examples, 60% average yield). Interestingly, 59 also 
reacted with methyl benzoate to provide 98 (52%), but reactions with more electron-
deficient arenes such as nitrobenzene, acetophenone and benzonitrile were unsuccessful. 
The regiochemistry of C-H functionalization is what would be expected for electrophilic 
aromatic substitution of the arene24  except for the C-H insertion reaction of pyridine. 
Although the reason for this observation is not known at this time, it is plausible that the 
nitrogen in the pyridine ring directs the C-H insertion to proceed at C2 instead of C3. In a 
few cases, regioisomeric products (80, p/o = 3.1:1; 92/93 = 3.1:1; 96, p/o = 3.5:1), which 
were easily separated, were obtained. The results suggest that the carbenoid derived from 
59 reacts with the arenes as an electrophile. This reactivity is consistent with the superior 
performance of Rh2(CF3COO)4 which presumably increases the electrophilicity of the 
bound carbene.23 
Based on these observations, we propose a plausible mechanism for the C-H 
insertion reaction (Figure 3.4). Addition of the carbanion 59 to the rhodium metal followed 
by elimination of N2 provides an electrophilic carbenoid 99 (acceptor/acceptor substituted 
carbenoid). Addition of the nucleophile, such as an alkoxy benzene, to the electrophilic 
carbenoid carbon in 99 followed by elimination of the rhodium catalyst generates the 
intermediate 101. Transfer of a proton to the tetronate oxygen, with concomitant 
aromatization of 101, provides 102 which is the product of a ‘net insertion’ of tetronic acid 
into the arene C-H bond. 
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Figure 3.4 A plausible mechanism for the C-H insertion reactions 
3.4.1 Synthesis of naturally-occurring tetronic acid derivatives 
Having established a general procedure for preparing 3-aryl tetronic acid 
derivatives, we next examined the application of our method in the synthesis of selected, 
naturally-occurring pulvinic acids (Figure 3.2). While the conversion of 3-aryl tetronic 
acids to pulvinates is well-known (Schemes 3.2 3.3 and 3.4),12,13a,14 an objective of the 
present study was to develop a modular functionalization of 59 by first introducing the 
arylidene functionality at C5 (Figure 3.5) and then adding the C3 aryl group employing the 
C-H insertion procedure. Compared to current methods for pulvinic acid synthesis, our 
procedure would use 59 as the common starting material for all of the structurally related 
tetronate natural products. This strategy is summarized in Figure 3.5. 
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Figure 3.5 Strategy for the synthesis of naturally occurring pulvinates from 59. 
As described in section 3.2, previous syntheses of C5-arylidene tetronic acid 
derivatives from 3-aryl tetronic acids have relied on protocols that involve multi-step 
assembly of the tetronate ring (schemes 3.01, 3.03 and 3.04),11,13b,14 or Wittig reaction of a 
preformed C3-substituted tetronate derivative (scheme 3.03).13,12 More recent strategies 
also involve several steps, specifically: (a) an aldol reaction of a C3-substituted tetronic 
acid derivative with an -keto ester; (b) dehydration of the aldol product by mesylation and 
elimination,12 or by conversion first to the trifluoroacetate followed by elimination, and (c) 
photoisomerization of the mixture of isomeric alkenes so obtained to the naturally-
occurring E-isomer (Schemes 3.03 and 3.09).13,17 Stereoisomers of the required alkene 
products are also obtained in the earlier procedures.12,14,18b Clearly, an alternative to these 
multi-step procedures, and especially to the stereorandom synthesis of the arylidene portion 
at C5, would be useful. 
Our search for alternative procedures focused on the possibility of using a mild 
aldolization protocol that would not affect the diazo group in 59. Initial attempts with 59 
and the methyl benzoylformate in the presence of LDA (Table 3.2, entry 1) or MgBr2 and 
triethylamine25a (Table 3.2, entry 2) provided a very low yield of the required aldol product. 
However, the use of a stronger Lewis acid (Table 3.2, entries 3 and 4)25b provided a mixture 
of the aldol product 104 and the dehydration product 103. A brief optimization revealed 
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that warming the reaction mixture (0 oC) provided only 103 (64%, Table 3.2, entry 5) with 
excellent diastereoselectivity (E/Z = ~40:1).26 These optimized reaction conditions were 
used for aldol condensation reactions in subsequent studies. 
Table 3.2 Optimization of aldol condensation reaction of 59. 
 
S. No. Reagents and conditions Product Yielda 104a 
1 LDA, THF, -78 oC, 1.5 h to 0 oC, 1 h 103 - 6 
2 MgCl2, Et3N, TMSCl, EtOAc, rt, 96 h  - <5 
3b 
TiCl4, -78 
oC to 0 oC, 1.5 h 
Et3N, -78 
oC, 1.5 h 
 20 67 
4c 
TiCl4, -78 
oC, 30 min 
Et3N, -78 
oC, 40 min 
 61 28 
5c 
TiCl4, -78 
oC, 30 min 
Et3N, -78 
oC, 3.5 h to 0 oC, 6 h 
 64 - 
6d 
TiCl4, -78 
oC, 30 min 
Et3N, -78 
oC, 1 h 
 - - 
7 
TiCl4, -78 
oC, 30 min 
Et3N, -78 
oC, 4 h 
 33 25 
8 
TiCl4, -78 
oC, 30 min 
Et3N, -78 
oC, 30 min to 0 oC, 5 h 
 61 - 
9 
TiCl4, -78 
oC, 30 min 
Et3N, -78 
oC, 40 min 
105 60  
aisolated yields. breaction with 1.5 equiv of TiCl4 and 2 equiv of Et3N. 
creaction with 3 
equiv of TiCl4 and 3 equiv of Et3N. 
dreaction with 7 equiv of TiCl4 and 7 equiv of Et3N.  
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Similarly, 105 was also obtained as a single isomer (60%, Table 3.2, entry 9) using 
this procedure but with methyl 3,4-dimethoxybenzoylformate. 
3.4.2 Determination of stereochemistry of aldol condensation products 
The geometry of the aldol condensation products, 103 and 105 has been assigned 
by comparison of characteristic chemical shifts of E and Z isomers of structurally similar 
compounds reported in the literature. Lerche27b reported the reactions of esters 106 with 
nitroenamines 107 in the presence of a base to give mixtures of E- and Z- alkyl-4-oxo-2-
arylpentenoates 108 (Scheme 3.16). 
 
Scheme 3.16 
The 1H NMR chemical shifts of selected hydrogen atoms in 109, obtained by the 
above methodology, were utilized to assign the stereochemistry of 103 obtained in our 
studies. The 1H NMR signal for the ester methyl group (CO2CH3) in Z-109 appears at δ 
3.97, whereas in E-109, it appears at δ 3.86 (Figure 3.6). Notably, the ester methyl group 
in Z-109 (δ 3.97) experiences a downfield shift due to anisotropic deshielding by the 
neighboring carbonyl group (CH3CO) group, as compared with the ester methyl group in 
E-109 (δ 3.86, Figure 3.6).  
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Figure 3.6 
In our studies, a similar trend in chemical shift for the methyl ester in 103 has been 
observed. In E-103, the ester methyl group appears downfield, at  3.95, compared to the 
Z-103 isomer, in which the ester methyl group is at  3.86. This is due to the anisotropic 
deshielding by the C4 carbonyl group in E-103. The geometry of 105 is assigned by anology 
to 103. 
With 103 and 105 in hand, their C-H insertion reactions were examined. 
Gratifyingly, Rh(II)-catalyzed reactions of 103 in benzene provided vulpinic acid (2, 91%, 
Scheme 3.17). The transformation of 2 to pulvinic acid (1) has been reported15a  by Le Gall.  
 
Scheme 3.17 Synthesis of vulpinic acid (2) 
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Similarly, the C-H insertion reaction of 103 with anisole (4 equiv in PhCF3, Method 
B) in the presence of Rh2(CF3COO)4 furnished pinastric acid (4, 70%, Scheme 3.18). The 
conversion of 4 to 4-hydroxypulvinic acid (3) has been reported15b by Pattenden.  
 
Scheme 3.18 synthesis of pinastric acid (4) 
Next, the synthesis of methyl isoxerocomate (6) was studied. The C-H insertion 
reaction of 105 with anisole provided 110 (72%). Chemoselective demethylation of the aryl 
methyl ethers in 110 with BBr3 furnished methyl isoxerocomate (6, 72%, Scheme 3.19). 
 
Scheme 3.19 Synthesis methyl isoxerocomate (6) 
The formation of 2, 4, and 6 also confirms the stereochemical assignments for 103 
and 105 which were initially based by analogy to structurally-related compounds (Section 
3.5.1.1). 
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3.4.3 The unique reactivity of diazotetronic acid (59) 
It is well known that stabilized diazo compounds such as diazomalonate react with 
an aromatic ring in a manner that is distinct from the C-H insertion reactions of 
diazotetronic acid 59. This, more conventional, reaction is the Büchner ring expansion 
reaction between aromatic compounds and carbenes to generate norcaradiene which can 
exist in equilibrium with cycloheptatriene (Scheme 3.20). From previous reports,27 Rh(II)-
catalyzed reactions of dimethyl diazomalonate and methyl diazoacetate with arenes 
provided the corresponding norcaradiene and bis-cyclopropanation products with only 
trace amounts of C-H insertion products. For example,27 the reaction of dimethyl 
diazomalonate 75 with benzene at the reflux temperature in the presence of Rh2(OAc)4 
provided a mixture of 111, 112, 113 and 114 (Scheme 3.20). A portion of the equilibrium 
mixture of 111 and 112 is converted into the bis-cyclopropanation product 114 by 
cyclopropanation of 111 during the reaction. 
Scheme 3.20 
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 In contrast, the reaction of diazotetronic acid (59) in benzene in the presence of 
Rh2(OAc)4 at reflux provided the insertion product 81 in 94% yield. Interestingly, this 
reaction afforded only insertion product 81 without any Büchner ring expansion products. 
 
Scheme 3.14 
 Interestingly when diazo compound 115, an open-chain analogue of 59, was 
employed in reactions with benzene in the presence of Rh2(OAc)4 or Rh2(CF3COO)4, both 
reactions generated complex mixtures which contained neither the insertion product 117 or 
any cyclopropanation products 116 (Scheme 3.21). These observations suggest that 
diazotetronic acid (59) has unusual reactivity that favors C-H insertion reactions with 
arenes in the presence of Rh(II) catalysts. 
 
Scheme 3.21 
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3.5 Conclusion 
 In conclusion, a one-step synthesis of 3-aryl tetronic acids has been developed from 
3-diazofuran-2,4-dione (59). The synthesis of vulpinic acid (2), pinastric acid (4) and 
methylisoxercomate (6), as well as a formal synthesis of pulvinic acid (1) and 4-
hydroxypulvinic acid (3) was achieved in three steps from commercially available tetronic 
acid. To the best of our knowledge, the two-step functionalization of 59 offers the shortest 
route to these natural products. The methodology provides direct access to a wide range of 
3-aryl tetronates and has the advantage of furnishing stereoisomerically-pure 5-arylidene 
tetronates. We anticipate that our modular strategy will be useful for preparing natural 
product-like libraries of tetronic acid derivatives by systematic variation of the C3 aryl 
group and the aryl group in the -keto ester used in the aldol condensation.  
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3.6 Experimental Section 
All commercially available reagents were used without purification. All reactions 
requiring anhydrous conditions were performed under an atmosphere of dry nitrogen using 
oven dried glassware. CH2Cl2 were distilled from CaH2. Commercial precoated silica gel 
plates were used for TLC. All melting points are uncorrected. Silica gel for flash column 
chromatography was 230-400 mesh. IR spectra were recorded on a Bruker TENSOR 27 
FT-IR instrument. 1H NMR and 13C NMR spectra were recorded on a Bruker AVANCE 
III 300 or an AVANCE 500 instrument. Mass spectra were obtained on an Agilent 1100 
series LC/MSD (Trap) or an Agilent 6200 LC/MSD (TOF) chromatographic system.  
3-Diazofuran-2,4(3H,5H)-dione (59):19c 
 
To a solution of tetronic acid (1.50 g, 15.0 mmol) in acetonitrile (20 mL) were added 
tosyl azide (2.90 g, 15.0 mmol) followed by dropwise addition of triethylamine (2.09 mL, 
15.0 mmol) over 10 min at 0 °C. The mixture gradually turned black and was stirred at 
room temperature for 1 h. The solvent was then removed under reduced pressure. The black 
residue and triethylammonium salt was removed by applying the crude product mixture to 
a column (3.0 cm x 17 cm) of flash silica gel and eluting with dichloromethane (~300 mL). 
The residue obtained by concentrating the dichloromethane eluate was further purified by 
flash column chromatography on silica gel (CH2Cl2/EtOAc, 9.8:0.2) to provide 773 mg 
(41%) of 59 as a white solid. 
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Rf = 0.31 (CH2Cl2/EtOAc, 9.5:0.5); mp: 90-91 °C; IR (neat): 2158, 1752, 1686, 1355, 1328, 
1220, 1105, 1015, 973 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.68 (s, 2H, OCH2); 13C NMR 
(75 MHz, CDCl3): δ 185.5 (C=O), 163.6 (OC=O), 72.7 (OCH2). 
Insertion reactions of 59 and arenes: 
General Procedure 1: To a solution of 59 in the aromatic compound (1.5 mL) was 
added the Rh(II) catalyst at room temperature. The reaction mixture was then placed in pre-
heated oil bath at 100 °C. The mixture was heated until complete consumption of the 
diazotetronic acid (TLC), then cooled to room temperature and ethyl acetate (5 mL) was 
added. The suspension was extracted with saturated aqueous NaHCO3 (3 x 2 mL). The 
unreacted aromatic compound was recovered by concentration of the organic layer. The 
combined aqueous extracts were acidified to pH ~3 with 2 N HCl and the suspension was 
extracted with ethyl acetate (4 x 5 mL). The combined extracts were dried (Na2SO4) and 
concentrated under reduced pressure to provide the crude product which was generally pure 
by 1H NMR. If necessary, the crude product was purified by flash chromatography on silica 
gel. 
General Procedure 2: To a suspension of 59 (1 equiv) in ,,-trifluorotoluene 
(2 mL) was added the aromatic compound (4 equiv) followed by the Rh(II) catalyst (1 
mol%) at room temperature and the reaction mixture was placed in a pre-heated oil bath at 
100 °C. The mixture was heated until complete consumption of 59 (TLC), then cooled to 
room temperature and ethyl acetate (5 mL) was added. The suspension was extracted with 
saturated aqueous NaHCO3 (3 x 2 mL). The unreacted aromatic compound was recovered 
by concentration of the organic layer. The combined aqueous extracts were acidified to pH 
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~3 with 2N HCl and the suspension was extracted with ethyl acetate (4 x 5 mL). The 
combined extracts were dried (Na2SO4) and concentrated under reduced pressure to provide 
the crude product that was generally pure by 1H NMR. If necessary, the crude product was 
purified by flash chromatography on silica gel. 
4-Hydroxy-3-(4-methoxyphenyl)furan-2(5H)-one (79): 
 
The reaction of 59 (50 mg, 0.39 mmol), Rh2(OAc)4 (1.7 mg, 3.9 x 10
-3 mmol) in 
anisole (1.5 mL) for 6 h according to General Procedure 1 provided, 78 mg (96%) of 79 as 
a white solid. 
Rf = 0.39 (EtOAc/hexanes, 3:2); mp: 227-229 °C; IR (neat): 2952 (br), 2925 (br), 2692 (br), 
1634, 1605, 1510, 1421, 1395, 1346, 1295, 1250, 1235, 1164, 1050, 1015, 955, 832 cm-1; 
1H NMR (300 MHz, DMSO-d6): δ 12.59 (br s, 1H, OH), 7.85 (d, 2H, J = 8.9 Hz, ArH), 
6.95 (d, 2H, J = 8.9 Hz, ArH), 4.75 (s, 2H, OCH2), 3.75 (s, 3H, OCH3); 
13C NMR (75 MHz, 
DMSO-d6): δ 173.4 (C=O or C=COH), 173.1 (C=O or C=COH), 157.6 (ArCipso), 127.6 (2 
× ArC), 123.0 (ArCipso), 113.6 (2 × ArC), 97.2 (C=COH), 66.0 (OCH2), 55.0 (OCH3); 
HRMS (ESI): m/z 206.0579 (206.0579 calc. for C11H10O4, (M)
+) and 229.0470 (229.0477 
calc. for C11H10NaO4, (M+Na)
+). 
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3-(Biphenyl-4-yl)-4-hydroxyfuran-2(5H)-one (80): 
 
The reaction of 59 (50 mg, 0.39 mmol), biphenyl (244 mg, 1.58 mmol), 
Rh2(CF3CO2)4 (2.6 mg, 3.9 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) for 5 h according 
to General Procedure 2 provided, after purification by flash column chromatography on 
silica gel (CH2Cl2/CH3OH, 9.7:0.3 to 9.5:0.5), 50 mg (51%) of 80 as a white solid. 
Rf = 0.26 (EtOAc/hexanes, 3:2); mp: 246-249 °C; IR (neat): 3035 (br), 2954, 2921, 2853 
(br), 2664 (br), 1688, 1637, 1414, 1395, 1339, 1312, 1235, 1166, 1052, 1017, 957, 840 cm-
1; 1H NMR (300 MHz, DMSO-d6): δ 8.04 (d, 2H, J = 8.4 Hz, ArH), 7.74-7.65 (m, 4H, 
ArH), 7.51-7.42 (m, 2H, ArH), 7.39-7.31 (m, 1H, ArH), 4.79 (s, 2H, OCH2); 
13C NMR (75 
MHz, DMSO-d6): δ 175.6 (C=O or C=COH), 173.0 (C=O or C=COH), 139.8 (ArCipso), 
137.7 (ArCipso), 129.9 (ArCipso), 128.9 (2 × ArC), 127.3 (ArC), 126.5 (2 × ArC), 126.4 (2 
× ArC), 126.2 (2 × ArC), 96.7 (C=COH), 66.2 (OCH2); HRMS (CI): m/z 252.0785 
(252.0786 calc. for C16H12O3, (M)
+) and 275.0677 (275.0684 calc. for C16H12NaO3, 
(M+Na)+). 
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4-Hydroxy-3-phenylfuran-2(5H)-one (81):28 
 
The reaction of 59 (50 mg, 0.39 mmol), Rh2(OAc)4 (1.7 mg, 3.9 x 10
-3 mmol) in benzene 
(1.5 mL) for 15 h according to General Procedure 1 provided 66 mg (94%) of 81 as a yellow 
solid. Detailed spectroscopic data for 88 was given in chapter 2, page 157.  
4-Hydroxy-3-p-tolylfuran-2(5H)-one (82):28 
 
The reaction of 59 (100 mg, 0.790 mmol), Rh2(OAc)4 (3.5 mg, 7.9 x 10
-3 mmol) in 
toluene (2.5 mL) for 76 h according to General Procedure 1 provided after purification by 
flash chromatography on silica gel (hexanes/EtOAc, 1:1 to 3:7), 93 mg (62%) of 82 as a 
white solid. 
Rf  = 0.26 (EtOAc/hexanes, 3:2); mp: 243-245 °C; IR (neat): 2921, 2859, 1717, 1651, 1601, 
1515, 1433, 1393, 1336, 1312, 1162, 1020, 949, 822 cm-1; 1H NMR (300 MHz, DMSO-
d6): δ 7.81 (d, 2H, J = 8.1 Hz, ArH), 7.18 (d, 2H, J = 8.1 Hz, ArH), 4.75 (s, 2H, OCH2), 
2.29 (s, 3H, ArCH3); 
13C NMR (75 MHz, DMSO-d6): δ 174.5 (C=O or C=COH), 173.0 
(C=O or C=COH), 135.4 (ArCipso), 128.6 (2 × ArC), 127.7 (ArCipso), 126.1 (2 × ArC), 97.2 
(C=COH), 66.0 (OCH2), 20.8 (ArCH3). 
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3-(3,4-Diethylphenyl)-4-hydroxyfuran-2(5H)-one (83):  
 
The reaction of 59 (100 mg, 0.790 mmol), Rh2(CF3CO2)4 (5.2 mg, 7.9 x 10
-3 mmol) 
in 1,2-diethylbenzene (2.5 mL) for 42 h according to General Procedure 1 provided, after 
purification by flash chromatography on silica gel (hexane/EtOAc, 3:2 to 2:3), 118 mg 
(64%) of 83 as a white solid. 
Rf = 0.28 (hexanes/EtOAc, 1:1); mp: 180-183 °C; IR (neat): 2970, 2961, 2933, 2871, 2564 
(br), 1588, 1439, 1381, 1370, 1343, 1058, 1044, 866, 830 cm-1; 1H NMR (300 MHz, 
DMSO-d6): δ 12.62 (br s, 1H, OH), 7.70 (d, 1H, J = 1.9 Hz, ArH), 7.64 (dd, 1H, J = 8.0, 
1.9 Hz, ArH), 7.14 (d, 1H, J = 8.0 Hz, ArH), 4.75 (s, 2H, OCH2), 2.60 (q, 2H, J = 7.5 Hz, 
CH2CH3), 2.59 (q, 2H, J = 7.5 Hz, CH2CH3), 1.16 (t, 3H, J = 7.5 Hz, CH2CH3), 1.15 (t, 3H, 
J = 7.5 Hz, CH2CH3); 
13C NMR (75 MHz, DMSO-d6): δ 174.1 (C=O or C=COH), 173.0 
(C=O or C=COH), 140.7 (ArCipso), 139.4 (ArCipso), 128.0 (ArCipso), 127.9 (ArC), 126.2 
(ArC), 124.1 (ArC), 97.6 (C=COH), 65.9 (OCH2), 25.0 (CH2CH3), 24.6 (CH2CH3), 15.4 
(CH2CH3), 15.3 (CH2CH3); HRMS (APPI): m/z 232.1093 (232.1099 calc. for C14H16O3, 
(M)+) and 233.1166 (233.1178calc. for C14H17O3, (M+H)
+) 
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4-Hydroxy-3-(4-isopropylphenyl)furan-2(5H)-one (84): 
 
The reaction of 59 (50 mg, 0.39 mmol), Rh2(OAc)4 (1.7 mg, 3.9 x 10
-3 mmol) in 
cumene (1.5 mL) for 91 h according to General Procedure 1 provided, after purification by 
flash chromatography on silica gel (CH2Cl2/CH3OH, 9.5:0.5 to 8.5:1.5), 28 mg (32%) of 
84 as a pale-yellow solid. 
Rf = 0.23 (CH2Cl2/CH3OH, 9:1); mp: 132-134 °C; IR (neat): 2960, 2934, 2869, 2662 (br), 
2600 (br), 1620, 1576, 1515, 1435, 1392, 1348, 1335, 1057, 1018, 960, 831 cm-1; 1H NMR 
(300 MHz, DMSO-d6): δ 7.83 (d, 2H, J = 8.3 Hz, ArH), 7.22 (d, 2H, J = 8.3 Hz, ArH), 4.72 
(s, 2H, OCH2), 2.86 (septet, 1H, J = 6.8 Hz, CH(CH3)2), 1.20 (d, 6H, J = 6.8 Hz, CH(CH3)2); 
13C NMR (75 MHz, DMSO-d6): δ 175.2 (C=O or C=COH), 173.2 (C=O or C=COH), 146.1 
(ArCipso), 128.3 (ArCipso), 126.2 (2 × ArC), 125.9 (2 × ArC), 96.8 (C=COH), 66.1 (OCH2), 
33.2 (CH(CH3)2), 23.9 (CH(CH3)2); HRMS (ESI): m/z 218.0944 (218.0943 calc. for 
C13H14O3, (M)
+) and 241.0836 (241.0841 calc. for C13H14NaO3, (M+Na)
+). 
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3-(4-tert-Butylphenyl)-4-hydroxyfuran-2(5H)-one (85): 
 
The reaction of 59 (50 mg, 0.39 mmol), Rh2(OAc)4 (1.7 mg, 3.9 x 10
-3 mmol) in 
tert-butylbenzene (1.5 mL) for 24 h according to General Procedure 1 provided, 87 mg 
(95%) of 85 as a white solid. 
Rf = 0.29 (EtOAc/hexanes, 3:2); mp: 153-156 °C; IR (neat): 2959, 2657 (br), 2596 (br), 
1697, 1599, 1581, 1517, 1434, 1393, 1343, 1314, 1064, 1016, 962, 840, 831 cm-1; 1H NMR 
(300 MHz, DMSO-d6): δ 12.71 (br s, 1H, OH), 7.80 (d, 2H, J = 8.5 Hz, ArH), 7.39 (d, 2H, 
J = 8.5 Hz, ArH), 4.76 (s, 2H, OCH2), 1.28 (s, 9H, C(CH3)3); 
13C NMR (75 MHz, DMSO-
d6): δ 174.3 (C=O or C=COH), 173.0 (C=O or C=COH), 148.7 (ArCipso), 127.5 (ArCipso), 
126.1 (2 × ArC), 124.8 (2 × ArC), 97.4 (C=COH), 66.0 (OCH2), 34.2 (C(CH3)3), 31.1 (3 × 
CH3); HRMS (APPI): m/z 232.1097 (232.1099 calc. for C14H16O3, (M)
+) and 233.1173 
(233.1178 calc. for C14H17O3, (M+H)
+). 
3-(3,4-Dimethoxyphenyl)-4-hydroxyfuran-2(5H)-one (86):28 
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The reaction of 59 (50 mg, 0.39 mmol), Rh2(OAc)4 (1.7 mg, 3.9 x 10
-3 mmol) in 
1,2-dimethoxybenzene (1.5 mL) for 11 h according to General Procedure 1 provided, 90 
mg (96%) of 86 as a white solid. 
Rf = 0.23 (CH2Cl2/CH3OH, 9:1); mp: 207-209 °C; IR (neat): 2957 (br), 2935 (br), 2917 
(br), 2681 (br), 1694, 1633 (br), 1584, 1518, 1400, 1344, 1322, 1259, 1236, 1145, 1024 cm-
1; 1H NMR (300 MHz, DMSO-d6): δ 12.65 (br s, 1H, OH), 7.57 (d, 1H, J = 1.9 Hz, ArH), 
7.49 (dd, 1H, J = 8.5, 1.9 Hz, ArH), 6.96 (d, 1H, J = 8.5 Hz, ArH), 4.75 (s, 2H, OCH2), 
3.75 (s, 3H, OCH3), 3.74 (s, 3H, OCH3); 
13C NMR (75 MHz, DMSO-d6): δ 173.6 (C=O or 
C=COH), 173.1 (C=O or C=COH), 148.2 (ArCipso), 147.4 (ArCipso), 123.2 (ArCipso), 119.1 
(ArC), 111.6 (ArC), 110.2 (ArC), 97.3 (C=COH), 66.0 (OCH2), 55.44 (OCH3), 55.37 
(OCH3). 
3-(2,5-Dimethoxyphenyl)-4-hydroxyfuran-2(5H)-one (87): 
 
The reaction of 59 (50 mg, 0.39 mmol), 1,4-dimethoxybenzene (219 mg, 1.58 
mmol), Rh2(CF3CO2)4 (2.6 mg, 3.9 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) for 27 h 
according to General Procedure 2 provided, after purification by flash column 
chromatography on silica gel (hexane/EtOAc, 1:1 to 3:7), 51 mg (55%) of 87 as a brown 
solid. 
Rf = 0.21 (hexanes/EtOAc, 7:3); mp: 133-136 °C; IR (neat): 3002, 2964, 2930, 2834, 1718, 
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1628 (br), 1506, 1470, 1408, 1321, 1253, 1227, 1207, 1155, 1024, 989, 870, 812 cm-1; 1H 
NMR (300 MHz, DMSO-d6): δ 12.02 (br s, 1H, OH), 6.95 (d, 1H, J = 8.9 Hz, ArH), 6.88 
(dd, 1H, J = 8.9, 3.0 Hz, ArH), 6.73 (d, 1H, J = 3.0 Hz, ArH), 4.73 (s, 2H, OCH2), 3.70 (s, 
3H, OCH3), 3.68 (s, 3H, OCH3); 
13C NMR (75 MHz, DMSO-d6): δ 174.2 (C=O or 
C=COH), 172.9 (C=O or C=COH), 152.6 (ArCipso), 151.5 (ArCipso), 119.2 (ArCipso), 116.8 
(ArC), 113.5 (ArC), 112.2 (ArC), 97.2 (C=COH), 66.6 (OCH2), 55.8 (OCH3), 55.4 (OCH3); 
HRMS (ESI): m/z 236.0686 (236.0685 calc. for C12H12O5, (M)
+) and 259.0579 (259.0582 
calc. for C12H12NaO5, (M+Na)
+). 
4-Hydroxy-3-(4-phenoxyphenyl)furan-2(5H)-one (88): 
 
The reaction of 59 (50 mg, 0.39 mmol), Rh2(OAc)4 (1.7 mg, 3.9 x 10
-3 mmol) in diphenyl 
ether (1.5 mL) for 12 h according to General Procedure 1 provided, 99 mg (93%) of 88 as 
a white solid. 
Rf = 0.20 (CH2Cl2/CH3OH, 9:1); mp: 192-194 °C; IR (neat): 2933 (br), 2638 (br), 2588 
(br), 1701, 1609, 1586, 1507, 1486, 1429, 1392, 1342, 1233, 1199, 1164, 1051, 1016, 842 
cm-1; 1H NMR (300 MHz, DMSO-d6): δ 13.50-12.25 (br s, 1H, OH), 7.92 (d, 2H, J = 8.9 
Hz, ArH), 7.44-7.34 (m, 2H, ArH), 7.18-7.10 (m, 1H, ArH), 7.07-6.98 (m, 4H, ArH), 4.78 
(s, 2H, OCH2); 
13C NMR (75 MHz, DMSO-d6): δ 174.4 (C=O or C=COH), 172.9 (C=O or 
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C=COH), 156.8 (ArCipso), 154.7 (ArCipso), 130.0 (2 × ArC), 127.9 (2 × ArC), 125.9 
(ArCipso), 123.3 (ArC), 118.5 (2 × ArC), 118.4 (2 × ArC), 96.8 (C=COH), 66.0 (OCH2); 
HRMS (APPI): m/z 268.0739 (268.0736 calc. for C16H12O4, (M)
+) and 269.0795 (269.0814 
calc. for C16H13O4, (M+H)
+). 
4-Hydroxy-3-(pyridin-2-yl)furan-2(5H)-one (89): 
 
The reaction of 59 (50 mg, 0.39 mmol), Rh2(CF3CO2)4 (2.6 mg, 3.9 x 10
-3 mmol) 
in pyridine (1.5 mL) for 23 h according to General Procedure 1 but the acid-base workup 
procedure was not followed. The reaction mixture was concentrated and the residue was 
directly purified by flash chromatography on silica gel (CH2Cl2/CH3OH, 9.7:0.3 to 9.5:0.5), 
25 mg (36%) of 89 as a brown solid. 
Rf = 0.38 (CH2Cl2/CH3OH, 9:1); mp: 220-223 °C; IR (neat): 3084 (br) 2923 (br), 1712, 
1621, 1574 (br), 1536, 1438, 1427, 1323, 1302, 1265, 1209, 1190, 1025, 1003, 952, 933 
cm-1; 1H NMR (300 MHz, DMSO-d6): δ 14.02 (br s, 1H, OH), 8.36 (d, 1H, J = 6.0 Hz, 
ArH), 8.29 (d, 1H, J = 8.6 Hz, ArH), 8.16 (ddd, 1H, J = 8.6, 7.2, 1.6 Hz, ArH), 7.28 (ddd, 
1H, J = 7.2, 6.0, 1.3 Hz, ArH), 4.44 (s, 2H, OCH2); 
13C NMR (75 MHz, DMSO-d6): δ 192.8 
(C=O), 173.6 (C=COH), 148.9 (ArCipso), 143.3 (ArC), 137.8 (ArC), 118.5 (ArC), 117.5 
(ArC), 84.1 (C=COH), 70.1 (OCH2); HRMS (ESI): m/z 177.0424 (177.0426 calc. for 
C9H7NO3, (M)
+) and 200.0316 (200.0324 calc. for C9H7NNaO3, (M+Na)
+). 
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4-Hydroxy-3-(3-methoxy-5,6,7,8-tetrahydronaphthalen-2-yl)furan-2(5H)-one (90): 
 
The reaction of 59 (50 mg, 0.39 mmol), 6-methoxy-1,2,3,4-tetrahydronaphthalene 
(0.25 mL, 1.6 mmol), Rh2(CF3CO2)4 (2.6 mg, 3.9 x 10
-3 mmol) in ,,-trifluorotoluene (2 
mL) for 27 h according to General Procedure 2 provided, after purification by flash column 
chromatography on silica gel (CH2Cl2/CH3OH, 9.7:0.3), 47 mg (46%) of 90 as a brown 
solid. 
Rf = 0.26 (CH2Cl2/CH3OH, 9.5:0.5); mp: 146-148 °C; IR (neat): 3002 (br), 2919 (br), 2853, 
1756, 1717, 1634, 1605, 1461, 1450, 1404, 1311, 1252, 1235, 1197, 1157, 1106, 1050, 
1028, 1014, 970, 850 cm-1; 1H NMR (300 MHz, DMSO-d6): δ 11.82 (br s, 1H, OH), 6.81 
(s, 1H, ArH), 6.68 (s, 1H, ArH), 4.71 (s, 2H, OCH2), 3.67 (s, 3H, OCH3), 2.77-2.67 (br m, 
2H, ArCH2), 2.66-2.56 (br m, 2H, ArCH2), 1.77-1.65 (br m, 4H, CH2CH2CH2CH2); 
13C 
NMR (75 MHz, DMSO-d6): δ 173.8 (C=O or C=COH), 173.2 (C=O or C=COH), 155.1 
(ArCipso), 137.2 (ArCipso), 131.4 (ArC), 127.7 (ArCipso), 115.8 (ArCipso), 111.2 (ArC), 97.4 
(C=COH), 66.6 (OCH2), 55.2 (OCH3), 29.1 (CH2), 27.9 (CH2), 23.0 (CH2), 22.7 (CH2); 
HRMS (ESI): m/z 260.1052 (260.1049 calc. for C15H16O4, (M)
+) and 283.0940 (283.0946 
calc. for C15H16NaO4, (M+Na)
+). 
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4-Hydroxy-3-(4-methoxynaphthalen-1-yl)furan-2(5H)-one (91): 
 
The reaction of 59 (50 mg, 0.39 mmol), Rh2(OAc)4 (1.7 mg, 3.9 x 10
-3 mmol) in 1-
methoxynaphthalene (1.5 mL) for 18 h according to General Procedure 1 provided after 
purification by flash chromatography on silica gel (EtOAc/hexanes, 1:1-7:3), 88 mg (87%) 
of 91 as a white solid. 
Rf = 0.23 (hexanes/EtOAc, 1:1); mp: 155-157 °C; IR (neat): 2930 (br), 2716 (br), 2673 (br), 
1644, 1580, 1427, 1406, 1368, 1341, 1319, 1269, 1241, 1068, 1024, 822 cm-1; 1H NMR 
(300 MHz, DMSO-d6): δ 12.30 (br s, 1H, OH), 8.25-8.14 (m, 1H, ArH), 7.74-7.65 (m, 1H, 
ArH), 7.58-7.45 (m, 2H, ArH), 7.32 (d, 1H, J = 7.9 Hz, ArH), 7.01 (d, 1H, J = 7.9 Hz, 
ArH), 4.90 (s, 2H, OCH2), 3.99 (s, 3H, OCH3); 
13C NMR (75 MHz, DMSO-d6): δ 174.8 
(C=O or C=COH), 173.7 (C=O or C=COH), 154.5 (ArCipso), 132.1 (ArCipso), 128.6 (ArC), 
126.2 (ArC), 125.6 (ArC), 125.0 (ArC), 124.8 (ArCipso), 121.5 (ArCipso), 119.2 (ArCipso), 
104.0 (ArC), 98.8 (C=COH), 66.7 (OCH2), 55.5 (OCH3); HRMS (ESI): m/z 256.0734 
(256.0736 calc. for C15H12O4, (M)
+) and 279.0626 (279.0633 calc. for C15H12NaO4, 
(M+Na)+). 
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4-Hydroxy-3-(naphthalen-1-yl)furan-2(5H)-one (92): 
 
The reaction of 59 (50 mg, 0.39 mmol), naphthalene (203 mg, 1.58 mmol), 
Rh2(CF3CO2)4 (2.6 mg, 3.9 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) for 22 h 
according to General Procedure 2 provided, after purification by flash column 
chromatography on silica gel (CH2Cl2/CH3OH, 0.3:9.7 to 0.5:9.5), 50 mg (56%) of 92 as a 
white solid and 16 mg (18%) of 93 as a pale-yellow solid. 
Rf = 0.22 (hexanes/EtOAc, 1:1); mp: 146-148 °C; IR (neat): 2922, 2853, 1706, 1648, 1629, 
1613, 1572, 1467, 1434, 1397, 1314, 1258, 1214, 1169, 1047, 1014, 936, 800 cm-1; 1H 
NMR (300 MHz, DMSO-d6): δ 12.45 (br s, 1H, OH), 8.00-7.88 (m, 2H, ArH), 7.81-7.72 
(m, 1H, ArH), 7.59-7.45 (m, 3H, ArH), 7.40 (d, 1H, J = 6.8 Hz, ArH), 4.92 (s, 2H, OCH2); 
13C NMR (75 MHz, DMSO-d6): δ 175.3 (C=O or C=COH), 173.5 (C=O or C=COH), 133.3 
(ArCipso), 131.3 (ArCipso), 128.3 (ArC), 128.2 (ArC), 127.9 (ArC), 127.5 (ArCipso), 125.8 
(3×ArC), 125.4 (ArC), 98.9 (C=COH), 66.9 (OCH2); HRMS (APPI): m/z  226.0621 
(226.0630 calc. for C14H10O3, (M)
+) and 227.0689 (227.0708 calc. for C14H11O3, (M+H)
+). 
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4-Hydroxy-3-(naphthalen-2-yl)furan-2(5H)-one (93): 
 
Rf = 0.21 (hexanes/EtOAc, 1:1); mp: 180-182 °C; IR (neat): 2955, 2922, 2852, 2725 (br), 
1699, 1631, 1556, 1439, 1415, 1331, 1053, 1023, 821 cm-1; 1H NMR (300 MHz, DMSO-
d6): δ 8.49 (s, 1H, ArH), 8.22 (dd, 1H, J = 8.6, 1.6 Hz, ArH), 7.90-7.80 (m, 3H, ArH), 7.51-
7.38 (m, 2H, ArH), 4.69 (s, 2H, OCH2); 
13C NMR (75 MHz, DMSO-d6): δ 178.4 (C=O or 
C=COH), 173.8 (C=O or C=COH), 133.0 (ArCipso), 131.1 (ArCipso), 129.6 (ArCipso), 127.7 
(ArC), 127.3 (ArC), 127.1 (ArC), 125.9 (ArC), 125.1 (ArC), 124.5 (ArC), 123.4 (ArC), 
95.1 (C=COH), 66.7 (OCH2); ); HRMS (APPI): m/z  226.0640 (226.0630 calc. for 
C14H10O3, (M)
+) and 244.1087 (244.0974 calc. for C14H14NO3, (M+NH4)
+). 
4-Hydroxy-3-(1-methyl-1H-indol-3-yl)furan-2(5H)-one (94): 
 
Prepared by the reaction of 59 (50 mg, 0.39 mmol), Rh2(OAc)4 (1.7 mg, 3.9 x 10
-3 
mmol) in ,,-trifluorotoluene (2 mL) for 17 h according to General Procedure 2 but the 
acid-base workup procedure was not followed. The reaction mixture was concentrated and 
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the residue was directly purified by flash chromatography on silica gel (EtOAc/hexanes, 
1:1 to 7:3) to provide 84 mg (92%) of 94 as a crimson solid. 
Rf = 0.32 (EtOAc/hexanes, 3:2); mp: 157-159 °C; IR (neat): 3050, 2925 (br), 2695 (br), 
2649, 1644 (br), 1611, 1540, 1408, 1331, 1193, 1075, 1018, 809 cm-1; 1H NMR (300 MHz, 
DMSO-d6): δ 12.14 (br s, 1H, OH), 7.95 (br d, 1H, J = 8.0, Hz, ArH), 7.61 (s, 1H, ArH), 
7.41 ( br d, 1H, J = 8.0, Hz, ArH), 7.16 (ddd, 1H, J = 8.1, 6.9, 1.0 Hz, ArH), 7.03 (ddd, 1H, 
J = 8.1, 6.9, 1.0 Hz, ArH), 4.81 (s, 2H, OCH2), 3.81 (s, 3H, NCH3); 
13C NMR (75 MHz, 
DMSO-d6): δ 173.5 (C=O or C=COH), 170.5 (C=O or C=COH), 136.2 (ArCipso), 128.1 
(ArC), 126.0 (ArCipso), 121.8 (ArC), 121.2 (ArC), 118.6 (ArC), 109.5 (ArC), 103.4 
(ArCipso), 95.1 (C=COH), 66.5 (OCH2), 32.5 (NCH3); HRMS (ESI): m/z 229.0739 
(229.0739 calc. for C13H11NO3, (M)
+) and 230.0811 (230.0817 calc. for C13H12NO3, 
(M+H)+). 
4-(4-Hydroxy-2-oxo-2,5-dihydrofuran-3-yl)phenyl acetate (95): 
 
Prepared by the reaction of 59 (50 mg, 0.39 mmol), phenyl acetate (0.20 mL, 1.6 
mmol) and Rh2(CF3CO2)4 (2.6 mg, 3.9 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) for 
66 h according to General Procedure 2 but the acid-base workup procedure was not 
followed. The reaction mixture was concentrated and the residue was directly purified by 
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flash chromatography on silica gel (CH2Cl2/CH3OH, 9.5:0.5 to 9:1) to provide 49 mg (53%) 
of 95 as a white solid. 
Rf = 0.26 (EtOAc/hexanes, 3:2); mp: 142-145 °C; IR (neat): 3411 (br), 2937 (br), 2657 (br), 
2592 (br), 1737, 1649 (br), 1604, 1429, 1397, 1367, 1340, 1218, 1192, 1165, 1049, 1014, 
959, 913  cm-1; 1H NMR (300 MHz, DMSO-d6): δ 12.75-11.75 (br s, 1H, OH), 7.94 (d, 2H, 
J = 8.6 Hz, ArH), 7.13 (d, 2H, J = 8.6 Hz, ArH), 4.78 (s, 2H, OCH2), 2.27 (s, 3H, COCH3); 
13C NMR (75 MHz, DMSO-d6): δ 175.1 (C=O or C=COH), 172.9 (C=O or C=COH), 169.3 
(CH3CO2Ar), 148.6 (ArCipso), 128.2 (ArCipso), 127.2 (2 × ArC), 121.5 (2 × ArC), 96.7 
(C=COH), 66.1 (OCH2), 20.8 (COCH3); HRMS (APPI): m/z 234.0523 (234.0528 calc. for 
C12H10O5, (M)
+) and 252.0861 (252.0872 calc. for C12H14NO5, (M+NH4)
+). 
3-(4-Bromophenyl)-4-hydroxyfuran-2(5H)-one (96):28 
 
The reaction of 59 (50 mg, 0.39 mmol), Rh2(CF3CO2)4 (2.6 mg, 3.9 x 10
-3 mmol) 
in bromobenzene (1.5 mL) for 46 h according to General Procedure 1 provided, 68 mg 
(67%) of 96 as a light brown solid. 
Rf = 0.23 (EtOAc/hexanes, 3:2); mp: 269-271 °C; IR (neat): 2971 (br), 2651 (br), 2555 (br), 
1693, 1567 (br), 1431, 1385, 1342, 1298, 1055, 1017, 955, 870, 821 cm-1; 1H NMR (300 
MHz, DMSO-d6): δ 7.91 (d, 2H, J = 8.6 Hz, ArH), 7.57 (d, 2H, J = 8.6 Hz, ArH), 4.77 (s, 
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2H, OCH2); 
13C NMR (75 MHz, DMSO-d6): δ 176.0 (C=O or C=COH), 172.7 (C=O or 
C=COH), 131.0 (2 × ArC), 130.0 (ArCipso), 128.0 (2 × ArC), 119.0 (ArCipso), 96.1 
(C=COH), 66.2 (OCH2). 
3-(2,4-Dichlorophenyl)-4-hydroxyfuran-2(5H)-one (97):28 
 
Prepared by the reaction of 59 (50 mg, 0.39 mmol), Rh2(CF3CO2)4 (2.6 mg, 3.9 x 
10-3 mmol) and 1,3-dichlorobenzene (1.5 mL) for 74 h according to General Procedure 1, 
but the acid-base workup procedure was not followed. The reaction mixture was 
concentrated and the residue was directly purified by flash chromatography on silica gel 
(CH2Cl2/CH3OH, 9.5:0.5 to 9:1) to provide 41 mg (42%) of 97 as a yellow solid.  
Rf = 0.35 (CH2Cl2/CH3OH, 9:1); mp: 206-209 °C; IR (neat): 2916, 2848, 2651, 2596, 1712, 
1697, 1606, 1573, 1542, 1428, 1341, 1048, 1027, 1016, 962, 864 cm-1; 1H NMR (300 MHz, 
DMSO-d6): δ 7.67 (d, 1H, J = 2.1 Hz, ArH), 7.46 (dd, 1H, J = 8.3, 2.1 Hz, ArH), 7.32 (d, 
1H, J = 8.3 Hz, ArH), 4.81 (s, 2H, OCH2); 
13C NMR (75 MHz, DMSO-d6): δ 176.0 (C=O 
or C=COH), 172.2 (C=O or C=COH), 134.6 (ArCipso), 133.6 (ArC), 133.0 (ArCipso), 128.7 
(ArC), 128.1 (ArCipso), 127.1 (ArC), 97.3 (C=COH), 67.0 (OCH2). 
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Methyl 3-(4-hydroxy-2-oxo-2,5-dihydrofuran-3-yl)benzoate (98): 
 
Prepared by the reaction of 59 (50 mg, 0.39 mmol), methyl benzoate (0.20 mL, 1.6 
mmol) and Rh2(CF3CO2)4 (2.6 mg, 3.9 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) for 
77 h according to General Procedure 2 but the acid-base workup procedure was not 
followed. The reaction mixture was concentrated and the residue was directly purified by 
flash chromatography on silica gel (CH2Cl2/CH3OH, 9.5:0.5 to 9:1) to provide, 48 mg 
(52%) of 98 as a white solid. 
Rf = 0.15 (CH2Cl2/CH3OH, 9.5:0.5); mp: 122-125 °C; IR (neat): 2955, 2920, 2660 (br), 
2597 (br), 1711, 1633, 1603, 1576, 1419, 1275, 1226, 1172, 1048, 1028, 960 cm-1; 1H NMR 
(300 MHz, DMSO-d6): δ 8.68 (t, 1H, J = 1.4 Hz, ArH), 8.29 (dt, 1H, J = 7.8, 1.4 Hz, ArH), 
7.72 (dt, 1H, J = 7.8, 1.4 Hz, ArH), 7.46 (t, 1H, J = 7.8 Hz, ArH), 4.61 (s, 2H, OCH2), 3.85 
(s, 3H, OCH3); 
13C NMR (75 MHz, DMSO-d6): δ 179.7 (C=O or C=COH), 173.8 (C=O or 
C=COH), 166.6 (CO2CH3), 132.8 (ArCipso), 129.7 (ArC), 129.3 (ArCipso), 128.3 (ArC), 
125.8 (ArC), 125.6 (ArC), 93.6 (C=COH), 66.9 (OCH2), 52.0 (OCH3); HRMS (APPI): m/z 
234.0535 (234.0528 calc. for C12H10O5, (M)
+) and 252.0853 (252.0872 calc. for 
C12H14NO5, (M+NH4)
+). 
 
 
272 
 
(E)-Methyl 2-(4-diazo-3,5-dioxodihydrofuran-2(3H)-ylidene)-2-phenylacetate (103): 
 
To a solution of 59 (80 mg, 0.63 mmol) and methyl 2-oxo-2-phenylacetate (125 mg, 
0.760 mmol) in CH2Cl2 (2 mL) was added TiCl4 (0.20 mL, 1.9 mmol) at -78 °C and the 
solution was stirred for 30 min and triethylamine (0.27 mL, 1.9 mmol) was added. The 
mixture stirred at -78 °C for 30 min and then at 0 °C for 5 h and saturated aqueous NH4Cl 
(~2 mL) was added followed by cold water (~1 mL). The resulting mixture was extracted 
with CH2Cl2 (3 x 2 mL). The combined organic layers were washed with brine, dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (hexanes/EtOAc, 4:1) to provide 106 mg (61%) of 103 as a 
light brown solid. 
Rf = 0.27 (hexanes/EtOAc, 4:1); mp: 155-157 °C; IR (neat): 2951, 2923, 2853, 2165, 1787, 
1729, 1697, 1621, 1359, 1325, 1298, 1273, 1225, 1201, 1067, 1043, 1028, 997, 974 cm-1; 
1H NMR (300 MHz, CDCl3): δ 7.72-7.62 (m, 2H, ArH), 7.49-7.38 (m, 3H, ArH), 3.95 (s, 
3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 173.3 (C=O), 165.7 (C=O), 159.3 (C=O), 140.3 
(ArCipso), 130.7 (ArC), 129.54 (2 × ArC), 129.46 (O-C=C), 129.0 (2 × ArC), 120.0 (Ph-C-
CO2CH3), 53.4 (OCH3); HRMS (APPI): m/z 272.0438 (272.0433 calc. for C13H8N2O5, 
(M)+) and 273.0509 (273.0511 calc. for C13H9N2O5, (M+H)
+). 
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(E)-Methyl 2-(4-diazo-3,5-dioxodihydrofuran-2(3H)-ylidene)-2-(3,4-
dimethoxyphenyl)acetate (105): 
 
To a solution of 59 (80 mg, 0.63 mmol) and methyl 2-(3,4-dimethoxyphenyl)-2-
oxoacetate3 (171 mg, 0.760 mmol) in CH2Cl2 (2 mL) was added TiCl4 (0.20 mL, 1.9 mmol) 
at  -78 °C and the solution was stirred for 30 min and triethylamine (0.27 mL, 1.9 mmol) 
was added. The mixture was stirred at -78 oC for 40 min saturated aqueous NH4Cl (~2 mL) 
was added. The mixture was then warmed to room temperature and cold water (~1 mL) 
was added. The resulting mixture was extracted with CH2Cl2 (3 x 2 mL). The combined 
organic layers were washed with brine, dried (Na2SO4) and concentrated under reduced 
pressure. The residue was purified by flash chromatography on silica gel (hexanes/EtOAc, 
7.5:2.5) to provide 124 mg (59%) of 105 as a yellow solid. 
Rf = 0.20 (hexanes/EtOAc, 7:3); mp: 108-110 °C; IR (neat): 2952, 2923, 2851, 2161, 1792, 
1735, 1693, 1616, 1587, 1513, 1444, 1425, 1363, 1290, 1238, 1215, 1150, 1068, 1048, 
1030, 1012, 933, 857 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.30 (d, 1H, J = 2.2 Hz, ArH), 
7.25 (dd, 1H, J = 8.6, 2.2 Hz, ArH), 6.90 (d, 1H, J = 8.6 Hz, ArH), 3.96 (s, 3H, OCH3), 
3.93 (s, 3H, OCH3), 3.91 (s, 3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 173.2 (C=O), 165.9 
(C=O), 159.4 (C=O), 151.3 (ArCipso or O-C=C), 149.1 (ArCipso or O-C=C), 138.9 (ArCipso 
or O-C=C), 123.9 (ArC), 122.0 (ArCipso or O-C=C), 120.2 (ArCipso or O-C=C), 112.2 
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(ArC), 111.1 (ArC), 56.0 (2 × OCH3), 53.4 (OCH3); HRMS (APPI): m/z 332.0645 
(332.0645 calc. for C15H12N2O7, (M)
+) and 333.0717 (333.0723calc. for C15H13N2O7, 
(M+H)+). 
(E)-Methyl 2-(3-hydroxy-5-oxo-4-phenylfuran-2(5H)-ylidene)-2-phenylacetate (2, 
Vuplinic acid):29 
 
The reaction of 103 (60 mg, 0.22 mmol), Rh2(OAc)4 (1.0 mg, 2.2 x 10
-3 mmol) in 
benzene (1.5 mL) for 24 h according to General Procedure 1 but the acid-base workup 
procedure was not followed. The reaction mixture was concentrated and the residue was 
directly purified by flash chromatography on silica gel (hexanes/EtOAc, 4:1 to 7:3) to 
provide 65 mg (91%) of 2 as a yellow solid. 
Rf = 0.51 (hexanes/EtOAc, 7:3); mp: 149-151 °C; IR (neat): 3032, 3021, 2962, 2922, 2852, 
2503, 2453, 1767, 1677, 1608, 1587, 1429, 1317, 1300, 1275, 1260, 1156, 1066, 949, 903, 
882 cm-1; 1H NMR (300 MHz, CDCl3): δ 13.77 (s, 1H, OH), 8.16-8.09 (m, 2H, ArH), 7.49-
7.23 (m, 8H, ArH), 3.88 (s, 3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 171.7 (C=O or 
C=COH), 165.9 (C=O or C=COH), 160.3 (C=O or C=COH), 154.9 (C=O or C=COH or 
C-O-C=C), 132.0 (ArCipso), 130.0 (2 × ArC), 129.0 (ArCipso), 128.6 (ArC), 128.5 (2 × ArC), 
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128.4 (ArC), 128.2 (2 × ArC), 127.9 (2 × ArC), 115.8 (Ph-C-CO2CH3), 105.2 (HO-C=C), 
54.5 (OCH3). 
(E)-Methyl-2-(3-hydroxy-4-(4-methoxyphenyl)-5-oxofuran-2(5H)-ylidene)-2-
phenylacetate (4, Pinastric acid):30 
 
Prepared by the reaction of 103 (60 mg, 0.22 mmol), anisole (96 µL, 0.88 mmol) 
and Rh2(CF3CO2)4 (1.4 mg, 2.2 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) for 7 h 
according to General Procedure 2 but the acid-base workup procedure was not followed. 
The reaction mixture was concentrated and the residue was directly purified by flash 
chromatography on silica gel (hexanes/EtOAc, 1.7:0.3 to 3:3) to provide 54 mg (70%) of 4 
as an orange solid. 
Rf = 0.41 (hexanes/EtOAc, 7:3); mp: 201-203 °C; IR (neat): 3017, 2958, 2931, 2838, 2510, 
2459, 1755, 1671, 1594, 1569, 1513, 1436, 1416, 1304, 1276, 1250, 1187, 1155, 1060, 
1022, 955, 841 cm-1; 1H NMR (300 MHz, CDCl3): δ 13.58 (s, 1H, OH), 8.12 (d, 2H, J = 
9.1 Hz, ArH), 7.46-7.35 (m, 3H, ArH), 7.30-7.21 (m, 2H, ArH), 6.97 (d, 2H, J = 9.1 Hz, 
ArH), 3.87 (s, 3H, OCH3), 3.85 (s, 3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 171.7 (C=O 
or C=COH), 166.1 (C=O or C=COH), 159.5 (C=O or C=COH), 158.6 (C-O-C=C or 
ArCipso), 155.0 (C-O-C=C or ArCipso), 132.1 (ArCipso), 130.0 (2 × ArC), 129.4 (2 × ArC), 
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128.5 (ArC), 128.1 (2 × ArC), 121.6 (ArCipso), 115.2 (Ph-C-CO2CH3), 113.9 (2 × ArC), 
105.3 (HO-C=C), 55.3 (OCH3), 54.4 (OCH3). 
(E)-Methyl 2-(3,4-dimethoxyphenyl)-2-(3-hydroxy-4-(4-methoxyphenyl)-5-oxofuran-
2(5H)-ylidene)acetate (110):10a 
 
Prepared by the reaction of 105 (120 mg, 0.360 mmol), anisole (0.160 mL, 1.44 
mmol) and Rh2(CF3CO2)4 (2.4 mg, 3.6 x 10
-3 mmol) in ,,-trifluorotoluene (3 mL) for 9 
h according to General Procedure 2 but the acid-base workup procedure was not followed. 
The reaction mixture was concentrated and the residue was directly purified by flash 
chromatography on silica gel (CH2Cl2/EtOAc, 10:0 to 9.9:0.1) to provide 105 mg (70%) of 
110 as an orange-yellow solid. 
Rf = 0.26 (CH2Cl2/EtOAc, 9.9:0.1); mp: 157-159 °C; IR (neat): 3003, 2956, 2929, 2838, 
2557, 1765, 1674, 1592, 1513, 1441, 1411, 1303, 1248, 1215, 1181, 1141, 1063, 1024, 996, 
948, 908, 835 cm-1; 1H NMR (300 MHz, CDCl3): δ 13.56 (s, 1H, OH), 8.12 (d, 2H, J = 9.0 
Hz, ArH), 6.96 (d, 2H, J = 9.0 Hz, ArH), 6.90 (d, 1H, J = 8.3 Hz, ArH), 6.83 (dd, 1H, J = 
8.3, 1.9 Hz, ArH), 6.77 (d, 1H, J = 1.9 Hz, ArH), 3.92 (s, 3H, OCH3), 3.89 (s, 3H, OCH3), 
3.88 (s, 3H, OCH3), 3.84 (s, 3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 171.8 (C=O), 166.2 
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(C=O), 159.5 (ArCipso or O-C=C or C=O), 158.6 (ArCipso or O-C=C or C=O), 155.0 (ArCipso 
or O-C=C or C=O), 149.3 (ArCipso), 148.5 (ArCipso), 129.3 (2 × ArC), 124.4 (ArCipso or O-
C=C), 122.9 (ArC), 121.7 (ArCipso or O-C=C), 115.1 (ArCipso or O-C=C), 113.9 (2 × ArC), 
113.3 (ArC), 110.7 (ArC), 105.2 (HO-C=C), 56.1 (OCH3), 55.9 (OCH3), 55.3 (OCH3), 54.4 
(OCH3); HRMS (APPI): m/z 412.1155 (412.1158 calc. for C22H20O8, (M)
+) and 413.1227 
(413.1236 calc. for C22H21O8, (M+H)
+). 
(E)-Methyl 2-(3,4-dihydroxyphenyl)-2-(3-hydroxy-4-(4-hydroxyphenyl)-5-oxofuran-
2(5H)-ylidene)acetate (6, Methyl isoxerocomate):31 
 
To a solution of compound 110 (45 mg, 0.11 mmol) in CH2Cl2 (1.5 mL) was added 
BBr3 (1.0 M in CH2Cl2, 0.76 mL, 0.76 mmol,) over 5 min at 0 °C. The mixture was then 
warmed to room temperature and stirred for 3 h. It was then cooled to 0 °C and cold water 
(2 mL) was added. The resulting mixture was extracted with ethyl acetate (4 x 3 mL) and 
the combined organic layers were dried (Na2SO4) and concentrated under reduced pressure. 
The residue was purified by flash chromatography on silica gel (hexanes/EtOAc, 3:2 to 
3:7) to provide 27 mg (72%) of 6 as a yellow-orange solid. 
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Rf = 0.31 (EtOAc/hexanes, 3:2); mp: 213-216 °C; IR (neat): 3323 (br), 2956, 2921, 2851, 
2600 (br), 1741, 1702, 1675, 1597, 1513, 1433, 1263, 1176, 1149, 1115, 1100, 1062, 999, 
911, 836, 811 cm-1; 1H NMR (500 MHz, acetone-d6): δ 13.71 (br, 1H, OH), 8.69 (br, 1H, 
OH), 8.16 (br, 1H, OH), 8.04 (br, 1H, OH), 8.00 (d, 2H, J = 8.8 Hz, ArH), 6.93 (d, 2H, J = 
8.8 Hz, ArH), 6.91 (d, 1H, J = 2.1 Hz, ArH), 6.87 (d, 1H, J = 8.2 Hz, ArH), 6.75 (dd, 1H, 
J = 8.2, 2.1 Hz, ArH), 3.90 (s, 3H, OCH3); 
13C NMR (75 MHz, acetone-d6): δ 173.0 (C=O 
or C=COH), 167.0 (C=O or C=COH), 159.7 (C=COH or C=O), 158.4 (ArCipso or O-C=C), 
154.4 (ArCipso or O-C=C), 146.4 (ArCipso or O-C=C), 145.3 (ArCipso or O-C=C), 130.1 (2 
× ArC), 125.0 (ArCipso or O-C=C), 123.1 (ArC), 121.8 (ArCipso or O-C=C), 118.4 (ArC), 
116.5 (ArCipso or O-C=C), 116.2 (2 × ArC), 115.6 (ArC), 105.1 (HO-C=C), 54.7 (OCH3). 
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3.8 Selected 1H NMR and 13C NMR Spectra 
 
 
 
 
 
 
284 
 
 
 
 
 
59 
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Chapter 4 
 
 
 
Stereoselective Synthesis of Naturally Occurring Pulvinones by Aldol 
Condensation and Undirected Rh(II)-Catalyzed C-H Insertion 
Reactions of Diazotetronic Acid 
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4.1 Introduction 
Tetronic acids or 4-hydroxy-5H-furan-2-ones are characteristic structural units in 
many natural products and pharmaceutical compounds.1 5-Arylidene-4-hydroxy-3-aryl-5-
furan-2(5H)-ones constitute a major group of naturally-occurring tetronic acids. Prominent 
examples of these tetronic acid derviatives2 are pulvinone (1, Figure 4.1), aspulvinone E 
(2), aspulvinone G (3), 3',4,4'-trihydroxypulvinone (4), aspulvinone A (5), aspulvinone C 
(6), aspulvinone B (7), aspulvinone D (8), aspulvinone H (9), aspulvinone F (10)3 and 
aspulvinone M (11).3 The aspulvinones display a wide range of biological activities4 which 
include anticoagulant and anti-inflammatory activities as well as inhibitory activity against 
Escherichia coli and several Gram-negative bacteria. Pulvinones5 are cellular membrane 
stabilizers. These compounds prevent complement activation5 or complement fixation in 
the immune system by irreversible binding to C1r and C1s, which are proteases in the C1 
complex. Pulvinones are yellow pigments, which were first isolated from common larch 
mushrooms Suillus grevillei and the culture filtrate of Aspergillus terreus.5 
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Figure 4.1 Naturally occurring pulvinones 
The wide spectrum of biological activities of the pulvinones has led to significant 
interest in their synthesis and the following section provides a summary of the reported 
synthesis of natural as well as non-natural pulvinones. 
4.2 Known synthetic routes to pulvinones 
4.2.1 The Pattenden synthesis of pulvinones  
In 1979, Pattenden and coworkers6 reported the syntheses of pulvinones from O-
methylated tetronic acids 12 (Scheme 4.01). Metallation of tetronic acids 12 with lithium 
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N-cyclohexyl-N-isopropylamide (LCPA) followed by addition of aryl aldehydes furnished 
the aldol products (13), which were subjected to dehydration in the presence of p-
toluenesulfonic acid (PTSA) to provide the corresponding pulvinones (14) as single 
diastereomers.  
 
Scheme 4.01 
4.2.2 The Ramage synthesis of 3',4',4-trihydroxypulvinone (4) 
In 1984, Ramage and coworkers 7  developed a method to synthesize 3',4',4-
trihydroxypulvinone (4, Scheme 4.02). Bromination of the glycolic acid-derived 
dioxolanone 15 with N-bromosuccinimide (NBS) provided 16, which was immediately 
treated with triphenylphosphine in toluene to provide phosphonium salt 17. Condensation 
of 17 with 3,4-dibenzyloxybenzaldehyde in the presence of DABCO provided 18. Claisen 
condensation of the lithium enolate 19 and alkene 18 provided the tetronic acid derivative 
22 as a single diastereomer. 22 was then debenzylated (Pd-C and HCl) to provide 3',4',4-
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trihydroxypulvinone (4). It is important to mention that 2.5 equivalents of ester enolate 19 
were used in the condensation reaction. The first equivalent of 19 opens the dioxolanone 
ring, resulting in the formation of lithium enolate 20, and cyclohexanone as the byproduct. 
The second equivalent forms the lithium bis(enolate) 21 which cyclizes to provide 22. 
 
Scheme 4.02 
4.2.3 The Campbell syntheses of pulvinones 
In 1985, Campbell and coworkers5 developed two methods for the synthesis of 
pulvinones. The first approach relies on a thermal [1,3]-sigmatropic rearrangement and the 
second involves a Wittig reaction as the key transformations. 
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In the first synthesis, 1,3-diarylacetones 23 were condensed with diethyl oxalate to 
access the symmetrical trione 24 which exists as a tautomeric mixture with the 
corresponding enol 25. Heating this mixture at 230 C provides the pulvinone 26. Poor 
yields are obtained when the aryl groups in 23 are p, p-disubstituted, and this method is 
also limited to the syntheses of pulvinones which contain two identical aryl groups (Scheme 
4.03).  
 
Scheme 4.03 
To overcome these limitations, a procedure that allowed the regiospecific 
introduction of the two aryl groups was investigated. In this approach, arylacetic acids 27 
were treated with ethyl bromoacetate in the presence of sodium ethoxide to give diesters 
28 (Scheme 4.04). These diesters were subjected to a Dieckmann-cyclization reaction in 
the presence of potassium t-butoxide to afford 3-aryltetronic acids 29. Methylation of 29 
using dimethyl sulfate followed by bromination with NBS furnished 31 which were then 
treated with triphenylphosphine to furnish the inner phosphonium salts 32. Wittig reaction 
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of 32 with various aryl aldehydes provided a mixture of E- 33 and Z-33 pulvinones, with 
the Z isomers as the major products (Scheme 4.04).  
 
Scheme 4.04 
4.2.4 The Gill synthesis of pulvinones 
In 1990, Gill and coworkers 8  reported the synthesis of pulvinones from 
unsymmetrical acyloins (34, Scheme 4.05). Alcoholate-enolate dianions 35, generated in 
situ by deprotonation of the acyloins 34 with lithium diisopropylamide (LDA), were treated 
with carbonyldiimidazole (CDI) to afford the dihydropulvinones 36. Methylation of 36 
with dimethyl sulfate ((CH3)2SO4) provided 37. The required 5-arylidene functionality was 
then introduced by bromination of 37 to provide 38, and subsequent dehydrobromination 
with 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) to afford the O-methyl pulvinones 39 as 
single diastereomers. Treatment of 39 with BBr3 cleaved only the phenolic O-methyl ethers 
but not the enolic O-methyl ether in 39. Removal of the enol methyl ether by acid or base 
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catalyzed hydrolysis was also unsuccessful. However, treatment of 39 with LiBr in DMF 
under reflux gave the corresponding pulvinones 40. 
 
Scheme 4.05 
4.2.5 The Antane syntheses of pulvinones 
In 2006, Antane and coworkers9 developed a synthesis of pulvinones by employing 
a Suzuki-coupling reaction as the key step (Scheme 4.06). Bromination of 4-methoxy-
2(5H)-furanone (41) with NBS gave 42 which was subjected to an aldol reaction with 
various aldehydes in the presence of lithium isopropyl cyclohexylamide (LICA) to furnish 
the 5-(hydroxyalkyl) tetronates 43. Alternatively, tetronates 43 were synthesized from 41 
by the aldol reaction followed by bromination. Dehydration of the aldol products 43 by 
mesylation and elimination provided 45 as the Z-isomer. Suzuki-Miyaura cross-coupling 
of bromoalkenes 45 with various boronic acid derivatives afforded O-methyl pulvinones 
46 which were demethylated (LiBr, microwave heating at 150 °C) to yield the pulvinones 
47. 
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Scheme 4.06 
4.2.6 The Brückner syntheses of pulvinones 
In 2007, Brückner and coworkers10 developed a synthesis of pulvinones involving 
tandem Horner–Wadsworth–Emmons and Claisen condensation reactions as the key 
transformations (Scheme 4.07). 2,2-Dihydroxyacetic acid (glyoxylic acid hydrate) was 
treated with dialkyl phosphites to furnish the corresponding dialkyl phosphonates 48-50, 
which were then reacted with acetone to give dioxolanone-containing dialkyl phosphonates 
51-53. Horner–Wadsworth–Emmons reactions of these phosphonates with a variety of 
aldehydes in the presence of LDA provided E- and Z-54 (E-alkene as the major product). 
In the final step, dioxolanones 54 were subjected to a tandem Claisen condensation with 
ester enolates 56 (generated in situ from alkyl aryl acetates 55 in the presence of LDA) to 
afford Z-pulvinones 57 selectively. The conversion of 51-53 to 57 is according to the 
Ramage synthesis of pulvinones described in Scheme 4.02. 
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Scheme 4.07 
The Brückner group has also reported2 another approach to the synthesis of 
pulvinones. This methodology includes Heck alkenylations of iodoarenes, 
transesterification and Dieckmann cyclization reactions as the key steps (Scheme 4.08). 
Stereoselective Heck coupling of iodoarenes 58 with trifluoroethyl 2-acetoxyacrylate 59 
provided trifluoroethyl (Z)-2-acetoxycinnamates 60 which were then subjected to a 
transesterification reaction with aryl acetic acids 61 to furnish trifluoroethyl (Z)-2-
(arylacetoxy)cinnamates 62. Dieckmann cyclization of 62 in the presence potassium tert-
butoxide (t-BuOK) provided the pulvinones 63. 
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Scheme 4.08 
4.2.7 The Le Gall synthesis of pulvinones  
In 2011, Le Gall and coworkers11 developed a synthetic route to pulvinones via a 
Dieckmann condensation and a -elimination of an alkoxide (Scheme 4.09). Esterification 
of hydroxy esters 64 and 65 with the arylacetic acid 66 afforded diesters 67 and 68 
respectively. These diesters 67-68 were converted to the corresponding pulvinones 69 in 
the presence of lithium hexamethyldisilazide (LiHMDS) by a Dieckmann condensation and 
a -elimination of an alkoxide. This procedure generates a mixture of E- and Z- pulvinones 
with the Z-isomer as the major product. 
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Scheme 4.09 
4.2.8 The Yamada synthesis of aspulvinone E 
Yamada and coworkers12 have recently developed a synthesis of 5-ylidene tetronic 
acids employing silver-catalyzed reactions of conjugated ynones with CO2. The procedure 
was applied in the synthesis of aspulvinone E (2, Scheme 4.10). The acylation reaction of 
(4-methoxyphenyl)acetylene with ethyl (4-methoxyphenyl)acetate in the presence of n-
BuLi and BF3.OEt2 provided ynone 70. The silver-catalyzed reaction of 70 with carbon 
dioxide (CO2) provided 5-arylidene tetronic acid 71 which was then demethylated with 
BBr3 to give aspulvinone E (2). 
 
Scheme 4.10 
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4.3 Objective 
As discussed above, previous reports on the syntheses of 3-aryl-5-arylidene tetronic 
acid motifs require starting materials that have the specific functionality which required in 
the target tetronic acids. Most of these methods use aryl acetic acids or alkyl aryl 
acetates,2,5,7,10,11, 12 1,3-diarylacetones,5 or dibenzyl acyloins8 as the starting materials. 
Although the Antane synthesis9 adds structural diversity by using cross-coupling reactions 
of bromofuranone (Scheme 4.06), the method requires multiple steps for the synthesis of 
the key intermediate. Also, although the Yamada synthesis claims to be the shortest route 
to aspulvinone E, the steps required to synthesize the phenyl acetates and the functionalized 
acetylene starting materials are ignored in this claim. All of these approaches are therefore 
limited by the availability of functionalized starting materials and/or advanced synthetic 
intermediates. In addition, two of the methods described above provide a mixture of E and 
Z pulvinones (Scheme 4.04 and 4.09). We therefore decided to develop a synthesis of 
pulvinones that would overcome these limitations.  
As described in Chapter 3 of this thesis, our synthesis13 of 3-aryl tetronic acids, 
pulvinic acids and vulpinic acids, employs a highly stereoselective aldol condensation and 
an undirected intermolecular, rhodium (II) catalyzed, C-H insertion reaction as the pivotal 
steps. We reasoned that a similar strategy could be applied for the synthesis of natural as 
well as unnatural pulvinones. Hence, the focus of our strategy for pulvinone synthesis is to 
introduce the C5 alkylidene/arylidene functionality by a stereoselective aldol condensation 
of 72 with a series of aldehydes using and installation of the C3 aryl substituent in a single 
step by a C-H insertion reaction using a diazo functionality (Figure 4.2). 
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Figure 4.2 Retrosynthetic strategy for synthesis of pulvinones and their derivatives 
4.4 Results and Discussion  
The initial focus of our synthetic strategy was the stereoselective aldol condensation 
of 72 to obtain the Z-diazo alkenes which are potentially the immediate precursors of the 
required pulvinones. At the outset, we employed the optimized aldol condensation 
conditions (Table 4.1, entry 1) that we had developed for the reactions of 72 with 
benzoylformate esters described in Chapter 3 (TiCl4, Et3N, Table 3.2, page 246). Somewhat 
unexpectedly, these conditions provided poor yields of the aldol condensation product of 
72 and p-tolualdehyde. We therefore conducted an optimization of the aldol condensation 
reaction of 72 with p-tolualdehyde by employing various Lewis acids and bases. Replacing 
TiCl4 in our previously optimized conditions with BF3.OEt2 (Table 4.1, entry 2) provided 
only the aldol product 74 as a mixture of diastereomers (dr = 1:1). Changing the base from 
triethylamine to heteroaromatic bases such as pyridine, N-methylimidazole and 2,4,6-
collidine improved the yield of the required product. With pyridine and N-methylimidazole 
(Table 4.1, entries 3 and 4), alkene 75 was obtained in good yields (82% and 77% 
respectively) but the reaction was slow. However, the reaction with 2,4,6-collidine as the 
base provided 75 in good yield and also (82%, Table 4.1, entry 5) as a single diastereomer. 
In addition, this reaction was completed in 80 min. This is the best result from the 
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optimization studies and the procedure was applied to a variety of aldehydes to provide 
alkylidene diazotetronates 75-86 (Figure 4.3). 
Table 4.1 Optimization of the aldol condensation of 72 with p-tolualdehyde. 
 
Entry Reagents and conditions 74a 75a 
1. TiCl4, -78 
oC, 20 min; Et3N, -78 
oC, 40 min to 0 oC, 1.5 h  41 
2. 
BF3.OEt2, -78 
oC, 20 min; Et3N, -78 
oC, 40 min; 0 oC, 1 h; 
rt, 1 h 
65  
3. 
TiCl4, -78 
oC, 20 min; pyridine, -78 oC, 30 min; 0 oC, 2 h; 
rt, 41 h 
 82 
4. 
TiCl4, -78 
oC, 20 min; N-methylimidazole, -78 oC, 30 min; 
0 oC, 1 h 20 min; rt, 18 h 
 77 
5. 
TiCl4, -78 
oC, 20 min; 2,4,6-collidine, -78 oC, 30 min; 0 oC, 
30 min 
 82 
aisolated yields 
Pleasingly, the aldol condensation reaction of 72 with electron-rich and electron-
deficient aromatic aldehydes, as well as aliphatic aldehydes, provided (Z)-5-arylidene-3-
diazofuran-2,4(3H,5H)-diones 75-86 as single diastereomers in excellent yields (12 
examples, 83% average yield, Figure 4.3). Interestingly, the reaction also worked well with 
chroman-6-carbaldehyde and 4-((tert-butyldimethylsilyl)oxy)-3-(3-methylbut-2-en-1-
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yl)benzaldehyde to afford 85 and 86 in 91% and 79% yields, respectively. The only 
exception was found with 83 which was obtained in relatively low yield (40%). A plausible 
explanation for the lower yield might be the enolization of cyclopentanecarboxaldehyde 
under the reaction conditions, and the resulting poor electrophilic reactivity of the enolate 
with 72. For reasons that are not known at this time, the reaction of 72 with 4-
pyridinecarboxaldehyde was unsuccessful.  
 
Figure 4.3 Aldol condensation reactions of 72. 
Having established a general method to prepare (Z)-5-arylidene/alkylidene-3-
diazofuran-2,4(3H,5H)-diones, the next objective was the introduction of an aryl 
substituent at C3 to construct the C3-aryl-C5-arylidene/alkylidene tetronic acid (pulvinone) 
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motif. Accordingly, Rh(II)-catalyzed C-H insertion reactions were examined for selected 
(Z)-5-arylidene/alkylidene-3-diazofuran-2,4(3H,5H)-diones. In the studies described in 
Chapter 3 (page 240), two methods were developed for the C-H insertion reactions. In one 
of the methods, the C-H insertion reactions of diazotetronic acid (72) in the presence of 
Rh2(OAc)4 in an excess of the arene reacting partner (neat) provided the respective 3-aryl 
tetronic acids. This procedure (Method A) was used with simple arenes which could be 
used as a solvent. In the second method, 72 was treated with 4 equivalents of the arene in 
PhCF3 as a solvent in the presence of catalyst Rh2(CF3CO2)4. This procedure (Method B) 
was employed for solid arenes. These two methods were employed for the reactions of 5-
ylidene diazotetronic acids with a variety of arenes. 
4.4.1 Synthesis of naturally occurring pulvinones 
With the diazotetronic acid derivative 81 in hand, a C-H insertion reaction was 
conducted in benzene to afford pulvinone (1, 78%, Method A, Scheme 4.11). Spectroscopic 
data (1H NMR, 13C NMR) of pulvinone (81) were identical with those reported in the 
literature.5,7,11 
 
Scheme 4.11 Synthesis of pulvinone (1) 
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4.4.2 Determination of stereochemical configuration of aldol condensation products 
Campbell and coworkers5 studied the geometry of the pulvinones and confirmed 
the stereochemistry of the exocyclic alkene. The Z-1 and E-1 geometrical isomers were 
synthesized from the corresponding inner phosphonium salts (32) by the Wittig reaction 
(Scheme 4.04). The stereochemical configurations of the olefins obtained were deduced by 
a comparison of the chemical shifts of characteristic protons and carbons in 
stereochemically pure Z-1 and E-1 products and in the O-acetylpulvinones Z-87 and E-87 
using 1H NMR and 13C NMR spectroscopy.  
For the pulvinones Z-1 and E-1, 1H NMR signals for the alkene protons at C6 in Z-
1 appeared at δ 6.75, whereas in the case of E-1 this proton appears at δ 6.80 (Figure 4.3). 
Similarly, in the 13C NMR, the signals for C3 and C6 in Z-1 are at δ 100.2 and δ 107.5 
respectively, whereas for E-1 these signals appeared at δ 104.9 and δ 114.5 respectively. 
This study concluded that the significant difference in chemical shifts for the E-1 and Z-1 
pulvinones can be used for assigning stereochemistry. The pulvinone (1) obtained in our 
study (Scheme 4.11) exhibited 1H and 13C chemical shifts that are identical (1H NMR 
proton at C6 δ 6.75 and 13C NMR C3, C6 at δ 100.1, 107.6 respectively) to those reported 
by Campbell for Z-1 (Figure 4.4). Hence, 1 obtained by our procedure was assigned the Z 
stereochemistry. 
 
Figure 4.4 1H and 13C chemical shifts of Z- and E- pulvinones 
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Additional evidence for the stereochemical assignment was obtained by conversion 
of Z-1 to Z-87 by acetylation. Campbell has also reported5 that in Z-87 the alkene proton at 
C6 and acetyl group appeared at δ 6.04 and δ 2.35 respectively, whereas in E-87, the alkene 
proton at C6 and the acetyl group appeared at δ 6.88 and δ 1.67 respectively (Figure 4.5). 
Notably, the acetyl group in E-87 (δ 1.67) experiences an upfield shift due to anisotropic 
shielding by the phenyl group, as compared to the acetyl group in Z-87 (δ 2.35). The Z-87 
which was prepared by the acetylation of 1 obtained by our aldol condensation procedure 
had key spectroscopic data (C6-H δ 6.08 and C(O)CH3 δ 2.42) which matched the data 
reported for Z-87 (Figure 4.5). Based on these observations, the geometry of the aldol 
condensation products (alkenes) in our studies, which are the immediate precursors of 
pulvinones, was assigned as Z. 
 
Figure 4.5 1H chemical shifts of Z-87 and E-87 
Next, the synthesis of aspulvinone E (2), aspulvinone G (3), and 3',4,4'-
trihydroxypulvinone (4) was investigated. The Rh(II)-catalyzed C-H insertion reaction of 
76 with anisole (Method B) provided the regioisomeric insertion products 88 and 89 (88/89 
= 3.5:1, 91%). A similar reaction of 77 provided 90 and 91 (90/91 = 4.4:1, 50%, Scheme 
4.12). The regioisomeric products (88 and 89, 90 and 91) were easily separated by flash 
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column chromatography. A similar C-H insertion reaction of 76 with 1,3-
dimethoxybenzene (Method B) provided 92 (76%, Scheme 4.12).  
 
Scheme 4.12  
Following the literature procedure,2 the pulvinones 88, 90 and 92 were 
demethylated with BBr3 to furnish aspulvinone E (2), 3',4,4'-trihydroxypulvinone (4) and 
aspulvinone G (3) in 79%, 82% and 86% yields respectively (Scheme 4.13). 
 
Scheme 4.13 Synthesis pulvinones 2, 4 and 3 
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Having achieved the synthesis of the naturally ocuring pulvinones 1, 2, 3 and 4, we 
next targeted the naturally occurring aspulvinone A (5), aspulvinone B (7), aspulvinone C 
(6) and aspulvinone D (8). In initial studies, Rh2(CF3COO)4 (Table 4.2, entry 1) and 
Rh2(OAc)4 (Table 4.2, entry 2) were screened as catalysts in the C-H insertion reactions of 
85 with chroman 93. However, in both cases, poor yields (29%, 38% respectively) of 5 
were observed. Changing the catalyst to Rh2(esp)2 (Du Bois’s catalyst, 1 mol%) improved 
the yield of aspulvinone A (5) to 60% (Table 4.2, entry 4). These conditions (4 equivalents 
of 93, Rh2(esp)2 in PhCF3 at 50 ºC, Method C) were also used for other insertion reactions 
of arylidene tetronates and chromans.  
Table 4.2 Optimization of C-H insertion reaction of chroman 93 
 
Entry Catalyst Temp (ºC) Time (h) 5 (%)a 
1 Rh2(CF3CO2)4 100 7.5 29 
2 Rh2(AcO)4 100 25 38 
3 Rh2(esp)2 100 1.5 58 
4 Rh2(esp)2 50 6 60 
aisolated yields 
331 
 
Thus, using the optimized conditions for the chroman insertion, diazotetronate 85 
was treated with 7-methoxy-2,2-dimethylchromane (94) using catalyst Rh2(esp)2 (Method 
C) to give 95 in 85% yield. Demethylation of 95 with BBr3 provided aspulvinone C (6, 
75%, Scheme 4.14). Notably, during this reaction BBr3 demethylated the O-CH3 on 
chroman and simultaneously cleaved the O─C25 and O─C20 bonds to provide the dibromo 
trihydroxy compound 96 as an intermediate (confirmed by 1H NMR and HRMS). 
Surprisingly, the intermediate 96 formed aspulvinone C (6) in 75% yield by leaving the 
crude demethylation product at room temperature. This unusually facile substitution 
reaction involves a tertiary alkyl bromide as the electrophile and a phenolic OH group as 
the nucleophile. A similar reaction of a 1,3-dimethoxy-2-prenyl aryl motif has been 
reported by Eicher14 (demethylation with BBr3 and subsequent cyclization with a prenyl 
group to provide a chroman skeleton at -78 ºC). 
 
Scheme 4.14 Synthesis of aspulvinone C (6) 
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Next, the syntheses of aspulvinone B (7) and D (8) were explored using the same 
strategy. Rh2(esp)2-catalyzed (Method C) C-H insertion of 86 with chroman 94 provided 
97 in 44% (Scheme 4.15). Unfortunately, the attempted demethylation of 97 with BBr3 was 
unsuccessful. Notably, examination of the 1H NMR of the crude reaction product indicated 
that the double bond of the prenyl group in 97 had reacted but the methoxy and silyl ether 
functional groups remained intact during the reaction. Investigations of this reaction 
employing other demethylating reagents and conditions are ongoing.  
In related studies, the insertion reaction of 86 and chroman 93 provided the required 
product 99 in very low yield (~10%). Notably, desilylation (TBS removal) of 99 would 
provide aspulvinone B (7), and the demethylation and desilylation of 97 will provide 
aspulvinone D (8). Although we are tantalizingly close to these targets, these synthetic 
efforts were discontinued due to the problems encountered with the deceptively simple 
deprotection chemistry of 97 and 99 (Scheme 4.15). 
 
Scheme 4.15 Attempted synthesis of aspulvinones B (7) and D (8) 
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4.4.3 Other synthetic approaches aspulvinones B (7) and D (8) 
Simultaneously with the studies described above, an alternative approach to 
aspulvinones B (7) and D (8) was also examined. We reasoned that these natural products 
could be accessed from tetronic acids 102 and 103 by aldol condensation with aldehydes 
100 and 101 respectively. In addition to changing the sequence of events in the pulvinone 
synthesis (insertion before aldol condensation) this study was planned to also avoid the 
problematic protecting groups (methyl ether and TBS ether) encountered in the previous 
studies (Figure 4.6). Thus, an acetate was used instead of the methyl ether and a benzyl 
ether replaced the TBS ether. 
 
Figure 4.6 Retrosynthetic route for synthesis of aspulvinones B (7) and D (8) 
Accordingly, the C-H insertion reaction was performed between diazotetronate 72 
and chroman 93 to afford 102 in 76% which was then protected to provide the acetate 103 
in 55% yield (Scheme 4.16). Aldol condensation reactions of 102 and 103 with unprotected 
aldehyde 100 (free phenolic OH group) under our optimized conditions (Table 4.1, entry 
5) did not provide the expected product 104 (R1 = H). Similarly, the reaction of 103 with 
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101 (O-benzyl 100) also failed. Unfortunately, these reactions generated complex mixtures 
which did not contain any of the required products. Investigations on these aldol reactions 
under various other conditions are ongoing. 
 
Scheme 4.16 Synthesis of aspulvinone B (7) 
4.4.4 Synthesis of unnatural pulvinones 
In related studies, the synthesis of unnatural pulvinones (pulvinone analogues) was 
also investigated. The C-H insertions of 83 and 84 with chroman 93 provided the 
corresponding pulvinone derivatives 105 and 106 in 58% and 42% yields respectively 
(Scheme 4.17). 
 
Scheme 4.17 Synthesis of pulvinone analogues  
In addition to the stereochemical observations described in Section 4.4.2 (page 
327), the 1H and 13C NMR spectroscopic data of compounds 2, 3, 4, 5, 6, 88, 90 and 92 are 
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in complete agreement with that reported for the Z-isomers in the literature. These 
observations also confirm the geometry of the aldol condensation products as Z. A detailed 
comparison of the spectroscopic data is provided in the experimental section. 
4.5 Conclusion 
 In conclusion, a facile and versatile methodology has been developed to synthesize 
naturally occurring pulvinones and their derivatives. The syntheses of pulvinone (1), 
aspluvinone A (5) and pulvinone derivatives 105, 106 were achieved in two steps from 
diazo tetronic acid (72). Similarly, syntheses of aspulvinone E (2), aspulvinone G (3), 
3',4,4'-trihydroxypulvinone (4), aspulvinone C (6) were accomplished in three steps from 
72. This methodology provides direct access to a wide range of stereoisomerically pure (Z)-
5-arylidene/alkylidene-3-diazofuran-2,4(3H,5H)-diones and 5-arylidene-4-hydroxy-3-
aryl-5-furan-2(5H)-ones. We anticipate that our modular strategy will be useful for 
preparing natural product-like libraries of pulvinones by systematic variation of the C3 aryl 
group and the aryl/alkyl group at C5. Investigations on the synthesis of aspulvinone B (7) 
and D (8) are ongoing. 
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4.6 Experimental Section 
All commercially available reagents were used without purification. All reactions 
requiring anhydrous conditions were performed under an atmosphere of dry nitrogen using 
oven dried glassware. CH2Cl2 was distilled from CaH2. Commercial precoated silica gel 
plates were used for TLC. All melting points are uncorrected. Silica gel for flash column 
chromatography was 230-400 mesh. IR spectra were recorded on a Bruker TENSOR 27 
FT-IR instrument. 1H NMR and 13C NMR spectra were recorded on a Bruker AVANCE 
III 300 or an AVANCE 500 instrument. Mass spectra were obtained on an Agilent 6200 
LC/MSD (TOF) chromatographic system.  
General procedure for the aldol condensation of diazotetronate 72 and aldehydes: 
To a solution of 72 (1 equiv) and aldehyde (1 equiv) in CH2Cl2 was added TiCl4 (3 
equiv) at -78 °C. The solution was stirred for 20 min, 2,4,6-collidine (3 equiv) was added 
and the mixture was stirred at -78 °C for 30 min and at 0 °C for 30 min. Saturated aqueous 
NH4Cl (~3 mL) was added followed by cold water (~2 mL). The resulting mixture was 
extracted with CH2Cl2 (3 x 6 mL). The combined organic layers were washed with brine, 
dried (Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel to provide the alkylidene diazotetronates 75-86. 
(Z)-3-Diazo-5-(4-methylbenzylidene)furan-2,4(3H,5H)-dione (75): 
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The reaction of 72 (126 mg, 1.00 mmol), 4-methylbenzaldehyde (118 µL, 1.00 
mmol), TiCl4 (0.32 mL, 3.0 mmol) and 2, 4, 6-collidine (0.40 mL, 3.0 mmol) in CH2Cl2 (5 
mL) according to the general procedure provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 9:1), 188 mg (82%) of 75 as a white solid.  
Rf = 0.32 (hexanes/EtOAc, 8.5:1.5); mp: 147-150 °C; IR (neat): 2157, 1758, 1689, 1634, 
1602, 1362, 1339, 1313, 1251, 1078, 1048, 962, 917 cm-1; 1H NMR (300 MHz, CDCl3): δ 
7.66 (d, 2H, J = 8.1 Hz, ArH), 7.23 (d, 2H, J = 8.1 Hz, ArH), 6.68 (s, 1H, ArCH=C), 2.39 
(s, 3H, CH3); 
13C NMR (75 MHz, CDCl3): δ 174.8 (C=O), 160.5 (OC=O), 141.6 (O-
C=CHAr or ArCipso), 141.3 (O-C=CHAr or ArCipso), 131.6 (2 × ArC), 129.9 (2 × ArC), 
128.3 (ArCipso), 112.2 (ArCH=C), 21.8 (CH3); HRMS (APPI, pos.): m/z 228.0537 
(228.0535 calc. for C12H8N2O3, (M)
+). 
(Z)-3-Diazo-5-(4-methoxybenzylidene)furan-2,4(3H,5H)-dione (76): 
 
The reaction of 72 (126 mg, 1.00 mmol), 4-methoxybenzaldehyde (121 µL, 1.00 
mmol), TiCl4 (0.32 mL, 3.0 mmol) and 2,4,6-collidine (0.40 mL, 3.0 mmol) in CH2Cl2 (6 
mL) according to the general procedure provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 9:1 to 4:1), 224 mg (92%) of 76 as a yellow 
solid.  
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Rf = 0.33 (hexanes/EtOAc, 7:3); mp: 141-145 °C; IR (neat): 2970, 2917, 2845, 2158, 1774, 
1690, 1646, 1598, 1565, 1508, 1366, 1341, 1305, 1250, 1174, 1134, 1070, 1021, 957   cm-
1; 1H NMR (300 MHz, CDCl3): δ 7.72 (d, 2H, J = 8.8 Hz, ArH), 6.94 (d, 2H, J = 8.8 Hz, 
ArH), 6.66 (s, 1H, ArCH=C), 3.86 (s, 3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 174.6 
(C=O), 161.4 (OC=O or ArCipso), 160.4 (OC=O or ArCipso), 140.5 (O-C=CHAr), 133.4 (2 
× ArC), 123.7 (ArCipso), 114.5 (2 × ArC), 112.0 (ArCH=C), 55.4 (OCH3); HRMS (APPI, 
pos.): m/z 244.0484 (244.0484 calc. for C12H8N2O4, (M)
+). 
(Z)-3-Diazo-5-(3,4-dimethoxybenzylidene)furan-2,4(3H,5H)-dione (77): 
 
The reaction of 72 (80 mg, 0.64 mmol), 3,4-dimethoxybenzaldehyde (106 mg, 
0.640 mmol), TiCl4 (0.21 mL, 1.9 mmol) and 2,4,6-collidine (0.25 mL, 1.9 mmol) in 
CH2Cl2 (4 mL) according to the general procedure provided, after purification by flash 
column chromatography on silica gel (hexanes/EtOAc, 7:3 to 1:1), 161 mg (92%) of 77 as 
a yellow solid.  
Rf = 0.19 (hexanes/EtOAc, 7:3); mp: 177-183 °C; IR (neat): 2961, 2936, 2913, 2836, 2143, 
1779, 1693, 1643, 1594, 1513, 1360, 1321, 1266, 1219, 1145, 1129, 1081, 1063, 1018, 979, 
916 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.36 (s, 1H, ArH), 7.35 (dd, 1H, J = 8.6, 2.0 Hz, 
ArH), 6.91 (d, 1H, J = 8.6 Hz, ArH), 6.66 (s, 1H, ArCH=C), 3.94 (s, 6H, 2 × OCH3); 
13C 
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NMR (75 MHz, CDCl3): δ 174.7 (C=O), 160.5 (OC=O), 151.4 (ArCipso), 149.3 (ArCipso), 
140.7 (O-C=CHAr), 126.2 (ArC), 124.1 (ArCipso), 113.5 (ArC or ArCH=C), 112.4 (ArC or 
ArCH=C), 111.3 (ArC or ArCH=C), 56.1 (2 × OCH3); HRMS (APPI, pos.): m/z 274.0597 
(274.0590 calc for C13H10N2O5 (M)
+). 
(Z)-3-Diazo-5-(3-methoxybenzylidene)furan-2,4(3H,5H)-dione (78): 
 
The reaction of 72 (150 mg, 1.19 mmol), 3-methoxybenzaldehyde (145 µL, 1.19 
mmol), TiCl4 (0.39 mL, 3.6 mmol) and 2,4,6-collidine (0.47 mL, 3.6 mmol) in CH2Cl2 (7 
mL) according to the general procedure provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 9:1 to 7:3), 231 mg (79%) of 78 as a yellow 
solid. 
Rf = 0.46 (hexanes/EtOAc, 7:3); mp: 159-161°C; IR (neat): 2923, 2844, 2132, 1764, 1705, 
1647, 1582, 1357, 1302, 1215, 1176, 1092, 1074, 1036, 981, 912 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 7.36-7.31 (m, 2H, ArH), 7.31-7.28 (m, 1H, ArH), 7.00-6.92 (m, 1H, ArH), 6.65 
(s, 1H, ArCH=C), 3.84 (s, 3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 174.6 (C=O), 160.1 
(OC=O or ArCipso), 159.8 (OC=O or ArCipso), 142.1 (O-C=CHAr), 132.1 (ArCipso), 129.9 
(ArC), 124.1 (ArC), 116.6 (ArC), 116.0 (ArC), 111.7 (ArCH=C), 55.4 (OCH3); HRMS 
(APPI, pos.): m/z 244.0480 (244.0484 calc. for C12H8N2O4, (M)
+). 
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(Z)-3-Diazo-5-(4-(trifluoromethyl)benzylidene)furan-2,4(3H,5H)-dione (79): 
 
The reaction of 72 (126 mg, 1.00 mmol), 4-(trifluoromethyl)benzaldehyde (134 µL, 
1.00 mmol), TiCl4 (0.32 mL, 3.0 mmol) and 2,4,6-collidine (0.40 mL, 3.0 mmol) in CH2Cl2 
(5 mL) according to the general procedure provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 8.5:1.5 to 4:1), 239 mg (85%) of 79 as a 
yellow solid.  
Rf = 0.56 (hexanes/EtOAc, 7:3); mp: 158-162 °C; IR (neat): 3072, 2924, 2168, 1783, 1710, 
1653, 1355, 1317, 1170, 1120, 1045, 1013, 963 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.84 
(d, 2H, J = 8.3 Hz, ArH), 7.65 (d, 2H, J = 8.3 Hz, ArH), 6.67 (s, 1H, ArCH=C); 13C NMR 
(75 MHz, CDCl3): δ 174.4 (C=O), 159.8 (OC=O), 143.4 (O-C=CHAr), 134.3 (q, 5JC-F = 
1.4 Hz, ArCipso), 131.6 (q, 
2JC-F = 32.7 Hz, ArCipso), 131.3 (2 × ArC), 125.85 (q, 
3JC-F = 3.8 
Hz, 2 × ArC), 123.7 (q, 1JC-F = 272.3 Hz, CF3), 109.5 (ArCH=C); HRMS (APPI, neg.): m/z 
282.0254 (282.0252 calc. for C12H5F3N2O3, (M)
-) and 341.0415 (341.0385 calc. for 
C14H8F3N2O5, (M+CH3COO)
-). 
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(Z)-5-(4-Bromobenzylidene)-3-diazofuran-2,4(3H,5H)-dione (80): 
 
The reaction of 72 (150 mg, 1.19 mmol), 4-bromobenzaldehyde (220 mg, 1.19 
mmol), TiCl4 (0.39 mL, 3.6 mmol) and 2,4,6-collidine (0.47 mL, 3.6 mmol) in CH2Cl2 (7 
mL) according to the general procedure provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 8.5:1.5 to 4:1), 287 mg (82%) of 80 as a 
yellow solid.  
Rf = 0.36 (hexanes/EtOAc, 7:3); mp: 214-218 °C; IR (neat): 2163, 1780, 1702, 1638, 1579, 
1484, 1354, 1306, 1244, 1131, 1064, 1045, 1003, 960 cm-1; 1H NMR (300 MHz, CDCl3): 
δ 7.62 (d, 2H, J = 8.6 Hz, ArH), 7.55 (d, 2H, J = 8.6 Hz, ArH), 6.62 (s, 1H, ArCH=C); 13C 
NMR (75 MHz, CDCl3): δ 174.4 (C=O), 159.9 (OC=O), 142.3 (O-C=CHAr), 132.7 (2 × 
ArC), 132.3 (2 × ArC), 129.8 (ArCipso), 125.0 (ArCipso), 110.4 (ArCH=C); HRMS (APPI, 
pos.): m/z 291.9481 (291.9484 calc. for C11H5
79BrN2O3, (M)
+) and 293.9455 (293.9463 
calc. for C11H5
81BrN2O3, (M)
+). 
(Z)-5-Benzylidene-3-diazofuran-2,4(3H,5H)-dione (81): 
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The reaction of 72 (70 mg, 0.56 mmol), benzaldehyde (57 µL, 0.56 mmol), TiCl4 
(0.18 mL, 1.7 mmol) and 2,4,6-collidine (0.22 mL, 1.7 mmol) in CH2Cl2 (3 mL) according 
to the general procedure provided, after purification by flash column chromatography on 
silica gel (hexanes/EtOAc, 8.5:1.5), 104 mg (87%) of 81 as a white solid. 
Rf = 0.51 (hexanes/EtOAc, 7:3); mp: 147-154 °C; IR (neat): 2921, 2852, 2151, 1763, 1699, 
1639, 1358, 1337, 1244, 1082, 1051, 963 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.81-7.72 
(m, 2H, ArH), 7.49-7.39 (m, 3H, ArH), 6.69 (s, 1H, PhCH); 13C NMR (75 MHz, CDCl3): 
δ 174.8 (C=O), 160.3 (OC=O), 142.1 (PhHC=C-O), 131.5 (2 × ArC), 131.0 (ArCipso), 130.5 
(ArC), 129.1 (2 × ArC), 111.9 (PhCH=C); HRMS (APPI, pos.): m/z 214.0378 (214.0378 
calc. for C11H6N2O3, (M)
+). 
(Z)-3-Diazo-5-(furan-2-ylmethylene)furan-2,4(3H,5H)-dione (82): 
 
The reaction of 72 (150 mg, 1.19 mmol), 2-furaldehyde (99 µL, 1.2 mmol), TiCl4 
(0.39 mL, 3.6 mmol) and 2,4,6-collidine (0.47 mL, 3.6 mmol) in CH2Cl2 (7 mL) according 
to the general procedure provided, after purification by flash column chromatography on 
silica gel (hexanes/EtOAc, 9:1 to 8.5:1.5), 227 mg (93%) of 82 as an orange-yellow solid. 
Rf = 0.29 (hexanes/EtOAc, 9:1); mp: 163-167 °C; IR (neat): 2923, 2853, 2166, 1761, 1698, 
1641, 1353, 1315, 1242, 1070, 1014, 964 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.58 (dd, 
1H, J = 1.7, 0.5 Hz, ArH), 7.03 (br dt, 1H, J = 3.5, 0.5 Hz, ArH), 6.70 (br s, 1H, ArCH=C), 
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6.57 (ddd, 1H, J = 3.5, 1.7, 0.5 Hz, ArH); 13C NMR (75 MHz, CDCl3): δ 173.8 (C=O), 
160.0 (OC=O), 147.5 (O-C=CHAr or ArCipso), 145.6 (ArC), 139.8 (O-C=CHAr or ArCipso), 
117.6 (ArC), 113.2 (ArC), 100.5 (ArCH=C); HRMS (APPI, pos.): m/z 204.0168 (204.0171 
calc. for C9H4N2O4, (M)
+)  
(Z)-5-(Cyclopentylmethylene)-3-diazofuran-2,4(3H,5H)-dione (83): 
 
To a solution of 72 (150 mg, 1.19 mmol) in CH2Cl2 (4 mL) was added TiCl4 (0.39 
mL, 3.57 mmol) at -78 °C and the solution was stirred for 20 min. To the mixture was 
added 2,4,6-collidine (0.47 mL, 3.6 mmol) followed by dropwise addition of 
cyclopentanecarboxaldehyde (127 µL, 1.19 mmol) in CH2Cl (2 mL) over 5 min. The 
mixture was stirred at -78 °C for 20 min and then at 0 °C for 1 h. Saturated aqueous NH4Cl 
(~3 mL) was added followed by cold water (~2 mL). The resulting mixture was extracted 
with CH2Cl2 (3 × 5 mL). The combined organic layers were washed with brine, dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (hexanes/EtOAc, 19:1) to provide 97 mg (40%) of 83 as a 
brown gum.  
Rf = 0.73 (hexanes/EtOAc, 7:3); IR (neat): 2953, 2868, 2145, 1777, 1709, 1663, 1347, 
1273, 1125, 1072, 1058, 1020, 960 cm-1; 1H NMR (300 MHz, CDCl3): δ 5.93 (d, 1H, J = 
9.9 Hz, C5H9CH=C), 3.03-2.87 (m, 1H, CH2CHCH2), 2.00-7.86 (m, 2H, CH2), 1.80-1.56 
344 
 
(m, 4H, CH2), 1.47-1.32 (m, 2H, CH2); 
13C NMR (75 MHz, CDCl3): δ 174.2 (C=O), 160.3 
(OC=O), 143.2 (O-C=CHC5H9), 121.2 (C5H9CH=C), 36.8 (CH2CHCH2), 33.1 (2 × CH2), 
25.4 (2 × CH2); HRMS (ESI, neg.): m/z 178.0628 (178.0630 calc. for C10H10O3, (M-N2)
-) 
and 223.0613 (223.0606 calc. for C11H11O5, (M+HCOO-N2)
-). 
(Z)-3-Diazo-5-(naphthalen-2-ylmethylene)furan-2,4(3H,5H)-dione (84): 
 
The reaction of 72 (150 mg, 1.19 mmol), 2-naphthaldehyde (186 mg, 1.19 mmol), 
TiCl4 (0.39 mL, 3.6 mmol) and 2,4,6-collidine (0.47 mL, 3.6 mmol) in CH2Cl2 (7 mL) 
according to the general procedure provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 8.5:1.5 to 1:1), 292 mg (93%) of 84 as an 
orange-yellow solid.  
Rf = 0.40 (hexanes/EtOAc, 7:3); mp: 156-160 °C; IR (neat): 2922, 2134, 1762, 1710, 1645, 
1358, 1322, 1078, 1048, 976, 929 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.22 (s, 1H, ArH), 
7.94-7.80 (m, 4H, ArH), 7.59-7.49 (m, 2H, ArH), 6.86 (s, 1H, ArCH=C); 13C NMR (75 
MHz, CDCl3): δ 174.7 (C=O), 160.4 (OC=O), 142.2 (O-C=CHAr), 134.0 (ArCipso), 133.3 
(ArCipso), 132.6 (ArC), 129.0 (ArC), 128.9 (ArC), 128.6 (ArCipso), 128.0 (ArC), 127.9 
(ArC), 127.4 (ArC), 126.9 (ArC), 112.2 (ArCH=C); HRMS (APPI, pos): m/z 264.0539 
(264.0535 calc for C15H8N2O3 (M)
+). 
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(Z)-3-Diazo-5-((2,2-dimethylchroman-6-yl)methylene)furan-2,4(3H,5H)-dione (85): 
 
The reaction of 72 (200 mg, 1.59 mmol), 2,2-dimethylchroman-6-carbaldehyde 
(302 mg, 1.59 mmol), TiCl4 (0.52 mL, 4.8 mmol) and 2,4,6-collidine (0.63 mL, 4.8 mmol) 
in CH2Cl2 (9 mL) according to the general procedure provided, after purification by flash 
column chromatography on silica gel (hexanes/EtOAc, 4:1 to 7:3), 430 mg (91%) of 85 as 
a yellow-orange solid.  
Rf = 0.46 (hexanes/EtOAc, 7:3); mp: 156-161 °C; IR (neat): 2979, 2926, 2163, 1774, 1702, 
1641, 1598, 1570, 1490, 1364, 1308, 1269, 1116, 1074, 1054, 948 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.53 (br s, 1H, ArH), 7.50 (dd, 1H, J = 8.3, 2.1 Hz, ArH), 6.81 (d, 1H, J = 
8.3 Hz, ArH), 6.64 (s, 1H, ArCH=C), 2.81 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.83 (t, 2H, J = 
6.7 Hz, ArCH2CH2), 1.36 (s, 6H, 2 × CH3); 
13C NMR (75 MHz, CDCl3): δ 174.6 (C=O), 
160.6 (OC=O), 156.6 (ArCipso), 140.1 (O-C=CHAr), 133.3 (ArC), 131.4 (ArC), 122.6 
(ArCipso), 121.7 (ArCipso), 118.1 (ArC), 112.7 (ArCH=C), 75.5 (Ar-O-C(CH3)2), 32.5 
(ArCH2CH2), 26.9 (2 × CH3), 22.4 (ArCH2CH2); HRMS (ESI, pos.): m/z 298.0939 
(298.0954 calc. for C16H14N2O4, (M)
+), 299.1012 (299.1032 calc. for C16H15N2O4, (M+H)
+) 
and 321.0827 (321.0851 calc. for C16H14N2NaO4, (M+Na)
+). 
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(Z)-5-(4-((tert-Butyldimethylsilyl)oxy)-3-(3-methylbut-2-en-1-yl)benzylidene)-3-
diazofuran-2,4(3H,5H)-dione (86):  
 
The reaction of 72 (350 mg, 2.78 mmol), 4-((tert-butyldimethylsilyl)oxy)-3-(3-
methylbut-2-en-1-yl)benzaldehyde (109) (846 mg, 2.78 mmol), TiCl4 (0.90 mL, 8.3 mmol) 
and 2,4,6-collidine (1.10 mL, 8.33 mmol) in CH2Cl2 (12 mL) according to the general 
procedure provided, after purification by flash column chromatography on silica gel 
(hexanes/EtOAc, 19:1), 902 mg (79%) of 86 as a yellow solid.  
Rf = 0.63 (hexanes/EtOAc, 7:3); mp: 118-121 °C; IR (neat): 2961, 2929, 2858, 2137, 1782, 
1708, 1648, 1598, 1497, 1364, 1276, 1076, 931 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.59 
(dd, 1H, J = 8.4, 2.3 Hz, ArH), 7.49 (d, 1H, J = 2.3 Hz, ArH), 6.82 (d, 1H, J = 8.4 Hz, 
ArH), 6.66 (s, 1H, ArCH=C), 5.24-5.33 (m, 1H, (CH3)2C=CH), 3.30 (d, 2H, J = 7.1 Hz, 
C=CHCH2), 1.77 (br d, 3H, J = 1.0 Hz, CH3), 1.71 (br s, 3H, CH3), 1.02 (s, 9H, 3 × CH3), 
0.27 (s, 6H, 2 × CH3); 
13C NMR (75 MHz, CDCl3): δ 174.7 (C=O), 160.4 (OC=O), 156.0 
(ArCipso), 140.4 (O-C=CHAr), 133.61 (ArC), 133.57 (ArCipso or (CH3)2C=CH), 133.1 
(ArCipso or (CH3)2C=CH), 130.6 (ArC or (CH3)2C=CH), 123.9 (ArCipso or (CH3)2C=CH), 
121.7 (ArC or ArCH=C), 118.9 (ArC or ArCH=C), 112.6 (ArC or ArCH=C), 28.4 (CH2), 
25.7 (4 × CH3), 18.3 (Si-C(CH3)3), 17.9 (CH3), -4.1 (2 × SiCH3); HRMS (APPI, pos.): m/z 
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412.1827 (412.1818 calc. for C22H28N2O4Si, (M)
+) and 413.1859 (413.1897 calc. for 
C22H29N2O4Si, (M+H)
+). 
 
General procedures for the insertion reactions of (Z)-5-arylidene/alkylidene-3-
diazofuran-2,4(3H,5H)-diones and arenes: 
Method A: To a solution of (Z)-5-arylidene/alkylidene-3-diazofuran-2,4(3H,5H)-dione (1 
equiv) in the aromatic compound was added the Rh(II) catalyst (1 mol%) at room 
temperature. The reaction mixture was then placed in a pre-heated oil bath at 100 °C. The 
mixture was heated until complete consumption of the diazo compound (TLC), then cooled 
to room temperature and concentrated. The residue was purified by flash chromatography 
on silica gel. 
Method B: To a suspension of (Z)-5-arylidene/alkylidene-3-diazofuran-2,4(3H,5H)-dione 
(1 equiv) in ,,-trifluorotoluene was added the aromatic compound (4 equiv) followed 
by the Rh(II) catalyst (1 mol%) at room temperature and the reaction mixture was placed 
in an oil bath that was pre-heated to 50 °C or to 100 °C. The mixture was heated until 
complete consumption of the diazo compound (TLC), then cooled to room temperature and 
concentrated. The residue was purified by flash chromatography on silica gel. 
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(Z)-5-Benzylidene-4-hydroxy-3-phenylfuran-2(5H)-one (1, Pulvinone):5 
 
The reaction of 81 (40 mg, 0.19 mmol), Rh2(OAc)4 (0.80 mg, 1.9 x 10
-3 mmol) in 
benzene (1.5 mL) at reflux for 42 h according to Method A provided, after purification by 
flash column chromatography on silica gel (hexanes/EtOAc, 7:3 to 1:1), 38 mg (78%, 81% 
based on recovery of 81) of 1 as a yellow solid.  
Rf = 0.17 (hexanes/EtOAc, 7:3); mp: 247-251 °C (Lit.
5 250-251 ºC); IR (neat): 3007 (br), 
2920, 2851, 2632 (br), 1698, 1621, 1595, 1406, 1332, 1303, 1210, 1150, 1122, 1001 cm-1; 
1H NMR (300 MHz, DMSO-d6): δ 7.98-7.91 (m, 2H, ArH), 7.80-7.72 (m, 2H, ArH), 7.53-
7.27 (m, 6H, ArH), 6.75 (s, 1H, PhCH); 13C NMR (75 MHz, DMSO-d6): δ 167.9 (C=O or 
C=COH), 163.8 (C=O or C=COH), 142.4 (O-C=CHPh), 132.7 (ArCipso), 130.1 (2 × ArC), 
129.8 (ArCipso), 129.0 (2 × ArC), 128.8 (ArC), 128.3 (2 × ArC), 127.2 (2 × ArC), 127.1 
(ArC), 107.6 (PhCH=C), 100.1 (C=COH); HRMS (APPI, pos.): m/z 264.0796 (264.0786 
calc. for C17H12O3, (M)
+) and 265.0868 (265.0865 calc. for C17H13O3, (M+H)
+). 
(Z)-2-Benzylidene-5-oxo-4-phenyl-2,5-dihydrofuran-3-yl acetate (87):5 
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To a solution of pulvinone 1 (24 mg, 0.090 mmol) in pyridine (0.5 mL) was added 
acetic anhydride (0.2 mL) at room temperature and the mixture was stirred for 19 h. Water 
(2 mL) was added and the resulting mixture was extracted with dichloromethane (3 × 3 
mL). The combined organic layers were dried (Na2SO4) and concentrated. The residue was 
purified by flash column chromatography on silica gel (hexanes/EtOAc, 4:1) to provide 9 
mg (33%) of 87 as a yellow solid. 
Rf = 0.51 (hexanes/EtOAc, 3:2); mp: 126-130 °C (Lit.
5 138-140 ºC); IR (neat): 2956, 2922, 
2852, 1785, 1761, 1614, 1492, 1446, 1370, 1286, 1167, 1134, 1093, 1065, 967, 921 cm-1; 
1H NMR (300 MHz, CDCl3): δ 7.83-7.72 (m, 4H, ArH), 7.49-7.31 (m, 6H, ArH), 6.08 (s, 
1H, PhCH=C), 2.42 (s, 1H, CH3); 
13C NMR (75 MHz, CDCl3): δ 166.5 (C(O)O), 165.7 
(C(O)O), 154.6 (C=COAc), 141.9 (O-C=CHPh), 132.3 (ArCipso), 130.8 (2 × ArC), 129.5 
(2 × ArC), 128.9 (2 × ArC), 128.8 (2 × ArC), 127.9 (2 × ArC, ArCipso), 115.9 (C=COAc), 
109.6 (PhCH=C), 20.8 (CH3); HRMS (APPI, pos.): m/z 306.0904 (306.0892 calc. for 
C19H14O4 (M)
+) and 307.0976 (307.0970 calc. for C19H15O4, (M+H)
+). 
1H-1H correlation spectroscopy does not show interaction between CH3C(O)O- and 
PhCH=C. 
(Z)-4-Hydroxy-5-(4-methoxybenzylidene)-3-(4-methoxyphenyl)furan-2(5H)-one 
(88):2 
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The reaction of 76 (60 mg, 0.25 mmol), anisole (107 µL, 0.980 mmol), 
Rh2(CF3CO2)4 (1.6 mg, 2.5 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) at 100 °C for 6 
h according to Method B provided, after purification by flash column chromatography on 
silica gel (hexanes/EtOAc, 4:1 to 3:7), 56 mg (71%) of 88 as a brown solid and 16 mg 
(20%) of 89 as a yellow solid.  
Rf = 0.21 (hexanes/EtOAc, 1:1); mp: 241-244 °C (Lit.
5 250-253 ºC); IR (neat): 3003, 2954, 
2833, 2601 (br), 1685, 1595, 1507, 1426, 1398, 1247, 1175, 1156, 1130, 1098, 1027, 1003 
cm-1; 1H NMR (300 MHz, CDCl3/one drop DMSO-d6): δ 7.90 (d, 2H, J = 8.9 Hz, ArH), 
7.71 (d, 2H, J = 8.8 Hz, ArH), 6.91 (d, 2H, J = 8.8 Hz, ArH), 6.87 (d, 2H, J = 8.9 Hz, ArH), 
6.47 (s, 1H, ArCH=C), 3.81 (s, 3H, OCH3), 3.79 (s, 3H, OCH3); 
13C NMR (75 MHz, 
CDCl3/one drop DMSO-d6): δ 169.0 (C=O or C=COH), 162.3 (C=O or C=COH), 159.7 
(ArCipso), 158.4 (ArCipso), 141.1 (O-C=CHAr), 131.8 (2 × ArC), 128.9 (2 × ArC), 125.8 
(ArCipso), 122.6 (ArCipso), 114.1 (2 × ArC), 113.5 (2 × ArC), 107.3 (ArCH=C), 100.6 
(C=COH), 55.2 (OCH3), 55.1 (OCH3); HRMS (APPI, pos.): m/z 324.0992 (324.0998 calc. 
for C19H16O5, (M)
+) and 325.1064 (325.1076 calc. for C19H17O5, (M+H)
+). 
(Z)-4-Hydroxy-5-(4-methoxybenzylidene)-3-(2-methoxyphenyl)furan-2(5H)-one (89): 
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Rf = 0.40 (hexanes/EtOAc, 7:3); mp: 109-115 R °C; IR (neat): 2922 (br), 2838 (br), 1708, 
1593, 1511, 1451, 1428, 1302, 1244, 1175, 1145, 1125, 1098, 1024, 983, 922 cm-1; 1H 
NMR (300 MHz, CDCl3): δ 9.12 (s, 1H, OH), 8.09 (dd, 1H, J = 7.8, 1.1 Hz, ArH), 7.78 (d, 
2H, J = 8.8 Hz, ArH), 7.35 (ddd, 1H, J = 7.8, 7.5, 1.2 Hz, ArH), 7.18 (br td, 1H, J = 7.8, 
1.1 Hz, ArH), 7.06 (dd, 1H, J = 8.2, 1.1 Hz, ArH), 6.93 (d, 2H, J = 8.8 Hz, ArH), 6.37 (s, 
1H, ArCH=), 4.03 (s, 3H, OCH3), 3.85 (s, 3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 168.4 
(C=O or C=COH), 162.8 (C=O or C=COH or ArCipso), 160.3 (C=O or C=COH or ArCipso), 
154.7 (ArCipso), 140.3 (O-C=CHAr), 132.4 (2 × ArC), 130.2 (ArC), 129.3 (ArC), 125.7 
(ArCipso), 123.3 (ArC), 119.4 (ArCipso), 114.4 (2 × ArC), 113.0 (ArC), 108.3 (ArCH=C), 
99.2 (C=COH), 57.7 (OCH3), 55.5 (OCH3); HRMS (APPI, pos.): m/z 324.0986 (324.0998 
calc. for C19H16O5, (M)
+) and 325.1058 (325.1076 calc. for C19H17O5, (M+H)
+). 
(Z)-5-(3,4-Dimethoxybenzylidene)-4-hydroxy-3-(4-methoxyphenyl)furan-2(5H)-one 
(90):2 
 
The reaction of 77 (90 mg, 0.33 mmol), anisole (142 µL, 1.31 mmol), 
Rh2(CF3CO2)4 (1.2 mg, 3.3 x 10
-3 mmol) in ,,-trifluorotoluene (3 mL) at 100 °C for 22 
h according to Method B provided, after purification by flash column chromatography on 
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silica gel (hexanes/EtOAc, 7:3 to 3:7), 61 mg (53%) of 90 as a brown solid and 16 mg 
(14%) of 91 as a yellow solid.  
Rf = 0.22 (hexanes/EtOAc, 1:1); mp: 215-219 °C (Lit.
2 219-222 °C); IR (neat): 3216 (br), 
2959, 2921, 2851, 1693, 1657, 1625, 1595, 1510, 1464, 1443, 1425, 1401, 1242, 1139, 
1096, 1018, 987 cm-1; 1H NMR (300 MHz, CDCl3/CD3OD, 97:3): δ 7.81 (d, 2H, J = 8.8 
Hz, ArH), 7.45 (d, 1H, J = 1.7 Hz, ArH), 7.30 (dd superimposed on CHCl3 s, 1H, J = 8.2, 
1.7 Hz, ArH), 6.96 (d, 2H, J = 8.8 Hz, ArH), 6.87 (d, 1H, J = 8.2 Hz, ArH), 6.34 (s, 1H, 
ArCH=C), 3.95 (s, 3H, OCH3), 3.91 (s, 3H, OCH3), 3.84 (s, 3H, OCH3); 
13C NMR (75 
MHz, DMSO-d6): δ 168.1 (C=O or C=COH), 162.7 (C=O or C=COH), 158.1 (ArCipso), 
149.6 (ArCipso), 148.7 (ArCipso), 141.0 (O-C=CHAr), 128.4 (2 × ArC), 125.6 (ArCipso), 
123.8 (ArC), 122.4 (ArCipso), 113.8 (2 × ArC), 113.0 (ArC), 112.0 (ArC), 107.3 (C=COH), 
99.4 (ArCH=C), 55.6 (OCH3), 55.5 (OCH3), 55.1 (OCH3); HRMS (APPI, pos.): m/z 
354.1116 (354.1103 calc. for C20H18O6, (M)
+) and 355.1189 (355.1182 calc. for C20H19O6, 
(M+H)+). 
(Z)-5-(3,4-Dimethoxybenzylidene)-4-hydroxy-3-(2-methoxyphenyl)furan-2(5H)-one 
(91): 
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Rf = 0.43 (hexanes/EtOAc, 1:1); mp: 104-108 °C; IR (neat): 3075 (br), 2954, 2923 (br), 
2839, 1748, 1596, 1515, 1451, 1328, 1272, 1237, 1142, 1121, 1012, 966 cm-1; 1H NMR 
(300 MHz, CDCl3): δ 8.09 (dd, 1H, J = 7.7, 1.7 Hz, ArH), 7.45 (d, 1H, J = 2.0 Hz, ArH), 
7.40-7.32 (m, 2H, ArH), 7.19 (td, 1H, J = 7.7, 1.1 Hz, ArH), 7.07 (dd, 1H, J = 8.3, 1.1 Hz, 
ArH), 6.89 (d, 1H, J = 8.3 Hz, ArH), 6.35 (s, 1H, ArCH=C), 4.04 (s, 3H, OCH3), 3.97 (s, 
3H, OCH3), 3.93 (s, 3H, OCH3); 
13C NMR (75 MHz, CDCl3): δ 168.3 (C=O or C=COH), 
162.8 (C=O or C=COH), 154.7 (ArCipso), 150.1 (ArCipso), 149.2 (ArCipso), 140.5 (O-
C=CHAr), 130.2 (ArC), 129.4 (ArC), 126.1 (ArCipso), 124.6 (ArC), 123.3 (ArC), 119.4 
(ArCipso), 113.0 (2 × ArC), 111.2 (ArC or ArCH=), 108.4 (ArC or ArCH=C), 99.2 
(C=COH), 57.7 (OCH3), 56.2 (OCH3), 56.1 (OCH3); HRMS (APPI, pos.): m/z 354.1100 
(354.1103 calc. for C20H18O6, (M)
+) and 355.1173 (355.1182 calc. for C20H19O6, (M+H)
+). 
(Z)-3-(2,4-Dimethoxyphenyl)-4-hydroxy-5-(4-methoxybenzylidene)furan-2(5H)-one 
(92):2 
 
The reaction of 76 (65 mg, 0.27 mmol), 1,3-dimethoxybenzene (139 µL, 1.06 
mmol), Rh2(CF3CO2)4 (1.7 mg, 2.7 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) at 100 
°C for 22 h according to Method B provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 7:3), 72 mg (76%) of 92 as a yellow solid.  
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Rf = 0.19 (hexanes/EtOAc, 7:3); mp: 176-178 °C (Lit.
2 180-183 °C); IR (neat): 3258 (br), 
2926 (br), 2841, 1751, 1603, 1577, 1508, 1327, 1299, 1253, 1210, 1160, 1096, 1023, 963, 
932 cm-1; 1H NMR (300 MHz, CDCl3): δ 8.92 (s, 1H, OH), 8.01 (d, 1H, J = 8.7 Hz, ArH), 
7.76 (d, 2H, J = 8.8 Hz, ArH), 6.92 (d, 2H, J = 8.8 Hz, ArH), 6.70 (dd, 1H, J = 8.7, 2.4 Hz, 
ArH), 6.59 (d, 1H, J = 2.4 Hz, ArH), 6.31 (s, 1H, ArCH=C), 4.00 (s, 3H, OCH3), 3.84 (s, 
6H, 2 × OCH3); 
13C NMR (75 MHz, CDCl3): δ 168.6 (C=O or C=COH), 161.3 (C=O or 
C=COH or ArCipso), 160.7 (C=O or C=COH or ArCipso), 160.1 (C=O or C=COH or 
ArCipso), 155.8 (ArCipso), 140.3 (O-C=CHAr), 132.1 (2 × ArC), 130.8 (ArC), 125.7 
(ArCipso), 114.3 (2 × ArC), 111.7 (ArCipso), 107.5 (ArC), 107.1 (ArC), 100.3 (ArCH=C), 
99.0 (C=COH), 57.3 (OCH3), 55.6 (OCH3), 55.3 (OCH3); HRMS (APPI, pos.): m/z 
354.1108 (354.1103 calc. for C20H18O6, (M)
+) and 355.1181 (355.1182 calc. for C20H19O6, 
(M+H)+). 
General procedure for the demethylation of aryl methyl ethers 88, 90 and 22: 
To a solution of methoxypulvinones in CH2Cl2 was added BBr3 (1M in CH2Cl2) at 
0 °C. The mixture was warmed to room temperature, stirred for 20 min and then heated to 
reflux until consumption of the starting material (TLC). The mixture was then cooled to     
0 °C and water (3 mL) was added. The resulting suspension was extracted with ethyl acetate 
(5 x 4 mL) and the combined organic layers were dried (Na2SO4) and concentrated under 
reduced pressure. The crude product was dissolved in dichloromethane with the aid of 
methanol and a few drops of hexanes were added. The mixture was left for a day at room 
temperature and the precipitated product (yellow solid) was isolated by filtration. This 
material was pure by 1H NMR.  
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(Z)-4-Hydroxy-5-(4-hydroxybenzylidene)-3-(4-hydroxyphenyl)furan-2(5H)-one (2, 
Aspulvinone E):2 
 
The reaction of 88 (80 mg, 0.25 mmol), BBr3 (1.5 mL 1.5 mmol, 1.0 M in CH2Cl2) 
in dichloromethane (3 mL) for 3 h, according to the general procedure, provided 61 mg 
(84%) of 2 as a brown solid. 
Rf = 0.27 (EtOAc/hexanes, 3:2); mp: 261-266 °C (Lit.
2 >250 °C); IR (neat): 3202 (br), 
2923, 2853, 1695, 1602, 1509, 1443, 1408, 1340, 1248, 1194, 1158 cm-1; 1H NMR (300 
MHz, CD3OD): δ 7.74 (d, 2H, J = 8.7 Hz, ArH), 7.65 (d, 2H, J = 8.7 Hz, ArH), 6.82 (d, 
4H, J = 8.7 Hz, ArH), 6.40 (s, 1H, ArCH=C); 13C NMR (75 MHz, CD3OD): δ 171.2 (C=O 
or C=COH), 163.3 (C=O or C=COH), 159.7 (ArCipso), 157.9 (ArCipso), 141.8 (O-C=CHAr), 
133.3 (2 × ArC), 130.3 (2 × ArC), 125.9 (ArCipso), 122.3 (ArCipso), 116.8 (2 × ArC), 116.1 
(2 × ArC), 108.9 (ArCH=C), 102.5 (C=COH); HRMS (APPI, pos.): m/z 296.0690 
(296.0685 calc. for C17H12O5, (M)
+) and 297.0763 (297.0763 calc. for C17H13O6, (M+H)
+). 
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(Z)-3-(2,4-Dihydroxyphenyl)-4-hydroxy-5-(4-hydroxybenzylidene)furan-2(5H)-one 
(3, Aspulvinone G):2 
 
The reaction of 92 (60 mg, 0.17 mmol), BBr3 (1.5 mL, 1.5 mmol, 1.0 M in CH2Cl2) 
in dichloromethane (3 mL) for 2 h, according to the general procedure, provided 43 mg 
(81%) of 3 as a yellow solid.  
Rf = 0.25 (EtOAc/hexanes, 3:2); mp: 243-248 °C (Lit.
2 >250 °C); IR (neat): 3151 (br), 
1729, 1603, 1513, 1464, 1443, 1376, 1343, 1307, 1256, 1226, 1174, 1118, 1093, 983 cm-1; 
1H NMR (300 MHz, CD3OD): δ 7.64 (d, 2H, J = 8.7 Hz, ArH), 7.60 (d, 1H, J = 8.2 Hz, 
ArH), 6.82 (d, 2H, J = 8.7 Hz, ArH), 6.43 (dd, 1H, J = 8.2, 2.1 Hz, ArH), 6.42 (s, 1H, ArH), 
6.32 (s, 1H, ArCH=C); 13C NMR (75 MHz, CD3OD): δ 171.4 (C=O or C=COH), 163.6 
(C=O or C=COH), 159.9 (ArCipso), 159.7 (ArCipso), 155.7 (ArCipso), 141.8 (O-C=CHAr), 
133.3 (2 × ArC), 131.7 (ArC), 126.1 (ArCipso), 116.8 (2 × ArC), 109.6 (ArCipso), 109.1 
(ArC), 108.5 (ArC), 103.9 (ArCH=C), 100.1 (C=COH); HRMS (APPI, pos.): m/z 312.0635 
(312.0634 calc. for C17H12O6, (M)
+) and 313.0708 (313.0712 calc. for C17H13O6, (M+H)
+). 
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(Z)-5-(3,4-Dihydroxybenzylidene)-4-hydroxy-3-(4-hydroxyphenyl)furan-2(5H)-one 
(3',4,’4-Trihydroxypulvinone (4)):7  
 
The reaction of 90 (55 mg, 0.16 mmol), BBr3 (1.6 mL, 1.6 mmol, 1.0 M in CH2Cl2) 
in dichloromethane (2 mL) for 4 h, according to general procedure, provided 41 mg (85%) 
of 4 as a brown solid. 
Rf = 0.31 (EtOAc/hexanes, 3:2); mp: 277-283 °C (Lit.
7 289-291 °C); IR (neat): 3304 (br), 
2921, 2628 (br), 1693, 1597, 1509, 1443, 1407, 1326, 1241, 1156, 1129, 1098, 1015, 964 
cm-1; 1H NMR (300 MHz, acetone-d6): δ 10.43 (br s, 1H, OH), 8.51 (s, 1H, OH), 8.36 (s, 
1H, OH), 8.24 (s, 1H, OH), 7.83 (d, 2H, J = 8.8 Hz, ArH), 7.47 (d, 1H, J = 2.0 Hz, ArH), 
7.09 (dd, 1H, J = 8.2, 2.0 Hz, ArH), 6.89 (d, 1H, J = 8.8 Hz, ArH), 6.87 (d, 1H, J = 8.2 Hz, 
ArH), 6.44 (s, 1H, ArCH=C); 13C NMR (75 MHz, CD3OD): δ 171.4 (C=O or C=COH), 
163.4 (C=O or C=COH), 158.0 (ArCipso), 148.2 (ArCipso), 146.7 (ArCipso), 141.8 (O-
C=CHAr), 130.3 (2 × ArC), 126.4 (ArCipso), 124.9 (ArC), 122.4 (ArCipso), 118.0 (ArC), 
116.5 (ArC), 116.1 (2 × ArC), 109.4 (ArCH=C), 102.5 (C=COH); HRMS (APPI, pos.): 
m/z 312.0628 (312.0634 calc. for C17H12O6, (M)
+) and  313.0704 (313.0712 calc. for 
C17H13O6, (M+H)
+). 
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(Z)-3-(2,2-Dimethylchroman-6-yl)-5-((2,2-dimethylchroman-6-yl)methylene)-4-
hydroxyfuran-2(5H)-one (5, Aspulvinone A):2,15 
 
The reaction of 85 (60 mg, 0.21 mmol), 2,2-dimethylchroman (134 mg, 0.830 
mmol), Rh2(esp)2 (1.6 mg, 2.1 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) at 50 °C for 
6 h according to Method B provided, after purification by flash column chromatography on 
silica gel (CH2Cl2/EtOAc, 9.8:0.2 to 9:1), 63 mg (60%) of 5 as a yellow solid.  
Rf = 0.12 (hexanes/EtOAc, 7:3); mp: 244-247 °C (Lit.
2 241-243 °C); IR (neat): 2973 (br), 
2928 (br), 1690, 1624, 1605, 1572, 1495, 1390, 1300, 1259, 1234, 1154, 1121, 947 cm-1; 
1H NMR (300 MHz, CDCl3/DMSO-d6, 95:5): δ 10.99 (br, 1H, OH), 7.70 (s, 1H, ArH), 7.68 
(dd, 1H, J = 8.6. 2.0 Hz, ArH), 7.56 (br d, 1H, J = 2.0 Hz, ArH), 7.48 (dd, 1H, J = 8.6. 2.0 
Hz, ArH), 6.79 (dd, 1H, J = 8.6. 2.0 Hz, ArH), 6.76 (d, 1H, J = 8.6 Hz, ArH), 6.47 (s, 1H, 
ArCH=C), 2.83 (br t, 2H, J = 6.7 Hz, ArCH2CH2), 2.82 (br t, 2H, J = 6.7 Hz, ArCH2CH2), 
1.83 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.82 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.35 (s, 6H, 2 × 
CH3), 1.34 (s, 6H, 2 × CH3); 
13C NMR (75 MHz, DMSO-d6): δ 168.1 (C=O or C=COH), 
162.0 (C=O or C=COH), 154.5 (ArCipso), 152.8 (ArCipso), 140.4 (O-C=CHAr), 131.6 
(ArC), 129.6 (ArC), 128.4 (ArC), 126.4 (ArC), 124.4 (ArCipso), 121.5 (ArCipso), 121.3 
359 
 
(ArCipso), 120.6 (ArCipso), 117.5 (ArC), 116.6 (ArC), 107.3 (O-C=CHAr), 99.7 (C=COH), 
74.9 (Ar-O-C(CH3)2), 74.3 (Ar-O-C(CH3)2), 32.1 (ArCH2CH2), 31.9 (ArCH2CH2), 26.6 (4 
× CH3), 22.0 (ArCH2CH2), 21.8 (ArCH2CH2); HRMS (APPI, pos.): m/z 432.1921 
(432.1937 calc for C27H28O5 (M)
+) and 433.1993 (433.2015 calc for C27H29O5 (M+H)
+). 
(Z)-5-((2,2-Dimethylchroman-6-yl)methylene)-4-hydroxy-3-(7-methoxy-2,2-
dimethylchroman-6-yl)furan-2(5H)-one (95): 
 
The reaction of 85 (60 mg, 0.20 mmol), 7-methoxy-2,2-dimethylchroman (94) (155 
mg, 0.800 mmol), Rh2(esp)2 (1.30 mg, 2.01 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) 
at 50 °C for 2 h according to Method B provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 9:1 to 8.5:1.5), 79 mg (85%) of 95 as a 
yellow solid.  
Rf = 0.26 (hexanes/EtOAc, 9.5:0.5); mp: 200-204 °C; IR (neat): 3277 (br), 2976, 2933 (br), 
2848, 1742, 1605, 1578, 1492, 1451, 1309, 1260, 1151, 1117, 1089, 1017, 976, 945 cm-1; 
1H NMR (300 MHz, CDCl3): δ 8.98 (s, 1H, OH), 7.78 (s, 1H, ArH), 7.60 (br d, 1H, J = 1.8 
Hz, ArH), 7.51 (dd, 1H, J = 8.5, 1.8 Hz, ArH), 6.79 (d, 1H, J = 8.5 Hz, ArH), 6.49 (s, 1H, 
ArH), 6.27 (s, 1H, ArCH=C), 3.96 (s, 3H, OCH3), 2.82 (t, 2H, J = 6.7 Hz, ArCH2CH2), 
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2.80 (t, 2H, J = 6.7 Hz, ArCH2CH2) (overlapping triplets), 1.83 (t, 2H, J = 6.7 Hz, 
ArCH2CH2), 1.82 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.35 (s, 12H, 4 × CH3); 
13C NMR (75 
MHz, CDCl3): δ 168.8 (C=O or C=COH), 161.3 (C=O or C=COH), 155.0 (ArCipso), 154.9 
(ArCipso), 154.2 (ArCipso), 139.9 (O-C=CHAr), 131.9 (ArC), 130.5 (ArC), 130.2 (ArC), 
124.8 (ArCipso), 121.3 (ArCipso), 117.7 (ArC), 115.5 (ArCipso), 110.7 (ArCipso), 107.8 (ArC), 
101.6 (ArCH=C), 99.0 (C=COH), 75.2 (Ar-O-C(CH3)2), 75.0 (Ar-O-C(CH3)2), 57.3 
(OCH3), 32.8 (ArCH2CH2), 32.7 (ArCH2CH2), 26.94 (2 × CH3), 26.86 (2 × CH3), 22.5 
(ArCH2CH2), 21.8 (ArCH2CH2); HRMS (APPI, pos.): m/z 462.2042 (462.2042 calc. for 
C28H30O6, (M)
+) and 463.2114 (463.2121 calc. for C28H31O6, (M+H)
+). 
(Z)-5-((2,2-Dimethylchroman-6-yl)methylene)-4-hydroxy-3-(7-hydroxy-2,2-
dimethylchroman-6-yl)furan-2(5H)-one (6, Aspulvinone C):15,16 
 
To a solution of compound 95 (50 mg, 0.11 mmol) in CH2Cl2 (2 mL) was added 
BBr3 (0.32 mL, 0.32 mmol, 1.0 M in CH2Cl2) at -78 °C and the mixture was stirred for 40 
min. The reaction mixture was then warmed to 0 °C and stirred for 20 min. Water (2 mL) 
was added. The resulting mixture was extracted with ethyl acetate (3 x 4 mL) and the 
combined organic layers were dried (Na2SO4) and concentrated. The residue was dissolved 
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in dichloromethane (3 mL), a few drops of hexanes were added, and the mixture was 
allowed to stand at room temperature for 22 h to provide 36 mg (75%) of 6 (Aspulvinone 
C) as a yellow solid that was isolated by filtration. This was pure by 1H NMR.  
Rf = 0.61 (EtOAc/hexanes, 7:3); mp: 224-230 °C; IR (neat): 3065 (br), 2973, 2924 (br), 
1709, 1602, 1494, 1428, 1343, 1284, 1263, 1229, 1154, 1109, 1088 cm-1; 1H NMR (300 
MHz, DMSO-d6): δ 7.50 (s, 1H, ArH), 7.48 (dd, 1H, J = 8.9, 2.1 Hz, ArH), 7.11 (s, 1H, 
ArH), 6.77 (d, 1H, J = 8.9 Hz, ArH), 6.28 (s, 1H, ArH or ArCH=C), 6.24 (s, 1H, ArH or 
ArCH=C), 2.78 (t, 2H, J = 6.6 Hz, ArCH2CH2), 2.64 (t, 2H, J = 6.6 Hz, ArCH2CH2), 1.79 
(t, 2H, J = 6.6 Hz, ArCH2CH2), 1.73 (t, 2H, J = 6.6 Hz, ArCH2CH2), 1.30 (s, 6H, 2 × CH3), 
1.27 (s, 6H, 2 × CH3); 
13C NMR (75 MHz, DMSO-d6): δ 168.6 (C=O or C=COH), 163.6 
(C=O or C=COH), 154.20 (ArCipso), 154.19 (ArCipso), 154.1 (ArCipso), 141.3 (O-C=CHAr), 
131.4 (ArC), 130.6 (ArC), 129.4 (ArC), 124.7 (ArCipso), 121.3 (ArCipso), 117.3 (ArC), 111.5 
(ArCipso), 108.8 (ArCipso), 105.5 (ArC or ArCH=C), 103.4 (ArC or ArCH=C), 97.9 
(C=COH), 74.8 (Ar-O-C(CH3)2), 74.1 (Ar-O-C(CH3)2), 32.4 (ArCH2CH2), 32.0 
(ArCH2CH2), 26.62 (2 × CH3), 26.59 (2 × CH3), 21.8 (ArCH2CH2), 21.2 (ArCH2CH2); 
HRMS (ESI, pos.): m/z 448.1866 (448.1886 calc for C27H28O6 (M)
+) and 471.1755 
(471.1784 calc for C27H28NaO6 (M+Na)
+). 
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(Z)-5-(4-((tert-Butyldimethylsilyl)oxy)-3-(3-methylbut-2-en-1-yl)benzylidene)-4-
hydroxy-3-(7-methoxy-2,2-dimethylchroman-6-yl)furan-2(5H)-one (97): 
 
The reaction of 86 (100 mg, 0.240 mmol), 7-methoxy-2,2-dimethylchroman (94) 
(186 mg, 0.970 mmol), Rh2(esp)2 (1.6 mg, 2.4 x 10
-3 mmol) in ,,-trifluorotoluene (2.5 
mL) at 50 °C for 4 h according to Method B provided, after purification by flash column 
chromatography on silica gel (hexanes/EtOAc, 9.5:0.5 to 9:1), 61 mg (44%) of 97 as a 
yellow solid.  
Rf = 0.29 (hexanes/EtOAc, 3:2); mp: 67-72 °C; IR (neat): 2953 (br), 2928 (br), 2855, 1749, 
1601, 1495, 1466, 1326, 1255, 1153, 1118, 1092 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.79 
(s, 1H, ArH), 7.66 (dd, 1H, J = 8.4, 2.3 Hz, ArH), 7.47 (d, 1H, J = 2.3 Hz, ArH), 6.81 (d, 
1H, J = 8.4 Hz, ArH), 6.49 (s, 1H, ArH or ArCH=C), 6.28 (s, 1H, ArH or ArCH=C), 5.32-
5.26 (m, 1H, (CH3)2C=CH), 3.95 (s, 3H, OCH3), 3.32 (d, 1H, J = 7.1 Hz, CH2CH=CH2), 
2.79 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.81 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.77 (d, 3H, J = 
1.3 Hz, CH3), 1.72 (s, 3H, CH3), 1.35 (s, 6H, 2 × CH3), 1.02 (s, 9H, C(CH3)3), 0.26 (s, 6H, 
Si(CH3)2); 
13C NMR (75 MHz, CDCl3): δ 168.7 (C=O or C=COH), 161.2 (C=O or 
C=COH), 154.9 (ArCipso), 154.3 (ArCipso), 154.2 (ArCipso), 140.3 (O-C=CHAr), 133.0 
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(ArCipso or (CH3)2C=C), 132.6 (ArCipso or (CH3)2C=C), 132.3 (ArC), 130.5 (ArC), 129.3 
(ArC), 126.1 (ArCipso or (CH3)2C=C), 122.3 (ArC or (CH3)2C=CH), 118.8 (ArC or 
(CH3)2C=CH), 115.5 (ArCipso), 110.7 (ArCipso), 107.8 (ArC or Ar-CH), 101.7 (ArC or 
ArCH=C), 99.2 (C=COH), 75.2 (Ar-O-C(CH3)2), 57.3 (OCH3), 32.8 (CH2), 28.5 (CH2), 
26.9 (O-C(CH3)2), 25.8 (Si-C(CH3)3 and 1 × C=C(CH3)2), 21.8 (CH2), 18.3 (Si-C(CH3)3), 
17.9 (1 × C=C(CH3)2), 4.1 (Si(CH3)2); HRMS (APPI, pos.): m/z 576.2897 (576.2907 calc. 
for C34H44O6Si, (M)
+) and 577.2969 (577.2985 calc. for C34H45O6Si, (M+H)
+).  
3-(2,2-Dimethylchroman-6-yl)-4-hydroxyfuran-2(5H)-one (102): 
 
The reaction of 72 (100 mg, 0.790 mmol), 2,2-dimethylchroman (515 mg, 3.17 
mmol), Rh2(esp)2 (6.0 mg, 7.9 × 10
-3 mmol) in ,,-trifluorotoluene (2 mL) at 50 °C for 
5 h according to Method B provided, after purification of the crude product by trituration 
with hexanes/dichloromethane (8:2), 157mg (76%) of 102 as a white solid.  
Rf = 0.11 (hexanes/EtOAc, 3:2); mp: 213-217 °C; IR (neat): 2974, 2930, 2583 (br), 1696, 
1585, 1498, 1438, 1381, 1346, 1327, 1261, 1219, 1154, 1122, 1064, 1024, 946 cm-1; 1H 
NMR (300 MHz, DMSO-d6): δ 12.49 (br s, 1H, OH), 7.63 (br d, 1H, J = 2.1 Hz, ArH), 7.60 
(br dd, 1H, J = 8.3, 2.1 Hz, ArH), 6.70 (d, 1H, J = 8.3 Hz, ArH), 4.73 (s, 2H, OCH2), 2.73 
(t, 2H, J = 6.7 Hz, ArCH2CH2), 1.76 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.27 (s, 6H, 2× CH3); 
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13C NMR (75 MHz, DMSO-d6): δ 173.1 (C=O or C=COH), 172.9 (C=O or C=COH), 152.1 
(ArCipso), 127.5 (ArC), 125.6 (ArC), 121.8 (ArCipso), 120.3 (ArCipso), 116.3 (ArC), 97.4 
(C=COH), 74.1 (Ar-O-C(CH3)2), 65.9 (OCH2), 32.2 (CH2), 26.6 (2 × CH3), 22.0 (CH2); 
HRMS (APPI, pos.): m/z 260.1052 (260.1049 calc. for C15H16O4, (M)
+)  
4-(2,2-Dimethylchroman-6-yl)-5-oxo-2,5-dihydrofuran-3-yl acetate (103): 
 
To a solution of tetronic acid 102 (150 mg, 0.580 mmol) in pyridine (2 mL) was 
added acetic anhydride (1 mL) over 5 min at room temperature and the mixture was stirred 
for 51 h. Water was added and the resulting mixture was extracted with dichloromethane 
(3 × 8 mL). The combined organic layers were dried (Na2SO4) and concentrated. The crude 
was purified by flash column chromatography on silica gel (hexanes/EtOAc, 3:1) to provide 
95 mg (55%) of 103 as a white solid. 
Rf = 0.21 (hexanes/EtOAc, 3:1); mp: 152-156 °C; IR (neat): 2977, 2934, 2847, 1787, 1732, 
1648, 1496, 1367, 1270, 1221, 1189, 1156, 1132, 1038, 1002, 981 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.63 (br d, 1H, J = 2.2 Hz, ArH), 7.51 (dd, 1H, J = 8.6, 2.2 Hz, ArH), 6.82 
(d, 1H, J = 8.6 Hz, ArH), 5.22 (s, 2H, OCH2), 2.82 (t, 2H, J = 6.7 Hz, ArCH2CH2), 2.36 (s, 
3H, COCH3), 1.82 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.35 (s, 6H, 2 × CH3); 
13C NMR (75 
MHz, CDCl3): δ 171.1 (C(O)O), 166.3 (C(O)O), 161.6 (ArCipso or CH3C(O)OC=C), 154.6 
(ArCipso or CH3C(O)OC=C), 129.4 (ArC), 127.4 (ArC), 121.0 (ArCipso), 119.1 (ArCipso), 
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117.4 (ArC), 110.6 (CH3C(O)OC=C), 74.8 (Ar-O-C(CH3)2), 67.3 (OCH2), 32.7 
(ArCH2CH2), 26.9 (2 × CH3), 22.5 (ArCH2CH2), 21.1 (COCH3); HRMS (ESI, pos.): m/z 
302.1155 (302.1154 calc. for C17H18O5, (M)
+) and 325.1047 (325.1052 calc. for 
C17H18NaO5, (M+Na)
+). 
(Z)-5-(Cyclopentylmethylene)-3-(2,2-dimethylchroman-6-yl)-4-hydroxyfuran-2(5H)-
one (105): 
  
The reaction of 83 (56 mg, 0.27 mmol), 2,2-dimethylchroman (93) (176 mg, 1.08 
mmol), Rh2(esp)2 (1.8 mg, 2.7 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) at 50 °C for 
22 h according to Method B provided, after purification by flash column chromatography 
on silica gel (hexanes/EtOAc, 9:1 to 7:3), 54 mg (58%) of 105 as a white solid. 
Rf = 0.21 (hexanes/EtOAc, 7:3); mp: 176-179 °C; IR (neat): 2942 (br), 2865 (br), 1697, 
1670, 1627, 1613, 1576, 1497, 1438, 1395, 1370, 1253, 1223, 1155, 1120, 1099, 1003 cm-
1; 1H NMR NMR (300 MHz, CDCl3/CD3OD, 95:5): δ 7.60 (br s, 1H, ArH), 7.57 (dd, 1H, 
J = 8.3, 2.2 Hz, ArH), 6.78 (d, 1H, J = 8.3, Hz, ArH), 5.56 (d, 1H, J = 9.7 Hz, C5H9CH=C), 
3.16-3.00 (m, 1H, CH2CHCH2), 2.81 (t, 2H, J = 6.7 Hz, ArCH2CH2), 2.02-1.87 (m, 2H, 
CH2), 1.81 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.77-1.56 (m, 4H, CH2), 1.48-1.24 (m, 2H, 
CH2), 1.34 (s, 6H, 2 × CH3); 
13C NMR (75 MHz, CDCl3/CD3OD, 95:5): δ 169.9 (C=O or 
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C=COH), 160.8 (C=O or C=COH), 153.4 (ArCipso), 142.9 (O-C=CHAr), 129.1 (ArC), 
127.2 (ArC), 121.2 (ArCipso), 121.0 (ArCipso), 117.1 (ArC or O-C=CHAr), 115.6 (ArC or 
O-C=CHAr), 102.6 (C=COH), 74.7 (Ar-O-C(CH3)2), 37.1 (CH(CH2)2), 33.7 (2 × CH2), 
32.9 (CH2), 26.9 (2 × CH3), 25.4 (2 × CH2), 22.5 (CH2); HRMS (APPI, pos.): m/z 340.1667 
(340.1675 calc. for C21H24O4, (M)
+) and 341.1739 (341.1753 calc. for C21H25O4, (M+H)
+). 
(Z)-3-(2,2-Dimethylchroman-6-yl)-4-hydroxy-5-(naphthalen-2-ylmethylene)furan-
2(5H)-one (106): 
 
The reaction of 84 (70 mg, 0.27 mmol), 2,2-dimethylchroman (93) (175 mg, 1.08 
mmol), Rh2(esp)2 (1.8 mg, 2.7 x 10
-3 mmol) in ,,-trifluorotoluene (2 mL) at 70 °C for 
5 h according to Method B provided, after purification by flash column chromatography on 
silica gel (hexanes/EtOAc, 4:1 to 1:1), 44 mg (42%) of 106 as a yellow solid.  
Rf = 0.15 (hexanes/EtOAc, 3:2); mp: 164-169 °C; IR (neat): 3053 (br), 2974 (br), 2929 (br) 
2849, 1695, 1621, 1495, 1386, 1314, 1267, 1222, 1156, 1118, 1020, 943 cm-1; 1H NMR 
(300 MHz, DMSO-d6): δ 8.20 (s, 1H, ArH), 8.04-7.88 (m, 4H, ArH), 7.70 (s, 1H, ArH), 
7.70-7.65 (br s, 1H, ArH), 7.60-7.57 (m, 2H, ArH), 6.83 (s, 1H, ArCH=C), 6.78 (d, 1H, J 
= 8.3 Hz, ArH), 2.78 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.79 (t, 2H, J = 6.7 Hz, ArCH2CH2), 
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1.30 (s, 6H, 2 × CH3); 
13C NMR (75 MHz, DMSO-d6): δ 168.1 (C=O or C=COH), 162.2 
(C=O or C=COH), 152.9 (ArCipso), 142.9 (O-C=CHAr), 133.0 (ArCipso), 132.6 (ArCipso), 
130.6 (ArCipso), 129.7 (ArC), 128.5 (2 × ArC), 128.3 (ArC), 127.6 (ArC), 127.0 (ArC), 
126.9 (ArC), 126.7 (ArC), 126.5 (ArC), 121.2 (ArCipso), 120.6 (ArCipso), 116.7 (ArC), 106.8 
(O-C=CHAr), 100.3 (C=COH), 74.4 (Ar-O-C(CH3)2), 32.1 (ArCH2CH2), 26.6 (2 × CH3), 
22.0 (ArCH2CH2); HRMS (APPI, pos.): m/z 398.1509 (398.1518 calc. for C26H22O4, (M)
+) 
and 399.1580 (399.1596 calc. for C26H23O4, (M+H)
+). 
(Z)-2-Benzylidene-5-oxo-4-phenyl-2,5-dihydrofuran-3-yl isobutyrate (107):5 
 
To a solution of pulvinone (1) (35 mg, 0.13 mmol) in dichloromethane (0.5 mL) 
were added DMAP (1.6 mg, 1.3 × 10-2 mmol) and diisopropylethylamine (25 µL, 0.15 
mmol) followed by isobutyryl chloride (15 µL, 0.15 mmol) at 0 °C. The mixture was then 
stirred at room temperature for 4 h. Water (2 mL) was added and the resulting mixture was 
extracted with dichloromethane (3 × 3 mL). The combined organic layers were dried 
(Na2SO4) and concentrated. The residue was purified by flash column chromatography on 
silica gel (hexanes/EtOAc, 95:5) to provide 36 mg (82%) of 107 as a yellow solid. 
Rf = 0.29 (hexanes/EtOAc, 9:1); mp: 125-129 °C (Lit.
5 128-129); IR (neat): 2972, 2929, 
1759, 1657, 1637, 1445, 1375, 1345, 1286, 1106, 1075, 1043, 966, 926 cm-1; 1H NMR (300 
MHz, CDCl3): δ 7.83-7.69 (m, 4H, ArH), 7.48-7.30 (m, 6H, ArH), 6.01 (s, 1H, PhCH=C), 
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2.94 (septet, 1H, J = 6.9 Hz, CH(CH3)2), 1.37 (d, 6H, J = 6.9 Hz, CH(CH3)2); 
13C NMR (75 
MHz, CDCl3): δ 172.0 (C(O)O), 166.7 (C(O)O), 155.0 (C=COC(O)CH(CH3)2), 142.2 (O-
C=CHAr), 132.4 (ArCipso), 130.9 (2 × ArC), 129.5 (2 × ArC), 129.0 (2 × ArC), 128.8 (2 × 
ArC), 128.2 (2 × ArC), 128.0 (ArCipso), 116.1 (PhC=COC(O)CH(CH3)2), 109.5 (PhCH=C), 
34.4 (CH(CH3)2), 18.9 (2 × CH3); HRMS (APPI, pos.): m/z 334.1205 (334.1205 calc. for 
C21H18O4 (M)
+) and 335.1282 (335.1283 calc. for C21H19O4, (M+H)
+). 
1H-1H correlation spectroscopy does not show interaction between (CH3)2CHC(O)O- and 
PhCH=C. 
2,2-Dimethylchromane-6-carbaldehyde (110)17 
 
To a suspension of 4-hydroxybenzaldehyde (2.00 g, 16.4 mmol) in petroleum ether 
(25 mL) was added orthophosphoric acid (1.70 mL, 32.8 mmol) followed by isoprene (3.28 
mL, 32.8 mmol) at 0 °C. The reaction mixture was then warmed to room temperature and 
stirred for 60 h. Cold water (25 mL) was added and the resulting mixture was extracted 
with ethyl acetate (3 × 20 mL). The combined organic layers were washed with saturated 
aqueous NaHCO3, brine, dried (Na2SO4) and concentrated under reduced pressure. The 
residue was purified by flash chromatography on silica gel (hexanes/EtOAc, 93:7) to 
provide 1.04 g (33%) of 2,2-dimethylchromane-6-carbaldehyde (110) as a brown liquid. 
Rf = 0.32 (hexanes/EtOAc, 4:1); IR (neat): 2976, 2920, 2828, 2796, 2737, 1672, 1606, 
1572, 1492, 1328, 1267, 1236, 1155, 1119, 1104, 948 cm-1; 1H NMR (300 MHz, CDCl3): 
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δ 9.83 (s, 1H, CHO), 7.65-7.59 (m, 2H, ArH), 6.86 (d, 1H, J = 8.9 Hz, ArH), 2.84 (t, 2H, J 
= 6.7 Hz, ArCH2CH2), 1.85 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.37 (s, 6H, 2 × CH3); 
13C 
NMR (75 MHz, CDCl3): δ 191.0 (CHO), 159.8 (ArCipso), 132.0 (ArC), 129.6 (ArC), 129.0 
(ArCipso), 121.4 (ArCipso), 117.9 (ArC), 75.9 (Ar-O-C(CH3)2), 32.4 (ArCH2CH2), 26.9 (2 × 
CH3), 22.2 (ArCH2CH2). 
2,2-Dimethylchromane (93):18 
 
To a solution of phenol (1.00 g, 10.6 mmol) in dichloroethane (25 mL) was added 
isoprene (1.60 mL, 15.9 mmol) followed by triflic acid (5.0 µL, 5.3 × 10-2 mmol) at room 
temperature and the mixture was stirred for 3 h. The mixture was then concentrated and the 
residue was directly purified by flash column chromatography on silica gel (hexanes) to 
provide 647 mg (38%) of 93 as a colorless liquid. 
Rf = 0.21 (hexanes/EtOAc, 9.5:0.5); IR (neat): 2974, 2927, 1582, 1489, 1452, 1368, 1305, 
1254, 1219, 1155, 1121, 947 cm-1; 1H NMR (300 MHz, CDCl3): δ 7.12-7.01 (m, 2H, ArH), 
6.82 (dd, 1H, J = 7.3, 1.2 Hz, ArH), 6.77 (br d, 1H, J = 8.4 Hz, ArH), 2.77 (t, 2H, J = 6.7 
Hz, ArCH2CH2), 1.80 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.33 (s, 6H, 2 × CH3); 
13C NMR (75 
MHz, CDCl3): δ 154.0 (ArCipso), 129.4 (ArC), 127.2 (ArC), 120.9 (ArCipso), 119.6 (ArC), 
117.2 (ArC), 74.1 (Ar-O-C(CH3)2), 32.8 (ArCH2CH2), 26.9 (2 × CH3), 22.5 (ArCH2CH2). 
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7-Methoxy-2,2-dimethylchromane (94):19 
 
To a solution of prenyl alcohol (0.70 mL, 7.0 mmol) in chloroform (10 mL) was 
added 3-methoxyphenol (3.00 mL, 28.9 mmol) followed by iodine (530 mg, 2.09 mmol) at 
room temperature and the mixture was heated to reflux for 6 h, cooled to room temperature 
and then diluted with dichloromethane (25 mL). The resulting mixture was washed with 
aqueous Na2S2O3 (5%, 2 × 15 mL) and the organic layer was dried (Na2SO4) and 
concentrated. The residue was purified by flash column chromatography on silica gel 
(hexanes/EtOAc, 99:1) to provide 496 mg (37%) of 94 as a colorless liquid. 
Rf = 0.34 (hexanes/EtOAc, 9.5:0.5); IR (neat): 2974, 2934 (br), 2850, 1620, 1585, 1503, 
1467, 1441, 1269, 1246, 1199, 1149, 1119, 1092, 1037, 981 cm-1; 1H NMR (300 MHz, 
CDCl3): δ 6.94 (d, 1H, J = 8.3 Hz, ArH), 6.42 (dd, 1H, J = 8.3, 2.5 Hz, ArH), 6.34 (d, 1H, 
J = 2.5 Hz, ArH), 3.74 (s, 3H, OCH3), 2.70 (t, 2H, J = 6.7 Hz, ArCH2CH2), 1.78 (t, 2H, J 
= 6.7 Hz, ArCH2CH2), 1.33 (s, 6H, 2 × CH3); 
13C NMR (75 MHz, CDCl3): δ 159.1 (ArCipso), 
154.7 (ArCipso), 129.9 (ArC), 113.0 (ArCipso), 106.9 (ArC), 101.7 (ArC), 74.3 (Ar-O-
C(CH3)2), 55.2 (OCH3), 33.0 (ArCH2CH2), 26.8 (2 × CH3), 21.7 (ArCH2CH2). 
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4-((tert-Butyldimethylsilyl)oxy)-3-(3-methylbut-2-en-1-yl)benzaldehyde (109):20 
 
To a solution of 4-hydroxybenzaldehyde (3.20 g, 26.5 mmol) in 10% aqueous 
potassium hydroxide (15 mL) was added prenyl bromide (5.50 mL, 47.6 mmol) dropwise 
over 10 min at room temperature and the mixture was stirred for 45 h. The reaction mixture 
was then cooled to 0 °C and acidified to pH~3 with 2 N HCl. The resulting suspension was 
extracted with dichloromethane (3 × 30 mL). The combined organic layers were washed 
with brine, dried (Na2SO4) and concentrated under reduced pressure. The residue was 
purified by flash chromatography on silica gel (hexanes/EtOAc, 9:1) to provide, 1.04 g 
(21%) of 4-hydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde (108) as a pale-yellow liquid. 
To a solution of 4-hydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde (108) (500 mg, 
2.63 mmol) in DMF (10 mL) was added imidazole (250 mg, 3.67 mmol) followed by 
TBSCl (515 mg, 3.42 mmol) at room temperature and the mixture was stirred for 7 h. Cold 
water (8 mL) was added and the resulting mixture was extracted with dichloromethane (3 
× 20 mL). The combined organic layers were washed with water (1 × 10 mL), brine, dried 
(Na2SO4) and concentrated under reduced pressure. The residue was purified by flash 
chromatography on silica gel (hexanes/EtOAc, 98:2) to provide 641 mg (80%) of 109 as a 
colorless liquid. 
Rf = 0.33 (hexanes/EtOAc, 9.5:0.5); IR (neat): 2956, 2930, 2858, 1693, 1598, 1493, 1256, 
1110, 1093 cm-1; 1H NMR (300 MHz, CDCl3): δ 9.85 (s, 1H, CO), 7.67 (d, 1H, J = 2.1 Hz, 
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ArH), 7.62 (dd, 1H, J = 8.2, 2.1 Hz, ArH), 6.88 (d, 1H, J = 8.2 Hz, ArH), 5.36-5.27 (m, 1H,  
C=CH), 3.34 (d, 1H, J = 7.5 Hz, CH2CH=C), 1.77 (br d, 3H, J = 0.9 Hz, CH3), 1.70 (s, 3H, 
CH3), 1.03 (s, 9H,C(CH3)3), 0.29 (s, 6H, Si(CH3)2); 
13C NMR (75 MHz, CDCl3): δ 191.2 
(CHO), 159.3 (ArCipso), 133.6 (ArCipso or C=C(CH3)2), 133.3 (ArCipso or C=C(CH3)2), 
131.4 (ArC), 130.2 (ArCipso or C=C(CH3)2), 129.6 (ArC), 121.5 (ArC or HC=C(CH3)2), 
118.4 (ArC and HC=C(CH3)2, or 2 × ArC), 28.4 (CH2), 25.8 (CH3), 25.7 (SiC(CH3)3), 18.3 
(SiC(CH3)3), 17.9 (CH3), -4.1 (Si(CH3)2). 
4-(Benzyloxy)-3-(3-methylbut-2-en-1-yl)benzaldehyde (101): 
 
To a solution of 4-hydroxy-3-(3-methylbut-2-en-1-yl)benzaldehyde (108) (85 mg, 
0.45 mmol) in DMF (1 mL) was added K2CO3 (74 mg, 0.54 mmol) followed by BnBr (64 
µL, 0.54 mmol) at room temperature and the mixture was stirred for 5 h. Cold water (2 mL) 
was added and the resulting mixture was extracted with dichloromethane (3 × 4 mL). The 
combined organic layers were washed with water (1 × 4 mL), brine, dried (Na2SO4) and 
concentrated under reduced pressure. The residue was purified by flash chromatography on 
silica gel (hexanes/EtOAc, 95:5) to provide 101 mg (81%) of 101 as colorless liquid. 
Rf = 0.32 (hexanes/EtOAc, 9:1); IR (neat): 2968, 2913, 2730, 1684, 1597, 1496, 1453, 
1435, 1250, 1112, 1005 cm-1; 1H NMR (500 MHz, CDCl3): δ 9.86 (s, 1H, CHO), 7.70 (s, 
1H, ArH), 7.69 (dd (partial overlap with s at 7.70), 1H, J = 8.2, 2.2 Hz, ArH), 7.45-7.38 
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(m, 4H, ArH), 7.37-7.32 (m, 1H, ArH) 6.99 (d, 1H, J = 8.2 Hz, ArH), 5.34-5.29 (m 1H, 
C=CH), 5.18 (s, 2H, PhCH2), 3.41 (d, 1H, J = 7.3 Hz, CH2CH=), 1.75 (br s, 3H, CH3), 1.65 
(s, 3H, CH3); 
13C NMR (75 MHz, CDCl3): δ 191.3 (CHO), 161.6 (ArCipso), 136.4 (ArCipso), 
133.6 (ArCipso), 131.5 (ArCipso or C=C(CH3)2), 130.65 (ArC), 130.63 (ArC), 129.9 (ArCipso 
or C=C(CH3)2), 128.8 (2 × ArC), 128.2 (ArC), 127.3 (2 × ArC), 121.5 (HC=C(CH3)2), 
111.3 (ArC), 70.3 (PhCH2), 28.7 (H2CHC=C), 25.9 (CH3), 17.9 (CH3); HRMS (ESI, pos.): 
m/z 280.1467 (280.1463 calc. for C19H20O2, (M)
+), 281.1535 (281.1542 calc. for C19H21O2, 
(M+H)+) and 303.1356 (303.1361 calc. for C19H20NaO2, (M+Na)
+). 
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4.8 Selected 1H NMR and 13C NMR Spectra 
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Chapter 5 
 
 
 
 
Synthesis of ()-(R,R)-L-factor Involving an Organocatalytic Direct 
Vinylogous Aldol Reaction 
 
 
 
 
 
 
 
The work described in this chapter has been published in Synlett: 
Cooze, C.; Manchoju, A.; Pansare, S. V. Synlett, 2017, 28, 2928 (invited paper). 
The synthesis of ()-(R,R)-L-factor and a portion of the catalyst survey were carried out 
by A. Manchoju. 
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5.1 Introduction 
The 5-hydroxyalkyl-2(5H)furanone (-butenolide) and 5-hydroxyalkyl-
2(3H)furanone (-butanolide) motif is a characteristic structural element in several natural 
products of polyketide origin. Prominent examples of this family are (−)-muricatacin (1),1 
(−)-isocladospolide B (2),2 (S,S)-L-factor (3) and (S,R)-L-factor (4),3 and (−)-botryolide E 
(5,4 Figure 5.1) to name but only a few. In particular, muricatacin (1) has attracted 
considerable attention for its cyctotoxic activity1 and its utility as a starting material for 
accessing more complex acetogenins such as (+)-squamotacin,5 (+)-muconin,6 (+)-cis-
solamin A,7 (+)-cis-solamin B7 and (+)-reticulatacin.7 The enantioselective synthesis of 
muricatacin has therefore been intensely investigated and several approaches to either 
enantiomer of muricatacin are reported.8a-g The synthesis of L-factors 3 and 4, and their 
enantiomers which influence leukaemomycin biosynthesis in certain strains of 
Streptomyces griseus,3 has also been actively investigated.9 
 
Figure 5.1 Selected -butenolide- and -butanolide-based natural products 
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5.2 Previous synthetic approaches to the L-factors 
5.2.1 The Kotsuki synthesis of (4S,5S)-L-factor 
In 1990, Kotsuki and coworkers9c developed an enantiospecific route to (4S,5S)-
L-factor (3) from D-tartrate using copper(I)-catalyzed alkylation reactions (Scheme 5.1). 
The synthetic approach follows compound 6 derived from D-tartrate, which was treated 
with p-TsCl to give 7, which was then converted into intermediate 8 in two ways. The 
first approach is a one-pot synthesis (approach 1, Scheme 5.1); the primary alcohol of 7 
was treated with the triflic anhydride (Tf2O) to give the tosyl-triflate which was allylated 
in situ with allylmagnesium bromide/CuBr. Subsequently, the addition of lithium di-n-
butylcuprate resulted in a second alkylation by displacement of the tosyl group, to provide 
8. On the other hand (approach 2, Scheme 5.1), 7 was first alkylated with lithium di-n-
butylcuprate to provide 9. Activation of 9, by conversion to the triflate 10, followed by 
copper(I)-catalyzed allylation provided 8.  
 
Scheme 5.1 
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 The intermediate 8 was subjected to ozonolysis followed by dimethyl sulfide 
reduction to furnish the aldehyde 11 which was converted to (4S,5S)-L-factor (3) by 
Ag2O oxidation, acetonide deprotection and in situ lactonization.  
5.2.2 The Gallos synthesis of (+)-(4S,5R)-L-factor 
In 2009, Gallos and coworkers9b reported the synthesis of (+)-(4S,5R)-L-factor (4) 
from L-erythrose by employing Wittig olefination and catalytic hydrogenation as the key 
steps (Scheme 5.2). Lactol 12, derived from L-erythrose, was subjected to Wittig 
olefination to give 13 as a mixture of E and Z alkenes. Compound 13 was transformed 
into the ester 14 in three steps which are, in sequence, Swern oxidation, a second Wittig 
olefination and catalytic reduction of the double bonds. Ester 14 was then subjected to 
acetonide deprotection and lactonization in the presence of PTSA to afford the 
enantiomerically pure natural product, (+)-(4S,5R)-L-factor (4) (Scheme 5.2). 
 
Scheme 5.2 
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5.2.3 The Bhaumik synthesis of ()-(4R,5R)-L-factor (ent-3) 
In 2014, Bhaumik and coworkers8c reported a chiron approach to the synthesis of 
()-(4R,5R)-L-factor (ent-3) from D-mannitol (15, Scheme 5.3). Protection of D-mannitol 
as the tris-acetonide 15 followed by selective hydrolysis of a terminal acetonide provided 
the glycol 16. Oxidative cleavage of the vicinal diol in 16 followed by a Horner–
Wadsworth–Emmons reaction of the resulting aldehyde provided the ,-unsaturated 
ester 17. Selective hydrolysis of the terminal acetonide of 17 in the presence CuCl2 and 
subsequent hydrogenation gave the diol 18. A periodate cleavage of 18 followed by 
Wittig olefination furnished alkene 19 as an E/Z mixture. Subsequent hydrogenation of 
19 followed by acidification with concentrated HCl provided (4R,5R)-L-factor (ent-3). 
 
 
Scheme 5.3 
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5.2.4 The Raji Reddy synthesis of (4R,5R)-L-factor (ent-3) 
In 2015, Raji Reddy and coworkers8b reported the asymmetric synthesis of 
(4R,5R)-L-factor (ent-3) from iodo ester 20 involving Sonogashira cross-coupling and 
Sharpless asymmetric dihydroxylation as the key reactions (Scheme 5.4). Iodoalkene 20 
was coupled with 1-pentyne to provide ester 21, which was then subjected to Sharpless 
asymmetric dihydroxylation followed by in situ lactonization to give lactone 22. 
Hydrogenation of 22 furnished (4R,5R)-L-factor (ent-3). 
 
Scheme 5.4 
5.2.5 The Fernandes synthesis of (4R,5R)-L-factor (ent-3) 
In 2016, Fernandes and coworkers8a reported a seven-step synthesis of (4R,5R)-L-
factor (ent-3) from D-glucono--lactone (23) by employing cross-metathesis and Wittig 
olefination reactions as the key steps (Scheme 5.5). DIBAL-H reduction of -vinyl--
lactone 24, obtained from D-glucono--lactone (23), followed by protection of the 
resulting triol as an acetonide gave 25. Cross-metathesis of 25 with ethyl acrylate 
provided E-26 which was converted into 27 by IBX oxidation of the alcohol and 
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subsequent Wittig olefination. Compound 27 was then transformed into (4R,5R)-L-factor 
(ent-3) employing a one pot procedure which involves hydrogenation of double bonds in 
27, deprotection of the acetonide and in situ lactonization of the resulting -hydroxy ester. 
 
Scheme 5.5 
5.2.6 The Sabitha synthesis of (4S,5S)-L-factor (3) 
In 2016, Sabitha and coworkers9a reported the synthesis of (4S,5S)-L-factor (3) 
from the commercially available, inexpensive starting material D-mannitol (15, Scheme 
5.6). Diol 28 was synthesized from D-mannitol (15) in 7 steps. The compound 28 was 
converted to 30 by protection of the primary alcohol as a benzoate, Mitsunobu inversion 
of the secondary alcohol and ester hydrolysis. Oxidation of 30 with 2,2,6,6-
tetramethylpiperidine-1-oxyl (TEMPO) provided lactone 31, which was further 
transformed into 33 by silyl ether deprotection to provide 32 followed by a Sonogashira 
cross-coupling of 32 with trans-1-bromo-1-propene. Hydrogenation of 33 furnished 
(4S,5S)-L-factor (3). 
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Scheme 5.6 
5.3 Objective 
A unifying theme for all of the known syntheses of L-factor is the stereoselective 
assembly of the two contiguous stereocenters, one on the lactone ring and the other in the 
alkyl side chain. Notably, despite the relative structural simplicity offered by L-factor, all 
of the reported strategies are synthetically intensive and require numerous steps (Schemes 
5.1-5.6); the shortest synthesis involves five steps (Scheme 5.2)9b while the longest 
requires fourteen steps (Scheme 5.6).9a In addition, none of these syntheses involve 
stereoselective carbon-carbon bond forming reactions. Instead, they rely either on a chiral 
starting material8a,c,9a-c or an asymmetric carbon-oxygen bond formation for setting the 
key stereocenters in the target.8b 
Our approach to L-factor (ent-3) and other 5-hydroxyalkyl-2(5H)furanone derived 
natural products stems from our interest in the organocatalytic direct vinylogous aldol 
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(ODVA) reaction of -crotonolactones. Previous studies10 on this reaction have 
established protocols that provide good stereoselectivity with aromatic aldehydes. The 
complementary version involving aliphatic aldehydes has been only briefly examined in 
these studies. In addition, in the context of L-factor syntheses, the more conventional 
aldol variants such as the metal-catalyzed vinylogous Mukaiyama aldol reaction of         
2-trialkylsiloxyfuran11a and the use of crotonolactone metal enolates11b are also less 
explored. We therefore chose to examine the metal-free vinylogous aldol reaction of       
-crotonolactone with hexanal as the key step in our synthesis of and L-factor (ent-3) 
respectively. 
Retrosynthetically, the vinylogous aldol approach would potentially provide 
access to muricatacin (1) and L-factor (3) in only two steps from commercially available 
starting materials, (Figure 5.2), provided that the diastereoselectivity of the aldol reaction 
is in favour of the required syn aldol product. Even if the diastereoselectivity of the aldol 
reaction is moderate, conversion of the diastereomeric mixture to a diastereomerically 
pure syn aldol product via oxidation to the ketone and subsequent stereoselective 
reduction should be feasible. 
 
Figure 5.2 Organocatalytic direct vinylogous aldol route to 5-hydroxyalkyl butenolide 
and butanolide natural products. 
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5.4 Previous work on the direct vinylogous aldol reaction of -crotonolactone in the 
Pansare group 
 In 2011, the Pansare group developed a methodology for the organocatalytic, 
asymmetric direct vinylogous aldol reaction of -crotonolactone with aryl aldehydes, 
using chiral aminothioureas and squaramides as catalysts, to access substituted γ-
butenolides 35 (Scheme 5.7) with excellent enantioselectivities.10c The γ-butenolide 
derivatives are potential intermediates for the synthesis of several natural products and 
biologically active compounds.  
 
Scheme 5.7 
 The above methodology has been used for the synthesis of substance P receptor 
antagonists (+)-L-733,060 (37)10e and (+)-CP-99,994 (3810e, Scheme 5.8), which have 
been associated with a variety of biological effects including smooth muscle contraction, 
neurogenic inflammation and pain transmission. The methodology was also applied in the 
synthesis of 3-hydroxypipecolic acid (3910e, Scheme 5.8) which is a component of 
tetrazomine, an antitumor antibiotic. 
 
Scheme 5.8 
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5.5 Results and Discussion 
We initiated our synthesis of L-factor by examining the direct vinylogous aldol 
reaction of -crotonolactone and hexanal. Previous observations10 on a variant of this 
reaction employing aromatic aldehydes suggested that the use of bifunctional 
organocatalysts may be beneficial for the required transformation and hence selected 
aminosquaramides and aminothioureas were chosen as potential catalysts for the reaction 
(Figure 5.3). 
 
Figure 5.3 Aminosquaramide and aminothiourea catalysts selected for this study. 
 In simultaneous studies in the Pansare group,12 a catalyst and solvent survey was 
conducted for the direct vinylogous aldol reaction between -crotonolactone and 
tridecanal, which are starting materials for the synthesis of muricatacin. The optimized 
conditions obtained from this study were also used for the synthesis of L-factor. Details 
of the solvent and catalyst survey for the reaction of -crotonolactone and tridecanal are 
described below. 
In order to simplify the task of identifying the optimal reaction conditions, we first 
decided to identify a suitable solvent for the vinylogous aldol reaction by conducting the 
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reaction with (R, R)-aminosquaramide 40 and aminothiourea 47, both of which have a 
dimethylamino functionality, in a selection of solvents. These studies indicated that while 
dichloromethane was the solvent of choice for 40 (anti/syn = 3.3:1, 98% ee for anti 50, 
and 77% ee for syn 50, Table 5.1, entry 2), the optimal solvent for 47 (anti/syn = 1.5:1, 
57% ee for anti 50, and 64% ee for syn 50, Table 5.1, entry 9) was THF in terms of 
diastereoselectivity and enantioselectivity (a complete solvent survey was examined by C. 
Cooze in the Pansare group12).  
Table 5.1: Solvent survey for organocatalytic direct vinylogous aldol reaction of -
crotonolactone and tridecanal 
 
Entrya Cat. Solvent Yield (%) drb (anti:syn) ee (%) anti/syn 
1 
(R,R)-40 
EtOAc 5 3.0:1 97/86 
2 CH2Cl2 21 3.3:1 98/77 
3 THF 4 2.7:1 44/85 
4 toluene 6 3.2:1 96/60 
5 DMF < 2 - 66/81 
6 diethyl ether 6 3.9:1 90/71 
7 
47 
EtOAc 30 1.3:1 57/61 
8 CH2Cl2 38 1.2:1 34/28 
9 THF 38 1.5:1 57/64 
10 toluene 35 1.3:1 33/26 
11 DMF 16 1.2:1 64/74 
12 diethyl ether 37 1:1 15/3 
a
2 equiv. of crotonolactone. 
b1
H NMR of isolated products   
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With this information in hand, a study of the effect of catalyst structure on the aldol 
reaction in the optimal solvent (dichloromethane for the aminosquaramides 4044 and 
THF for the aminothioureas 4549) was undertaken. These results are summarized in 
Table 5.1. 
Table 5.2 Organocatalytic direct vinylogous aldol reaction of -crotonolactone and 
tridecanal 
 
Entry Cat.a Time (days) 50 (%)  dr (anti/syn) ee (%) anti/syn 
1 40 15 32 3.3/1 98/77 
2 41 13 8 3.4/1 41/61 
3b 42 12 29 2.1/1 81/73 
4 43 12 65 2.2/1 81/54 
5b 44 12 28 1.1/1 75/51 
6 45 13 25 2.4/1 99/26 
7b 46 11 6 1.6/1 84/80 
8 47 10 38 1.5/1 64/74 
9 48 13 22 2.0/1 81/69 
10b 49 11 3 1.3/1 78/58 
adichloromethane as the solvent for catalysts 4044, and THF for catalysts 4549. 
bwere carried out by Manchoju A. 
All of the selected catalyst candidates were capable of facilitating the vinylogous 
aldol reaction. Although the diastereoselectivity of the reaction was moderate (highest dr 
= 3.4:1, anti/syn), it may be noted that this reaction offers the shortest assembly of the 5-
hydroalkyl -butenolide motif. On the basis of our previous studies with aromatic 
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aldehydes,10c the absolute configuration at the lactone stereocenter in both diastereomers 
of 50 is assigned as R. Since our strategy for conversion of the mixture of diastereomers 
of 50 to the required syn diastereomer relied on an oxidation/reduction protocol, it was 
important that the syn diastereomer obtained from the aldol reaction is also of high 
enantiomeric excess. Hence, although catalysts 40 and 45 both provided the anti 
diastereomer of 50 with high ee, catalyst 40 was chosen for further studies since it not 
only offered slightly higher diastereoselectivity than 45, but also provided syn 50 with 
much higher ee compared to catalyst 45 (Table 5.2, entries 1 and 6).13 
5.5.1 Stereochemical model for the vinylogous aldol reaction of -crotonolactone 
with aliphatic aldehydes  
A plausible transition state has been proposed for the vinylogous aldol reaction of 
-crotonolactone with aliphatic aldehydes (Figure 5.4). The carbonyl group of the 
electrophile (aldehyde) is hydrogen bonded with the squaramide functionality and the 
deprotonated nucleophile is associated with the ammonium group in the catalyst by ionic 
interaction. Previous studies14 on the triethylamine-catalyzed reaction of -crotonolactone 
with aldehydes (used for the preparation of racemic products) has an intrinsic preference 
for the anti diastereomer (dr = ~2/1). The present results suggest that the hydrogen 
bonding functionality in the catalyst enhances this diastereoselectivity. 
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Figure 5.4 Proposed transition state for the ODVA reaction leading to the anti aldol 
product. 
Having established the conditions for the key aldol reaction, we proceeded to 
complete the synthesis of ()-L-factor. As with tridecanal, the aldol reaction of -
crotonolactone with hexanal in the presence of catalyst 40, gave the required aldol 
product 53 (Scheme 5.9, 30%, anti/syn = 3:1) with good enantiomeric excess for both 
diasteromers (98% ee for anti 53, and 89% ee for syn 53). Subsequent hydrogenation of 
53 gave 54 (96%, Scheme 5.9). Conversion of 54 to ()-L-factor (3) was achieved in two 
steps. Oxidation of 54 with DMP provided the ketone 55 (75%, Scheme 5.9). 
Diastereoselective reduction15 of 55 with K-Selectride®, presumably via the Felkin-Anh 
mode (56),16 gave ()-L-factor (3). Chiral HPLC analysis of 3 was difficult due to the 
absence of chromophore.  Hence, the enantiomeric excess of 3 was determined by HPLC 
analysis of the derived benzoate ester 57 (87%, 93% ee, Scheme 5.9). 
428 
 
 
Scheme 5.9 Synthesis of ()-L-factor (ent-3). 
5.6 Conclusion 
In conclusion, the shortest reported synthesis of ()-(R,R)-L-factor (ent-3) was 
developed using an organocatalytic direct vinylogous aldol reaction as the key step. These 
studies provide a point of reference for future studies on the organocatalytic direct 
vinylogous aldol reaction of -crotonolactone and unbranched aliphatic aldehydes. 
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5.7 Experimental section 
General: 
All commercially available reagents were used without purification. All reactions 
requiring anhydrous conditions were performed under an atmosphere of dry nitrogen 
using oven dried glassware. Dichloromethane and tetrahydrofuran were distilled from 
CaH2 and sodium/benzophenone respectively. Commercial precoated silica gel plates 
were used for TLC. All melting points are uncorrected. Silica gel for flash column 
chromatography was 230-400 mesh. IR spectra were recorded on a Bruker TENSOR 27 
FT-IR instrument. 1H NMR and 13C NMR spectra were recorded on a Bruker AVANCE 
III 300 or an AVANCE 500 instrument. Mass spectra were obtained on an Agilent 1100 
series LC/MSD (Trap) or an Agilent 6200 LC/MSD (TOF) chromatographic system.  
(5R)-5-(1-Hydroxyhexyl)furan-2(5H)-one (53): 
 
To a solution of 2(5H)-furanone (0.69 mL, 9.7 mmol) and the hexanal (0.59 mL, 
4.8 mmol) in dichloromethane (7mL) was added the (S,S)-aminosquaramide catalyst 40 
(533 mg, 0.966 mmol) at room temperature. The reaction mixture was stirred at room 
temperature for 15 days and the solvent was removed under reduced pressure. The crude 
product was purification by flash chromatography on silica gel (CH2Cl2/EtOAc, 9:1), 266 
mg (30%) of 53 as a colorless liquid (anti:syn = 3:1). 
Rf = 0.20 (CH2Cl2/EtOAc, 4:1); IR (neat): 3428 (br), 2954, 2929, 2859, 1740, 1163, 1101, 
1028, 819 cm-1; 1H NMR (300 MHz, CDCl3): Anti diastereomer (major): δ 7.54 (dd, 
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1H, J = 5.7, 1.5 Hz, COCH=CH), 6.19 (ddd, 1H, J = 5.7, 2.0, 0.1 Hz, COCH=CH), 4.96 
(dt, 1H, J = 4.7, 1.7 Hz, CH=CHCH), 3.92-3.82 (m, 1H, CHOH), 2.11 (d, 1H, J = 5.4 Hz, 
OH (D2O exchange)), 1.68-1.22 (m, 8H, CH2), 0.90 (t, 3H, J = 6.5 Hz, CH3); Visible 
resonances of syn diastereomer (minor): δ 7.46 (dd, 1H, J = 5.7, 1.5 Hz, COCH=CH), 
4.99 (dd, 1H, J = 3.2, 1.4 Hz, CH=CHCH), 3.80-3.71 (m, 1H, CHOH), 1.68-1.22 (m, 8H, 
CH2); 
13C NMR (75 MHz, CDCl3): Anti diastereomer (major):  173.1 (C(O)O), 153.6 
(COCH=CH), 122.8 (COCH=CH), 86.16 (CH=CHCH), 71.5 (CHOH), 33.1 (CH2), 31.6 
(CH2), 25.22 (CH2), 22.5 (CH2), 14.0 (CH3); Visible resonances of syn diastereomer 
(minor): δ 173.0 (C(O)O), 153.9 (COCH=CH), 122.7 (COCH=CH), 86.21 (CH=CHCH), 
71.8 (CHOH), 33.2 (CH2), 25.16 (CH2); HRMS (APPI, pos): 184.1091 (184.1099 calc for 
C10H16O3 (M)
+) and 185.1162 (185.1178 calc for C10H17O3 (M+H)
+); Chiralpak AS-H 
(hexanes/2-propanol 95:5, flow rate 1 mL min−1, 254 nm): t1 = 20.18 min (major anti), t2 
= 27.63 min, (major syn), t3 = 42.80 min (minor syn), t4 = 55.46 min (minor anti). ee: 
98% (anti); ee: 89% (syn). 
 
rac 5-(1-Hydroxyhexyl)furan-2(5H)-one (53): 
 
To a solution of hexanal (0.34 mL, 2.8 mmol) and 2-(triisopropylsilyloxy)furan 
(800 mg, 3.32 mmol) in THF (6 mL) was added Cu(OTf)2 (100 mg, 0.277 mmol) at 0 
oC. 
The reaction mixture was stirred at room temperature for 48 h. The mixture was then 
431 
 
concentrated, and the residue was purified by flash chromatography on silica gel 
(CH2Cl2/EtOAc, 9:1) 188 mg (36%) of racemic 53 (dr = 1.7:1) as a colorless liquid.  
 
(5R)-5-(1-Hydroxyhexyl)dihydrofuran-2(3H)-one (54): 
 
To a solution of the hydroxy -butenolide 53 (170 mg, 0.920 mmol) in methanol 
(5 mL) was added Pd/C (10%, 98 mg) and the mixture was stirred at room temperature 
under an atmosphere of hydrogen (balloon) overnight. After completion of the reaction 
(NMR of an aliquot) the mixture was filtered through a pad of Celite and the residue 
washed with methanol (2 × 20 mL). The combined filtrates were concentrated under 
reduced pressure to provide the product 165 mg (96%) of 54 as a colorless liquid 
(anti:syn = 3:1). The crude product was used in the next step without purification.  
Rf= 0.22 (CH2Cl2/EtOAc, 4:1); IR (neat): 3434 (br), 2954, 2930, 2859, 1759, 1460, 1185, 
1073 1054, 1024, 992, 927 cm-1; 1H NMR (300 MHz, CDCl3): Anti diasteromer 
(major): δ 4.44 (td, 1H, J = 7.3, 3.2 Hz, OCH), 3.97-3.90 (m, 1H, CHOH), 2.69-2.44 (m, 
2H, CH2), 2.35-2.05 (m, 2H, CH2), 2.05 (br s, 1H, OH), 1.60-1.21 (m, 8H, 4 × CH2), 0.90 
(t, 3H, J = 6.7 Hz, CH3); Visible resonances of syn diastereomer (minor): δ 3.62-3.53 
(m, 1H, CHOH), 2.69-2.44 (m, 2H, CH2), 2.32-2.05 (m, 2H, CH2), 1.60-1.21 (m, 8H, 2 × 
CH2); 
13C NMR (75 MHz, CDCl3) Anti diasteromer (major):  177.5 (C(O)O), 82.8 
(OCH), 71.4 (CHOH), 31.9 (CH2), 31.7 (CH2), 28.7 (CH2), 25.3 (CH2), 22.5 (CH2), 21.1 
(CH2), 14.0 (CH3); Visible resonances of syn diastereomer (minor): 177.2 (C(O)O), 
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83.0 (OCH), 73.7 (CHOH), 32.9 (CH2), 31.7 (CH2), 25.1 (CH2), 24.1 (CH2); HRMS 
(APPI, pos): 186.1250 (186.1256 calc for C10H18O3 (M)
+) and 187.1323 (187.1334 calc 
for C10H19O3 (M+H)
+). 
(R)-5-Hexanoyldihydrofuran-2(3H)-one (55): 
 
To a solution of the hydroxy -butanolide 54 (144 mg, 0.770 mmol) in 
dichloromethane (5 mL) was added Dess-Martin periodinane (657 mg, 1.54 mmol) at 
room temperature and the mixture was stirred for 1 h. Saturated NaHCO3 (5 mL) was 
added, the mixture was stirred for 5 min and then extracted with dichloromethane (3 × 10 
mL). The combined organic layers were dried (Na2SO4) and concentrated under reduced 
pressure. The crude product was purified by flash chromatography on silica gel 
(CH2Cl2/EtOAc, 97:3), 107 mg (75%) of 55 as a colorless liquid. 
Rf = 0.34 (CH2Cl2/EtOAc, 9:1); []D23 = –11.6 (c = 1.80, MeOH); IR (neat): 2956, 2932, 
2871, 1782, 1721, 1161, 1135, 1049 cm-1; 1H NMR (300 MHz, CDCl3): δ 4.87-4.80 (m, 
1H, OCH), 2.70-2.43 (m, 5H, CH2), 2.32-2.17 (m, 1H, CH2), 1.61 (quint, 2H, J = 7.3 Hz, 
CH2), 1.40-1.22 (m, 4H, CH2), 0.90 (t, 3H, J = 6.8 Hz, CH3); 
13C NMR (75 MHz, 
CDCl3):  207.7 (C=O), 176.1 (C(O)O), 81.8 (OCH), 38.8 (CH2), 31.2 (CH2), 27.4 (CH2), 
24.6 (CH2), 22.6 (CH2), 22.4 (CH2), 13.9 (CH3); HRMS (APPI, pos): 184.1095 (184.1099 
calc for C10H16O3 (M)
+) and 185.1166 (185.1178 calc for C10H17O3 (M+H)
+); HPLC: 
Chiralpak AD-H (hexanes/i-PrOH, 95:5, flow rate 1 mL min−1, λ = 254 nm): tmajor = 13.12 
min; tminor = 15.20 min; 97% ee. 
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rac 5-Hexanoyldihydrofuran-2(3H)-one (55): 
DMP oxidation of rac-54 provided racemic ketone 55. 
 
(R)-5-((R)-1-Hydroxyhexyl)dihydrofuran-2(3H)-one ((‒)-L-factor (ent-3)): 
 
To a solution of the ketone 55 (60 mg, 0.33 mmol) in dry THF (2 mL) was added 
K-Selectride (0.48 mL, 0.49 mmol, 1.0 M in THF) at –78 °C and the mixture was stirred 
for 1 h. Saturated NH4Cl (5 mL) was added at –78 °C and the mixture was warmed to 
room temperature. The mixture was then extracted with ethyl acetate (3 × 5 mL) and the 
combined extracts were dried (Na2SO4) and concentrated. The crude product was purified 
by flash chromatography on silica gel (CH2Cl2/EtOAc, 9:1), 48 mg (78%) of ent-3 as a 
white solid. 
Rf = 0.22 (CH2Cl2/EtOAc, 4:1); []D23 = –29.3 (c = 1.27, CHCl3); mp: 41-43 °C; lit.8a 
[α]D25 = –27.1 (c = 0.6, CHCl3), mp: 42-44 °C; lit.8b [α]D23 = –32.8 (c = 1.54, CHCl3), mp: 
45-48 °C; IR: 3450 (br), 2954, 2928, 2858, 1765, 1185, 1133, 1075, 1057, 1023, 992, 
929, 907 cm-1; 1H NMR (300 MHz, CDCl3) δ 4.42 (td, 1H, J = 7.3, 4.4 Hz, OCH), 3.62-
3.52 (br m 1H, CHOH), 2.69-2.46 (m, 2H, CH2), 2.32-2.01 (m, 3H, CH2, OH (D2O 
exchange)), 1.62-1.21 (m, 8H, CH2), 0.89 (t, 3H, J = 6.7 Hz, CH3); 
13C NMR (75 MHz, 
CDCl3):  177.3 (C(O)O), 83.0 (OCH), 73.6 (CHOH), 32.9 (CH2), 31.7 (CH2), 28.7 
(CH2), 25.1 (CH2), 24.1 (CH2), 22.5 (CH2), 14.0 (CH3); HRMS (APPI, pos): 186.1252 
(186.1256 calc for C10H18O3 (M)
+) and 187.1325 (187.1334 calc for C10H19O3 (M+H)
+). 
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(R)-1-((R)-5-Oxotetrahydrofuran-2-yl)hexyl benzoate (57): 
 
To a solution of L-factor (ent-3) (20 mg, 0.11 mmol) in dichloromethane (1 mL) 
were added triethylamine (30 µL, 0.22 mmol) and DMAP (4.0 mg, 3.2 × 10-2 mmol) 
followed by BzCl (25 µL, 0.22 mmol) at 0 °C. The reaction mixture was warmed to room 
temperature and stirred for 15 h. The solvent was removed under reduced pressure and 
the crude product was purified by flash chromatography on silica gel (CH2Cl2), 27 mg 
(87%) of 57 as a pale-yellow liquid. 
Rf = 0.29 (CH2Cl2); IR: 2955, 2929, 2860, 1776, 1716, 1452, 1266, 1175, 1108, 1068, 
1025, 917 cm-1; 1H NMR (300 MHz, CDCl3) δ 8.07-8.00 (m, 2H, ArH), 7.63-7.55 (m, 
1H, ArH), 7.51-7.42 (m, 2H, ArH), 5.28 (ddd, 1H, J = 8.1, 5.3, 2.6 Hz, BzOCH), 4.74 
(ddd, 1H, J = 8.1, 5.3, 2.6 Hz, OCH), 2.53-2.45 (m, 2H, CH2), 2.44-2.27 (m, 1H, CH2), 
2.12-1.98 (m, 1H, CH2), 1.94-1.72 (m, 2H, CH2), 1.46-1.20 (m, 6H, CH2), 0.87 (t, 3H, J = 
7.0 Hz, CH3); 
13C NMR (75 MHz, CDCl3):  176.9 (C(O)O), 166.0 (C(O)O), 133.4 
(ArC), 129.8 (2 × ArC), 129.5 (ArCipso), 128.6 (2 × ArC), 80.0 (OCH), 75.0 (BzOCH), 
31.5 (CH2), 30.8 (CH2), 28.1 (CH2), 24.9 (CH2), 24.0 (CH2), 22.4 (CH2), 13.9 (CH3); 
HRMS (APPI, pos): 290.1517 (290.1518 calc for C17H22O4 (M)
+) and 291.1590 
(291.1596 calc for C17H23O4 (M+H)
+); HPLC: Chiralcel OD-H (hexanes/i-PrOH, 97:3, 
flow rate 1 mL min−1, λ = 254 nm): tminor = 10.49 min; tmajor = 12.21 min; 93% ee. 
 
 
435 
 
5.8 References  
 
1. Rieser, M. J.; Kozlowski, J. F.; Wood, K. V.; McLaughlin, J. L. Tetrahedron Lett. 
1991, 32, 1137. 
2. (a) Smith, C. J.; Abbanat, D.; Bernon, V. S.; Maiese, W. M.; Greenstein, M.; Jompa, J.; 
Tahir, A.; Ireland, C. M. J. Nat. Prod. 2000, 63, 142. (b) Gesner, S.; Cohen, N.; Ilan, 
M.; Yarden, O.; Carmeli, S. J. Nat. Prod. 2005, 68, 1350. 
3 Grafe, U.; Reinhardt, G.; Schade, W.; Krebs, D.; Eritt, I.; Fleck, W. F.; Heinrich, E.; 
Radics, L. J. Antibiot. 1982, 609. 
4. Sy, A. A.; Swenson, D. C.; Gloer, J. B.; Wicklow, D. T. J. Nat. Prod. 2008, 71, 415. 
5. Sinha, S. C.; Sinha, S. C.; Keinan, E. J. Org. Chem. 1999, 64, 7067. 
6. Yoshimitsu, T.; Makino, T.; Nagaoka, H. J. Org. Chem. 2004, 69, 1993. 
7. Konno, H.; Makabe, H.; Hattori, Y.; Nosaka, K.; Akaji, K. Tetrahedron 2010, 66, 
7946. 
8 (a) Chaudhari, D. A.; Ingle, A. B.; Fernandes, R. A. Tetrahedron: Asymmetry 2016, 27, 
114. (b) Raji Reddy, C.; Suman, D.; Narsimha Rao, N. Helv. Chim. Acta 2015, 98, 
967. (c) Chatterjee, S.; Manna, A.; Bhaumik, T. Tetrahedron: Asymmetry 2014, 25, 
1624. (d) Doran, R.; Guiry, P. J. Synthesis 2014, 46, 761. (e) Dong, H.-B.; Yang, M.-
Y.; Liu, B.; Wang, M.-A. J. Asian Nat. Prod. Res. 2014, 16, 847. (f) Gonzalez, M.; 
Gandara, Z.; Martinez, A.; Gomez, G.; Fall, Y. Synthesis 2013, 45, 1693. (g) 
Gonzalez, M.; Gandara, Z.; Pazos, G.; Gomez, G.; Fall, Y. Synthesis 2013, 45, 625. (h) 
Fernandes, R. A.; Kattanguru, P. Asian J. Org. Chem. 2013, 2, 74. 
436 
 
 
9. Selected syntheses: (a) Nagi Reddy, K.S.; Sabitha,G.; Poornachandra, Y.; Kumar, G. 
C. RSC Adv., 2016, 6, 101501. (b) Totokotsopoulos, S. M.; Anagnostaki, E.E.; 
Stathakis, C.-I.; Yioti, E. G.; Hadjimichael, C. Z.; Gallos, J. K. ARKIVOC 2009, x, 
209. (c) Kotsuki, H.; Kadota, I.; Ochi, M. J. Org. Chem. 1990, 55, 4417. (d) Fujisawa, 
T.; Kojima, E.; Ito, T. Sato, T. Chem. Lett. 1985, 1751. (e) Larchevêque, M.; Lalande, 
J. J. Chem. Soc. Chem. Commun. 1985, 83. 
10. Organocatalytic vinylogous aldol reactions of unsubstituted -crotonolactone: (a) 
Sakai, T.; Hirashima, S.; Yamashita, Y.; Arai, R.; Nakashima, K.; Yoshida, A.; 
Koseki, Y.; Miura, T. J. Org. Chem. 2017, 82, 4661. (b) Claraz, A.; Oudeyer, S.; 
Levacher, V. Adv. Synth. Catal. 2013, 355, 841. (c) Pansare, S. V.; Paul, E. K. Chem. 
Commun. 2011, 47, 1027. (d) Yang, Y.; Zheng, K.; Zhao, J.; Shi, J.; Lin, L..; Liu, X.; 
Feng, X. J. Org. Chem. 2010, 75, 5382. (e) Pansare. S.V; Paul. E. K, Org. Biomol. 
Chem. 2012, 10, 2119. 
11. (a) Szlosek, M.; Franck, X.; Figadère, B.; Cave, A. J. Org. Chem. 1998, 63, 5169. (b) 
Bella, M.; Piancatelli, G.; Squarcia, A. Tetahedron 2001, 57, 4429 
12. Christopher Cooze in the Pansare group. Cooze, C. undergraduate thesis, Memorial 
University, 2016. 
13 The syn and anti diastereomers in 53 were assigned by comparison of the trend in 
chemical shift of their methine hydrogens with that in structurally related aldol 
products obtained from aromatic aldehydes (ref. 10c). These assignments were 
subsequently confirmed by the conversion of syn 53 to 3. 
437 
 
 
14. Eldho K. Paul in the Pansare group. Paul, E. K. Ph.D. Dissertation, Memorial 
University, 2013. 
15 Cavé, A.; Chaboche, C.; Figadère, B.; Harmange, J. C.; Laurens, A.; Peyrat, J. F.; 
Pichon, M.; Szlosek, M.; Cotte-Lafitte, J.; Quéro, A. M. Eur. J. Med. Chem. 1997, 
32, 617 
16. Anh, N. Y. Top. Curr. Chem., 1980, 88, 145. 
 
438 
 
 
 
 
 
 
 
 
 
 
 
5.9 Selected 1H NMR and 13C NMR Spectra 
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5.10 Selected HPLC traces 
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Chapter 6 
Conclusions  
6.1 Summary of the thesis 
An enantioselective synthesis of functionalized quaternary stereocenters was 
developed from chiral amino alcohol-derived (bromoalkylidene)morpholinones (7-10, 
Scheme 6.1). The stereoselective cross-coupling of the morpholinones (7-10) with 
arylboronic acids or alkyl trifluoroborates provided a variety of disubstituted 
alkylidenemorpholinones (11) in 64-96% yields as single diastereomers. A highly 
stereoselective Prins reaction of the cross-coupling products (11) generated spiro dioxanyl-
morpholinones (12, in 32-92% yields) bearing the target quaternary stereocenter. Prins 
adducts (12) are readily converted to a variety of enantiomerically enriched aldehydes, 
acyclic carboxylic acids (16-19), or their derivatives (15), all possessing a quaternary 
stereocenter. The compounds (15-19) can be used as starting materials for the synthesis of 
small organic molecules with quaternary stereocenters or they can be incorporated into 
more complex structures. The methyl ester of the hydroxy acid 18 (Scheme 6.1) prepared 
in this study is a key component for the total synthesis of (+)--cuparenone. The results of 
this work are described in Chapter 1. 
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Scheme 6.1 Synthesis of functionalized quaternary stereocenters 
In a separate approach, the enantioselective synthesis of functionalized quaternary 
centers-containing furan-2,4(3H,5H)-diones (23) and pyrrolidine-2,4-diones (24) has been 
investigated and details of the studies undertaken are described in Chapter 2. The approach 
relies on the conjugate addition of a variety of 3-alkyl/aryltetronic acids (20) and 3-
alkyl/aryltetramic acids (21) to a selection of α,β-unsaturated systems (22, Michael 
acceptors) using bifunctional, chiral catalysts such as aminothioureas and 
aminosquaramides. These reactions were feasible with the vast majority of chiral catalysts 
that were examined, and they provided the expected Michael adducts in good yields (up to 
96% for tetronic acids and up to 97% for tetramic acids, Scheme 6.2), but with low to 
moderate enantiomeric excess (up to 49% ee for tetronic acids and up to 27% ee for tetramic 
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acids). Further optimization of these reactions is required, and these studies are continuing 
in the Pansare group. The enantiomerically-enriched Michael adducts 23 are key 
intermediates for the asymmetric syntheses of natural products1 such as fraxinellonone, 
saudin, trisporic acids A-B and (+)-cassiol. 
 
Scheme 6.2 
A variety of 3-aryltetronic acids (26) were synthesized by employing an undirected, 
intermolecular C−H functionalization reaction of arenes with 3-diazofuran-2,4-dione (25) 
as the key step. This method was applied in the synthesis of a series of naturally occurring 
3-aryl-5-arylidene tetronic acids such as pulvinic acids and vulpinic acids (28-32). Salient 
features of the methodology include a highly stereoselective aldol condensation of 25 with 
-keto esters for installation of the C5 arylidene functionality and a single step introduction 
of the C3 aryl substituent. Chapter 3 of this thesis describes the details of this methodology 
and its applications. 
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Scheme 6.3 Synthesis of pulvinic acids and vulpinic acids 
An application of the above methodology in the synthesis of a variety of naturally 
occurring pulvinones 34-39 has also been investigated. This synthetic approach follows 
highly stereoselective aldol condensation of 25 with a variety of aliphatic or aromatic 
aldehydes under optimized conditions (TiCl4, 2,4,6-collidine) to provide (Z)-5-
arylidene/alkylidene-3-diazofuran-2,4(3H,5H)-diones 33 in excellent yields (12 examples, 
83% average yield, Scheme 6.4) as single diastereomers. Diones 33 are the immediate 
precursors of the required pulvinone natural products. The aryl substituents at C3, required 
in the targeted pulvinones, were installed by employing undirected, intermolecular C−H 
insertion reactions. Six naturally occurring pulvinones, 34-39 (Scheme 6.4), were 
synthesized using this strategy. Details of this study are described in Chapter 4. 
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Scheme 6.4 Synthesis of naturally-occurring pulvinones 
A concise, four step enantioselective synthesis of (4R,5R)-L-factor (43) was 
achieved by employing the organocatalytic direct vinylogous aldol reaction of -
crotonolactone with hexanal using aminosquaramide catalyst 40 (Scheme 6.5). This 
synthetic strategy follows the vinylogous direct aldol reaction of -crotonolactone with 
hexanal to provide 41 with excellent ee. Compound 41 was converted into (4R,5R)-L-factor 
(43) in three steps, namely, hydrogenation, DMP oxidation and a highly diastereoselctive 
K-selectride reduction of the ketone obtained by the DMP oxidation. Details of the 
synthesis are described in Chapter 5 of this thesis. 
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Scheme 6.4 Synthesis of ()-(4R, 5R)-L-factor 
In summary, the work described in this thesis has developed an enantioselective 
synthesis of functionalized quaternary stereocenters, a one-step synthesis of a variety of 3-
aryltetronic acids and natural (pulvinic acids and pulvinones) as well as non-naturally-
occurring tetronates from 3-diazofuran-2,4-dione, and also a short synthesis of L-factor. 
6.2 Future Work 
Functionalised furans are important building blocks in organic synthesis. Such 
furans 47, can be easily synthesized from diazo 1,3-dicarbonyl (44) and ,-unsaturated 
alcohol (45, Scheme 6.6). This reaction is expected to proceed through an initial OH 
insertion 2 reaction followed by an intramolecular conjugate addition to provide 
functionalized furans.  
 
Scheme 6.6 
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Furoindolines (50) and pyrroloindolines (51) are found as key structural units in a 
large number of indole alkaloids.3 These structural motifs can be potentially synthesized 
by metal-catalyzed 1,3 dipolar cycloadditions4 of diazo 1,3-dicarbonyl compounds (44) 
with various benzofurans (48) and indoles (49), respectively (Scheme 6.7). 
 
Scheme 6.7 
The importance of the enantiomerically enriched, functionalised quaternary 
stereocenters is mentioned in Chapters 1 and 2 of this thesis. One possible approach to 
functionalized quaternary stereocenters is shown in Scheme 6.8. The methodology relies 
on directed C-H insertion 5  reactions of an oxime derivative such as 52 with diazo 
compounds 25 or 53 to provide 54. Hydrolysis 6  of the oxime should provide 55. 
Intramolecular Michael addition reactions of these tetronic or tetramic acids 55 in the 
presence of chiral bifunctional catalysts can provide enantiomerically enriched quaternary 
stereocenter-containing furan-2,4-diones or pyrrolidine-2,4-diones 56 (Scheme 6.8). 
 
Scheme 6.8 
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